data_2gdy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gdy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.512 0.672 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -46.95 124.05 5.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.575 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 51.35 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.456 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' H ' HG11 ' A' ' 9' ' ' VAL . . . -167.11 97.66 0.66 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.497 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.1 124.37 10.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.678 2.252 . . . . 0.0 111.602 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -74.15 0.66 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.44 37.29 4.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.181 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.34 -62.64 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.055 0.542 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -45.87 90.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 0.0 110.207 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.09 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -44.18 97.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.209 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -63.76 -34.55 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.433 0.635 . . . . 0.0 110.193 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -67.09 -45.59 76.82 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.063 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.485 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.55 -40.5 62.61 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.586 0.553 . . . . 0.0 111.589 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -79.28 -24.74 42.72 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.925 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -87.89 -27.43 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.594 ' HH2' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -109.82 -38.18 5.44 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.238 -175.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.6 tm-20 52.89 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.863 0.865 . . . . 0.0 110.642 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -110.27 -9.18 14.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.457 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 66.03 -2.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.702 -176.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.1 -54.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.064 -0.398 . . . . 0.0 111.487 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -110.09 -6.48 27.88 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.51 HG22 ' C ' ' A' ' 28' ' ' GLY . 2.3 m 32.93 80.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.898 0.879 . . . . 0.0 112.987 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.49 60.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.586 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -145.4 -59.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.653 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 37' ' ' ASN . 12.8 mm -38.92 110.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.556 0.743 . . . . 0.0 112.149 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 35' ' ' LEU . . . -134.78 -143.09 4.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.708 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.18 15.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.648 0.379 . . . . 0.0 111.882 -175.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -165.83 39.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.24 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 12.0 t70 64.21 -142.42 0.28 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.683 0.614 . . . . 0.0 110.018 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.586 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 8.2 t-20 -127.55 47.85 2.32 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 44.06 -101.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.691 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.705 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -140.9 55.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.758 0.313 . . . . 0.0 110.733 177.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.5 pt20 -149.38 60.63 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.495 0.664 . . . . 0.0 110.956 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 tt -106.81 -20.22 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.112 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.49 ' HA2' ' HE1' ' A' ' 49' ' ' MET . . . -150.96 33.22 0.96 Allowed Glycine 0 C--O 1.229 -0.163 0 C-N-CA 119.825 -1.179 . . . . 0.0 113.29 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.07 -107.62 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.882 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 15.7 p-80 59.62 -51.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.015 1.726 . . . . 0.0 114.263 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 p -96.53 -65.65 0.95 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.605 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.6 OUTLIER -92.33 -12.74 31.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.245 177.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 44' ' ' HIS . 5.1 mmtp 49.75 63.32 2.22 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.452 0.47 . . . . 0.0 111.232 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.95 -9.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.882 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.605 ' HG2' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -54.7 -41.16 69.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 110.976 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.594 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -75.25 -33.02 61.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.709 ' HA ' HG21 ' A' ' 55' ' ' VAL . 41.4 t -62.41 -26.42 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.497 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.36 -20.8 15.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.795 0.331 . . . . 0.0 111.124 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 49' ' ' MET . . . -86.61 -43.47 12.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.941 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.684 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.23 -40.58 2.93 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.926 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 51' ' ' VAL . 39.7 t -67.43 -59.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.848 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 70.1 t60 -51.79 -27.35 12.01 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -172.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 57' ' ' ARG . 9.5 ptt180 -127.08 2.45 6.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 7.4 mt-10 -138.99 -26.48 0.84 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 12.6 m-85 -126.43 -21.47 4.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.992 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -68.41 -15.12 63.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.79 -32.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.91 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 2.7 tp10 -126.38 -84.99 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.889 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -138.73 131.65 15.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 -175.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -86.32 112.53 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.602 2.201 . . . . 0.0 111.816 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -75.69 -32.11 59.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HE3' HG11 ' A' ' 81' ' ' VAL . 21.0 mtmt 61.5 -138.79 0.51 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.875 ' HB ' HD22 ' A' ' 77' ' ' LEU . 2.4 m 55.46 21.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.975 . . . . 0.0 113.464 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.754 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -151.64 37.94 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.609 0.718 . . . . 0.0 111.697 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 7.5 p90 -153.8 -46.51 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.667 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.22 41.01 0.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.559 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.754 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.0 pm0 -153.06 138.65 11.75 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.298 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.0 Cg_endo -87.53 -42.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.15 2.567 . . . . 0.0 112.037 173.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.705 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 9.9 t 176.94 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.696 1.236 . . . . 0.0 109.609 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.636 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -121.51 163.04 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.96 24.35 0.13 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.836 0.827 . . . . 0.0 108.897 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.636 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -66.21 -21.6 66.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.003 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.875 HD22 ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.77 -34.83 75.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.453 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -83.5 -38.16 22.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.912 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.77 3.62 16.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.373 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -108.4 -56.48 2.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.058 0.456 . . . . 0.0 109.821 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.538 HG11 ' HE3' ' A' ' 66' ' ' LYS . 21.4 t -79.74 -11.72 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.655 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.05 21.61 13.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.781 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.139 174.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.581 ' HG2' ' O ' ' A' ' 7' ' ' GLN . 9.3 tt0 . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 122.41 1.1 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 58.5 t80 -57.73 115.6 2.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.475 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 8' ' ' TYR . 89.8 t 73.38 115.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.611 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.49 101.45 42.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.54 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 174.76 11.13 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.703 2.269 . . . . 0.0 112.459 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.71 -68.44 0.72 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -112.43 -100.37 0.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.4 -50.09 0.92 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.571 . . . . 0.0 109.664 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 19' ' ' LEU . 85.4 t -63.21 -39.53 85.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.976 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -64.15 -37.97 89.37 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.515 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.4 73.25 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.49 -44.8 93.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.472 HD11 HG11 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -62.35 -44.27 96.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.977 -178.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.274 0.359 . . . . 0.0 110.779 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.7 pt-20 -80.78 -12.86 59.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.282 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 18' ' ' LYS . 25.4 mm -99.53 -37.47 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.612 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -88.7 -36.24 16.3 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.713 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 6.9 tt0 59.53 -57.47 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.623 1.169 . . . . 0.0 112.969 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.4 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.33 -6.35 1.79 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 66.07 -2.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.983 0.913 . . . . 0.0 112.802 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.71 -59.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.105 -0.372 . . . . 0.0 111.437 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.87 2.24 33.8 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.482 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 2.7 m 36.36 64.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.093 0.957 . . . . 0.0 113.02 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.4 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -152.44 59.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.958 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.49 -13.12 0.66 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.663 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mm -71.55 112.93 7.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 117.108 0.454 . . . . 0.0 110.055 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -150.48 -143.02 3.65 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.906 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.44 -0.39 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.04 34.4 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 t70 59.65 -136.34 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.752 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.628 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 12.4 m-80 -105.89 44.08 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -92.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.991 0.807 . . . . 0.0 111.107 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.576 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.14 51.44 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 110.643 177.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.665 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -147.9 61.64 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.242 0.544 . . . . 0.0 110.052 174.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 42' ' ' GLY . 6.4 tp -106.6 -43.44 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.13 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.515 ' C ' ' HG2' ' A' ' 49' ' ' MET . . . -121.78 44.79 1.29 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.869 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 176.06 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.938 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -53.48 0.31 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.606 1.562 . . . . 0.0 112.221 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.1 p -113.39 -65.34 1.2 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.564 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 33.1 tp -67.65 -31.29 71.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.573 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.858 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 8.1 mmtm 53.8 62.5 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.389 0.431 . . . . 0.0 110.7 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB1' ' HG ' ' A' ' 46' ' ' LEU . . . -172.59 -18.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.6 -29.97 69.54 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.654 -176.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.495 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . . . -76.39 -38.74 55.28 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.314 0.578 . . . . 0.0 110.055 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 28.9 t -61.13 -24.4 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.749 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -102.46 -17.15 15.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' MET . . . -76.0 -53.33 8.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.431 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.56 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.9 pm0 -122.3 -35.48 3.12 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.367 -175.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.86 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.6 t -63.33 -53.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.823 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.607 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 39.7 t60 -45.15 -46.78 12.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.19 5.14 8.52 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -168.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.18 -15.15 1.12 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.681 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.86 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.6 m-85 -125.46 -37.59 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.654 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -16.41 63.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.41 -32.48 48.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.819 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -114.65 -78.19 0.58 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.056 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.22 128.99 6.94 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.804 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.41 115.22 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -70.49 -40.85 73.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.593 ' HD2' HG13 ' A' ' 81' ' ' VAL . 10.1 mttt 61.76 -138.76 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.33 0.394 . . . . 0.0 111.036 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.544 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER 44.4 40.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.52 1.128 . . . . 0.0 113.308 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -164.87 37.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.821 0.82 . . . . 0.0 111.275 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -151.0 -49.74 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.858 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -89.99 57.51 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.467 ' CG ' ' HB3' ' A' ' 77' ' ' LEU . 2.9 pm0 -164.63 136.58 3.55 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.399 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 5.0 Cg_exo -79.11 -44.22 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.962 2.441 . . . . 0.0 111.51 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 8.4 t 174.1 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.806 1.289 . . . . 0.0 109.256 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 76' ' ' ALA . 2.1 mt -126.75 168.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.493 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.46 18.57 0.09 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.388 0.614 . . . . 0.0 109.53 173.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -67.64 -23.65 65.37 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.383 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -61.15 -43.92 98.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.142 179.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.44 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -75.68 -40.24 56.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.114 0.483 . . . . 0.0 110.063 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -70.17 -20.04 63.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.351 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -83.25 -56.72 3.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.186 0.517 . . . . 0.0 110.315 -177.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.593 HG13 ' HD2' ' A' ' 66' ' ' LYS . 98.1 t -69.1 -30.66 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.946 -175.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.34 -8.84 58.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.182 178.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.552 ' HD1' HG21 ' A' ' 9' ' ' VAL . 2.8 t80 -59.37 132.11 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.533 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.552 HG21 ' HD1' ' A' ' 8' ' ' TYR . 99.3 t 75.89 -55.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.116 0.567 . . . . 0.0 111.604 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 58.54 68.12 1.86 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.528 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 21.5 Cg_exo -65.43 160.2 43.9 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 112.318 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -67.76 0.86 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.951 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 64.0 m-80 -128.37 -89.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.198 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.79 -53.95 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 110.374 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.644 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 58.8 t -62.06 -41.44 91.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.345 0.593 . . . . 0.0 110.126 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.6 mp0 -63.52 -47.34 82.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.754 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.7 -46.53 89.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.478 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -64.85 -32.21 73.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.035 -178.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.41 -41.81 55.2 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.969 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.17 -41.61 62.74 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.567 0.542 . . . . 0.0 111.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.505 ' HG3' HG12 ' A' ' 22' ' ' ILE . 3.5 pt-20 -74.48 -38.47 62.88 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.505 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mm -109.63 45.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.47 ' HZ2' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -147.26 -32.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.134 169.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 15.8 tp10 65.04 -55.76 0.3 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.413 1.085 . . . . 0.0 112.482 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -150.24 -3.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.433 ' HB ' ' CE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 59.94 1.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.068 0.947 . . . . 0.0 113.545 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HB3' ' HE2' ' A' ' 49' ' ' MET . 0.6 OUTLIER -141.33 -53.75 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.934 -0.479 . . . . 0.0 111.104 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.75 10.84 11.19 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.86 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER 35.05 72.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.078 0.951 . . . . 0.0 113.206 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.671 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -170.57 62.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.32 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.765 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -133.35 -45.39 0.12 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.042 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.438 ' HA ' HD13 ' A' ' 32' ' ' ILE . 39.8 mm -68.23 109.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 0.0 111.759 -171.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.32 -151.19 7.09 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG12 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.22 13.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.0 111.175 -177.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.474 ' HG ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -167.58 36.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.65 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.517 ' OD2' ' HB ' ' A' ' 41' ' ' ILE . 11.8 t70 62.12 -151.17 0.37 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.765 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -91.11 59.28 3.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 49.35 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.533 1.146 . . . . 0.0 110.13 -170.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -150.25 50.99 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.873 0.368 . . . . 0.0 110.589 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.858 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -169.79 67.55 0.05 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 110.873 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.517 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -86.41 -35.27 8.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.956 -0.465 . . . . 0.0 111.788 -174.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 41' ' ' ILE . . . -142.49 65.47 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.414 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.07 -119.97 0.58 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 58.14 -48.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.008 1.723 . . . . 0.0 114.266 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 p -94.16 -71.21 0.67 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.207 0.527 . . . . 0.0 109.633 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.0 tp -76.31 -22.01 55.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.177 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 12.9 mmtp 50.79 60.6 3.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.034 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.12 -5.97 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.296 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.493 ' HB3' ' HE3' ' A' ' 49' ' ' MET . 36.4 mmm -53.61 -43.12 68.38 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 111.17 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . . . -78.34 -30.54 48.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.202 0.525 . . . . 0.0 110.705 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -65.0 -27.23 41.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.813 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.16 -16.76 16.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.595 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . . . -71.2 -53.55 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.993 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.778 ' HB3' HD21 ' A' ' 19' ' ' LEU . 8.0 pm0 -128.11 -36.46 1.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.404 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 51' ' ' VAL . 60.5 t -60.38 -42.3 90.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.4 t-160 -54.3 -34.81 61.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 11.37 12.23 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.266 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 19.2 mm-40 -133.9 -25.54 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.9 -38.67 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.283 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -18.04 65.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.107 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.32 -31.54 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.242 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 1.1 tp10 -113.78 -82.63 0.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.75 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -138.4 117.58 9.62 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.82 123.3 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.024 2.483 . . . . 0.0 112.378 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -78.65 -41.5 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.836 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 30.5 mtmt 63.5 -141.24 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.937 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.78 30.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.054 0.542 . . . . 0.0 111.92 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.02 49.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -165.78 -48.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.855 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.685 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.5 67.29 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 111.132 -175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HG3' ' HG ' ' A' ' 77' ' ' LEU . 7.6 pm0 -161.68 147.28 10.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.55 -60.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.359 2.039 . . . . 0.0 110.615 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.858 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -171.29 -41.48 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.814 0.816 . . . . 0.0 111.146 177.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.43 59.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.806 -164.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.783 ' HA ' HD11 ' A' ' 77' ' ' LEU . 3.2 mttp 52.41 19.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.041 0.537 . . . . 0.0 111.79 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.721 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . . . -64.93 -21.87 66.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.794 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -62.06 -49.32 76.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.458 175.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.794 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -70.21 -45.71 66.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.587 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.721 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 3.5 pt20 -68.06 -18.69 64.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -72.25 -52.57 15.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.621 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.76 -26.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.49 59.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 83' ' ' THR . 99.6 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.552 0.691 . . . . 0.0 109.312 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 3.9 mt-30 . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 120.556 0.217 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 37.0 t80 59.4 99.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 124.209 0.943 . . . . 0.0 109.589 -171.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.652 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 65.65 127.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.488 1.115 . . . . 0.0 110.381 -168.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.87 103.57 20.14 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.421 -173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 71.7 Cg_endo -95.38 152.18 1.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.026 2.484 . . . . 0.0 111.973 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -116.57 -65.9 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.353 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -124.15 -75.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.456 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.26 -54.82 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.926 0.393 . . . . 0.0 110.296 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.68 -38.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.404 0.621 . . . . 0.0 109.606 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -65.47 -43.96 88.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.969 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -63.84 -41.15 97.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.686 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.557 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 6.6 tptt -63.56 -33.74 76.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.349 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 54' ' ' GLN . 7.8 mt -70.76 -47.43 59.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.31 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.46 39.29 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.401 0.438 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -75.15 -40.66 59.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.184 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -125.05 69.02 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.982 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HZ2' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -171.12 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.685 171.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.92 ' HG2' HG12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER 54.35 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.467 1.107 . . . . 0.0 111.555 175.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -105.68 -3.31 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.741 -175.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.06 9.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.889 0.876 . . . . 0.0 112.908 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -146.54 -57.35 0.28 Allowed 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.95 -0.469 . . . . 0.0 111.446 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.01 4.31 14.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.506 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.618 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 10.0 m 31.79 81.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.194 0.997 . . . . 0.0 113.69 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.91 64.98 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.155 -0.34 . . . . 0.0 111.895 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.574 ' HA3' HD22 ' A' ' 37' ' ' ASN . . . -157.44 -6.75 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.679 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.92 HG12 ' HG2' ' A' ' 24' ' ' GLU . 36.2 mm -53.83 118.71 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.23 -154.24 6.91 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -69.49 -4.42 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -175.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 25.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.146 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 67.7 m-20 44.77 -125.46 1.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.382 -175.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.574 HD22 ' HA3' ' A' ' 31' ' ' GLY . 14.2 m-80 -117.09 29.57 7.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER 38.56 -95.57 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.119 0.887 . . . . 0.0 111.736 -175.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.53 43.61 3.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.358 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 4.2 pt20 -139.72 54.93 1.67 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.644 HG22 ' HZ2' ' A' ' 23' ' ' TRP . 1.1 tt -110.99 -23.89 4.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.684 -167.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -154.93 59.07 0.39 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.975 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 173.79 -127.36 1.33 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 57.57 -28.51 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.77 1.628 . . . . 0.0 115.001 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 43' ' ' GLY . 8.4 p -92.23 -70.32 0.7 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.963 0.801 . . . . 0.0 110.293 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.731 HD21 ' HE1' ' A' ' 49' ' ' MET . 1.5 pp -102.5 -2.98 27.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.602 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 11.2 mmtp 51.85 66.86 1.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.593 0.558 . . . . 0.0 112.044 174.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.12 -10.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.731 ' HE1' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -58.03 -35.26 71.03 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.701 -178.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.563 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -72.09 -33.1 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 110.473 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 66.5 t -64.09 -26.97 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.095 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -98.82 -16.45 18.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . . . -75.87 -51.49 12.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.379 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.547 ' HB3' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.99 -48.28 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.949 0.404 . . . . 0.0 110.587 -176.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.5 t -55.12 -47.45 77.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.39 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.4 t60 -47.17 -43.46 21.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -121.63 3.74 10.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 -36.4 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 53.5 m-85 -118.03 -34.96 3.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -64.97 -13.62 57.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.445 0.64 . . . . 0.0 109.82 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.28 -35.23 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.622 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -124.03 -76.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.866 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 116.01 9.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.334 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -86.77 113.25 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.665 2.244 . . . . 0.0 112.736 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.829 HD21 ' H ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -83.18 -59.17 2.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.627 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.829 ' H ' HD21 ' A' ' 65' ' ' LEU . 18.6 mtmt 68.12 -111.72 0.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.268 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER 55.12 37.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.832 0.348 . . . . 0.0 111.337 -178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 1.4 pt? -165.53 42.86 0.07 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.761 0.791 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.538 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.3 p90 -151.03 -48.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -171.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -95.92 61.56 2.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 0.0 111.09 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.7 pm0 -164.77 148.99 7.88 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 3.8 Cg_exo -77.12 -72.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 110.956 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -171.97 36.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.46 0.647 . . . . 0.0 110.729 178.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -105.72 -121.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 40.4 mmtm -131.08 17.7 5.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.36 -37.6 83.94 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.198 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.827 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -56.41 -42.15 77.53 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.754 0.312 . . . . 0.0 111.672 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.492 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -68.24 -48.92 63.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.702 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 1.1 pt20 -78.19 -4.23 46.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.375 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 13.3 t80 -82.11 -54.17 5.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.11 -29.16 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.314 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 7.78 13.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.409 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 110.114 173.412 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 40.5 t80 -74.82 105.16 5.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.264 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.756 HG11 ' HA ' ' A' ' 36' ' ' ASP . 7.0 m 29.03 70.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.576 1.173 . . . . 0.0 112.626 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -42.32 107.92 0.57 Allowed Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.261 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.9 Cg_exo -67.26 136.77 41.46 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.326 2.684 . . . . 0.0 112.289 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.518 ' HB ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -94.13 -70.74 0.69 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.782 0.325 . . . . 0.0 111.046 -176.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 12' ' ' THR . 2.1 p30 -142.21 42.24 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.5 -51.23 0.56 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.955 0.502 . . . . 0.0 112.256 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.08 -53.58 41.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 0.0 110.281 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -39.0 93.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.9 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.0 -46.01 92.5 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.437 178.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.616 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -64.45 -40.14 95.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -40.77 96.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.117 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -54.39 -42.21 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -77.3 -23.54 51.03 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.516 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 18' ' ' LYS . 1.5 mt -112.67 31.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -146.94 -34.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.603 170.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.4 tm-20 52.23 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.215 1.006 . . . . 0.0 111.37 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -107.91 -0.36 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.87 -177.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.715 HG11 ' HE3' ' A' ' 49' ' ' MET . 1.4 p 52.59 23.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.264 1.026 . . . . 0.0 112.552 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.88 -55.09 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.512 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -106.96 -11.82 25.37 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.928 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 15.4 m 36.09 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.94 65.14 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.77 -52.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.168 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' HG2' ' A' ' 24' ' ' GLU . 1.7 mm -38.4 116.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.44 1.096 . . . . 0.0 112.56 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 35' ' ' LEU . . . -155.27 -152.15 6.09 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.44 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -77.48 13.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.522 ' HG ' HG12 ' A' ' 34' ' ' ILE . 12.9 mt -140.03 17.77 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.756 ' HA ' HG11 ' A' ' 9' ' ' VAL . 0.8 OUTLIER 66.36 -125.54 0.27 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.392 0.615 . . . . 0.0 109.529 177.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.489 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 2.9 t-20 -155.18 51.67 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.51 -106.69 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.659 -167.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.826 ' HD2' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -133.15 50.34 2.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.019 174.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.957 ' HB2' ' HB3' ' A' ' 44' ' ' HIS . 1.5 pt20 -143.96 63.38 1.34 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.866 0.841 . . . . 0.0 110.056 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 tt -96.61 -26.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.215 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 49' ' ' MET . . . -118.12 -60.77 0.29 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.922 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -76.1 -87.18 0.32 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.196 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.957 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 3.4 p-80 62.46 -47.15 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.215 1.806 . . . . 0.0 113.762 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.1 p -90.41 -88.59 0.17 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 5.78 24.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 1.012 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.9 mmtp 50.87 61.26 3.33 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.519 176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.61 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.679 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.715 ' HE3' HG11 ' A' ' 26' ' ' VAL . 3.6 mmm -52.6 -37.54 58.39 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.225 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.506 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.14 -34.91 68.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.45 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.649 ' HA ' HG22 ' A' ' 55' ' ' VAL . 81.2 t -64.28 -23.51 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.362 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.689 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.65 -19.82 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 26' ' ' VAL . . . -82.25 -49.15 10.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.621 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.29 -41.18 3.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.595 -175.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.921 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -63.13 -46.77 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.37 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.689 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 5.5 t-160 -54.43 -37.53 65.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.45 -2.18 14.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.4 mm-40 -138.92 -33.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.921 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.9 m-85 -110.72 -39.68 4.79 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.743 -167.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -64.42 -22.69 67.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.409 0.624 . . . . 0.0 109.608 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -29.76 47.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.345 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.209 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -144.35 114.95 5.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.824 -174.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.595 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 5.9 Cg_exo -79.6 130.0 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.094 2.529 . . . . 0.0 112.428 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.822 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.56 -41.38 14.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.342 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 64' ' ' PRO . 1.3 mtpt 64.52 -137.31 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.971 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m 54.67 21.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.4 1.08 . . . . 0.0 111.39 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.592 ' HA ' HE22 ' A' ' 71' ' ' GLN . 2.3 mt -145.49 33.2 1.06 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.306 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 p90 -153.81 -50.29 0.09 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.299 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.012 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -88.84 46.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.066 0.46 . . . . 0.0 111.535 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.592 HE22 ' HA ' ' A' ' 68' ' ' LEU . 8.9 pm0 -166.57 134.77 2.23 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.769 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 74' ' ' ILE . 1.3 Cg_endo -87.8 -40.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.868 2.379 . . . . 0.0 111.644 170.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.826 ' HA ' ' HD2' ' A' ' 39' ' ' PHE . 7.7 t 177.92 45.71 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.699 1.238 . . . . 0.0 109.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.623 HG13 ' HD2' ' A' ' 72' ' ' PRO . 2.7 mt -121.08 174.15 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 113.437 -1.711 . . . . 0.0 107.311 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -80.93 17.82 1.13 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -62.66 -29.74 70.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.485 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.601 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -53.77 -47.82 70.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.462 177.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.601 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -74.41 -46.18 41.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.939 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.554 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -76.96 5.49 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.76 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -104.96 -62.71 1.31 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.992 0.425 . . . . 0.0 109.951 172.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 66' ' ' LYS . 6.9 t -78.68 -14.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.432 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -108.32 13.44 25.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.192 0.52 . . . . 0.0 110.671 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.264 173.54 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.295 0.569 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -72.26 124.97 26.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.042 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 2.8 t 55.37 50.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.697 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.3 116.6 2.16 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.11 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 3.3 Cg_exo -75.89 141.32 24.03 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.153 2.569 . . . . 0.0 111.669 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.18 -73.95 0.67 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.61 0.243 . . . . 0.0 110.422 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -137.4 50.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.47 -68.87 0.11 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.38 0.672 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.07 -47.87 82.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.411 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 mp0 -63.17 -35.84 81.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.392 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -65.7 -45.26 83.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.013 0.435 . . . . 0.0 110.932 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 18.6 mmmt -63.9 -36.98 85.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.529 0.681 . . . . 0.0 109.955 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -42.72 96.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.286 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.24 -43.77 67.6 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.415 0.447 . . . . 0.0 111.122 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 3.1 pt-20 -83.14 -10.83 58.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.224 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HA ' HD13 ' A' ' 22' ' ' ILE . 5.3 mm -97.37 -30.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.52 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -107.62 -26.09 11.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.294 -175.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 57.43 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.519 -175.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -117.34 -5.78 11.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.989 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG13 HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.64 -4.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.124 0.97 . . . . 0.0 112.972 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.489 HD21 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -139.48 -54.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 111.789 -177.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.7 -6.0 29.01 Favored Glycine 0 CA--C 1.504 -0.62 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.708 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 16.0 m 33.7 66.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.922 . . . . 0.0 113.149 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.41 ' H ' ' HD2' ' A' ' 25' ' ' ARG . 71.3 m -161.23 52.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 111.745 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . -121.27 -37.27 0.7 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.454 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.522 HG12 ' HG2' ' A' ' 24' ' ' GLU . 10.9 mm -31.88 110.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 112.343 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -78.65 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.624 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.567 ' C ' ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -133.03 -10.88 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.567 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -164.51 42.97 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.585 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 54.2 m-20 36.56 -112.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.908 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 67.6 m-80 -119.74 23.32 11.18 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' HD1' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 39.32 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.424 1.077 . . . . 0.0 112.286 -177.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 43.31 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.452 0.644 . . . . 0.0 110.514 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -152.17 61.13 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.026 173.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -110.14 -19.76 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.241 -172.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.92 97.01 0.16 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.731 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' SER . . . 126.78 -113.46 1.77 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.72 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 58.92 -21.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.453 1.501 . . . . 0.0 114.081 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' GLY . 2.1 p -90.93 -89.35 0.17 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -8.7 59.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.0 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 1.004 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER 61.4 72.71 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.759 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.4 -12.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.138 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.3 mmm -53.13 -39.75 63.73 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . . . -75.65 -32.16 60.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.131 0.491 . . . . 0.0 110.552 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 1.1 t -62.23 -27.14 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.933 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -100.38 -18.1 16.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.785 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . . . -72.28 -54.59 9.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.5 pm0 -124.77 -36.6 2.56 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.471 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.848 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 67.4 t -60.66 -44.55 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t60 -51.57 -46.21 63.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -127.87 9.67 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -170.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.1 mm-40 -131.49 -21.97 2.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.475 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.848 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m-85 -118.47 -28.53 5.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.815 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.5 -16.88 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.28 -36.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.014 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -125.52 -80.08 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.979 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.29 129.01 6.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.196 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.34 111.96 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.418 2.079 . . . . 0.0 112.28 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -43.71 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HE3' HG13 ' A' ' 81' ' ' VAL . 6.5 mtmt 62.45 -143.32 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.229 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.719 HG13 HD21 ' A' ' 77' ' ' LEU . 1.8 t 62.16 36.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.205 0.602 . . . . 0.0 111.475 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.5 HD13 HE22 ' A' ' 54' ' ' GLN . 0.4 OUTLIER -167.51 54.53 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 111.455 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.7 p90 -167.99 -46.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.296 -0.253 . . . . 0.0 111.619 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.004 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.4 56.36 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.397 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.664 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.1 pm0 -163.99 140.34 5.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.018 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 17.0 Cg_exo -68.79 -56.82 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.345 2.03 . . . . 0.0 110.931 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.1 t 173.26 46.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.883 0.849 . . . . 0.0 110.031 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -120.39 -107.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -146.14 19.57 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.342 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.03 -33.71 76.37 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.761 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.719 HD21 HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.06 -42.69 73.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 111.385 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.599 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -75.11 -43.57 52.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 6.75 17.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.833 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -103.63 -59.36 1.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.145 0.497 . . . . 0.0 109.848 175.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 66' ' ' LYS . 46.8 t -70.82 -30.5 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.114 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -84.47 -2.69 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.217 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 111.342 179.325 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.977 0.418 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.678 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 42.4 t80 -65.49 101.76 0.63 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 7.6 p 34.39 82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 124.474 1.109 . . . . 0.0 112.662 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.86 107.36 20.15 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 82.6 Cg_endo -96.55 -159.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.662 2.908 . . . . 0.0 112.422 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.86 -73.2 0.49 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.625 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.95 150.86 22.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.59 -42.59 16.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.826 0.704 . . . . 0.0 112.603 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.25 -49.02 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.919 0.39 . . . . 0.0 110.498 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -43.8 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.473 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 11.0 m -51.76 -54.93 23.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.329 0.393 . . . . 0.0 111.968 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -38.77 92.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -43.61 80.57 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.132 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.6 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.88 -41.01 63.96 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.577 0.548 . . . . 0.0 111.524 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.486 ' HG3' HG12 ' A' ' 22' ' ' ILE . 5.7 pt-20 -80.39 -25.35 39.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.278 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 mm -115.05 30.3 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.632 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -134.64 -36.64 0.85 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 170.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.658 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 11.5 tt0 62.1 -71.19 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.349 1.06 . . . . 0.0 113.264 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.401 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -124.23 -5.04 7.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.48 HG13 HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.24 -5.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 124.192 0.932 . . . . 0.0 112.827 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.842 HD22 ' HE2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -142.24 -51.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.663 -177.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.532 ' C ' HG23 ' A' ' 29' ' ' VAL . . . -113.9 3.04 24.33 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.694 -175.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.658 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER 35.71 74.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 124.586 0.815 . . . . 0.0 112.163 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.401 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -153.25 64.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.705 -173.055 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.571 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . 168.13 61.58 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.513 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.651 HG12 ' HA ' ' A' ' 24' ' ' GLU . 3.5 mm -134.14 116.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.25 -144.47 4.33 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.971 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -76.68 19.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.425 HD22 HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -166.75 26.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.916 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 32.36 -110.72 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.364 1.04 . . . . 0.0 112.446 -176.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.431 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 1.7 t-20 -148.32 36.37 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.47 -99.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.267 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.967 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.8 m-85 -122.66 37.53 4.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.018 0.437 . . . . 0.0 111.77 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.2 pt20 -147.73 60.0 1.13 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.522 0.677 . . . . 0.0 110.437 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 tp -102.4 -34.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.733 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.92 -68.27 0.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.82 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.33 -96.16 0.11 Allowed Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.289 -175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.842 ' HE2' HD22 ' A' ' 27' ' ' LEU . 14.0 p-80 62.13 -40.87 0.15 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.833 1.653 . . . . 0.0 113.949 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -90.31 -82.06 0.28 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 12.2 tp -76.13 -10.59 59.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.939 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.83 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.2 mmtm 58.65 56.13 4.38 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.445 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.34 -8.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.918 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -57.82 -32.65 67.79 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.324 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.653 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.77 -31.28 59.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.195 0.521 . . . . 0.0 110.176 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 94.7 t -69.42 -23.21 26.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.133 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.42 -17.45 16.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.83 -51.87 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.662 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.93 -42.8 2.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.776 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 45.1 t -59.04 -43.22 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.251 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 7.8 t-160 -43.98 -41.67 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -17.89 10.23 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.05 -28.22 7.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.776 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 93.9 m-85 -115.51 -27.69 7.07 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.353 -171.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.82 -23.07 63.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.94 -35.48 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.909 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' HD21 ' A' ' 63' ' ' LEU . 3.7 tp10 -117.75 -78.33 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.751 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD21 ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -154.98 141.66 13.34 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.198 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.88 119.62 5.97 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.308 2.005 . . . . 0.0 111.582 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 1.1 pt? -66.05 -37.8 86.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 8.5 mtmt 60.89 -159.55 0.32 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.284 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 77' ' ' LEU . 2.3 t 66.2 21.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.403 0.681 . . . . 0.0 111.794 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.901 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -164.0 47.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.389 0.614 . . . . 0.0 111.424 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.535 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.2 p90 -160.25 -45.97 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.196 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.83 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.33 47.24 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.121 0.486 . . . . 0.0 111.153 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.901 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.1 pm0 -159.82 140.1 8.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.9 Cg_exo -77.45 -39.37 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.763 2.309 . . . . 0.0 111.616 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.967 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 2.0 m 156.45 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.538 1.535 . . . . 0.0 108.043 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.433 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -141.83 -117.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.491 175.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 16.2 ptmt -136.0 17.0 3.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 173.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.66 66.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.064 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.819 HD23 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -55.71 -42.6 75.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.42 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.819 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -88.84 -31.33 18.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.108 0.48 . . . . 0.0 110.151 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 0.25 9.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.96 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -109.93 -49.35 3.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.793 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -72.41 -21.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.712 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.35 7.7 38.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 110.714 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.583 177.712 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.6 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.427 ' CD2' ' HA ' ' A' ' 34' ' ' ILE . 29.2 t80 -69.79 111.05 5.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 9' ' ' VAL . 7.1 p 39.09 58.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.345 1.069 . . . . 0.0 112.066 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.93 122.51 77.56 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.757 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.37 173.27 14.78 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.766 2.311 . . . . 0.0 112.081 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -107.07 -63.37 1.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.59 -76.76 0.44 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.144 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.72 -44.16 0.48 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -67.2 -41.04 86.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.628 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -72.87 -36.68 67.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.96 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -53.61 55.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.928 0.394 . . . . 0.0 110.457 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -60.72 -39.51 88.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.178 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -70.72 -39.74 73.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.58 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.31 73.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.741 0.305 . . . . 0.0 111.368 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.66 -28.58 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.164 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.486 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.5 mm -86.03 -50.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.612 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -75.92 -33.55 59.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.141 -170.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.612 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 1.7 tp10 58.6 -64.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.049 0.94 . . . . 0.0 111.667 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.913 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -134.05 1.99 3.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG22 ' HE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 64.39 -5.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.651 1.18 . . . . 0.0 113.357 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.52 -56.58 0.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.961 0.41 . . . . 0.0 111.051 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.608 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -108.96 6.15 32.59 Favored Glycine 0 CA--C 1.501 -0.816 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.566 -173.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.608 HG22 ' C ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 38.73 70.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 124.594 0.82 . . . . 0.0 112.518 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.913 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -160.15 60.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.756 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -126.88 -17.83 2.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.921 -170.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -81.55 87.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.492 0.646 . . . . 0.0 110.834 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.23 -159.01 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.539 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -73.48 -2.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.286 0.565 . . . . 0.0 111.75 -175.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -164.84 51.98 0.12 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.842 177.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 49.02 -128.75 2.02 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.604 -174.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.756 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -115.46 46.82 1.42 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.99 -97.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.328 1.017 . . . . 0.0 110.809 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.736 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 11.0 m-85 -129.38 47.93 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.817 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.434 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -168.32 53.53 0.05 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 42' ' ' GLY . 4.6 tt -93.52 -29.84 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.285 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 41' ' ' ILE . . . -146.05 44.46 0.85 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.494 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -162.65 -112.93 0.29 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 61.08 -52.19 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.892 1.677 . . . . 0.0 114.031 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -88.51 -75.75 0.42 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.596 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 14.3 tp -80.74 -16.77 53.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.012 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 5.8 mmtm 53.46 61.42 3.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.52 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . 177.89 -1.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.081 -173.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.2 -35.56 75.68 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.698 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . . . -75.53 -30.55 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 110.317 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.543 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 2.9 t -63.93 -26.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.04 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.17 -23.19 16.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.0 110.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -70.51 -50.7 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.324 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.586 ' HB3' HD11 ' A' ' 19' ' ' LEU . 7.0 pm0 -122.77 -43.7 2.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.118 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 95.3 t -57.42 -43.63 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.429 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.5 t60 -49.63 -33.88 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -128.86 18.22 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 4.2 mm-40 -139.11 -46.54 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.088 0.47 . . . . 0.0 111.797 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 62.0 m-85 -113.95 -15.48 12.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -168.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -12.81 58.2 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.75 -30.59 5.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.969 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.72 -78.96 0.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.961 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -159.96 121.79 1.81 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.692 -177.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.617 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 11.2 Cg_exo -70.48 130.7 18.88 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.75 2.3 . . . . 0.0 112.539 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.08 -63.16 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.144 177.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 2.7 mtmp? 82.44 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.406 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 66' ' ' LYS . 19.9 m 45.01 33.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 112.239 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.494 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -151.94 25.49 0.64 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.23 -173.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.1 p90 -165.6 -49.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.005 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.672 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -91.35 56.7 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.47 . . . . 0.0 111.529 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 13.1 pm0 -151.35 147.16 19.87 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.352 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.537 ' O ' HG21 ' A' ' 73' ' ' THR . 3.4 Cg_exo -78.04 -72.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.011 2.474 . . . . 0.0 111.521 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.736 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -172.72 35.68 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.538 0.524 . . . . 0.0 112.189 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.846 HG22 ' HD2' ' A' ' 75' ' ' LYS . 2.9 mp -137.87 -89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.006 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HD2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -145.38 18.56 1.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -174.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.49 -28.03 68.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.198 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.718 HD21 ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -51.42 -49.03 62.45 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.201 174.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.12 67.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -0.73 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.349 0.595 . . . . 0.0 111.18 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -104.71 -50.95 3.17 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.411 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -72.12 -26.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.376 -176.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -93.5 10.57 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.917 0.389 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.299 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 41.7 t80 -61.83 121.99 14.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 26.6 m 31.95 54.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.334 1.021 . . . . 0.0 112.143 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.4 127.46 57.59 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.091 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 3.7 Cg_exo -75.29 130.08 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.335 2.69 . . . . 0.0 111.678 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -68.06 0.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.458 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 67.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.049 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.26 -72.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.583 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.84 -48.61 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.41 -39.27 78.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.286 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -64.7 -46.67 81.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 0.0 111.591 -178.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -32.66 74.23 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.74 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -75.11 -49.65 18.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.41 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -39.14 41.4 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.53 0.519 . . . . 0.0 111.582 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.765 ' HG3' HG12 ' A' ' 22' ' ' ILE . 2.3 pt-20 -82.62 -28.67 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.704 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.765 HG12 ' HG3' ' A' ' 21' ' ' GLU . 10.7 mm -122.17 61.32 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -155.11 -42.22 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.112 163.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.829 ' HA ' HG12 ' A' ' 32' ' ' ILE . 1.9 tp10 63.58 -62.38 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.196 0.998 . . . . 0.0 112.924 176.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.754 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -139.19 6.9 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.406 . . . . 0.0 109.949 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 25' ' ' ARG . 0.6 OUTLIER 56.65 18.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.274 1.03 . . . . 0.0 113.106 176.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -177.43 -51.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 111.253 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.11 37.3 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 32.69 76.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.297 1.039 . . . . 0.0 113.406 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.754 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -176.21 74.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.794 177.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -164.14 7.48 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.584 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.829 HG12 ' HA ' ' A' ' 24' ' ' GLU . 1.3 mm -82.1 127.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.376 0.588 . . . . 0.0 110.273 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -162.17 9.98 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.83 10.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 122.538 0.335 . . . . 0.0 111.761 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -166.43 35.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 1.5 m-20 58.42 -135.24 0.97 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.892 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.884 ' HB2' HD13 ' A' ' 41' ' ' ILE . 1.4 t-20 -114.34 46.94 1.28 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.423 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 42.19 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.248 0.967 . . . . 0.0 111.727 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.955 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -127.99 43.42 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 -176.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.457 ' HB2' ' HE2' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -163.03 63.65 0.19 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.971 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.884 HD13 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -119.5 -11.69 10.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.033 -174.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 50' ' ' ALA . . . -167.28 93.01 0.1 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.899 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.63 -107.46 0.33 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.663 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' GLN . 20.2 m80 73.97 -57.48 0.62 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.963 0.905 . . . . 0.0 112.4 171.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -82.83 -80.12 0.18 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.411 0.624 . . . . 0.0 110.169 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 1.22 57.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.88 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 54.12 70.2 0.63 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.324 0.39 . . . . 0.0 110.47 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' A' ' 51' ' ' VAL . . . -177.17 -4.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.296 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.403 ' HE1' HD23 ' A' ' 27' ' ' LEU . 41.2 mmm -56.17 -38.13 70.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -78.59 -31.33 47.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 48' ' ' ALA . 98.5 t -62.57 -29.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.054 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -94.01 -17.93 22.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.67 -51.22 13.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.5 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.56 ' HB3' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -115.63 -53.22 2.6 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.651 -177.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.85 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 37.7 t -53.76 -47.33 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.646 -173.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.2 t60 -36.95 -52.72 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 5.71 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -173.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 5.1 mm-40 -124.28 -10.24 7.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.92 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.85 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -140.0 -33.75 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.771 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.738 ' HG2' HG11 ' A' ' 55' ' ' VAL . 4.1 mm100 -61.47 -26.77 68.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.091 0.472 . . . . 0.0 110.618 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -66.56 -36.19 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.024 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -77.22 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.02 112.62 3.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.638 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 15.0 Cg_exo -68.02 128.51 17.81 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.987 2.458 . . . . 0.0 112.468 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -56.98 2.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mttt 63.84 -123.57 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.745 0.418 . . . . 0.0 111.053 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 81' ' ' VAL . 2.0 t 62.81 28.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.309 0.644 . . . . 0.0 111.842 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.07 68.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.1 p90 -163.36 -48.21 0.03 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.788 0.327 . . . . 0.0 111.443 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.88 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -101.37 62.7 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.394 -173.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pm0 -167.35 136.98 2.26 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 111.47 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 96.2 Cg_endo -94.42 59.57 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.493 2.795 . . . . 0.0 111.944 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.955 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 56.84 62.57 2.21 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 175.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mm -138.0 -86.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.2 13.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.792 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -66.91 -26.06 66.68 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.367 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -57.29 -44.64 84.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.985 0.421 . . . . 0.0 111.054 177.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.58 -50.56 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.736 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.95 5.0 7.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -177.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.696 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -97.4 -58.34 2.03 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.493 HG22 HG23 ' A' ' 67' ' ' VAL . 1.2 t -67.44 -33.65 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.827 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.1 -8.27 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.772 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 120.673 0.273 . . . . 0.0 111.654 -178.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.123 0.487 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -61.23 133.38 55.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.167 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 m 61.43 -21.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.37 1.468 . . . . 0.0 113.593 -172.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . 56.21 73.87 0.77 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.053 0.541 . . . . 0.0 111.882 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.786 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 32.0 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.106 2.538 . . . . 0.0 112.34 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.501 HG22 HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -101.84 -70.16 0.76 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.834 -177.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -120.54 -60.67 1.65 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.561 -0.855 . . . . 0.0 112.125 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.85 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 72.6 t -69.16 -44.26 80.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.44 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -70.4 -46.33 64.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.91 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.786 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -56.48 -51.39 68.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.482 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.3 tttt -60.91 -46.39 90.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.939 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -36.43 79.94 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.0 -44.91 79.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 1.3 pt-20 -84.48 -4.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.33 -44.38 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.078 0.465 . . . . 0.0 112.204 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.633 ' HE3' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -85.31 -31.69 22.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.075 -172.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 2.0 tt0 62.26 -62.22 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' A' ' 27' ' ' LEU . 6.2 mtt180 -135.78 -7.41 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.179 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG21 ' HE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 61.02 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.211 1.004 . . . . 0.0 113.314 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -136.28 -54.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.871 0.367 . . . . 0.0 110.789 -177.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.63 -12.76 29.67 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.133 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.444 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 42.73 59.27 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.358 0.663 . . . . 0.0 111.807 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.422 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.24 65.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.75 -1.88 0.1 OUTLIER Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.323 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.443 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 4.0 mt -69.8 131.39 34.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.726 0.763 . . . . 0.0 110.539 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.93 -154.06 7.36 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -77.06 -3.31 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -176.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 24.47 0.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 1.5 m-20 39.96 -108.69 0.08 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.047 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.701 HD21 HD13 ' A' ' 41' ' ' ILE . 33.8 m-80 -122.29 28.0 7.67 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.94 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.32 -96.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.087 0.867 . . . . 0.0 111.99 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.831 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -117.49 36.25 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.267 0.556 . . . . 0.0 111.314 -175.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -154.25 59.67 0.71 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.082 177.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.701 HD13 HD21 ' A' ' 37' ' ' ASN . 1.1 tt -99.44 -37.3 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -148.45 81.63 0.2 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.902 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.76 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 151.43 -116.74 0.78 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.233 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 58.79 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.424 1.49 . . . . 0.0 113.825 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.7 p -87.56 -88.77 0.13 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD22 ' HE3' ' A' ' 49' ' ' MET . 0.5 OUTLIER -84.11 -0.91 53.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.317 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.881 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 53.61 68.95 0.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 178.13 -5.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -173.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.76 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 5.0 mtp -54.92 -41.02 70.48 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.283 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . . . -77.81 -32.23 52.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 0.0 110.719 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.508 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.2 t -62.08 -26.99 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.023 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.09 -13.03 15.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -71.15 -56.88 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.896 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 7.1 pm0 -125.98 -42.12 1.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.56 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 95.0 t -52.85 -42.75 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.871 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.3 t-160 -38.2 -52.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.304 1.003 . . . . 0.0 113.035 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -0.92 16.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.933 0.397 . . . . 0.0 111.463 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -104.3 -42.63 5.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -173.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 6.4 m-85 -146.16 -22.77 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -169.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.42 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 3.5 tp60 -66.66 -13.28 61.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.344 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.23 -32.36 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.142 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.651 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 3.0 tt0 -130.4 -76.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -152.19 101.35 2.81 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 111.636 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 92.2 Cg_endo -86.0 160.39 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.807 2.338 . . . . 0.0 112.698 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -77.69 -40.03 42.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' O ' HD22 ' A' ' 68' ' ' LEU . 28.4 mttt 63.0 -132.19 0.47 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.512 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 77' ' ' LEU . 3.2 t 61.03 37.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.999 0.428 . . . . 0.0 111.21 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 1.7 pt? -161.54 40.75 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 112.283 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 51' ' ' VAL . 3.9 p90 -157.91 -49.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.776 -0.577 . . . . 0.0 112.121 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.881 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -98.69 75.21 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 111.34 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . 5.6 pm0 -162.22 137.01 5.24 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.154 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.472 ' C ' ' HG1' ' A' ' 73' ' ' THR . 72.1 Cg_endo -87.4 53.88 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.097 2.531 . . . . 0.0 111.478 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.831 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 50.99 53.98 12.06 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.768 0.827 . . . . 0.0 112.906 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 8.1 mt -135.48 -108.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 pttt -135.3 11.67 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.512 . . . . 0.0 110.291 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . . . -64.74 -27.48 68.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.582 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.739 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -56.08 -49.11 74.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.51 176.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.37 -38.14 56.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.195 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.41 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.77 -48.69 36.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.226 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -68.87 -31.27 49.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' HG11 ' A' ' 81' ' ' VAL . . . -71.03 -23.25 62.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.545 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 m . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.73 178.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 pm0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.29 0.567 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.23 121.7 13.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.356 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 32' ' ' ILE . 75.8 t 67.56 124.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.489 0.662 . . . . 0.0 111.663 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.05 15.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 17' ' ' SER . 2.8 Cg_exo -76.85 -170.04 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.361 2.707 . . . . 0.0 112.508 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.403 ' HB ' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -117.56 -73.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.064 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -114.63 -101.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.454 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.36 -49.15 0.92 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.3 -43.44 96.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.829 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' OE1' ' HB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -60.57 -45.99 91.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.115 178.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -57.87 -47.83 81.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 178.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.652 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.99 -44.92 95.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.609 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -40.0 93.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.252 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.52 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.52 -39.57 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.423 0.452 . . . . 0.0 111.291 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.3 pt-20 -82.17 -17.66 45.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.254 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 18' ' ' LYS . 16.5 mt -93.61 -39.39 10.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 112.11 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -89.74 -31.16 17.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 -177.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.655 ' HG2' ' C ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER 57.22 -64.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.881 1.273 . . . . 0.0 113.066 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.873 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -133.66 0.59 3.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' CE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 66.05 -8.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.999 . . . . 0.0 113.544 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.65 -57.93 0.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.449 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -113.54 13.46 22.97 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.655 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 4.6 m 32.46 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.264 1.026 . . . . 0.0 113.255 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.873 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 47.4 m -151.15 58.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.209 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.586 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -116.72 -27.79 2.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.218 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 9' ' ' VAL . 36.8 mm -72.42 98.93 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.152 0.501 . . . . 0.0 110.138 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.55 -155.09 7.59 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.2 pt -67.66 -12.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 123.434 0.693 . . . . 0.0 111.937 -171.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.0 43.21 0.21 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.852 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 66.82 -151.22 0.2 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.721 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.506 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -108.05 18.68 20.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.55 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.615 1.197 . . . . 0.0 112.152 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.949 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.58 43.24 3.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.955 -177.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -160.72 67.19 0.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.462 177.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.706 ' N ' ' HE2' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.36 -33.32 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.6 -66.32 0.34 Allowed Glycine 0 C--O 1.223 -0.54 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.179 -174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -77.84 -100.67 0.19 Allowed Glycine 0 C--O 1.224 -0.505 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.706 -170.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.706 ' HE2' ' N ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 66.65 -50.17 0.45 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.001 1.32 . . . . 0.0 112.649 177.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 p -75.08 -82.43 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -90.08 4.13 51.25 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.539 172.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 20.4 mmtm 53.09 58.82 4.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.777 ' HB3' HD13 ' A' ' 46' ' ' LEU . . . 178.56 -3.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.929 -172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.445 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 35.3 mmm -54.48 -35.57 63.2 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.049 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -27.85 53.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.488 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 24.6 t -64.78 -29.0 46.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.83 -21.74 17.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 49' ' ' MET . . . -80.68 -46.77 15.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -117.9 -42.98 2.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -175.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 85.9 t -62.04 -56.29 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 11.6 t-160 -38.1 -45.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 4.42 8.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 79.8 mm-40 -131.91 -31.05 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.654 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -121.79 -19.54 6.73 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.139 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -67.7 -14.29 62.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 109.195 169.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.29 -32.1 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.649 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 5.3 tp10 -132.72 -82.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.762 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.404 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -162.23 123.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.349 -178.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 141.42 18.9 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.711 2.274 . . . . 0.0 112.87 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -86.72 -20.45 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 177.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 61.13 -131.83 0.73 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.477 175.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.508 ' H ' HG23 ' A' ' 81' ' ' VAL . 3.5 m 53.95 26.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.639 1.176 . . . . 0.0 113.335 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.827 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.6 OUTLIER -153.22 40.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.974 0.416 . . . . 0.0 111.849 177.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 2.9 p90 -153.68 -44.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.75 35.65 1.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.062 0.458 . . . . 0.0 111.476 -173.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.827 HE22 ' HA ' ' A' ' 68' ' ' LEU . 16.7 pm0 -141.45 134.89 14.51 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.608 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 47.9 Cg_endo -76.04 -42.66 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.2 1.933 . . . . 0.0 111.946 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 t 168.88 52.73 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.931 1.348 . . . . 0.0 109.193 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.558 ' C ' ' H ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -136.75 175.61 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.591 -1.64 . . . . 0.0 107.693 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -74.38 19.27 0.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.706 174.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -64.83 -18.83 65.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.275 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.949 HD21 ' HB3' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -51.89 -46.26 64.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.218 0.532 . . . . 0.0 110.241 173.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -88.42 -28.44 20.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 7.98 18.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.094 0.473 . . . . 0.0 111.263 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -120.74 -48.09 2.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.741 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 67' ' ' VAL . 97.6 t -82.01 -22.38 9.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.302 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -113.48 21.23 15.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.197 0.523 . . . . 0.0 110.113 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 -179.76 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 2.2 t80 48.04 78.4 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.447 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 72.42 132.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.81 0.814 . . . . 0.0 111.525 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.5 103.61 41.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.973 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 14.9 Cg_exo -70.04 157.89 58.36 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.913 2.409 . . . . 0.0 111.79 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.74 -64.88 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.75 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 63.6 m-80 -126.56 -81.36 0.61 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.71 -54.6 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.301 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.81 -38.1 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.82 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.2 mp0 -66.96 -45.01 79.07 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.49 -49.07 78.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.507 . . . . 0.0 110.945 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -45.25 93.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.861 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -45.88 79.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.138 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.69 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.588 0.555 . . . . 0.0 111.742 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.506 ' HG3' HG13 ' A' ' 22' ' ' ILE . 15.7 pt-20 -83.34 -27.76 29.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.326 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.506 HG13 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -115.04 24.1 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 119.772 -0.771 . . . . 0.0 113.047 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -132.65 -48.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.123 -0.36 . . . . 0.0 110.667 172.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.633 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.1 tm-20 51.76 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.28 1.032 . . . . 0.0 111.443 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.551 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 mtt85 -103.31 -4.88 23.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.246 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.72 15.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.908 0.755 . . . . 0.0 112.071 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -147.49 -57.4 0.25 Allowed 'General case' 0 C--O 1.23 0.048 0 O-C-N 122.03 -0.419 . . . . 0.0 111.468 179.168 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.401 ' C ' HG21 ' A' ' 29' ' ' VAL . . . -129.07 9.86 6.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.14 -1.028 . . . . 0.0 112.836 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 19.8 m 34.34 72.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 0.0 113.156 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.04 59.01 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -172.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.605 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -149.47 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.986 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.614 HD11 HG21 ' A' ' 9' ' ' VAL . 14.4 mm -48.72 111.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.341 0.591 . . . . 0.0 111.675 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -133.25 -118.0 1.87 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.455 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -1.88 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 110.257 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.2 40.93 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.412 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 4.9 m-20 59.7 -136.22 0.76 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.43 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.605 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 7.7 t-20 -128.41 37.11 4.18 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.745 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 39.2 -100.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.526 -174.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.985 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 m-85 -128.46 43.13 3.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.139 0.495 . . . . 0.0 111.254 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.745 HE21 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt20 -151.36 64.35 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.458 0.646 . . . . 0.0 110.123 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 41' ' ' ILE . 1.3 tp -120.92 -11.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 122.161 0.981 . . . . 0.0 108.771 -175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -163.12 125.68 1.43 Allowed Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 109.12 -96.78 1.01 Allowed Glycine 0 C--N 1.303 -1.276 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.937 170.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.8 m80 79.99 -65.09 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.882 0.873 . . . . 0.0 111.882 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 p -94.14 -76.57 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.599 HD21 ' HG2' ' A' ' 49' ' ' MET . 0.5 OUTLIER -79.92 -4.14 51.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.105 177.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 1.004 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 mmtp 53.5 64.22 1.92 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 178.19 1.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.256 -172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.599 ' HG2' HD21 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -57.09 -35.52 69.51 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 177.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.74 62.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.47 0.652 . . . . 0.0 110.265 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 55' ' ' VAL . 58.6 t -65.7 -24.13 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.165 177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.13 -11.26 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.064 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.62 -50.27 8.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.823 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -121.65 -30.73 4.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 0.0 111.588 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 51' ' ' VAL . 12.2 t -73.17 -38.56 55.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 22.6 t-160 -35.2 -56.48 0.6 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.473 1.108 . . . . 0.0 113.371 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -138.66 14.55 2.72 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.191 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.2 -29.12 4.93 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.475 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.631 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -123.45 -27.06 4.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.504 -173.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -63.54 -16.75 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.328 0.585 . . . . 0.0 109.871 172.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -67.13 -32.41 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.835 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.51 -76.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.9 135.51 11.05 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.704 0.288 . . . . 0.0 110.742 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 62.1 Cg_endo -75.74 119.48 5.45 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.62 2.213 . . . . 0.0 112.314 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -49.67 12.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 12.9 mttt 60.52 -137.77 0.63 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.918 0.487 . . . . 0.0 111.48 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 t 62.71 26.41 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.626 0.77 . . . . 0.0 112.025 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.4 62.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 111.494 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.778 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 p90 -158.6 -49.18 0.06 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-O 120.916 0.388 . . . . 0.0 111.97 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.004 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.18 63.7 2.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.735 -173.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.582 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 2.7 pm0 -170.87 138.79 1.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 111.769 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 84.5 Cg_endo -99.6 52.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.749 2.966 . . . . 0.0 111.882 171.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.985 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.1 m 67.64 66.64 0.38 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.145 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 72' ' ' PRO . 7.2 mt -134.55 -102.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.78 17.09 0.69 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.407 0.622 . . . . 0.0 110.048 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -69.63 -32.63 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.242 -171.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.605 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.08 -45.88 75.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.027 0.442 . . . . 0.0 110.866 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.605 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.49 -50.74 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.848 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -66.71 -13.56 61.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -89.82 -56.55 3.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.56 -33.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 78' ' ' ALA . . . -69.93 -18.36 63.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.957 0.408 . . . . 0.0 110.542 178.569 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.523 -0.086 0 CA-C-O 121.538 0.685 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -79.53 129.04 34.1 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.03 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 59.9 t 76.71 -85.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.52 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 159.87 71.68 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 124.232 0.958 . . . . 0.0 111.618 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 8.1 Cg_exo -72.96 109.24 2.77 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.035 1.823 . . . . 0.0 111.568 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -113.3 -74.71 0.62 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -177.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 8.2 p30 -141.22 38.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 13' ' ' ASN . . . 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.394 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.608 HG12 ' HH ' ' A' ' 59' ' ' TYR . 10.6 t -62.52 -48.97 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.7 OUTLIER -64.43 -44.45 91.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.011 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.83 -43.4 98.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.422 -178.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.616 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.1 ttpp -62.66 -50.53 70.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.007 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.847 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -57.39 -43.19 83.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.653 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.585 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.15 -40.17 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.677 0.61 . . . . 0.0 111.477 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -25.49 60.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.468 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.847 HD11 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -87.4 -39.11 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HH2' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -95.17 -36.27 11.54 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.5 -171.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.533 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.1 tm-20 53.78 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.796 0.838 . . . . 0.0 110.845 -173.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -114.6 -2.04 13.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.092 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.688 HG13 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.45 13.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.833 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.688 HD23 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -162.26 -55.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.58 178.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.4 -5.03 32.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.09 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 6.9 m 31.26 78.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.997 0.919 . . . . 0.0 113.295 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 41.76 0.35 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.722 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -136.2 -58.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.47 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 9' ' ' VAL . 5.7 mm -28.83 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 113.118 -176.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.77 -126.95 2.11 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.301 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -95.95 22.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.761 0.315 . . . . 0.0 110.677 -175.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER 175.87 54.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.716 -178.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.86 -126.79 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.347 1.07 . . . . 0.0 111.964 170.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.722 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 3.6 t-20 -146.77 36.13 0.95 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.201 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.88 -99.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.203 -168.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 1.007 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.78 42.13 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.502 . . . . 0.0 111.929 -177.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -150.97 61.69 0.92 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 178.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -59.4 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.417 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -133.69 84.11 0.29 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.23 -0.51 . . . . 0.0 111.885 -175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 147.75 -118.57 1.01 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 56.51 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.496 1.518 . . . . 0.0 114.59 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.9 p -94.62 -85.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.62 -17.23 62.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.75 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.838 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 9.1 mmtm 59.66 59.95 2.38 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.425 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 175.49 -2.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.599 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.482 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.8 mmm -55.07 -37.51 66.86 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.662 0.268 . . . . 0.0 111.017 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.609 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -70.27 -40.99 74.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.644 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 59.9 t -60.14 -21.84 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.622 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.729 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -108.91 -6.18 15.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.383 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.99 -47.19 7.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.443 ' OE1' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -113.32 -56.11 2.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.997 0.427 . . . . 0.0 109.884 -178.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 2.8 t -53.27 -45.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.333 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.729 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 19.0 t-160 -36.4 -56.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.84 3.24 9.46 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.199 -171.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HG2' ' HG2' ' A' ' 57' ' ' ARG . 73.8 mm-40 -119.93 -25.69 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.894 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 25.9 m-85 -125.49 -41.81 2.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.226 -172.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -12.6 59.53 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.737 0.303 . . . . 0.0 110.836 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.5 t -53.27 -31.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 168.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -81.82 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.709 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.34 131.15 24.15 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.78 0.324 . . . . 0.0 111.449 -171.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -91.52 113.92 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.856 2.371 . . . . 0.0 112.133 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -46.76 55.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 24.9 mtmt 68.11 -148.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 t 65.81 39.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.332 0.653 . . . . 0.0 112.146 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.11 37.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.252 0.549 . . . . 0.0 111.434 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 3.0 p90 -151.13 -51.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.838 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -97.37 65.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 111.433 -172.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG3' HD22 ' A' ' 77' ' ' LEU . 4.2 pm0 -155.25 129.36 4.71 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.19 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' ' 73' ' ' THR . 2.0 Cg_endo -85.64 62.63 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.044 2.496 . . . . 0.0 110.953 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 1.007 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 14.2 t 51.04 51.51 16.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.755 1.264 . . . . 0.0 112.121 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.5 mt -130.24 -179.66 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 113.593 -1.64 . . . . 0.0 106.981 168.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -80.57 14.7 1.95 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.779 0.799 . . . . 0.0 108.862 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -61.47 -26.64 68.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.086 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.667 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -52.68 -49.86 64.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.346 0.593 . . . . 0.0 110.349 176.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.667 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -79.83 -39.9 29.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.065 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.85 10.23 2.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.627 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -111.08 -59.66 1.94 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 t -75.45 -25.62 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.664 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 78' ' ' ALA . . . -95.68 0.48 52.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.564 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 177.276 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HG2' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 34' ' ' ILE . 2.4 t80 53.18 58.91 4.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.579 0.55 . . . . 0.0 111.579 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.7 t 67.02 91.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.586 0.708 . . . . 0.0 110.913 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.03 131.52 66.38 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.452 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.29 163.93 36.59 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.809 2.34 . . . . 0.0 112.556 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -106.52 -65.78 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 61.5 m-80 -126.94 -89.09 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.0 110.925 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.99 -59.66 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.088 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 58' ' ' GLU . 31.6 t -57.91 -40.35 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.512 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 13.0 mp0 -63.7 -46.43 85.53 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.829 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -62.93 -42.24 99.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.792 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.685 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 3.4 mtpm? -70.03 -40.82 74.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.674 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.01 -40.2 83.02 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.738 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -56.51 -38.61 72.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.4 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.9 pt-20 -75.96 -26.67 57.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.055 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 18' ' ' LYS . 6.7 mt -93.24 -36.8 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.539 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -90.01 -33.37 16.38 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.85 -172.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.858 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 58.01 -66.36 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.052 0.941 . . . . 0.0 111.674 -174.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.719 ' HB2' ' H ' ' A' ' 30' ' ' SER . 6.6 ttt85 -135.21 2.86 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.245 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.466 HG13 HD23 ' A' ' 27' ' ' LEU . 0.9 OUTLIER 54.65 20.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.466 HD23 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -162.15 -56.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.733 -0.605 . . . . 0.0 111.857 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.05 13.85 9.03 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.974 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.858 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 39.96 73.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.781 0.832 . . . . 0.0 112.697 177.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.719 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -158.28 59.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.718 177.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.586 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -124.84 -16.3 3.02 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.876 -172.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -97.2 82.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -116.41 43.67 1.61 Allowed Glycine 0 C--O 1.225 -0.463 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.022 -167.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 8.0 mm 79.03 -20.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.986 0.898 . . . . 0.0 110.09 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.635 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -147.5 42.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.846 -172.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 61.53 -143.22 0.45 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.083 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.586 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -127.54 36.75 4.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 41.51 -102.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.735 -173.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 1.076 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.0 m-85 -132.51 49.0 2.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.856 0.36 . . . . 0.0 111.012 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.75 57.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.893 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 tt -101.43 -33.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.859 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -122.74 -55.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.699 -174.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.31 -99.61 0.18 Allowed Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.554 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 60.23 -44.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.597 1.559 . . . . 0.0 114.52 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 p -97.19 -73.97 0.59 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.2 tp -75.1 -19.86 59.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.082 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 10.8 mmtp 56.11 54.36 7.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.903 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.82 -17.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.465 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.41 ' H ' ' HG2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -53.78 -34.86 60.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.75 0.31 . . . . 0.0 111.432 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.54 -29.77 52.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.97 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HA ' HG21 ' A' ' 55' ' ' VAL . 3.2 t -66.25 -29.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.686 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -92.61 -19.39 21.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.099 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 -49.9 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.811 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.531 ' HB3' HD22 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -122.45 -47.13 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.153 -177.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' A' ' 51' ' ' VAL . 36.7 t -55.05 -47.69 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.064 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 20.9 t-160 -41.23 -48.36 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 112.826 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -118.86 5.74 11.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -170.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 15' ' ' VAL . 18.1 mm-40 -134.02 -19.33 2.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 14.1 m-85 -133.72 -44.2 0.81 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.386 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -15.9 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.233 0.539 . . . . 0.0 111.201 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 t -68.91 -31.08 49.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.361 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -129.08 -76.6 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.209 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.4 117.74 36.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.21 -48.91 13.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.741 2.961 . . . . 0.0 113.895 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.482 ' HB3' ' H ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER 61.72 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.492 0.495 . . . . 0.0 110.933 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.482 ' H ' ' HB3' ' A' ' 65' ' ' LEU . 72.2 mttt 61.75 -124.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.046 0.538 . . . . 0.0 111.105 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.869 HG13 ' HB2' ' A' ' 77' ' ' LEU . 3.3 t 63.35 49.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.991 0.516 . . . . 0.0 111.219 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 1.9 pt? -174.03 39.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.399 0.619 . . . . 0.0 112.059 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' A' ' 70' ' ' ALA . 4.4 p90 -151.45 -54.93 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.403 -0.811 . . . . 0.0 112.43 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -100.25 75.97 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.915 0.388 . . . . 0.0 111.428 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.522 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 3.8 pm0 -162.23 139.78 6.46 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.824 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HG2' HD13 ' A' ' 74' ' ' ILE . 85.1 Cg_endo -88.64 46.78 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.154 2.569 . . . . 0.0 112.563 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 1.076 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER 60.55 39.61 17.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.223 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.547 HD13 ' HG2' ' A' ' 72' ' ' PRO . 7.2 mt -139.96 48.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 122.304 -0.247 . . . . 0.0 110.562 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HA ' HD13 ' A' ' 77' ' ' LEU . 9.7 pttt 46.71 23.8 0.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.221 1.008 . . . . 0.0 112.502 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -72.41 -15.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.759 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.869 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.38 -44.38 92.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.312 0.577 . . . . 0.0 110.003 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 77' ' ' LEU . . . -72.3 -43.43 64.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.814 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -75.47 5.18 6.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.796 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.2 -62.49 1.31 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.73 -31.73 42.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.394 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.3 2.61 50.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.94 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.025 0.441 . . . . 0.0 109.934 176.641 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.366 0.603 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.49 109.01 5.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.201 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 62.1 t 70.25 -71.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.675 0.609 . . . . 0.0 111.756 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 81.55 0.19 Allowed Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.373 0.669 . . . . 0.0 110.967 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 34.3 Cg_exo -58.98 154.64 43.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.134 2.556 . . . . 0.0 112.036 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -86.97 -65.84 0.97 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.2 m-80 -128.53 -83.91 0.58 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.38 174.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.91 -49.84 0.22 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.447 0.642 . . . . 0.0 109.298 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.76 -45.74 91.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.691 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 34.6 mp0 -67.42 -43.01 82.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.611 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -54.49 -52.95 60.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -59.92 -44.64 94.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.87 89.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.023 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.01 -42.82 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 17' ' ' SER . 2.1 pt-20 -83.19 -14.24 53.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.315 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 22' ' ' ILE . 6.0 mm -91.31 -39.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 0.0 112.086 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HH2' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -93.14 -29.53 15.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -176.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG2' ' CA ' ' A' ' 29' ' ' VAL . 2.4 tp10 59.74 -64.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.409 1.084 . . . . 0.0 111.705 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.616 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -141.1 5.15 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.374 170.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.503 HG13 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 63.45 -5.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.622 1.169 . . . . 0.0 113.885 176.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -140.1 -60.78 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.855 0.359 . . . . 0.0 111.2 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.86 7.45 25.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.762 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.513 ' CA ' ' HG2' ' A' ' 24' ' ' GLU . 12.4 m 36.22 76.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.616 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -155.78 57.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.13 0.491 . . . . 0.0 110.009 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.61 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -125.39 -50.75 0.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.475 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG23 HG21 ' A' ' 9' ' ' VAL . 49.3 mm -60.6 108.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.527 0.68 . . . . 0.0 111.086 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 35' ' ' LEU . . . -159.93 -163.59 13.75 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.506 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -76.24 14.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 111.511 -175.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -158.68 7.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 177.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 51.08 -127.07 2.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.753 -176.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -128.55 26.22 5.66 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.091 -176.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.84 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.552 1.158 . . . . 0.0 111.291 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -135.21 51.54 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.044 0.449 . . . . 0.0 110.768 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -154.72 51.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.982 0.42 . . . . 0.0 111.009 176.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.1 tt -106.35 -15.28 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.345 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.52 45.64 0.46 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.83 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.36 -123.73 0.69 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.846 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.683 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 13.5 p-80 58.82 -47.89 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.061 1.744 . . . . 0.0 114.346 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -96.01 -68.9 0.78 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.302 0.573 . . . . 0.0 110.272 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 tp -78.73 -18.22 54.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.092 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 48.47 52.38 13.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 173.74 10.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.97 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.437 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.1 mmt -64.24 -39.27 93.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.364 0.602 . . . . 0.0 109.449 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB1' ' HH2' ' A' ' 23' ' ' TRP . . . -78.84 -30.55 45.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.45 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 11.0 t -63.95 -28.23 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.109 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.15 -18.74 17.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 49' ' ' MET . . . -73.55 -51.95 15.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.09 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.89 -41.35 2.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.366 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.935 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 66.4 t -58.56 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.2 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -54.91 -38.98 68.31 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.39 -4.84 16.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -168.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -142.9 -11.07 0.77 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.935 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 10.5 m-85 -124.88 -48.01 1.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.79 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.7 -18.84 63.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.019 0.437 . . . . 0.0 110.918 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 61' ' ' VAL . 3.2 t -68.4 -32.87 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.268 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 -74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.873 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.11 127.91 15.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.74 0.305 . . . . 0.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.93 118.58 5.76 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.539 2.159 . . . . 0.0 112.09 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -90.99 -63.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.605 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 4.6 mtpt 64.15 -132.75 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.7 0.4 . . . . 0.0 111.375 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.632 HG12 HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER 60.12 33.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.483 0.713 . . . . 0.0 112.599 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -170.27 46.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.444 0.64 . . . . 0.0 112.37 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.8 p90 -156.33 -47.78 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.418 -0.801 . . . . 0.0 112.752 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.42 50.9 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.196 0.522 . . . . 0.0 111.686 -172.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.74 132.72 4.2 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.683 ' HA ' ' HB3' ' A' ' 44' ' ' HIS . 31.5 Cg_endo -69.21 -40.67 5.86 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.169 1.913 . . . . 0.0 111.278 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 8.8 t 168.27 45.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 123.427 1.584 . . . . 0.0 108.208 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -118.97 176.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 112.628 -2.078 . . . . 0.0 107.482 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.471 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -81.66 17.28 1.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.25 -25.49 68.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.891 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.766 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.98 -44.63 96.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.421 . . . . 0.0 110.911 176.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.766 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.22 -41.52 49.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.175 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -29.8 70.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.312 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -73.77 -48.15 33.76 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.133 -178.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 t -73.99 -24.86 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.67 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.39 177.456 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -65.27 119.07 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.062 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 32' ' ' ILE . 3.4 t 56.74 51.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.96 116.78 1.01 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.988 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.21 151.09 20.47 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.759 2.306 . . . . 0.0 112.217 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.1 -74.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.943 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -128.92 39.94 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.1 -57.53 0.42 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.294 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.22 -47.93 91.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 -44.04 97.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.995 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 -44.86 87.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.6 ttpp -64.25 -40.87 96.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.349 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.497 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.4 -43.76 68.16 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.554 0.533 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.8 -13.8 57.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.666 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' HG21 ' A' ' 22' ' ' ILE . 44.9 mm -102.7 -16.62 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 112.025 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -111.3 -32.67 6.66 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.217 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.771 ' HG3' HG12 ' A' ' 32' ' ' ILE . 6.0 tt0 61.22 -66.45 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.983 0.913 . . . . 0.0 111.801 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.764 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.81 2.09 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 67.25 -15.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.139 . . . . 0.0 113.308 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -136.14 -53.53 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.048 0.452 . . . . 0.0 111.074 -175.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.45 4.18 32.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.175 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 3.3 m 34.77 74.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.949 1.029 . . . . 0.0 112.927 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.764 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -156.94 61.43 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.886 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.674 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . -121.61 -46.78 0.31 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.665 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.771 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.1 mm -44.47 121.61 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.565 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.91 -161.18 12.63 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.78 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.556 HD12 HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -66.47 -5.86 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.008 0.523 . . . . 0.0 111.607 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.591 HD12 ' HD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -171.53 38.18 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 175.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 2.5 m-20 45.08 -121.27 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.394 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.601 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 1.8 m-20 -112.83 41.2 2.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.591 ' HD1' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 42.02 -93.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.411 1.069 . . . . 0.0 111.404 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.4 59.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.71 ' HB2' ' HE2' ' A' ' 44' ' ' HIS . 2.0 pt20 -164.32 66.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.25 0.547 . . . . 0.0 110.704 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -111.27 -32.45 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.581 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.44 86.66 0.14 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.48 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.734 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 168.84 -126.67 1.41 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.405 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.71 ' HE2' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m80 66.28 -54.14 0.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -72.57 -74.09 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.338 0.59 . . . . 0.0 109.9 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.555 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 7.4 tp -93.73 -10.21 35.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.172 173.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.616 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.9 mmtp 55.53 67.65 0.98 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.139 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 173.19 1.97 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.128 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.734 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 7.6 mmm -61.13 -34.11 74.47 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 -177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.44 65.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.413 0.625 . . . . 0.0 109.976 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.5 t -63.29 -24.13 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.317 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.99 -12.21 16.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.489 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 49' ' ' MET . . . -86.68 -51.11 6.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.448 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.16 -35.94 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.718 -174.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.911 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 58.8 t -70.08 -40.94 78.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.342 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.8 t-160 -44.2 -52.2 7.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.996 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.79 13.97 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 65.8 mm-40 -135.85 -7.8 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.834 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.911 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -134.46 -42.16 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.875 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -21.54 64.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.8 t -58.1 -32.05 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.922 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.69 -80.67 0.63 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 135.81 18.15 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.265 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 73.8 Cg_endo -82.01 115.86 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.331 2.021 . . . . 0.0 112.011 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -40.27 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.422 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.5 mtmt 58.25 -120.64 1.21 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.391 0.432 . . . . 0.0 110.898 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 66' ' ' LYS . 15.9 m 48.37 25.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.208 1.403 . . . . 0.0 114.573 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HA ' HD22 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -173.19 66.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.0 111.887 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 5.3 p90 -162.98 -47.69 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 -176.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.616 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -99.33 84.53 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.907 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.771 HE21 HD23 ' A' ' 77' ' ' LEU . 0.6 OUTLIER -158.75 148.96 15.47 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HG2' HD13 ' A' ' 74' ' ' ILE . 58.5 Cg_endo -100.34 40.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.014 3.143 . . . . 0.0 111.403 168.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.49 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER 55.52 55.37 7.37 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.767 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.656 HD13 ' HG2' ' A' ' 72' ' ' PRO . 4.3 mt -134.38 -103.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HG2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -139.68 16.23 2.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.233 0.539 . . . . 0.0 110.261 175.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.82 -32.14 73.7 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.77 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.771 HD23 HE21 ' A' ' 71' ' ' GLN . 0.2 OUTLIER -59.14 -44.64 92.07 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.408 0.623 . . . . 0.0 110.523 178.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' N ' HD12 ' A' ' 77' ' ' LEU . . . -74.74 -43.44 54.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.255 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -27.49 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.301 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.2 t80 -66.86 -53.4 32.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.418 0.628 . . . . 0.0 109.383 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 66' ' ' LYS . 99.1 t -71.28 -23.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.643 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.41 -0.04 39.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.48 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.972 0.415 . . . . 0.0 109.932 174.273 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 9.0 pt20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.977 0.418 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.435 ' CE1' HG21 ' A' ' 32' ' ' ILE . 1.6 t80 -69.46 121.23 16.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.79 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 2.0 t 56.63 49.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.74 109.71 1.09 Allowed Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.26 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.59 165.49 1.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.383 2.722 . . . . 0.0 111.837 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.02 -69.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.282 174.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.9 m-80 -124.55 -86.9 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.491 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.68 -49.64 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.0 t -60.54 -43.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.785 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 8.9 mp0 -67.68 -48.82 65.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.023 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -41.79 92.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.91 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -46.69 88.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.891 HD23 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -60.34 -48.96 79.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.826 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.08 -40.25 57.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.544 0.527 . . . . 0.0 111.622 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -87.0 -12.54 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.325 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.42 -38.77 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.931 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.608 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -101.52 -29.82 11.76 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -174.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.784 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 2.2 tt0 57.37 -68.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.011 0.924 . . . . 0.0 111.496 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.483 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -130.6 2.59 4.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 175.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.586 HG23 ' HE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 64.55 0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.308 1.043 . . . . 0.0 113.586 177.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 -57.76 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.15 -0.344 . . . . 0.0 111.367 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.67 -1.0 29.09 Favored Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.964 -172.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.784 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 39.35 67.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.337 0.655 . . . . 0.0 112.393 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 60.04 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.958 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.619 ' HA3' HD22 ' A' ' 37' ' ' ASN . . . -127.76 -15.26 2.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.238 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.435 HG21 ' CE1' ' A' ' 8' ' ' TYR . 43.2 mm -71.8 83.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.009 0.433 . . . . 0.0 110.1 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.52 -85.66 1.87 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.938 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.441 HD12 HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -136.95 -5.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 110.731 177.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.813 HD13 ' HD1' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -167.53 43.56 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.897 -178.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m-20 49.63 -129.04 2.11 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.705 -173.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.634 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 61.9 m-80 -116.54 27.06 9.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.813 ' HD1' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 40.92 -91.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.113 0.883 . . . . 0.0 111.744 -175.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.7 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.83 40.81 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.258 0.551 . . . . 0.0 111.696 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -138.72 52.59 1.79 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.712 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 42' ' ' GLY . 3.9 tt -110.78 -28.1 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 41' ' ' ILE . . . -144.66 45.99 0.83 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.983 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -179.34 -103.0 0.17 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.755 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' GLN . 4.8 p-80 59.96 -50.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.223 1.809 . . . . 0.0 113.898 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 p -106.06 -68.31 0.88 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.445 HD23 ' SD ' ' A' ' 49' ' ' MET . 19.7 tp -74.22 -25.93 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.89 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 7.0 mmtp 53.24 63.66 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.9 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.0 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.242 -174.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' HD23 ' A' ' 46' ' ' LEU . 31.1 mmm -52.82 -42.46 65.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.489 0.185 . . . . 0.0 111.242 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.59 51.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.556 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HA ' HG22 ' A' ' 55' ' ' VAL . 16.0 t -62.65 -29.1 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.971 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.91 -20.78 15.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.664 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.2 -51.78 12.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.038 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.891 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.7 pm0 -120.93 -38.03 2.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.143 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 30.2 t -64.62 -41.86 93.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.312 -174.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -40.41 -59.36 1.34 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -132.14 18.41 4.51 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 9.5 mm-40 -130.16 -6.4 4.36 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.829 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 40.0 m-85 -137.83 -54.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.567 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -19.0 65.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.33 . . . . 0.0 111.337 -174.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.29 -34.94 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.325 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.69 -73.51 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.957 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 113.95 9.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.947 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.66 127.23 15.15 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.664 2.243 . . . . 0.0 111.615 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -58.21 2.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.653 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 14.1 mttt 62.35 -134.49 0.5 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.421 0.288 . . . . 0.0 110.98 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 t 60.73 27.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.14 62.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 111.524 177.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 5.6 p90 -165.84 -50.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.705 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.864 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -87.83 45.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.609 -173.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' HIS . 3.8 pm0 -154.12 143.2 14.84 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.8 Cg_exo -64.7 -56.47 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.313 2.009 . . . . 0.0 110.853 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.8 t 170.72 48.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.817 0.818 . . . . 0.0 109.898 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.55 -106.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.576 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.21 13.69 2.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.059 0.456 . . . . 0.0 110.531 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.66 68.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.216 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.7 -48.31 75.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.551 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.707 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.14 -43.77 66.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.164 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.24 0.06 12.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.238 0.542 . . . . 0.0 111.403 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -100.46 -63.31 1.14 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.81 -28.67 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.596 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -95.54 10.08 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.488 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.485 173.648 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 45.1 t80 -74.73 116.71 15.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t 56.53 55.73 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.682 0.753 . . . . 0.0 109.276 -168.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -49.62 126.91 18.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.078 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 17.4 Cg_exo -68.29 138.58 43.35 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.063 2.508 . . . . 0.0 112.32 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.595 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -103.94 -73.98 0.66 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.791 0.329 . . . . 0.0 110.345 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -137.01 45.61 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.054 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.21 -69.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.246 0.619 . . . . 0.0 111.165 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.39 -48.76 76.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.595 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.49 -34.95 79.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.542 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -62.08 -45.14 94.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.124 0.488 . . . . 0.0 110.526 178.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 18.2 ttpt -64.76 -40.96 96.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.377 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -34.29 77.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.533 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -58.41 -44.52 89.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.657 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 2.4 pt-20 -79.29 -14.17 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 18' ' ' LYS . 2.2 mm -118.22 32.32 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.279 . . . . 0.0 111.719 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.66 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -144.96 -47.82 0.24 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.724 171.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 28.1 tt0 60.48 -65.65 0.05 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.058 0.943 . . . . 0.0 112.306 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -134.77 -1.76 2.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG13 HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 63.62 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.635 HD22 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.13 -51.65 0.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.048 -0.408 . . . . 0.0 111.102 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.65 -14.98 28.24 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.111 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 43.29 72.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 124.423 0.719 . . . . 0.0 112.018 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 m -162.51 70.37 0.28 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.551 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -169.94 10.2 0.05 OUTLIER Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.01 -1.091 . . . . 0.0 114.477 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.31 129.74 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 117.949 0.875 . . . . 0.0 110.022 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.19 5.87 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.073 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -79.59 18.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.401 0.28 . . . . 0.0 111.754 -176.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.555 HD13 ' HD1' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -179.33 42.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 7.3 m-20 59.73 -121.47 1.04 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.707 ' HB2' HD13 ' A' ' 41' ' ' ILE . 2.4 t-20 -128.82 43.79 3.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.555 ' HD1' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 42.49 -101.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.147 0.905 . . . . 0.0 111.229 -175.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -124.49 43.77 2.93 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.553 ' HA ' ' HE2' ' A' ' 44' ' ' HIS . 1.1 pt20 -160.8 67.38 0.32 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.707 HD13 ' HB2' ' A' ' 37' ' ' ASN . 0.7 OUTLIER -105.66 -41.05 6.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.11 89.98 0.13 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.092 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 160.52 -121.93 1.08 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 66.52 -51.99 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 113.013 174.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -84.0 -73.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.296 0.569 . . . . 0.0 110.277 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 9.5 tp -84.29 -13.19 53.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.457 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 1.068 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.5 mmtm 51.12 65.28 1.53 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.604 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.65 -6.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.307 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.788 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 21.4 mmm -53.42 -37.79 62.88 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.183 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 69' ' ' PHE . . . -74.84 -35.73 62.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.186 0.517 . . . . 0.0 110.596 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.586 ' HA ' HG21 ' A' ' 55' ' ' VAL . 59.2 t -61.87 -27.52 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.211 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.59 -15.86 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 49' ' ' MET . . . -77.74 -48.54 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.621 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 10.7 pm0 -127.83 -39.85 1.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.165 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.623 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -58.55 -51.33 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.337 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.4 t-160 -59.43 -26.62 65.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -174.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.98 -4.44 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -138.12 -19.82 1.12 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.623 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 37.2 m-85 -124.76 -50.43 1.72 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.221 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -12.0 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.606 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.88 -30.89 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.293 0.568 . . . . 0.0 110.051 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.72 -62.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.601 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.58 140.25 14.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.77 154.1 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.517 2.145 . . . . 0.0 111.819 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -119.23 -42.77 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.937 179.243 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.605 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mppt? 63.87 -145.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.587 0.355 . . . . 0.0 111.367 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 81' ' ' VAL . 2.0 t 65.6 26.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -166.33 42.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 111.849 174.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.597 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.5 p90 -148.2 -45.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 1.068 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.86 53.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.056 0.455 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.456 ' HA ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -141.33 119.15 7.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HG2' HD12 ' A' ' 74' ' ' ILE . 23.4 Cg_exo -65.95 -69.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.478 2.118 . . . . 0.0 111.285 170.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -179.7 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 109.806 175.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.546 HD12 ' HG2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.94 38.62 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.458 -171.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 60.34 23.61 13.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.172 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 71' ' ' GLN . . . -66.27 -24.77 66.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -55.1 -48.64 73.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.487 175.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.66 62.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.487 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 -6.95 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -100.02 -50.77 3.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 67' ' ' VAL . 5.8 p -69.47 -23.05 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.997 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.18 18.66 14.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.233 0.539 . . . . 0.0 110.697 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.0 m . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.269 176.573 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 120.684 0.278 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 8.5 t80 49.24 82.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.127 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.623 ' HB ' HD12 ' A' ' 32' ' ' ILE . 3.3 p 33.94 96.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 124.97 1.419 . . . . 0.0 112.42 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.43 115.18 27.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.242 -169.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.0 Cg_endo -95.8 138.73 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.891 3.061 . . . . 0.0 112.586 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -128.12 -71.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.43 60.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.628 -0.429 . . . . 0.0 112.064 -169.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -46.87 -47.8 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 122.949 0.5 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -44.04 74.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.556 -176.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.21 -51.96 66.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.391 -177.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.595 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.87 -38.48 91.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.771 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -67.6 -44.92 76.92 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.568 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.42 -38.36 68.86 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.453 0.471 . . . . 0.0 111.611 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -86.73 -19.2 29.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.34 . . . . 0.0 110.67 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -90.08 -29.52 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -174.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.557 ' HZ3' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -102.68 -27.86 12.47 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 -176.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 6.8 tm-20 59.71 -79.81 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.943 0.897 . . . . 0.0 110.513 -175.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HB2' ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -115.88 -12.25 11.43 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.838 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 58.01 5.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.356 1.035 . . . . 0.0 113.146 -173.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.17 -55.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.798 -0.564 . . . . 0.0 110.876 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.79 -13.88 5.91 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.771 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.547 ' O ' HG21 ' A' ' 29' ' ' VAL . 16.5 m 46.44 96.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 122.558 1.17 . . . . 0.0 112.192 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -86.33 -37.97 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.253 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . 139.13 70.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.842 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.623 HD12 ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -55.31 127.97 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 177.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.36 -138.82 2.61 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.617 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -70.55 -2.54 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -117.73 -4.08 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 9' ' ' VAL . 5.3 t70 62.03 -142.03 0.44 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.759 ' HB2' HD13 ' A' ' 41' ' ' ILE . 3.2 m-80 -135.41 23.99 3.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.2 -97.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.489 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.947 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.8 m-85 -122.22 37.32 4.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.043 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -155.56 63.59 0.6 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.429 . . . . 0.0 110.804 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.759 HD13 ' HB2' ' A' ' 37' ' ' ASN . 1.2 tt -108.76 -21.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 0.0 111.041 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.83 96.9 0.16 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.636 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 49' ' ' MET . . . 124.11 -117.7 3.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.596 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 16.4 p-80 56.89 -26.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.196 1.399 . . . . 0.0 114.501 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 43' ' ' GLY . 1.2 p -89.4 -75.04 0.45 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.117 0.484 . . . . 0.0 109.909 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -11.77 57.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.994 174.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 15.0 mmtp 57.23 64.32 1.65 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.467 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.81 -9.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.774 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.559 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.7 mmt -50.32 -42.51 52.87 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' HH2' ' A' ' 23' ' ' TRP . . . -75.21 -30.11 60.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.829 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 53.3 t -64.28 -27.41 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.029 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.32 -21.38 14.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.557 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -77.16 -46.61 22.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.714 ' HB3' HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -120.78 -50.37 2.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.493 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 53.9 t -52.1 -45.69 42.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 14.4 t-160 -39.63 -56.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.902 0.752 . . . . 0.0 112.753 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -114.02 1.61 14.71 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -116.27 -23.34 8.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -134.12 -42.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.533 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.93 55.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.703 0.287 . . . . 0.0 111.371 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.97 -36.09 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.388 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -121.06 -70.42 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.674 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.03 117.72 9.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.91 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 10.2 Cg_exo -69.73 121.56 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.522 2.148 . . . . 0.0 111.442 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -54.14 4.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.843 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 64.92 -116.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.492 -177.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.637 HG13 HD21 ' A' ' 77' ' ' LEU . 0.5 OUTLIER 57.96 27.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.5 0.72 . . . . 0.0 112.557 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.4 69.71 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 111.132 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.1 p90 -165.22 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.694 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.71 51.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.129 0.49 . . . . 0.0 111.16 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.519 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.27 136.03 6.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.511 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.85 -36.09 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.159 1.906 . . . . 0.0 111.736 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.947 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 10.1 t 171.22 51.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.907 1.336 . . . . 0.0 109.541 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.64 ' C ' ' H ' ' A' ' 76' ' ' ALA . 6.2 mt -133.33 162.24 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.667 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.407 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -73.36 22.97 0.07 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 172.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -65.41 -27.73 68.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.7 -39.9 86.14 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.947 177.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -76.41 -44.98 33.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -66.45 -18.04 65.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.612 -176.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.98 -53.24 5.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.612 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 81' ' ' VAL . 25.7 t -72.58 -34.53 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.965 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 110.425 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 83' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.1 t80 56.21 89.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.557 -173.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER 63.83 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.06 -166.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.17 109.05 54.65 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.554 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.81 115.92 3.68 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.796 2.331 . . . . 0.0 111.693 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -55.51 3.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.193 0.52 . . . . 0.0 109.854 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -128.04 -101.55 0.34 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.98 -45.56 0.65 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.89 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.488 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -63.44 -44.64 93.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.123 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -48.7 79.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.283 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 22' ' ' ILE . 2.5 mtpm? -61.5 -41.52 97.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 54' ' ' GLN . 2.4 mp -66.18 -44.09 85.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.251 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -50.81 -43.41 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.612 0.57 . . . . 0.0 111.346 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -80.78 -23.84 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.667 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 18' ' ' LYS . 40.3 mm -90.72 -32.32 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -95.13 -30.08 14.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.929 -176.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.649 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER 59.22 -64.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.511 1.124 . . . . 0.0 112.309 -175.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -135.94 -1.57 2.43 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.827 HG13 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 68.28 -14.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.254 1.022 . . . . 0.0 112.954 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.827 HD23 HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -138.71 -57.53 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.76 -1.24 58.79 Favored Glycine 0 CA--C 1.5 -0.883 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.569 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 35.21 50.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 113.999 -1.1 . . . . 0.0 112.978 -179.03 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -149.35 57.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.371 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.415 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -133.05 -5.05 3.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.883 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.436 HG12 ' HA ' ' A' ' 24' ' ' GLU . 5.2 mm -76.18 108.98 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 117.736 0.768 . . . . 0.0 109.975 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.74 -153.42 7.83 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.415 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.674 HD12 HD21 ' A' ' 35' ' ' LEU . 0.6 OUTLIER -70.91 -1.06 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.674 HD21 HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -167.9 51.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 12.9 m-20 60.37 -135.66 0.7 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -104.12 46.75 0.9 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.81 -98.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.284 0.99 . . . . 0.0 109.908 -168.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -136.26 50.48 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 110.349 175.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -150.78 45.32 0.85 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.673 172.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -90.34 -27.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.401 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.34 54.84 0.62 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.718 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 179.97 -81.78 0.06 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.505 ' HE2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 62.52 -60.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.967 1.707 . . . . 0.0 112.611 170.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 p -121.43 -50.13 2.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.472 0.653 . . . . 0.0 109.869 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 tp -68.73 -29.6 68.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.268 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.759 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.1 mmtp 48.76 57.42 6.38 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.632 0.582 . . . . 0.0 111.262 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.14 -5.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.934 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.718 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 7.0 mtp -56.41 -40.62 74.98 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.977 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . . . -79.11 -31.82 44.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.29 0.567 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 10.7 t -62.15 -25.43 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.473 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.48 -16.58 14.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.221 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -70.78 -54.72 10.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.9 pm0 -128.21 -29.67 2.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.197 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.882 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 77.8 t -66.05 -36.91 78.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.98 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.8 t60 -50.45 -51.17 49.17 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 57' ' ' ARG . 8.4 ptp85 -131.28 12.7 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.577 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 72.6 mm-40 -123.97 -12.88 7.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.282 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.882 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 6.9 m-85 -127.59 -41.88 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.924 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -14.24 36.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.2 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 t -61.64 -31.51 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.082 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.9 -74.74 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.351 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.62 137.05 8.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.54 150.16 13.06 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.699 2.266 . . . . 0.0 112.93 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.84 -60.62 2.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.343 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.1 mttt 73.72 -141.95 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.692 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 m 57.34 21.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.153 0.981 . . . . 0.0 112.355 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -159.57 46.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.753 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.557 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 p90 -148.65 -55.23 0.2 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.111 -0.368 . . . . 0.0 111.317 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.759 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.19 60.79 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.473 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.93 ' HG3' ' HB3' ' A' ' 77' ' ' LEU . 2.5 pm0 -174.19 150.34 1.55 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.793 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HG2' HD12 ' A' ' 74' ' ' ILE . 5.2 Cg_endo -90.55 -77.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.299 2.666 . . . . 0.0 112.113 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.608 ' HA ' ' CD2' ' A' ' 39' ' ' PHE . 14.3 t -161.97 22.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.556 0.693 . . . . 0.0 110.344 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 72' ' ' PRO . 2.0 mt -108.54 39.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.818 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 16.45 5.49 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.081 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . . . -69.63 -28.63 66.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.171 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.93 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -56.71 -41.36 77.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.948 0.404 . . . . 0.0 111.231 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.607 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -76.11 -45.61 33.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.092 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.75 1.9 11.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.154 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.55 -56.8 2.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 81' ' ' VAL . 47.7 t -74.9 -26.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.092 -176.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 78' ' ' ALA . . . -86.22 3.24 43.87 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.44 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.405 0.621 . . . . 0.0 109.978 174.258 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpp? . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.018 0.437 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.24 122.81 2.9 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.917 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.29 128.57 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.707 0.289 . . . . 0.0 110.517 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.48 169.04 9.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.3 pm0 -79.14 80.96 5.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.321 0.582 . . . . 0.0 111.743 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.43 -54.1 6.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.5 36.09 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.512 0.672 . . . . 0.0 109.763 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 3.5 t80 -46.95 124.05 5.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.575 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 51.35 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.456 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' H ' HG11 ' A' ' 9' ' ' VAL . . . -167.11 97.66 0.66 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.497 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.1 124.37 10.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.678 2.252 . . . . 0.0 111.602 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -74.15 0.66 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.44 37.29 4.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.181 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.34 -62.64 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.055 0.542 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -45.87 90.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 0.0 110.207 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.09 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -44.18 97.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.209 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -63.76 -34.55 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.433 0.635 . . . . 0.0 110.193 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.684 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -67.09 -45.59 76.82 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.063 177.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.485 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.55 -40.5 62.61 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.586 0.553 . . . . 0.0 111.589 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -79.28 -24.74 42.72 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.925 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -87.89 -27.43 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.594 ' HH2' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -109.82 -38.18 5.44 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.238 -175.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.6 tm-20 52.89 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.863 0.865 . . . . 0.0 110.642 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -110.27 -9.18 14.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.457 -177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 66.03 -2.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.702 -176.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.1 -54.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.064 -0.398 . . . . 0.0 111.487 -176.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -110.09 -6.48 27.88 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.51 HG22 ' C ' ' A' ' 28' ' ' GLY . 2.3 m 32.93 80.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.898 0.879 . . . . 0.0 112.987 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.49 60.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.586 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -145.4 -59.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.653 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 37' ' ' ASN . 12.8 mm -38.92 110.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.556 0.743 . . . . 0.0 112.149 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 35' ' ' LEU . . . -134.78 -143.09 4.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.708 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -75.18 15.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.648 0.379 . . . . 0.0 111.882 -175.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 33' ' ' GLY . 0.2 OUTLIER -165.83 39.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.24 179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 12.0 t70 64.21 -142.42 0.28 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.683 0.614 . . . . 0.0 110.018 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.586 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 8.2 t-20 -127.55 47.85 2.32 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 44.06 -101.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.691 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.705 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -140.9 55.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.758 0.313 . . . . 0.0 110.733 177.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.5 pt20 -149.38 60.63 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.495 0.664 . . . . 0.0 110.956 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 tt -106.81 -20.22 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.112 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.49 ' HA2' ' HE1' ' A' ' 49' ' ' MET . . . -150.96 33.22 0.96 Allowed Glycine 0 C--O 1.229 -0.163 0 C-N-CA 119.825 -1.179 . . . . 0.0 113.29 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.07 -107.62 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.882 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 15.7 p-80 59.62 -51.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.015 1.726 . . . . 0.0 114.263 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 p -96.53 -65.65 0.95 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.605 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.6 OUTLIER -92.33 -12.74 31.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.245 177.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 44' ' ' HIS . 5.1 mmtp 49.75 63.32 2.22 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.452 0.47 . . . . 0.0 111.232 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.95 -9.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.882 -173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.605 ' HG2' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -54.7 -41.16 69.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 110.976 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.594 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -75.25 -33.02 61.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.709 ' HA ' HG21 ' A' ' 55' ' ' VAL . 41.4 t -62.41 -26.42 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.497 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.36 -20.8 15.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.795 0.331 . . . . 0.0 111.124 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 49' ' ' MET . . . -86.61 -43.47 12.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.941 -175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.684 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.23 -40.58 2.93 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.926 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG21 ' HA ' ' A' ' 51' ' ' VAL . 39.7 t -67.43 -59.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.848 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 70.1 t60 -51.79 -27.35 12.01 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -172.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 57' ' ' ARG . 9.5 ptt180 -127.08 2.45 6.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 7.4 mt-10 -138.99 -26.48 0.84 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 12.6 m-85 -126.43 -21.47 4.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.992 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -68.41 -15.12 63.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.79 -32.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.91 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 2.7 tp10 -126.38 -84.99 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.889 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -138.73 131.65 15.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 -175.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -86.32 112.53 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.602 2.201 . . . . 0.0 111.816 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -75.69 -32.11 59.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' HE3' HG11 ' A' ' 81' ' ' VAL . 21.0 mtmt 61.5 -138.79 0.51 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.875 ' HB ' HD22 ' A' ' 77' ' ' LEU . 2.4 m 55.46 21.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.975 . . . . 0.0 113.464 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.754 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -151.64 37.94 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.609 0.718 . . . . 0.0 111.697 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 7.5 p90 -153.8 -46.51 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.667 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.22 41.01 0.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.559 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.754 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.0 pm0 -153.06 138.65 11.75 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.298 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.0 Cg_endo -87.53 -42.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.15 2.567 . . . . 0.0 112.037 173.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.705 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 9.9 t 176.94 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.696 1.236 . . . . 0.0 109.609 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.636 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -121.51 163.04 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.96 24.35 0.13 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.836 0.827 . . . . 0.0 108.897 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.636 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -66.21 -21.6 66.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.003 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.875 HD22 ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.77 -34.83 75.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.453 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -83.5 -38.16 22.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.912 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.77 3.62 16.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.373 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -108.4 -56.48 2.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.058 0.456 . . . . 0.0 109.821 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.538 HG11 ' HE3' ' A' ' 66' ' ' LYS . 21.4 t -79.74 -11.72 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.655 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.05 21.61 13.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.781 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 m -134.85 -36.15 0.85 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.139 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -103.47 14.63 30.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 109.536 175.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 18.7 m . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.52 100.63 2.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.645 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.98 91.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 110.748 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 39.08 2.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -104.9 137.75 42.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -118.22 -82.17 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.581 ' HG2' ' O ' ' A' ' 7' ' ' GLN . 9.3 tt0 -147.78 87.17 1.61 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.41 1.1 . . . . 0.0 108.853 170.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 58.5 t80 -57.73 115.6 2.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.475 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 8' ' ' TYR . 89.8 t 73.38 115.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.611 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.49 101.45 42.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.54 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 174.76 11.13 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.703 2.269 . . . . 0.0 112.459 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.71 -68.44 0.72 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -112.43 -100.37 0.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.4 -50.09 0.92 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.571 . . . . 0.0 109.664 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 19' ' ' LEU . 85.4 t -63.21 -39.53 85.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.976 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -64.15 -37.97 89.37 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.515 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.4 73.25 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.49 -44.8 93.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.472 HD11 HG11 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -62.35 -44.27 96.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.977 -178.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.274 0.359 . . . . 0.0 110.779 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.7 pt-20 -80.78 -12.86 59.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.282 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 18' ' ' LYS . 25.4 mm -99.53 -37.47 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.612 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -88.7 -36.24 16.3 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.713 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 6.9 tt0 59.53 -57.47 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.623 1.169 . . . . 0.0 112.969 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.4 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.33 -6.35 1.79 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 66.07 -2.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.983 0.913 . . . . 0.0 112.802 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.71 -59.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.105 -0.372 . . . . 0.0 111.437 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.87 2.24 33.8 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.482 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 2.7 m 36.36 64.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.093 0.957 . . . . 0.0 113.02 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -152.44 59.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.958 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.49 -13.12 0.66 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.663 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mm -71.55 112.93 7.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 117.108 0.454 . . . . 0.0 110.055 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -150.48 -143.02 3.65 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.906 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.44 -0.39 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.04 34.4 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 t70 59.65 -136.34 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.752 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.628 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 12.4 m-80 -105.89 44.08 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -92.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.991 0.807 . . . . 0.0 111.107 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.576 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.14 51.44 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 110.643 177.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.665 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -147.9 61.64 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.242 0.544 . . . . 0.0 110.052 174.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 42' ' ' GLY . 6.4 tp -106.6 -43.44 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.13 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' C ' ' HG2' ' A' ' 49' ' ' MET . . . -121.78 44.79 1.29 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.869 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 176.06 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.938 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -53.48 0.31 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.606 1.562 . . . . 0.0 112.221 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.1 p -113.39 -65.34 1.2 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.564 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 33.1 tp -67.65 -31.29 71.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.573 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.858 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 8.1 mmtm 53.8 62.5 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.389 0.431 . . . . 0.0 110.7 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB1' ' HG ' ' A' ' 46' ' ' LEU . . . -172.59 -18.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.6 -29.97 69.54 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.654 -176.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.495 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . . . -76.39 -38.74 55.28 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.314 0.578 . . . . 0.0 110.055 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 28.9 t -61.13 -24.4 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.749 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -102.46 -17.15 15.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' MET . . . -76.0 -53.33 8.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.431 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.56 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.9 pm0 -122.3 -35.48 3.12 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.367 -175.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.86 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.6 t -63.33 -53.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.823 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.607 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 39.7 t60 -45.15 -46.78 12.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.19 5.14 8.52 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -168.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.18 -15.15 1.12 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.681 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.86 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.6 m-85 -125.46 -37.59 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.654 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -16.41 63.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.41 -32.48 48.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.819 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -114.65 -78.19 0.58 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.056 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.22 128.99 6.94 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.804 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.41 115.22 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -70.49 -40.85 73.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.593 ' HD2' HG13 ' A' ' 81' ' ' VAL . 10.1 mttt 61.76 -138.76 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.33 0.394 . . . . 0.0 111.036 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.544 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER 44.4 40.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.52 1.128 . . . . 0.0 113.308 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -164.87 37.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.821 0.82 . . . . 0.0 111.275 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -151.0 -49.74 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.858 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -89.99 57.51 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.467 ' CG ' ' HB3' ' A' ' 77' ' ' LEU . 2.9 pm0 -164.63 136.58 3.55 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.399 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 5.0 Cg_exo -79.11 -44.22 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.962 2.441 . . . . 0.0 111.51 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.576 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 8.4 t 174.1 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.806 1.289 . . . . 0.0 109.256 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 76' ' ' ALA . 2.1 mt -126.75 168.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.493 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.46 18.57 0.09 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.388 0.614 . . . . 0.0 109.53 173.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -67.64 -23.65 65.37 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.383 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.699 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -61.15 -43.92 98.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.142 179.251 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.44 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -75.68 -40.24 56.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.114 0.483 . . . . 0.0 110.063 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -70.17 -20.04 63.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.351 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -83.25 -56.72 3.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.186 0.517 . . . . 0.0 110.315 -177.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.593 HG13 ' HD2' ' A' ' 66' ' ' LYS . 98.1 t -69.1 -30.66 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.946 -175.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.34 -8.84 58.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m -101.45 -35.11 9.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -95.09 -23.1 17.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.412 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.57 ' O ' ' HD3' ' A' ' 84' ' ' ARG . 63.0 m . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.391 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.67 -103.68 0.21 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.24 82.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.126 0.965 . . . . 0.0 108.691 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.01 7.21 6.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.946 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -94.38 81.82 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.707 -175.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.58 -20.59 60.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.442 0.639 . . . . 0.0 109.929 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -78.02 -8.71 58.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.803 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.552 ' HD1' HG21 ' A' ' 9' ' ' VAL . 2.8 t80 -59.37 132.11 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.533 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.552 HG21 ' HD1' ' A' ' 8' ' ' TYR . 99.3 t 75.89 -55.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.116 0.567 . . . . 0.0 111.604 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 58.54 68.12 1.86 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.528 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 21.5 Cg_exo -65.43 160.2 43.9 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 112.318 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -67.76 0.86 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.951 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 64.0 m-80 -128.37 -89.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.198 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.79 -53.95 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 110.374 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.644 ' HA ' ' HD3' ' A' ' 18' ' ' LYS . 58.8 t -62.06 -41.44 91.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.345 0.593 . . . . 0.0 110.126 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.6 mp0 -63.52 -47.34 82.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.754 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.528 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.7 -46.53 89.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.478 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -64.85 -32.21 73.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.035 -178.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.778 HD21 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.41 -41.81 55.2 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.969 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.17 -41.61 62.74 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.567 0.542 . . . . 0.0 111.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.505 ' HG3' HG12 ' A' ' 22' ' ' ILE . 3.5 pt-20 -74.48 -38.47 62.88 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.505 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mm -109.63 45.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.47 ' HZ2' HG21 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -147.26 -32.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.134 169.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 15.8 tp10 65.04 -55.76 0.3 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.413 1.085 . . . . 0.0 112.482 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -150.24 -3.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.433 ' HB ' ' CE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 59.94 1.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.068 0.947 . . . . 0.0 113.545 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.401 ' HB3' ' HE2' ' A' ' 49' ' ' MET . 0.6 OUTLIER -141.33 -53.75 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.934 -0.479 . . . . 0.0 111.104 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.75 10.84 11.19 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.86 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER 35.05 72.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.078 0.951 . . . . 0.0 113.206 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.671 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -170.57 62.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.32 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.765 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -133.35 -45.39 0.12 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.042 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.438 ' HA ' HD13 ' A' ' 32' ' ' ILE . 39.8 mm -68.23 109.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 0.0 111.759 -171.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.32 -151.19 7.09 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG12 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.22 13.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.0 111.175 -177.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.474 ' HG ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -167.58 36.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.65 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' OD2' ' HB ' ' A' ' 41' ' ' ILE . 11.8 t70 62.12 -151.17 0.37 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.765 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -91.11 59.28 3.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.251 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 49.35 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.533 1.146 . . . . 0.0 110.13 -170.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -150.25 50.99 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.873 0.368 . . . . 0.0 110.589 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.858 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -169.79 67.55 0.05 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 110.873 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' HB ' ' OD2' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -86.41 -35.27 8.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.956 -0.465 . . . . 0.0 111.788 -174.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 41' ' ' ILE . . . -142.49 65.47 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.414 -172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.07 -119.97 0.58 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 58.14 -48.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.008 1.723 . . . . 0.0 114.266 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 p -94.16 -71.21 0.67 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.207 0.527 . . . . 0.0 109.633 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.0 tp -76.31 -22.01 55.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.177 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.685 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 12.9 mmtp 50.79 60.6 3.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.034 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.12 -5.97 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.296 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.493 ' HB3' ' HE3' ' A' ' 49' ' ' MET . 36.4 mmm -53.61 -43.12 68.38 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 111.17 -177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . . . -78.34 -30.54 48.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.202 0.525 . . . . 0.0 110.705 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -65.0 -27.23 41.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.813 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.16 -16.76 16.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.595 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . . . -71.2 -53.55 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.993 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.778 ' HB3' HD21 ' A' ' 19' ' ' LEU . 8.0 pm0 -128.11 -36.46 1.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.404 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 51' ' ' VAL . 60.5 t -60.38 -42.3 90.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.4 t-160 -54.3 -34.81 61.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 11.37 12.23 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.266 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 19.2 mm-40 -133.9 -25.54 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.9 -38.67 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.283 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -18.04 65.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.107 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.32 -31.54 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.242 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 1.1 tp10 -113.78 -82.63 0.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.75 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -138.4 117.58 9.62 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.82 123.3 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.024 2.483 . . . . 0.0 112.378 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -78.65 -41.5 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.836 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 30.5 mtmt 63.5 -141.24 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.937 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.78 30.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.054 0.542 . . . . 0.0 111.92 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.02 49.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -165.78 -48.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.855 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.685 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.5 67.29 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 111.132 -175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HG3' ' HG ' ' A' ' 77' ' ' LEU . 7.6 pm0 -161.68 147.28 10.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.55 -60.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.359 2.039 . . . . 0.0 110.615 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.858 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -171.29 -41.48 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.814 0.816 . . . . 0.0 111.146 177.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.43 59.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.806 -164.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.783 ' HA ' HD11 ' A' ' 77' ' ' LEU . 3.2 mttp 52.41 19.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.041 0.537 . . . . 0.0 111.79 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.721 ' HA ' ' HG2' ' A' ' 79' ' ' GLN . . . -64.93 -21.87 66.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.794 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -62.06 -49.32 76.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.458 175.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.794 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -70.21 -45.71 66.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.587 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.721 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 3.5 pt20 -68.06 -18.69 64.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -72.25 -52.57 15.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.621 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.76 -26.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.49 59.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 83' ' ' THR . 99.6 m -99.91 -15.4 18.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.552 0.691 . . . . 0.0 109.312 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.48 42.9 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.569 176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.71 0.291 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.75 -53.66 5.77 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.93 101.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.18 142.18 39.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.094 0.473 . . . . 0.0 111.413 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.95 79.73 2.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.953 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.53 -48.48 32.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.586 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 3.9 mt-30 -102.9 -81.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.552 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 37.0 t80 59.4 99.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 124.209 0.943 . . . . 0.0 109.589 -171.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.652 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 65.65 127.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.488 1.115 . . . . 0.0 110.381 -168.067 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.87 103.57 20.14 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.421 -173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 71.7 Cg_endo -95.38 152.18 1.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.026 2.484 . . . . 0.0 111.973 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -116.57 -65.9 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.353 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -124.15 -75.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.456 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.26 -54.82 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.926 0.393 . . . . 0.0 110.296 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.68 -38.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.404 0.621 . . . . 0.0 109.606 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -65.47 -43.96 88.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.969 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -63.84 -41.15 97.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.686 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.557 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 6.6 tptt -63.56 -33.74 76.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.349 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.547 HD12 ' HB3' ' A' ' 54' ' ' GLN . 7.8 mt -70.76 -47.43 59.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.31 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.46 39.29 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.401 0.438 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -75.15 -40.66 59.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.184 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -125.05 69.02 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.982 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HZ2' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -171.12 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.685 171.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.92 ' HG2' HG12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER 54.35 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.467 1.107 . . . . 0.0 111.555 175.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -105.68 -3.31 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.741 -175.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.06 9.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.889 0.876 . . . . 0.0 112.908 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -146.54 -57.35 0.28 Allowed 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.95 -0.469 . . . . 0.0 111.446 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.01 4.31 14.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.506 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.618 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 10.0 m 31.79 81.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.194 0.997 . . . . 0.0 113.69 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.91 64.98 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.155 -0.34 . . . . 0.0 111.895 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.574 ' HA3' HD22 ' A' ' 37' ' ' ASN . . . -157.44 -6.75 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.679 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.92 HG12 ' HG2' ' A' ' 24' ' ' GLU . 36.2 mm -53.83 118.71 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.23 -154.24 6.91 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -69.49 -4.42 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -175.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 25.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.146 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.652 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 67.7 m-20 44.77 -125.46 1.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.382 -175.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.574 HD22 ' HA3' ' A' ' 31' ' ' GLY . 14.2 m-80 -117.09 29.57 7.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CD2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER 38.56 -95.57 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.119 0.887 . . . . 0.0 111.736 -175.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.53 43.61 3.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.358 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 4.2 pt20 -139.72 54.93 1.67 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.644 HG22 ' HZ2' ' A' ' 23' ' ' TRP . 1.1 tt -110.99 -23.89 4.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.684 -167.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -154.93 59.07 0.39 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.975 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 173.79 -127.36 1.33 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 57.57 -28.51 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.77 1.628 . . . . 0.0 115.001 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 43' ' ' GLY . 8.4 p -92.23 -70.32 0.7 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.963 0.801 . . . . 0.0 110.293 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.731 HD21 ' HE1' ' A' ' 49' ' ' MET . 1.5 pp -102.5 -2.98 27.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.602 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 11.2 mmtp 51.85 66.86 1.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.593 0.558 . . . . 0.0 112.044 174.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.12 -10.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.731 ' HE1' HD21 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -58.03 -35.26 71.03 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.701 -178.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.563 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -72.09 -33.1 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 110.473 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 66.5 t -64.09 -26.97 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.095 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -98.82 -16.45 18.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . . . -75.87 -51.49 12.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.379 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.547 ' HB3' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.99 -48.28 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.949 0.404 . . . . 0.0 110.587 -176.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.5 t -55.12 -47.45 77.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.39 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.66 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.4 t60 -47.17 -43.46 21.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -121.63 3.74 10.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 -36.4 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 53.5 m-85 -118.03 -34.96 3.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -64.97 -13.62 57.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.445 0.64 . . . . 0.0 109.82 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.28 -35.23 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.622 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -124.03 -76.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.866 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.93 116.01 9.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.334 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -86.77 113.25 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.665 2.244 . . . . 0.0 112.736 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.829 HD21 ' H ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -83.18 -59.17 2.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.627 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.829 ' H ' HD21 ' A' ' 65' ' ' LEU . 18.6 mtmt 68.12 -111.72 0.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.268 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' CD2' ' A' ' 77' ' ' LEU . 0.9 OUTLIER 55.12 37.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.832 0.348 . . . . 0.0 111.337 -178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 1.4 pt? -165.53 42.86 0.07 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.761 0.791 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.3 p90 -151.03 -48.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -171.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -95.92 61.56 2.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 0.0 111.09 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.7 pm0 -164.77 148.99 7.88 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 3.8 Cg_exo -77.12 -72.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 110.956 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.422 HG23 ' CD2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -171.97 36.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.46 0.647 . . . . 0.0 110.729 178.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.46 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.2 OUTLIER -105.72 -121.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 40.4 mmtm -131.08 17.7 5.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.36 -37.6 83.94 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.198 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.827 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -56.41 -42.15 77.53 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.754 0.312 . . . . 0.0 111.672 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.492 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -68.24 -48.92 63.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.702 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 1.1 pt20 -78.19 -4.23 46.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.375 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 13.3 t80 -82.11 -54.17 5.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -69.11 -29.16 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.314 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 7.78 13.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.409 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -102.0 -43.97 5.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 110.114 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -11.38 59.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.687 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.78 153.78 20.52 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.508 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.99 111.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.234 0.54 . . . . 0.0 110.348 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.477 ' HB ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.93 110.01 20.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.267 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.73 -20.03 65.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.65 26.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.042 0.449 . . . . 0.0 111.472 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.477 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 7.6 pt20 -163.59 -32.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.461 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 40.5 t80 -74.82 105.16 5.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.264 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.756 HG11 ' HA ' ' A' ' 36' ' ' ASP . 7.0 m 29.03 70.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.576 1.173 . . . . 0.0 112.626 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -42.32 107.92 0.57 Allowed Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.261 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.473 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.9 Cg_exo -67.26 136.77 41.46 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.326 2.684 . . . . 0.0 112.289 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.518 ' HB ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -94.13 -70.74 0.69 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.782 0.325 . . . . 0.0 111.046 -176.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 12' ' ' THR . 2.1 p30 -142.21 42.24 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.5 -51.23 0.56 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.955 0.502 . . . . 0.0 112.256 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.08 -53.58 41.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 0.0 110.281 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -39.0 93.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.9 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.0 -46.01 92.5 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.437 178.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.616 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -64.45 -40.14 95.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -40.77 96.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.117 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -54.39 -42.21 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.616 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -77.3 -23.54 51.03 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.516 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 18' ' ' LYS . 1.5 mt -112.67 31.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -146.94 -34.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.603 170.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.4 tm-20 52.23 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.215 1.006 . . . . 0.0 111.37 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.613 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -107.91 -0.36 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.87 -177.076 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.715 HG11 ' HE3' ' A' ' 49' ' ' MET . 1.4 p 52.59 23.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.264 1.026 . . . . 0.0 112.552 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.88 -55.09 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.512 176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' VAL . . . -106.96 -11.82 25.37 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.928 -174.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 15.4 m 36.09 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.94 65.14 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.77 -52.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.168 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' HG2' ' A' ' 24' ' ' GLU . 1.7 mm -38.4 116.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.44 1.096 . . . . 0.0 112.56 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 35' ' ' LEU . . . -155.27 -152.15 6.09 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.44 176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -77.48 13.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.522 ' HG ' HG12 ' A' ' 34' ' ' ILE . 12.9 mt -140.03 17.77 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.756 ' HA ' HG11 ' A' ' 9' ' ' VAL . 0.8 OUTLIER 66.36 -125.54 0.27 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.392 0.615 . . . . 0.0 109.529 177.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.489 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 2.9 t-20 -155.18 51.67 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.51 -106.69 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.659 -167.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.826 ' HD2' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -133.15 50.34 2.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.019 174.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.957 ' HB2' ' HB3' ' A' ' 44' ' ' HIS . 1.5 pt20 -143.96 63.38 1.34 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.866 0.841 . . . . 0.0 110.056 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.0 tt -96.61 -26.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.215 -175.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 49' ' ' MET . . . -118.12 -60.77 0.29 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.922 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -76.1 -87.18 0.32 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.196 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.957 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 3.4 p-80 62.46 -47.15 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.215 1.806 . . . . 0.0 113.762 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.1 p -90.41 -88.59 0.17 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.93 5.78 24.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 176.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.012 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.9 mmtp 50.87 61.26 3.33 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.519 176.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.61 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.679 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.715 ' HE3' HG11 ' A' ' 26' ' ' VAL . 3.6 mmm -52.6 -37.54 58.39 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.225 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.506 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.14 -34.91 68.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.45 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.649 ' HA ' HG22 ' A' ' 55' ' ' VAL . 81.2 t -64.28 -23.51 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.362 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.689 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.65 -19.82 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 26' ' ' VAL . . . -82.25 -49.15 10.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.621 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.29 -41.18 3.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.595 -175.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.921 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -63.13 -46.77 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.37 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.689 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 5.5 t-160 -54.43 -37.53 65.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.45 -2.18 14.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.4 mm-40 -138.92 -33.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.921 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.9 m-85 -110.72 -39.68 4.79 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.743 -167.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -64.42 -22.69 67.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.409 0.624 . . . . 0.0 109.608 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -29.76 47.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.345 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.209 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -144.35 114.95 5.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.824 -174.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.595 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 5.9 Cg_exo -79.6 130.0 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.094 2.529 . . . . 0.0 112.428 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.822 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.56 -41.38 14.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.342 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 64' ' ' PRO . 1.3 mtpt 64.52 -137.31 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.971 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 m 54.67 21.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.4 1.08 . . . . 0.0 111.39 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.592 ' HA ' HE22 ' A' ' 71' ' ' GLN . 2.3 mt -145.49 33.2 1.06 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.306 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 2.4 p90 -153.81 -50.29 0.09 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.299 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.012 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -88.84 46.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.066 0.46 . . . . 0.0 111.535 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.592 HE22 ' HA ' ' A' ' 68' ' ' LEU . 8.9 pm0 -166.57 134.77 2.23 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.769 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 74' ' ' ILE . 1.3 Cg_endo -87.8 -40.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.868 2.379 . . . . 0.0 111.644 170.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.826 ' HA ' ' HD2' ' A' ' 39' ' ' PHE . 7.7 t 177.92 45.71 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.699 1.238 . . . . 0.0 109.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.623 HG13 ' HD2' ' A' ' 72' ' ' PRO . 2.7 mt -121.08 174.15 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 113.437 -1.711 . . . . 0.0 107.311 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.592 ' HA ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -80.93 17.82 1.13 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -62.66 -29.74 70.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.485 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.601 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -53.77 -47.82 70.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.462 177.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.601 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -74.41 -46.18 41.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.939 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -76.96 5.49 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.76 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.555 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -104.96 -62.71 1.31 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.992 0.425 . . . . 0.0 109.951 172.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.525 HG13 ' HB2' ' A' ' 66' ' ' LYS . 6.9 t -78.68 -14.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.432 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -108.32 13.44 25.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.192 0.52 . . . . 0.0 110.671 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.0 m -126.41 -36.31 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.264 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.34 -13.19 17.43 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.049 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.9 m . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.263 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.6 135.48 2.12 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.033 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.1 t -122.38 101.82 10.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.81 109.34 1.21 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.265 0.555 . . . . 0.0 110.888 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.711 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 10.4 tt0 -72.55 68.49 0.82 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.337 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.02 -62.68 1.45 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.099 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -84.54 -12.36 54.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.626 173.711 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 10.3 t80 -72.26 124.97 26.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.042 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.549 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 2.8 t 55.37 50.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.697 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.3 116.6 2.16 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.11 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 3.3 Cg_exo -75.89 141.32 24.03 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.153 2.569 . . . . 0.0 111.669 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.18 -73.95 0.67 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.61 0.243 . . . . 0.0 110.422 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -137.4 50.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.47 -68.87 0.11 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.38 0.672 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.07 -47.87 82.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.411 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 mp0 -63.17 -35.84 81.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.392 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -65.7 -45.26 83.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.013 0.435 . . . . 0.0 110.932 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 18.6 mmmt -63.9 -36.98 85.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.529 0.681 . . . . 0.0 109.955 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -42.72 96.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.286 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.24 -43.77 67.6 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.415 0.447 . . . . 0.0 111.122 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 3.1 pt-20 -83.14 -10.83 58.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.224 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HA ' HD13 ' A' ' 22' ' ' ILE . 5.3 mm -97.37 -30.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.52 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -107.62 -26.09 11.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.294 -175.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 57.43 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.519 -175.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -117.34 -5.78 11.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.989 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG13 HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.64 -4.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.124 0.97 . . . . 0.0 112.972 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.489 HD21 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -139.48 -54.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 111.789 -177.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.7 -6.0 29.01 Favored Glycine 0 CA--C 1.504 -0.62 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.708 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.556 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 16.0 m 33.7 66.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.922 . . . . 0.0 113.149 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.41 ' H ' ' HD2' ' A' ' 25' ' ' ARG . 71.3 m -161.23 52.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 111.745 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . -121.27 -37.27 0.7 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.454 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.522 HG12 ' HG2' ' A' ' 24' ' ' GLU . 10.9 mm -31.88 110.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 112.343 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -78.65 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.624 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.567 ' C ' ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -133.03 -10.88 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.567 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -164.51 42.97 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.585 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 54.2 m-20 36.56 -112.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.908 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 67.6 m-80 -119.74 23.32 11.18 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' HD1' HD11 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 39.32 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.424 1.077 . . . . 0.0 112.286 -177.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 43.31 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.452 0.644 . . . . 0.0 110.514 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -152.17 61.13 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.026 173.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -110.14 -19.76 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.241 -172.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.92 97.01 0.16 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.731 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 45' ' ' SER . . . 126.78 -113.46 1.77 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.72 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 58.92 -21.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.453 1.501 . . . . 0.0 114.081 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 43' ' ' GLY . 2.1 p -90.93 -89.35 0.17 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -8.7 59.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.0 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.004 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER 61.4 72.71 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.759 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.4 -12.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.138 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 34.3 mmm -53.13 -39.75 63.73 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 53' ' ' ALA . . . -75.65 -32.16 60.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.131 0.491 . . . . 0.0 110.552 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 1.1 t -62.23 -27.14 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.933 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.733 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -100.38 -18.1 16.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.785 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . . . -72.28 -54.59 9.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.5 pm0 -124.77 -36.6 2.56 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.471 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.848 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 67.4 t -60.66 -44.55 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t60 -51.57 -46.21 63.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HE ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -127.87 9.67 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -170.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.1 mm-40 -131.49 -21.97 2.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.475 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.848 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m-85 -118.47 -28.53 5.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.815 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.5 -16.88 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.28 -36.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.014 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -125.52 -80.08 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.979 -174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.29 129.01 6.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.196 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.34 111.96 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.418 2.079 . . . . 0.0 112.28 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -43.71 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HE3' HG13 ' A' ' 81' ' ' VAL . 6.5 mtmt 62.45 -143.32 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.229 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.719 HG13 HD21 ' A' ' 77' ' ' LEU . 1.8 t 62.16 36.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.205 0.602 . . . . 0.0 111.475 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.5 HD13 HE22 ' A' ' 54' ' ' GLN . 0.4 OUTLIER -167.51 54.53 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 111.455 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.7 p90 -167.99 -46.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.296 -0.253 . . . . 0.0 111.619 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.004 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.4 56.36 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.397 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.664 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.1 pm0 -163.99 140.34 5.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.018 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 17.0 Cg_exo -68.79 -56.82 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.345 2.03 . . . . 0.0 110.931 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.1 t 173.26 46.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.883 0.849 . . . . 0.0 110.031 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -120.39 -107.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -146.14 19.57 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.342 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.03 -33.71 76.37 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.761 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.719 HD21 HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.06 -42.69 73.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 111.385 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.599 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -75.11 -43.57 52.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 6.75 17.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.833 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -103.63 -59.36 1.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.145 0.497 . . . . 0.0 109.848 175.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' HE3' ' A' ' 66' ' ' LYS . 46.8 t -70.82 -30.5 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.114 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -84.47 -2.69 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.217 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 m -107.78 -36.63 6.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 111.342 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 -33.42 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.938 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.514 -176.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtp . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.37 -156.05 15.79 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.749 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.35 112.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 0.0 110.628 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -153.61 103.7 2.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.433 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.27 72.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.592 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -11.58 59.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -83.8 -8.95 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.891 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.678 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 42.4 t80 -65.49 101.76 0.63 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 7.6 p 34.39 82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 124.474 1.109 . . . . 0.0 112.662 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.86 107.36 20.15 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 82.6 Cg_endo -96.55 -159.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.662 2.908 . . . . 0.0 112.422 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.86 -73.2 0.49 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.625 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.95 150.86 22.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.59 -42.59 16.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.826 0.704 . . . . 0.0 112.603 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.25 -49.02 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.919 0.39 . . . . 0.0 110.498 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -43.8 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 11.0 m -51.76 -54.93 23.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.329 0.393 . . . . 0.0 111.968 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -38.77 92.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 -175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -43.61 80.57 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.132 178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.6 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.88 -41.01 63.96 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.577 0.548 . . . . 0.0 111.524 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' HG3' HG12 ' A' ' 22' ' ' ILE . 5.7 pt-20 -80.39 -25.35 39.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.278 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 mm -115.05 30.3 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.632 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -134.64 -36.64 0.85 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 170.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.658 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 11.5 tt0 62.1 -71.19 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.349 1.06 . . . . 0.0 113.264 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -124.23 -5.04 7.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.48 HG13 HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.24 -5.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 124.192 0.932 . . . . 0.0 112.827 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.842 HD22 ' HE2' ' A' ' 44' ' ' HIS . 0.4 OUTLIER -142.24 -51.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.663 -177.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.532 ' C ' HG23 ' A' ' 29' ' ' VAL . . . -113.9 3.04 24.33 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.694 -175.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.658 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER 35.71 74.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 124.586 0.815 . . . . 0.0 112.163 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.401 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -153.25 64.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.705 -173.055 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.571 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . 168.13 61.58 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.513 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.651 HG12 ' HA ' ' A' ' 24' ' ' GLU . 3.5 mm -134.14 116.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.25 -144.47 4.33 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.971 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -76.68 19.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.425 HD22 HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -166.75 26.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.916 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 32.36 -110.72 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.364 1.04 . . . . 0.0 112.446 -176.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.431 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 1.7 t-20 -148.32 36.37 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.47 -99.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.267 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.967 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.8 m-85 -122.66 37.53 4.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.018 0.437 . . . . 0.0 111.77 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.2 pt20 -147.73 60.0 1.13 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.522 0.677 . . . . 0.0 110.437 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.7 tp -102.4 -34.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.733 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.653 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.92 -68.27 0.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.82 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.33 -96.16 0.11 Allowed Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.289 -175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.842 ' HE2' HD22 ' A' ' 27' ' ' LEU . 14.0 p-80 62.13 -40.87 0.15 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.833 1.653 . . . . 0.0 113.949 174.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -90.31 -82.06 0.28 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 12.2 tp -76.13 -10.59 59.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.939 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.83 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.2 mmtm 58.65 56.13 4.38 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.445 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.34 -8.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.918 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -57.82 -32.65 67.79 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.324 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.653 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.77 -31.28 59.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.195 0.521 . . . . 0.0 110.176 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 94.7 t -69.42 -23.21 26.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.133 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.42 -17.45 16.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.83 -51.87 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.662 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -121.93 -42.8 2.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 -176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.776 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 45.1 t -59.04 -43.22 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.251 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 7.8 t-160 -43.98 -41.67 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -17.89 10.23 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.05 -28.22 7.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.776 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 93.9 m-85 -115.51 -27.69 7.07 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.353 -171.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.82 -23.07 63.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.94 -35.48 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.909 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' HD21 ' A' ' 63' ' ' LEU . 3.7 tp10 -117.75 -78.33 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.751 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD21 ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -154.98 141.66 13.34 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.198 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.88 119.62 5.97 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.308 2.005 . . . . 0.0 111.582 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 1.1 pt? -66.05 -37.8 86.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 8.5 mtmt 60.89 -159.55 0.32 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.284 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 77' ' ' LEU . 2.3 t 66.2 21.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.403 0.681 . . . . 0.0 111.794 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.901 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -164.0 47.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.389 0.614 . . . . 0.0 111.424 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.535 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.2 p90 -160.25 -45.97 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.196 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.83 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.33 47.24 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.121 0.486 . . . . 0.0 111.153 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.901 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.1 pm0 -159.82 140.1 8.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.9 Cg_exo -77.45 -39.37 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.763 2.309 . . . . 0.0 111.616 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.967 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 2.0 m 156.45 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.538 1.535 . . . . 0.0 108.043 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.433 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -141.83 -117.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.491 175.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 16.2 ptmt -136.0 17.0 3.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 173.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.66 66.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.064 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.819 HD23 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -55.71 -42.6 75.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.42 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.819 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -88.84 -31.33 18.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.108 0.48 . . . . 0.0 110.151 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 0.25 9.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.96 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -109.93 -49.35 3.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.793 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -72.41 -21.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.712 -175.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.35 7.7 38.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 110.714 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.412 HG21 ' HD2' ' A' ' 84' ' ' ARG . 92.1 m -119.1 -38.46 3.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.583 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' HD2' HG21 ' A' ' 83' ' ' THR . 1.7 mmm180 -117.16 -20.42 9.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.519 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 75.7 m . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.956 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.94 72.07 2.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.112 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.97 158.26 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -143.3 140.48 30.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.2 0.524 . . . . 0.0 110.224 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -75.89 5.3 6.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.288 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.448 ' H ' HG23 ' A' ' 4' ' ' THR . . . -82.72 -16.64 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.6 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.57 -41.6 2.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.099 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.427 ' CD2' ' HA ' ' A' ' 34' ' ' ILE . 29.2 t80 -69.79 111.05 5.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 9' ' ' VAL . 7.1 p 39.09 58.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.345 1.069 . . . . 0.0 112.066 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.93 122.51 77.56 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.757 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.37 173.27 14.78 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.766 2.311 . . . . 0.0 112.081 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -107.07 -63.37 1.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.59 -76.76 0.44 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.144 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.72 -44.16 0.48 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -67.2 -41.04 86.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.628 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -72.87 -36.68 67.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.96 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -53.61 55.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.928 0.394 . . . . 0.0 110.457 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -60.72 -39.51 88.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.178 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -70.72 -39.74 73.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.58 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.96 -43.31 73.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.741 0.305 . . . . 0.0 111.368 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.66 -28.58 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.164 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.486 ' HA ' HD13 ' A' ' 22' ' ' ILE . 17.5 mm -86.03 -50.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.612 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -75.92 -33.55 59.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.141 -170.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.612 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 1.7 tp10 58.6 -64.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.049 0.94 . . . . 0.0 111.667 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.913 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -134.05 1.99 3.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG22 ' HE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 64.39 -5.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.651 1.18 . . . . 0.0 113.357 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.52 -56.58 0.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.961 0.41 . . . . 0.0 111.051 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.608 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -108.96 6.15 32.59 Favored Glycine 0 CA--C 1.501 -0.816 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.566 -173.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.608 HG22 ' C ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER 38.73 70.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 124.594 0.82 . . . . 0.0 112.518 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.913 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -160.15 60.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.756 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -126.88 -17.83 2.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.921 -170.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -81.55 87.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.492 0.646 . . . . 0.0 110.834 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.23 -159.01 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.539 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -73.48 -2.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.286 0.565 . . . . 0.0 111.75 -175.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -164.84 51.98 0.12 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.842 177.207 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 49.02 -128.75 2.02 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.604 -174.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.756 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -115.46 46.82 1.42 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.99 -97.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.328 1.017 . . . . 0.0 110.809 -175.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.736 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 11.0 m-85 -129.38 47.93 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.817 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.434 ' HG2' HG21 ' A' ' 73' ' ' THR . 0.5 OUTLIER -168.32 53.53 0.05 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 42' ' ' GLY . 4.6 tt -93.52 -29.84 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.285 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 41' ' ' ILE . . . -146.05 44.46 0.85 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.494 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -162.65 -112.93 0.29 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 61.08 -52.19 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.892 1.677 . . . . 0.0 114.031 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -88.51 -75.75 0.42 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.596 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 14.3 tp -80.74 -16.77 53.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.012 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 5.8 mmtm 53.46 61.42 3.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.52 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' HD23 ' A' ' 46' ' ' LEU . . . 177.89 -1.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.081 -173.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.2 -35.56 75.68 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.698 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . . . -75.53 -30.55 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 110.317 177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 2.9 t -63.93 -26.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.04 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.17 -23.19 16.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.0 110.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -70.51 -50.7 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.324 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.586 ' HB3' HD11 ' A' ' 19' ' ' LEU . 7.0 pm0 -122.77 -43.7 2.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.118 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 95.3 t -57.42 -43.63 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.429 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.5 t60 -49.63 -33.88 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -128.86 18.22 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 4.2 mm-40 -139.11 -46.54 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.088 0.47 . . . . 0.0 111.797 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.461 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 62.0 m-85 -113.95 -15.48 12.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -168.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -12.81 58.2 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.75 -30.59 5.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.969 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.72 -78.96 0.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.961 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -159.96 121.79 1.81 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.692 -177.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.617 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 11.2 Cg_exo -70.48 130.7 18.88 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.75 2.3 . . . . 0.0 112.539 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -74.08 -63.16 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.144 177.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.617 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 2.7 mtmp? 82.44 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.406 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 66' ' ' LYS . 19.9 m 45.01 33.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 112.239 -176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.494 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -151.94 25.49 0.64 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.23 -173.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.1 p90 -165.6 -49.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.005 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.672 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -91.35 56.7 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.47 . . . . 0.0 111.529 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.59 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 13.1 pm0 -151.35 147.16 19.87 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.352 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.537 ' O ' HG21 ' A' ' 73' ' ' THR . 3.4 Cg_exo -78.04 -72.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.011 2.474 . . . . 0.0 111.521 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.736 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -172.72 35.68 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.538 0.524 . . . . 0.0 112.189 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.846 HG22 ' HD2' ' A' ' 75' ' ' LYS . 2.9 mp -137.87 -89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.006 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HD2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -145.38 18.56 1.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -174.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.49 -28.03 68.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.198 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.718 HD21 ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -51.42 -49.03 62.45 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.201 174.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.12 67.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -0.73 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.349 0.595 . . . . 0.0 111.18 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -104.71 -50.95 3.17 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.411 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -72.12 -26.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.376 -176.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 81' ' ' VAL . . . -93.5 10.57 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.917 0.389 . . . . 0.0 110.687 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -117.9 -36.23 3.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -141.44 52.88 1.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.268 0.556 . . . . 0.0 111.135 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 54.9 m . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.707 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.581 0.229 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.65 -122.79 6.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.389 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t 57.22 41.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 0.0 110.821 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -58.44 3.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.18 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.75 48.52 0.66 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.777 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.93 -30.01 20.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.26 0.553 . . . . 0.0 110.345 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.566 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 41.7 t80 -61.83 121.99 14.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 26.6 m 31.95 54.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.334 1.021 . . . . 0.0 112.143 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.4 127.46 57.59 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.091 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.636 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 3.7 Cg_exo -75.29 130.08 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.335 2.69 . . . . 0.0 111.678 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -68.06 0.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.458 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 67.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.049 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.26 -72.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.583 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.84 -48.61 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.41 -39.27 78.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.286 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.636 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -64.7 -46.67 81.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 0.0 111.591 -178.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -32.66 74.23 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.74 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD12 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -75.11 -49.65 18.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.41 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -39.14 41.4 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.53 0.519 . . . . 0.0 111.582 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.765 ' HG3' HG12 ' A' ' 22' ' ' ILE . 2.3 pt-20 -82.62 -28.67 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.704 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.765 HG12 ' HG3' ' A' ' 21' ' ' GLU . 10.7 mm -122.17 61.32 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -155.11 -42.22 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.112 163.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.829 ' HA ' HG12 ' A' ' 32' ' ' ILE . 1.9 tp10 63.58 -62.38 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.196 0.998 . . . . 0.0 112.924 176.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.754 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -139.19 6.9 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.406 . . . . 0.0 109.949 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 25' ' ' ARG . 0.6 OUTLIER 56.65 18.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.274 1.03 . . . . 0.0 113.106 176.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -177.43 -51.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 111.253 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.11 37.3 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 32.69 76.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.297 1.039 . . . . 0.0 113.406 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.754 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -176.21 74.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.794 177.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -164.14 7.48 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.584 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.829 HG12 ' HA ' ' A' ' 24' ' ' GLU . 1.3 mm -82.1 127.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.376 0.588 . . . . 0.0 110.273 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -162.17 9.98 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.83 10.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 122.538 0.335 . . . . 0.0 111.761 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.461 HD22 HD12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -166.43 35.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 1.5 m-20 58.42 -135.24 0.97 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.892 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.884 ' HB2' HD13 ' A' ' 41' ' ' ILE . 1.4 t-20 -114.34 46.94 1.28 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.423 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 42.19 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.248 0.967 . . . . 0.0 111.727 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.955 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -127.99 43.42 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 -176.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.457 ' HB2' ' HE2' ' A' ' 44' ' ' HIS . 0.6 OUTLIER -163.03 63.65 0.19 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.971 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.884 HD13 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -119.5 -11.69 10.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.033 -174.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 50' ' ' ALA . . . -167.28 93.01 0.1 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.899 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.63 -107.46 0.33 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.663 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 40' ' ' GLN . 20.2 m80 73.97 -57.48 0.62 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.963 0.905 . . . . 0.0 112.4 171.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -82.83 -80.12 0.18 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.411 0.624 . . . . 0.0 110.169 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 1.22 57.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.88 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 54.12 70.2 0.63 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.324 0.39 . . . . 0.0 110.47 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HA ' HG21 ' A' ' 51' ' ' VAL . . . -177.17 -4.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.296 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.403 ' HE1' HD23 ' A' ' 27' ' ' LEU . 41.2 mmm -56.17 -38.13 70.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 42' ' ' GLY . . . -78.59 -31.33 47.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 48' ' ' ALA . 98.5 t -62.57 -29.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.054 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -94.01 -17.93 22.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.67 -51.22 13.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.5 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.56 ' HB3' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -115.63 -53.22 2.6 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.651 -177.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.85 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 37.7 t -53.76 -47.33 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.646 -173.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.2 t60 -36.95 -52.72 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 5.71 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -173.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 5.1 mm-40 -124.28 -10.24 7.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.92 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.85 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -140.0 -33.75 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.771 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.738 ' HG2' HG11 ' A' ' 55' ' ' VAL . 4.1 mm100 -61.47 -26.77 68.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.091 0.472 . . . . 0.0 110.618 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -66.56 -36.19 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.024 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -77.22 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.02 112.62 3.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.638 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 15.0 Cg_exo -68.02 128.51 17.81 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.987 2.458 . . . . 0.0 112.468 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -56.98 2.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.0 mttt 63.84 -123.57 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.745 0.418 . . . . 0.0 111.053 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.493 HG23 HG22 ' A' ' 81' ' ' VAL . 2.0 t 62.81 28.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.309 0.644 . . . . 0.0 111.842 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.07 68.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.1 p90 -163.36 -48.21 0.03 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.788 0.327 . . . . 0.0 111.443 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.88 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -101.37 62.7 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.394 -173.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' HG3' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pm0 -167.35 136.98 2.26 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 111.47 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 96.2 Cg_endo -94.42 59.57 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.493 2.795 . . . . 0.0 111.944 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.955 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 56.84 62.57 2.21 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 175.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mm -138.0 -86.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.2 13.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.792 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.696 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -66.91 -26.06 66.68 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.367 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -57.29 -44.64 84.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.985 0.421 . . . . 0.0 111.054 177.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.58 -50.56 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.736 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.95 5.0 7.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -177.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.696 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -97.4 -58.34 2.03 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.232 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.893 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 1.2 t -67.44 -33.65 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.827 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.1 -8.27 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.772 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -112.9 -32.27 6.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.673 0.273 . . . . 0.0 111.654 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 3.8 ptp180 -147.13 -12.6 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.893 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 70.1 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.87 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.48 84.55 0.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.676 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.57 130.56 68.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.34 126.38 53.33 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.543 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 2.5 pm0 -94.32 34.71 1.25 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.148 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 47.36 0.72 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.304 0.573 . . . . 0.0 111.156 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.5 -24.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.738 -179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.543 ' CD1' ' HB2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -61.23 133.38 55.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.167 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 m 61.43 -21.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.37 1.468 . . . . 0.0 113.593 -172.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . 56.21 73.87 0.77 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.053 0.541 . . . . 0.0 111.882 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.786 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 32.0 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.106 2.538 . . . . 0.0 112.34 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.501 HG22 HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -101.84 -70.16 0.76 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.834 -177.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.522 ' ND2' ' H ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -120.54 -60.67 1.65 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.561 -0.855 . . . . 0.0 112.125 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.85 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 72.6 t -69.16 -44.26 80.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.44 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -70.4 -46.33 64.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.91 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.786 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -56.48 -51.39 68.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.482 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.3 tttt -60.91 -46.39 90.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.939 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -36.43 79.94 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.0 -44.91 79.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 1.3 pt-20 -84.48 -4.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 mm -99.33 -44.38 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.078 0.465 . . . . 0.0 112.204 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.633 ' HE3' HG21 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -85.31 -31.69 22.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.075 -172.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 2.0 tt0 62.26 -62.22 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' A' ' 27' ' ' LEU . 6.2 mtt180 -135.78 -7.41 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.179 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG21 ' HE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 61.02 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.211 1.004 . . . . 0.0 113.314 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER -136.28 -54.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.871 0.367 . . . . 0.0 110.789 -177.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.63 -12.76 29.67 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.133 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.444 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 42.73 59.27 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.358 0.663 . . . . 0.0 111.807 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.422 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.24 65.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.75 -1.88 0.1 OUTLIER Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.323 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.443 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 4.0 mt -69.8 131.39 34.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.726 0.763 . . . . 0.0 110.539 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.93 -154.06 7.36 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -77.06 -3.31 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -176.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 24.47 0.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 1.5 m-20 39.96 -108.69 0.08 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.047 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.701 HD21 HD13 ' A' ' 41' ' ' ILE . 33.8 m-80 -122.29 28.0 7.67 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.94 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.32 -96.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.087 0.867 . . . . 0.0 111.99 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.831 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -117.49 36.25 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.267 0.556 . . . . 0.0 111.314 -175.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -154.25 59.67 0.71 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.082 177.619 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.701 HD13 HD21 ' A' ' 37' ' ' ASN . 1.1 tt -99.44 -37.3 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -148.45 81.63 0.2 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.902 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.76 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 151.43 -116.74 0.78 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.233 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 58.79 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.424 1.49 . . . . 0.0 113.825 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.7 p -87.56 -88.77 0.13 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD22 ' HE3' ' A' ' 49' ' ' MET . 0.5 OUTLIER -84.11 -0.91 53.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.317 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.881 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 53.61 68.95 0.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 178.13 -5.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -173.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.76 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 5.0 mtp -54.92 -41.02 70.48 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.283 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . . . -77.81 -32.23 52.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 0.0 110.719 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.508 ' O ' HG11 ' A' ' 51' ' ' VAL . 2.2 t -62.08 -26.99 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.023 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.641 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.09 -13.03 15.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -71.15 -56.88 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.896 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 7.1 pm0 -125.98 -42.12 1.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.56 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 95.0 t -52.85 -42.75 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.871 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.3 t-160 -38.2 -52.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.304 1.003 . . . . 0.0 113.035 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -0.92 16.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.933 0.397 . . . . 0.0 111.463 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -104.3 -42.63 5.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -173.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 6.4 m-85 -146.16 -22.77 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -169.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.42 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 3.5 tp60 -66.66 -13.28 61.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.344 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.23 -32.36 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.142 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.651 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 3.0 tt0 -130.4 -76.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -152.19 101.35 2.81 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 111.636 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 92.2 Cg_endo -86.0 160.39 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.807 2.338 . . . . 0.0 112.698 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 12' ' ' THR . 0.0 OUTLIER -77.69 -40.03 42.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' O ' HD22 ' A' ' 68' ' ' LEU . 28.4 mttt 63.0 -132.19 0.47 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.512 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 77' ' ' LEU . 3.2 t 61.03 37.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.999 0.428 . . . . 0.0 111.21 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 1.7 pt? -161.54 40.75 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 112.283 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CD2' HG21 ' A' ' 51' ' ' VAL . 3.9 p90 -157.91 -49.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.776 -0.577 . . . . 0.0 112.121 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.881 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -98.69 75.21 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 111.34 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 76' ' ' ALA . 5.6 pm0 -162.22 137.01 5.24 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.154 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.472 ' C ' ' HG1' ' A' ' 73' ' ' THR . 72.1 Cg_endo -87.4 53.88 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.097 2.531 . . . . 0.0 111.478 173.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.831 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 50.99 53.98 12.06 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.768 0.827 . . . . 0.0 112.906 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 8.1 mt -135.48 -108.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 pttt -135.3 11.67 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.512 . . . . 0.0 110.291 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . . . -64.74 -27.48 68.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.582 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.739 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -56.08 -49.11 74.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.51 176.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.37 -38.14 56.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.195 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.41 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.77 -48.69 36.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.226 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.412 HG11 ' N ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -68.87 -31.27 49.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' N ' HG11 ' A' ' 81' ' ' VAL . . . -71.03 -23.25 62.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.545 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 m -62.3 -49.7 74.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.73 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.25 -25.38 42.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.79 176.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 73.0 m . . . . . 0 C--O 1.243 0.755 0 O-C-N 124.071 0.857 . . . . 0.0 111.431 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.843 0.354 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.1 125.41 1.68 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.551 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.75 28.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.198 0.999 . . . . 0.0 108.864 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.95 91.86 4.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.765 -173.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -97.47 79.62 2.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.188 176.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.44 -27.06 38.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 pm0 -76.34 -13.65 60.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.755 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.552 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -62.23 121.7 13.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.356 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 32' ' ' ILE . 75.8 t 67.56 124.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.489 0.662 . . . . 0.0 111.663 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.05 15.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 17' ' ' SER . 2.8 Cg_exo -76.85 -170.04 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.361 2.707 . . . . 0.0 112.508 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.403 ' HB ' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -117.56 -73.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.064 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -114.63 -101.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.454 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.36 -49.15 0.92 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.3 -43.44 96.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.829 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' OE1' ' HB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -60.57 -45.99 91.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.115 178.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -57.87 -47.83 81.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 178.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.652 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.99 -44.92 95.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.609 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -40.0 93.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.252 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.52 -39.57 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.423 0.452 . . . . 0.0 111.291 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.3 pt-20 -82.17 -17.66 45.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.254 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.652 HG13 ' O ' ' A' ' 18' ' ' LYS . 16.5 mt -93.61 -39.39 10.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 112.11 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.644 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -89.74 -31.16 17.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 -177.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.655 ' HG2' ' C ' ' A' ' 29' ' ' VAL . 1.0 OUTLIER 57.22 -64.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.881 1.273 . . . . 0.0 113.066 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.873 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -133.66 0.59 3.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG23 ' CE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 66.05 -8.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.999 . . . . 0.0 113.544 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.65 -57.93 0.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.449 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' C ' HG22 ' A' ' 29' ' ' VAL . . . -113.54 13.46 22.97 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.655 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 4.6 m 32.46 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.264 1.026 . . . . 0.0 113.255 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.873 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 47.4 m -151.15 58.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.209 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.586 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -116.72 -27.79 2.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.218 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 9' ' ' VAL . 36.8 mm -72.42 98.93 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.152 0.501 . . . . 0.0 110.138 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.55 -155.09 7.59 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.49 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.2 pt -67.66 -12.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 123.434 0.693 . . . . 0.0 111.937 -171.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.0 43.21 0.21 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.852 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 66.82 -151.22 0.2 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.721 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.506 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -108.05 18.68 20.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.55 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.615 1.197 . . . . 0.0 112.152 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.949 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.58 43.24 3.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.955 -177.296 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -160.72 67.19 0.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.462 177.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.706 ' N ' ' HE2' ' A' ' 44' ' ' HIS . 0.9 OUTLIER -116.36 -33.32 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.6 -66.32 0.34 Allowed Glycine 0 C--O 1.223 -0.54 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.179 -174.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -77.84 -100.67 0.19 Allowed Glycine 0 C--O 1.224 -0.505 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.706 -170.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.706 ' HE2' ' N ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER 66.65 -50.17 0.45 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.001 1.32 . . . . 0.0 112.649 177.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 p -75.08 -82.43 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.777 HD13 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -90.08 4.13 51.25 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.539 172.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 20.4 mmtm 53.09 58.82 4.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.777 ' HB3' HD13 ' A' ' 46' ' ' LEU . . . 178.56 -3.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.929 -172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.445 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 35.3 mmm -54.48 -35.57 63.2 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.049 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.24 -27.85 53.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.488 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 24.6 t -64.78 -29.0 46.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.577 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.83 -21.74 17.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 49' ' ' MET . . . -80.68 -46.77 15.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -176.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -117.9 -42.98 2.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -175.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 85.9 t -62.04 -56.29 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.577 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 11.6 t-160 -38.1 -45.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 4.42 8.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 79.8 mm-40 -131.91 -31.05 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.654 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -121.79 -19.54 6.73 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.139 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HG2' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -67.7 -14.29 62.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 109.195 169.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.29 -32.1 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.649 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 5.3 tp10 -132.72 -82.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.762 -179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.404 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.5 OUTLIER -162.23 123.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.349 -178.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 141.42 18.9 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.711 2.274 . . . . 0.0 112.87 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -86.72 -20.45 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 177.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 61.13 -131.83 0.73 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.477 175.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.508 ' H ' HG23 ' A' ' 81' ' ' VAL . 3.5 m 53.95 26.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.639 1.176 . . . . 0.0 113.335 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.827 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.6 OUTLIER -153.22 40.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.974 0.416 . . . . 0.0 111.849 177.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 2.9 p90 -153.68 -44.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.75 35.65 1.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.062 0.458 . . . . 0.0 111.476 -173.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.827 HE22 ' HA ' ' A' ' 68' ' ' LEU . 16.7 pm0 -141.45 134.89 14.51 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.608 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 47.9 Cg_endo -76.04 -42.66 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.2 1.933 . . . . 0.0 111.946 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 t 168.88 52.73 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.931 1.348 . . . . 0.0 109.193 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.558 ' C ' ' H ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -136.75 175.61 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.591 -1.64 . . . . 0.0 107.693 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -74.38 19.27 0.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.706 174.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -64.83 -18.83 65.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.275 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.949 HD21 ' HB3' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -51.89 -46.26 64.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.218 0.532 . . . . 0.0 110.241 173.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -88.42 -28.44 20.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 7.98 18.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.094 0.473 . . . . 0.0 111.263 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -120.74 -48.09 2.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.741 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.508 HG23 ' H ' ' A' ' 67' ' ' VAL . 97.6 t -82.01 -22.38 9.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.302 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -113.48 21.23 15.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.197 0.523 . . . . 0.0 110.113 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.0 m -137.75 -32.48 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -125.73 -64.65 1.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.463 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.491 ' OXT' ' HA ' ' A' ' 81' ' ' VAL . 15.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.747 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.35 125.17 8.27 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.441 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.45 106.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.27 164.23 14.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -173.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.76 94.76 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.62 -83.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.206 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -108.62 -48.26 3.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.917 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 2.2 t80 48.04 78.4 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.447 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.614 HG21 HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 72.42 132.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.81 0.814 . . . . 0.0 111.525 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.5 103.61 41.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.973 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.572 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 14.9 Cg_exo -70.04 157.89 58.36 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.913 2.409 . . . . 0.0 111.79 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.74 -64.88 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.75 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.468 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 63.6 m-80 -126.56 -81.36 0.61 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.71 -54.6 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.301 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.81 -38.1 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.82 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.2 mp0 -66.96 -45.01 79.07 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.572 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.49 -49.07 78.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.507 . . . . 0.0 110.945 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -45.25 93.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.861 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -45.88 79.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.138 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.69 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.588 0.555 . . . . 0.0 111.742 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.506 ' HG3' HG13 ' A' ' 22' ' ' ILE . 15.7 pt-20 -83.34 -27.76 29.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.326 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 HG13 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -115.04 24.1 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 119.772 -0.771 . . . . 0.0 113.047 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -132.65 -48.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.123 -0.36 . . . . 0.0 110.667 172.643 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.633 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.1 tm-20 51.76 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.28 1.032 . . . . 0.0 111.443 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.551 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.6 mtt85 -103.31 -4.88 23.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.246 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.72 15.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.908 0.755 . . . . 0.0 112.071 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -147.49 -57.4 0.25 Allowed 'General case' 0 C--O 1.23 0.048 0 O-C-N 122.03 -0.419 . . . . 0.0 111.468 179.168 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.401 ' C ' HG21 ' A' ' 29' ' ' VAL . . . -129.07 9.86 6.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.14 -1.028 . . . . 0.0 112.836 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 19.8 m 34.34 72.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 0.0 113.156 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.04 59.01 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -172.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.605 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -149.47 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.986 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.614 HD11 HG21 ' A' ' 9' ' ' VAL . 14.4 mm -48.72 111.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.341 0.591 . . . . 0.0 111.675 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -133.25 -118.0 1.87 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.455 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -1.88 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 110.257 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.2 40.93 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.412 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 4.9 m-20 59.7 -136.22 0.76 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.43 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.605 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 7.7 t-20 -128.41 37.11 4.18 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.745 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 39.2 -100.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.526 -174.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.985 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 m-85 -128.46 43.13 3.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.139 0.495 . . . . 0.0 111.254 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.745 HE21 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt20 -151.36 64.35 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.458 0.646 . . . . 0.0 110.123 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 41' ' ' ILE . 1.3 tp -120.92 -11.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 122.161 0.981 . . . . 0.0 108.771 -175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.778 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -163.12 125.68 1.43 Allowed Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 109.12 -96.78 1.01 Allowed Glycine 0 C--N 1.303 -1.276 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.937 170.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.8 m80 79.99 -65.09 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.882 0.873 . . . . 0.0 111.882 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 p -94.14 -76.57 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.599 HD21 ' HG2' ' A' ' 49' ' ' MET . 0.5 OUTLIER -79.92 -4.14 51.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.105 177.453 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.004 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 mmtp 53.5 64.22 1.92 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 178.19 1.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.256 -172.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.599 ' HG2' HD21 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -57.09 -35.52 69.51 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 177.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.74 62.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.47 0.652 . . . . 0.0 110.265 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.709 ' HA ' HG22 ' A' ' 55' ' ' VAL . 58.6 t -65.7 -24.13 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.165 177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.13 -11.26 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.064 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.62 -50.27 8.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.823 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -121.65 -30.73 4.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 0.0 111.588 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.709 HG22 ' HA ' ' A' ' 51' ' ' VAL . 12.2 t -73.17 -38.56 55.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 22.6 t-160 -35.2 -56.48 0.6 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.473 1.108 . . . . 0.0 113.371 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -138.66 14.55 2.72 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.191 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.2 -29.12 4.93 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.475 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.631 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -123.45 -27.06 4.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.504 -173.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -63.54 -16.75 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.328 0.585 . . . . 0.0 109.871 172.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -67.13 -32.41 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.835 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.51 -76.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.9 135.51 11.05 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.704 0.288 . . . . 0.0 110.742 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 62.1 Cg_endo -75.74 119.48 5.45 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.62 2.213 . . . . 0.0 112.314 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -49.67 12.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 12.9 mttt 60.52 -137.77 0.63 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.918 0.487 . . . . 0.0 111.48 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.7 t 62.71 26.41 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.626 0.77 . . . . 0.0 112.025 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.4 62.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 111.494 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.778 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 p90 -158.6 -49.18 0.06 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-O 120.916 0.388 . . . . 0.0 111.97 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.004 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.18 63.7 2.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.735 -173.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.582 ' HB3' ' HB1' ' A' ' 76' ' ' ALA . 2.7 pm0 -170.87 138.79 1.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 111.769 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 84.5 Cg_endo -99.6 52.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.749 2.966 . . . . 0.0 111.882 171.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.985 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.1 m 67.64 66.64 0.38 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.145 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.434 HD11 ' HD2' ' A' ' 72' ' ' PRO . 7.2 mt -134.55 -102.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.78 17.09 0.69 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.407 0.622 . . . . 0.0 110.048 175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 71' ' ' GLN . . . -69.63 -32.63 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.242 -171.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.605 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.08 -45.88 75.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.027 0.442 . . . . 0.0 110.866 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.605 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.49 -50.74 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.848 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -66.71 -13.56 61.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -89.82 -56.55 3.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 77.0 t -70.56 -33.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HB1' ' O ' ' A' ' 78' ' ' ALA . . . -69.93 -18.36 63.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -93.12 -38.61 11.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.957 0.408 . . . . 0.0 110.542 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 7.8 mmt180 -83.31 -29.84 28.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.702 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.531 -179.162 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.14 -66.37 0.55 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.617 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.32 -179.4 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.34 -15.86 58.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.808 0.337 . . . . 0.0 110.368 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 79.05 -11.92 1.15 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.793 0.837 . . . . 0.0 112.502 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.31 -22.0 63.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.974 0.416 . . . . 0.0 110.998 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.14 -6.95 22.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.538 0.685 . . . . 0.0 110.803 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -79.53 129.04 34.1 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.03 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 59.9 t 76.71 -85.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.52 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 9' ' ' VAL . . . 159.87 71.68 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 124.232 0.958 . . . . 0.0 111.618 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 8.1 Cg_exo -72.96 109.24 2.77 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.035 1.823 . . . . 0.0 111.568 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -113.3 -74.71 0.62 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -177.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 8.2 p30 -141.22 38.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 13' ' ' ASN . . . 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.394 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.608 HG12 ' HH ' ' A' ' 59' ' ' TYR . 10.6 t -62.52 -48.97 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.7 OUTLIER -64.43 -44.45 91.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.011 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.83 -43.4 98.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.422 -178.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.616 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.1 ttpp -62.66 -50.53 70.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.007 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.847 ' HA ' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -57.39 -43.19 83.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.653 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.585 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.15 -40.17 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.677 0.61 . . . . 0.0 111.477 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.31 -25.49 60.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.468 -178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.847 HD11 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -87.4 -39.11 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HH2' ' HB2' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -95.17 -36.27 11.54 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.5 -171.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.533 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.1 tm-20 53.78 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.796 0.838 . . . . 0.0 110.845 -173.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -114.6 -2.04 13.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.092 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.688 HG13 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.45 13.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.833 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.688 HD23 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -162.26 -55.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.58 178.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.4 -5.03 32.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.09 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 6.9 m 31.26 78.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.997 0.919 . . . . 0.0 113.295 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 41.76 0.35 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.722 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -136.2 -58.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.47 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.527 HG22 ' HA ' ' A' ' 9' ' ' VAL . 5.7 mm -28.83 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 113.118 -176.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.77 -126.95 2.11 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.301 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -95.95 22.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.761 0.315 . . . . 0.0 110.677 -175.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 34' ' ' ILE . 0.7 OUTLIER 175.87 54.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.716 -178.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.86 -126.79 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.347 1.07 . . . . 0.0 111.964 170.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.722 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 3.6 t-20 -146.77 36.13 0.95 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.201 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.88 -99.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.203 -168.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 1.007 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.78 42.13 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.502 . . . . 0.0 111.929 -177.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -150.97 61.69 0.92 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 178.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.76 -59.4 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.417 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -133.69 84.11 0.29 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.23 -0.51 . . . . 0.0 111.885 -175.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 147.75 -118.57 1.01 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 56.51 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.496 1.518 . . . . 0.0 114.59 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.9 p -94.62 -85.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.62 -17.23 62.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.75 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.838 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 9.1 mmtm 59.66 59.95 2.38 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.425 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 175.49 -2.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.599 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.482 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.8 mmm -55.07 -37.51 66.86 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.662 0.268 . . . . 0.0 111.017 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.609 ' HB2' ' HH2' ' A' ' 23' ' ' TRP . . . -70.27 -40.99 74.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.644 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 59.9 t -60.14 -21.84 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.622 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.729 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -108.91 -6.18 15.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.383 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.99 -47.19 7.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' OE1' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -113.32 -56.11 2.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.997 0.427 . . . . 0.0 109.884 -178.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 2.8 t -53.27 -45.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.333 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.729 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 19.0 t-160 -36.4 -56.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.84 3.24 9.46 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.199 -171.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HG2' ' HG2' ' A' ' 57' ' ' ARG . 73.8 mm-40 -119.93 -25.69 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.894 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 25.9 m-85 -125.49 -41.81 2.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.226 -172.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -12.6 59.53 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.737 0.303 . . . . 0.0 110.836 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.5 t -53.27 -31.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 168.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -81.82 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.709 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.34 131.15 24.15 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.78 0.324 . . . . 0.0 111.449 -171.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -91.52 113.92 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.856 2.371 . . . . 0.0 112.133 174.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -46.76 55.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 24.9 mtmt 68.11 -148.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 t 65.81 39.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.332 0.653 . . . . 0.0 112.146 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.11 37.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.252 0.549 . . . . 0.0 111.434 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 3.0 p90 -151.13 -51.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.838 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -97.37 65.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 111.433 -172.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' HG3' HD22 ' A' ' 77' ' ' LEU . 4.2 pm0 -155.25 129.36 4.71 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.19 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.627 ' O ' HG22 ' A' ' 73' ' ' THR . 2.0 Cg_endo -85.64 62.63 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.044 2.496 . . . . 0.0 110.953 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 1.007 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 14.2 t 51.04 51.51 16.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.755 1.264 . . . . 0.0 112.121 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.5 mt -130.24 -179.66 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 113.593 -1.64 . . . . 0.0 106.981 168.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mtmm -80.57 14.7 1.95 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.779 0.799 . . . . 0.0 108.862 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -61.47 -26.64 68.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.086 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.667 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -52.68 -49.86 64.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.346 0.593 . . . . 0.0 110.349 176.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.667 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -79.83 -39.9 29.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.065 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.85 10.23 2.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.627 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -111.08 -59.66 1.94 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 8.9 t -75.45 -25.62 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.664 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 78' ' ' ALA . . . -95.68 0.48 52.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.564 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 m -105.13 -42.15 5.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.78 17.53 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.807 -176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.572 179.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.048 0.451 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.69 61.43 0.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.103 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.33 145.57 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.12 116.99 20.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.34 177.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 11.2 pm0 -69.33 144.55 53.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' H ' HG23 ' A' ' 34' ' ' ILE . . . -83.85 -30.53 26.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.879 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.635 ' HG2' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -158.21 -36.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.397 175.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 2.4 t80 53.18 58.91 4.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.579 0.55 . . . . 0.0 111.579 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.7 t 67.02 91.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.586 0.708 . . . . 0.0 110.913 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.03 131.52 66.38 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.452 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.29 163.93 36.59 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.809 2.34 . . . . 0.0 112.556 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -106.52 -65.78 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 61.5 m-80 -126.94 -89.09 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.0 110.925 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.99 -59.66 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.088 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.607 HG13 ' HG3' ' A' ' 58' ' ' GLU . 31.6 t -57.91 -40.35 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.512 177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 13.0 mp0 -63.7 -46.43 85.53 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.829 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -62.93 -42.24 99.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.792 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.685 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 3.4 mtpm? -70.03 -40.82 74.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.674 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.01 -40.2 83.02 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.738 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -56.51 -38.61 72.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.4 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.9 pt-20 -75.96 -26.67 57.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.055 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 18' ' ' LYS . 6.7 mt -93.24 -36.8 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.539 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -90.01 -33.37 16.38 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.85 -172.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.858 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 58.01 -66.36 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.052 0.941 . . . . 0.0 111.674 -174.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.719 ' HB2' ' H ' ' A' ' 30' ' ' SER . 6.6 ttt85 -135.21 2.86 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.245 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.466 HG13 HD23 ' A' ' 27' ' ' LEU . 0.9 OUTLIER 54.65 20.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 HD23 HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -162.15 -56.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.733 -0.605 . . . . 0.0 111.857 178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.05 13.85 9.03 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.974 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.858 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 39.96 73.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.781 0.832 . . . . 0.0 112.697 177.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.719 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -158.28 59.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.718 177.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.586 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -124.84 -16.3 3.02 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.876 -172.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -97.2 82.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -116.41 43.67 1.61 Allowed Glycine 0 C--O 1.225 -0.463 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.022 -167.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 6' ' ' ALA . 8.0 mm 79.03 -20.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.986 0.898 . . . . 0.0 110.09 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.635 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -147.5 42.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.846 -172.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 61.53 -143.22 0.45 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.083 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.586 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -127.54 36.75 4.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 41.51 -102.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.735 -173.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 1.076 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.0 m-85 -132.51 49.0 2.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.856 0.36 . . . . 0.0 111.012 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.75 57.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.893 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 tt -101.43 -33.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.859 -174.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -122.74 -55.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.699 -174.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.31 -99.61 0.18 Allowed Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.554 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 60.23 -44.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.597 1.559 . . . . 0.0 114.52 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 p -97.19 -73.97 0.59 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 13.2 tp -75.1 -19.86 59.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.082 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 10.8 mmtp 56.11 54.36 7.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.903 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.82 -17.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.465 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.41 ' H ' ' HG2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -53.78 -34.86 60.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.75 0.31 . . . . 0.0 111.432 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.54 -29.77 52.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.97 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HA ' HG21 ' A' ' 55' ' ' VAL . 3.2 t -66.25 -29.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.686 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -92.61 -19.39 21.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.099 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 -49.9 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.811 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.531 ' HB3' HD22 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -122.45 -47.13 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.153 -177.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' A' ' 51' ' ' VAL . 36.7 t -55.05 -47.69 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.064 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 20.9 t-160 -41.23 -48.36 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 112.826 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -118.86 5.74 11.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -170.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' HG3' HG13 ' A' ' 15' ' ' VAL . 18.1 mm-40 -134.02 -19.33 2.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.586 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 14.1 m-85 -133.72 -44.2 0.81 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.386 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -15.9 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.233 0.539 . . . . 0.0 111.201 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 t -68.91 -31.08 49.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.361 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -129.08 -76.6 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.209 -174.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.4 117.74 36.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -47.21 -48.91 13.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.741 2.961 . . . . 0.0 113.895 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.482 ' HB3' ' H ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER 61.72 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.492 0.495 . . . . 0.0 110.933 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.482 ' H ' ' HB3' ' A' ' 65' ' ' LEU . 72.2 mttt 61.75 -124.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.046 0.538 . . . . 0.0 111.105 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.869 HG13 ' HB2' ' A' ' 77' ' ' LEU . 3.3 t 63.35 49.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.991 0.516 . . . . 0.0 111.219 -177.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 1.9 pt? -174.03 39.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.399 0.619 . . . . 0.0 112.059 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' A' ' 70' ' ' ALA . 4.4 p90 -151.45 -54.93 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.403 -0.811 . . . . 0.0 112.43 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -100.25 75.97 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.915 0.388 . . . . 0.0 111.428 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.522 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 3.8 pm0 -162.23 139.78 6.46 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.824 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.547 ' HG2' HD13 ' A' ' 74' ' ' ILE . 85.1 Cg_endo -88.64 46.78 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.154 2.569 . . . . 0.0 112.563 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 1.076 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER 60.55 39.61 17.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.223 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.547 HD13 ' HG2' ' A' ' 72' ' ' PRO . 7.2 mt -139.96 48.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 122.304 -0.247 . . . . 0.0 110.562 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HA ' HD13 ' A' ' 77' ' ' LEU . 9.7 pttt 46.71 23.8 0.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.221 1.008 . . . . 0.0 112.502 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -72.41 -15.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.759 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.869 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -59.38 -44.38 92.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.312 0.577 . . . . 0.0 110.003 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 77' ' ' LEU . . . -72.3 -43.43 64.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.814 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -75.47 5.18 6.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.796 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.2 -62.49 1.31 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.73 -31.73 42.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.394 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.3 2.61 50.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.94 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -106.86 -38.2 6.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.025 0.441 . . . . 0.0 109.934 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -84.56 -60.71 1.99 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.608 -179.861 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.214 0.53 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.548 ' O ' ' HB ' ' A' ' 3' ' ' VAL . . . -153.34 -147.83 4.73 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 2' ' ' GLY . 2.8 p 170.83 -30.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.043 0.449 . . . . 0.0 110.394 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.59 HG21 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -154.93 138.82 16.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.085 0.469 . . . . 0.0 110.081 -177.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 17.11 10.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.018 0.437 . . . . 0.0 110.739 -176.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.59 ' H ' HG21 ' A' ' 4' ' ' THR . . . -83.62 -33.41 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -81.0 -24.21 38.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.366 0.603 . . . . 0.0 109.684 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.49 109.01 5.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.201 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 62.1 t 70.25 -71.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.675 0.609 . . . . 0.0 111.756 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 81.55 0.19 Allowed Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.373 0.669 . . . . 0.0 110.967 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 34.3 Cg_exo -58.98 154.64 43.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.134 2.556 . . . . 0.0 112.036 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -86.97 -65.84 0.97 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.2 m-80 -128.53 -83.91 0.58 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.38 174.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.91 -49.84 0.22 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.447 0.642 . . . . 0.0 109.298 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.76 -45.74 91.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.691 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 34.6 mp0 -67.42 -43.01 82.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.611 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.531 ' CB ' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -54.49 -52.95 60.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -59.92 -44.64 94.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.87 89.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.023 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.01 -42.82 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 17' ' ' SER . 2.1 pt-20 -83.19 -14.24 53.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.315 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 22' ' ' ILE . 6.0 mm -91.31 -39.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 0.0 112.086 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HH2' ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -93.14 -29.53 15.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -176.231 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HG2' ' CA ' ' A' ' 29' ' ' VAL . 2.4 tp10 59.74 -64.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.409 1.084 . . . . 0.0 111.705 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.616 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -141.1 5.15 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.374 170.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.503 HG13 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 63.45 -5.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.622 1.169 . . . . 0.0 113.885 176.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.503 HD23 HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -140.1 -60.78 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.855 0.359 . . . . 0.0 111.2 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.86 7.45 25.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.762 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.513 ' CA ' ' HG2' ' A' ' 24' ' ' GLU . 12.4 m 36.22 76.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.616 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -155.78 57.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.13 0.491 . . . . 0.0 110.009 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.61 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -125.39 -50.75 0.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.475 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG23 HG21 ' A' ' 9' ' ' VAL . 49.3 mm -60.6 108.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.527 0.68 . . . . 0.0 111.086 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 35' ' ' LEU . . . -159.93 -163.59 13.75 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.506 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -76.24 14.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 111.511 -175.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -158.68 7.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 177.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 51.08 -127.07 2.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.753 -176.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.61 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -128.55 26.22 5.66 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.091 -176.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.84 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.552 1.158 . . . . 0.0 111.291 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -135.21 51.54 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.044 0.449 . . . . 0.0 110.768 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.524 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -154.72 51.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.982 0.42 . . . . 0.0 111.009 176.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.1 tt -106.35 -15.28 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.345 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.52 45.64 0.46 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.83 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.36 -123.73 0.69 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.846 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.683 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 13.5 p-80 58.82 -47.89 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.061 1.744 . . . . 0.0 114.346 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -96.01 -68.9 0.78 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.302 0.573 . . . . 0.0 110.272 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.0 tp -78.73 -18.22 54.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.092 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 48.47 52.38 13.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 173.74 10.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.97 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.437 ' O ' ' HB3' ' A' ' 53' ' ' ALA . 4.1 mmt -64.24 -39.27 93.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.364 0.602 . . . . 0.0 109.449 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' HB1' ' HH2' ' A' ' 23' ' ' TRP . . . -78.84 -30.55 45.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.45 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 11.0 t -63.95 -28.23 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.109 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.15 -18.74 17.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 49' ' ' MET . . . -73.55 -51.95 15.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.09 -177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.89 -41.35 2.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.366 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.935 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 66.4 t -58.56 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.2 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -54.91 -38.98 68.31 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.39 -4.84 16.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -168.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -142.9 -11.07 0.77 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.935 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 10.5 m-85 -124.88 -48.01 1.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.79 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.7 -18.84 63.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.019 0.437 . . . . 0.0 110.918 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 61' ' ' VAL . 3.2 t -68.4 -32.87 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.268 175.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 -74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.873 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.11 127.91 15.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.74 0.305 . . . . 0.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.93 118.58 5.76 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.539 2.159 . . . . 0.0 112.09 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -90.99 -63.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.605 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 4.6 mtpt 64.15 -132.75 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.7 0.4 . . . . 0.0 111.375 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.632 HG12 HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER 60.12 33.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.483 0.713 . . . . 0.0 112.599 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -170.27 46.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.444 0.64 . . . . 0.0 112.37 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.8 p90 -156.33 -47.78 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.418 -0.801 . . . . 0.0 112.752 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.42 50.9 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.196 0.522 . . . . 0.0 111.686 -172.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.74 132.72 4.2 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.683 ' HA ' ' HB3' ' A' ' 44' ' ' HIS . 31.5 Cg_endo -69.21 -40.67 5.86 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.169 1.913 . . . . 0.0 111.278 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 8.8 t 168.27 45.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 123.427 1.584 . . . . 0.0 108.208 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -118.97 176.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 112.628 -2.078 . . . . 0.0 107.482 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.471 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -81.66 17.28 1.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.25 -25.49 68.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.891 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.766 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.98 -44.63 96.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.421 . . . . 0.0 110.911 176.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.766 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.22 -41.52 49.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.175 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -29.8 70.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.312 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -73.77 -48.15 33.76 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.133 -178.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.631 HG22 HG22 ' A' ' 67' ' ' VAL . 1.2 t -73.99 -24.86 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.67 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.9 m -82.91 -32.29 27.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.39 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -92.32 6.14 47.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.7 176.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 2.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.621 172.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.06 177.77 43.84 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.185 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.15 -36.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.882 0.373 . . . . 0.0 111.265 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -150.89 146.9 26.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.737 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.711 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 11.8 mp0 -117.49 5.86 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.48 65.18 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -114.63 -10.68 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 177.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.711 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 79.3 t80 -65.27 119.07 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.062 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 32' ' ' ILE . 3.4 t 56.74 51.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.96 116.78 1.01 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.988 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.21 151.09 20.47 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.759 2.306 . . . . 0.0 112.217 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.1 -74.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.943 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -128.92 39.94 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.1 -57.53 0.42 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.294 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.22 -47.93 91.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 -44.04 97.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.995 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 -44.86 87.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.6 ttpp -64.25 -40.87 96.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.349 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' A' ' 54' ' ' GLN . 0.5 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.497 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.4 -43.76 68.16 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.554 0.533 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -81.8 -13.8 57.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.666 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' HG21 ' A' ' 22' ' ' ILE . 44.9 mm -102.7 -16.62 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 112.025 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.561 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -111.3 -32.67 6.66 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.217 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.771 ' HG3' HG12 ' A' ' 32' ' ' ILE . 6.0 tt0 61.22 -66.45 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.983 0.913 . . . . 0.0 111.801 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.764 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.81 2.09 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 67.25 -15.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.139 . . . . 0.0 113.308 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 25' ' ' ARG . 0.4 OUTLIER -136.14 -53.53 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.048 0.452 . . . . 0.0 111.074 -175.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.45 4.18 32.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.175 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.577 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 3.3 m 34.77 74.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.949 1.029 . . . . 0.0 112.927 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.764 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -156.94 61.43 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.886 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.674 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . -121.61 -46.78 0.31 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.665 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.771 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.1 mm -44.47 121.61 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.565 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.91 -161.18 12.63 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.78 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.556 HD12 HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -66.47 -5.86 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.008 0.523 . . . . 0.0 111.607 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.591 HD12 ' HD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -171.53 38.18 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 175.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 2.5 m-20 45.08 -121.27 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.394 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.601 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 1.8 m-20 -112.83 41.2 2.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.591 ' HD1' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 42.02 -93.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.411 1.069 . . . . 0.0 111.404 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.4 59.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.71 ' HB2' ' HE2' ' A' ' 44' ' ' HIS . 2.0 pt20 -164.32 66.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.25 0.547 . . . . 0.0 110.704 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -111.27 -32.45 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.581 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.44 86.66 0.14 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.48 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.734 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 168.84 -126.67 1.41 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.405 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.71 ' HE2' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m80 66.28 -54.14 0.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -72.57 -74.09 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.338 0.59 . . . . 0.0 109.9 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.555 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 7.4 tp -93.73 -10.21 35.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.172 173.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.616 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.9 mmtp 55.53 67.65 0.98 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.139 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 173.19 1.97 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.128 -174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.734 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 7.6 mmm -61.13 -34.11 74.47 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 -177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.44 65.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.413 0.625 . . . . 0.0 109.976 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.5 t -63.29 -24.13 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.317 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.99 -12.21 16.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.489 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 49' ' ' MET . . . -86.68 -51.11 6.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.448 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.16 -35.94 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.718 -174.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.911 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 58.8 t -70.08 -40.94 78.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.342 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.8 t-160 -44.2 -52.2 7.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.996 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.79 13.97 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.604 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 65.8 mm-40 -135.85 -7.8 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.834 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.911 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -134.46 -42.16 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.875 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -21.54 64.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.8 t -58.1 -32.05 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.922 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.69 -80.67 0.63 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 135.81 18.15 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.265 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 73.8 Cg_endo -82.01 115.86 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.331 2.021 . . . . 0.0 112.011 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -40.27 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.422 -178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 67' ' ' VAL . 4.5 mtmt 58.25 -120.64 1.21 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.391 0.432 . . . . 0.0 110.898 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 66' ' ' LYS . 15.9 m 48.37 25.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.208 1.403 . . . . 0.0 114.573 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' HA ' HD22 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -173.19 66.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.0 111.887 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 5.3 p90 -162.98 -47.69 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 -176.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.616 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -99.33 84.53 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.907 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.771 HE21 HD23 ' A' ' 77' ' ' LEU . 0.6 OUTLIER -158.75 148.96 15.47 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HG2' HD13 ' A' ' 74' ' ' ILE . 58.5 Cg_endo -100.34 40.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.014 3.143 . . . . 0.0 111.403 168.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.49 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.2 OUTLIER 55.52 55.37 7.37 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.767 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.656 HD13 ' HG2' ' A' ' 72' ' ' PRO . 4.3 mt -134.38 -103.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.593 ' HG2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -139.68 16.23 2.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.233 0.539 . . . . 0.0 110.261 175.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.82 -32.14 73.7 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.77 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.771 HD23 HE21 ' A' ' 71' ' ' GLN . 0.2 OUTLIER -59.14 -44.64 92.07 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.408 0.623 . . . . 0.0 110.523 178.523 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' N ' HD12 ' A' ' 77' ' ' LEU . . . -74.74 -43.44 54.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.255 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -27.49 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.301 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.2 t80 -66.86 -53.4 32.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.418 0.628 . . . . 0.0 109.383 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 66' ' ' LYS . 99.1 t -71.28 -23.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.643 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.41 -0.04 39.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.48 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -95.86 -42.41 8.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.972 0.415 . . . . 0.0 109.932 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -45.38 14.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.241 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.528 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.85 168.72 14.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.691 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.89 166.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.029 0.442 . . . . 0.0 110.699 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -151.55 163.65 38.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 3.6 tt0 -139.41 18.44 2.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.235 0.541 . . . . 0.0 110.21 173.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.52 -58.47 3.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.876 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.722 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 9.0 pt20 -100.01 -16.56 17.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.67 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 1.6 t80 -69.46 121.23 16.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.79 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 2.0 t 56.63 49.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.74 109.71 1.09 Allowed Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.26 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.59 165.49 1.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.383 2.722 . . . . 0.0 111.837 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.02 -69.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.282 174.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.9 m-80 -124.55 -86.9 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.491 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.68 -49.64 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.0 t -60.54 -43.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.785 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 8.9 mp0 -67.68 -48.82 65.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.023 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -41.79 92.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.91 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -46.69 88.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.891 HD23 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -60.34 -48.96 79.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.826 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.08 -40.25 57.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.544 0.527 . . . . 0.0 111.622 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -87.0 -12.54 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.325 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.1 mm -95.42 -38.77 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.931 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.608 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -101.52 -29.82 11.76 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -174.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.784 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 2.2 tt0 57.37 -68.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.011 0.924 . . . . 0.0 111.496 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.483 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -130.6 2.59 4.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 175.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.586 HG23 ' HE3' ' A' ' 23' ' ' TRP . 0.3 OUTLIER 64.55 0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.308 1.043 . . . . 0.0 113.586 177.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 -57.76 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.15 -0.344 . . . . 0.0 111.367 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.67 -1.0 29.09 Favored Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.964 -172.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.784 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 39.35 67.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.337 0.655 . . . . 0.0 112.393 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 60.04 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.958 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.619 ' HA3' HD22 ' A' ' 37' ' ' ASN . . . -127.76 -15.26 2.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.238 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.435 HG21 ' CE1' ' A' ' 8' ' ' TYR . 43.2 mm -71.8 83.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.009 0.433 . . . . 0.0 110.1 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.52 -85.66 1.87 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.938 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.441 HD12 HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -136.95 -5.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 110.731 177.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.813 HD13 ' HD1' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -167.53 43.56 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.897 -178.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m-20 49.63 -129.04 2.11 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.705 -173.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.634 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 61.9 m-80 -116.54 27.06 9.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.813 ' HD1' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 40.92 -91.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.113 0.883 . . . . 0.0 111.744 -175.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.7 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.83 40.81 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.258 0.551 . . . . 0.0 111.696 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.634 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -138.72 52.59 1.79 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.712 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 42' ' ' GLY . 3.9 tt -110.78 -28.1 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 41' ' ' ILE . . . -144.66 45.99 0.83 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.983 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -179.34 -103.0 0.17 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.755 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' GLN . 4.8 p-80 59.96 -50.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.223 1.809 . . . . 0.0 113.898 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 p -106.06 -68.31 0.88 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.445 HD23 ' SD ' ' A' ' 49' ' ' MET . 19.7 tp -74.22 -25.93 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.89 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 7.0 mmtp 53.24 63.66 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.9 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.0 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.242 -174.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' HD23 ' A' ' 46' ' ' LEU . 31.1 mmm -52.82 -42.46 65.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.489 0.185 . . . . 0.0 111.242 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.76 -29.59 51.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.556 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.636 ' HA ' HG22 ' A' ' 55' ' ' VAL . 16.0 t -62.65 -29.1 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.971 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.91 -20.78 15.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.664 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.2 -51.78 12.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.038 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.891 ' HB3' HD23 ' A' ' 19' ' ' LEU . 4.7 pm0 -120.93 -38.03 2.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.143 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 30.2 t -64.62 -41.86 93.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.312 -174.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -40.41 -59.36 1.34 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -132.14 18.41 4.51 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 9.5 mm-40 -130.16 -6.4 4.36 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.829 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 40.0 m-85 -137.83 -54.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.567 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -19.0 65.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.33 . . . . 0.0 111.337 -174.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.29 -34.94 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.325 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.69 -73.51 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.957 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 113.95 9.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.947 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.66 127.23 15.15 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.664 2.243 . . . . 0.0 111.615 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -58.21 2.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.653 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 14.1 mttt 62.35 -134.49 0.5 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.421 0.288 . . . . 0.0 110.98 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 t 60.73 27.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.14 62.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 111.524 177.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 5.6 p90 -165.84 -50.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.705 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.864 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -87.83 45.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.609 -173.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.453 ' O ' ' HA ' ' A' ' 44' ' ' HIS . 3.8 pm0 -154.12 143.2 14.84 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.559 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.8 Cg_exo -64.7 -56.47 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.313 2.009 . . . . 0.0 110.853 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.8 t 170.72 48.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.817 0.818 . . . . 0.0 109.898 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.55 -106.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.576 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.21 13.69 2.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.059 0.456 . . . . 0.0 110.531 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.66 68.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.216 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.7 -48.31 75.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.551 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.707 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.14 -43.77 66.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.164 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.24 0.06 12.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.238 0.542 . . . . 0.0 111.403 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -100.46 -63.31 1.14 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.81 -28.67 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.596 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 78' ' ' ALA . . . -95.54 10.08 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.488 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.1 m -120.11 -35.38 3.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.485 173.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -75.23 -16.24 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.632 177.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.653 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.832 0.349 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.35 -178.19 48.3 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.82 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p -142.06 131.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.294 0.568 . . . . 0.0 110.86 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.57 126.05 34.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.712 0.768 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.34 44.95 1.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.185 -177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.02 -31.38 66.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.183 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -17.77 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.644 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 45.1 t80 -74.73 116.71 15.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 t 56.53 55.73 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.682 0.753 . . . . 0.0 109.276 -168.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -49.62 126.91 18.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.078 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 17.4 Cg_exo -68.29 138.58 43.35 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.063 2.508 . . . . 0.0 112.32 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.595 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -103.94 -73.98 0.66 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.791 0.329 . . . . 0.0 110.345 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -137.01 45.61 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.054 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.21 -69.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.246 0.619 . . . . 0.0 111.165 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.39 -48.76 76.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.49 -34.95 79.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.542 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -62.08 -45.14 94.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.124 0.488 . . . . 0.0 110.526 178.528 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 18.2 ttpt -64.76 -40.96 96.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.377 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -34.29 77.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.533 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -58.41 -44.52 89.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.657 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 2.4 pt-20 -79.29 -14.17 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 18' ' ' LYS . 2.2 mm -118.22 32.32 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.279 . . . . 0.0 111.719 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.66 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -144.96 -47.82 0.24 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.724 171.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 28.1 tt0 60.48 -65.65 0.05 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.058 0.943 . . . . 0.0 112.306 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -134.77 -1.76 2.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG13 HD22 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 63.62 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.635 HD22 HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.13 -51.65 0.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.048 -0.408 . . . . 0.0 111.102 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.65 -14.98 28.24 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.111 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER 43.29 72.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 124.423 0.719 . . . . 0.0 112.018 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 m -162.51 70.37 0.28 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.551 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -169.94 10.2 0.05 OUTLIER Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.01 -1.091 . . . . 0.0 114.477 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.31 129.74 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 117.949 0.875 . . . . 0.0 110.022 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.19 5.87 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.073 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -79.59 18.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.401 0.28 . . . . 0.0 111.754 -176.155 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.555 HD13 ' HD1' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -179.33 42.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 7.3 m-20 59.73 -121.47 1.04 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.707 ' HB2' HD13 ' A' ' 41' ' ' ILE . 2.4 t-20 -128.82 43.79 3.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.555 ' HD1' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER 42.49 -101.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.147 0.905 . . . . 0.0 111.229 -175.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.583 ' HB3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -124.49 43.77 2.93 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' HA ' ' HE2' ' A' ' 44' ' ' HIS . 1.1 pt20 -160.8 67.38 0.32 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.707 HD13 ' HB2' ' A' ' 37' ' ' ASN . 0.7 OUTLIER -105.66 -41.05 6.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.11 89.98 0.13 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.092 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 160.52 -121.93 1.08 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 66.52 -51.99 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 113.013 174.709 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -84.0 -73.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.296 0.569 . . . . 0.0 110.277 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 9.5 tp -84.29 -13.19 53.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.457 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 1.068 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.5 mmtm 51.12 65.28 1.53 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.604 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.65 -6.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.307 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.788 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 21.4 mmm -53.42 -37.79 62.88 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.183 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 69' ' ' PHE . . . -74.84 -35.73 62.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.186 0.517 . . . . 0.0 110.596 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.586 ' HA ' HG21 ' A' ' 55' ' ' VAL . 59.2 t -61.87 -27.52 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.211 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.59 -15.86 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 49' ' ' MET . . . -77.74 -48.54 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -178.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.621 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 10.7 pm0 -127.83 -39.85 1.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.165 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.623 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -58.55 -51.33 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.337 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.4 t-160 -59.43 -26.62 65.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -174.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.98 -4.44 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -138.12 -19.82 1.12 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.623 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 37.2 m-85 -124.76 -50.43 1.72 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.221 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -12.0 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.606 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.88 -30.89 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.293 0.568 . . . . 0.0 110.051 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.72 -62.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.601 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.58 140.25 14.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.77 154.1 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.517 2.145 . . . . 0.0 111.819 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -119.23 -42.77 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.937 179.243 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.605 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mppt? 63.87 -145.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.587 0.355 . . . . 0.0 111.367 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' HB ' ' A' ' 81' ' ' VAL . 2.0 t 65.6 26.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -166.33 42.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 111.849 174.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.597 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.5 p90 -148.2 -45.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 1.068 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.86 53.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.056 0.455 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.456 ' HA ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -141.33 119.15 7.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.546 ' HG2' HD12 ' A' ' 74' ' ' ILE . 23.4 Cg_exo -65.95 -69.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.478 2.118 . . . . 0.0 111.285 170.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -179.7 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 109.806 175.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.546 HD12 ' HG2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -126.94 38.62 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.458 -171.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 60.34 23.61 13.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.172 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 71' ' ' GLN . . . -66.27 -24.77 66.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.583 HD23 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -55.1 -48.64 73.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.487 175.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.66 62.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.487 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 -6.95 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -100.02 -50.77 3.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.468 ' HB ' HG23 ' A' ' 67' ' ' VAL . 5.8 p -69.47 -23.05 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.997 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.18 18.66 14.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.233 0.539 . . . . 0.0 110.697 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.0 m -123.22 -43.99 2.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.269 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -83.19 -76.87 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.046 173.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.015 0 O-C-N 124.851 1.344 . . . . 0.0 107.795 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.46 171.28 55.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.604 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.65 58.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.135 0.493 . . . . 0.0 110.071 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 107.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.49 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -63.56 126.02 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.428 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.18 -41.34 13.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -110.45 -59.89 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.39 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.708 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 8.5 t80 49.24 82.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.127 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.623 ' HB ' HD12 ' A' ' 32' ' ' ILE . 3.3 p 33.94 96.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 124.97 1.419 . . . . 0.0 112.42 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.43 115.18 27.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.242 -169.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.0 Cg_endo -95.8 138.73 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.891 3.061 . . . . 0.0 112.586 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -128.12 -71.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.43 60.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.628 -0.429 . . . . 0.0 112.064 -169.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -46.87 -47.8 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 122.949 0.5 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -44.04 74.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.556 -176.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.21 -51.96 66.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.391 -177.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.595 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.87 -38.48 91.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.771 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -67.6 -44.92 76.92 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.568 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.42 -38.36 68.86 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.453 0.471 . . . . 0.0 111.611 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -86.73 -19.2 29.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.34 . . . . 0.0 110.67 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -90.08 -29.52 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -174.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.557 ' HZ3' ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -102.68 -27.86 12.47 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 -176.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 6.8 tm-20 59.71 -79.81 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.943 0.897 . . . . 0.0 110.513 -175.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HB2' ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -115.88 -12.25 11.43 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.838 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 58.01 5.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.356 1.035 . . . . 0.0 113.146 -173.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.17 -55.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.798 -0.564 . . . . 0.0 110.876 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.79 -13.88 5.91 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.771 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.547 ' O ' HG21 ' A' ' 29' ' ' VAL . 16.5 m 46.44 96.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 122.558 1.17 . . . . 0.0 112.192 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -86.33 -37.97 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.253 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . 139.13 70.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.842 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.623 HD12 ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -55.31 127.97 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 177.106 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.36 -138.82 2.61 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.617 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.708 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -70.55 -2.54 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.413 HD21 HD13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -117.73 -4.08 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 9' ' ' VAL . 5.3 t70 62.03 -142.03 0.44 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.759 ' HB2' HD13 ' A' ' 41' ' ' ILE . 3.2 m-80 -135.41 23.99 3.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.2 -97.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.489 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.947 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.8 m-85 -122.22 37.32 4.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.043 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -155.56 63.59 0.6 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.429 . . . . 0.0 110.804 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.759 HD13 ' HB2' ' A' ' 37' ' ' ASN . 1.2 tt -108.76 -21.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 0.0 111.041 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.83 96.9 0.16 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.636 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 49' ' ' MET . . . 124.11 -117.7 3.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.596 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 16.4 p-80 56.89 -26.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.196 1.399 . . . . 0.0 114.501 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 43' ' ' GLY . 1.2 p -89.4 -75.04 0.45 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.117 0.484 . . . . 0.0 109.909 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -11.77 57.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.994 174.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.637 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 15.0 mmtp 57.23 64.32 1.65 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.467 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.81 -9.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.774 -175.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.559 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 4.7 mmt -50.32 -42.51 52.87 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' HH2' ' A' ' 23' ' ' TRP . . . -75.21 -30.11 60.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.829 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.471 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 53.3 t -64.28 -27.41 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.029 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.32 -21.38 14.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.557 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -77.16 -46.61 22.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.714 ' HB3' HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -120.78 -50.37 2.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.493 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 53.9 t -52.1 -45.69 42.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 14.4 t-160 -39.63 -56.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.902 0.752 . . . . 0.0 112.753 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -114.02 1.61 14.71 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -116.27 -23.34 8.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -134.12 -42.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.533 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.93 55.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.703 0.287 . . . . 0.0 111.371 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.97 -36.09 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.388 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -121.06 -70.42 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.674 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.03 117.72 9.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.91 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 10.2 Cg_exo -69.73 121.56 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.522 2.148 . . . . 0.0 111.442 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -54.14 4.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.843 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 64.92 -116.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.492 -177.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.637 HG13 HD21 ' A' ' 77' ' ' LEU . 0.5 OUTLIER 57.96 27.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.5 0.72 . . . . 0.0 112.557 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.4 69.71 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 111.132 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.1 p90 -165.22 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.694 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.71 51.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.129 0.49 . . . . 0.0 111.16 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.519 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.27 136.03 6.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.511 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -79.85 -36.09 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.159 1.906 . . . . 0.0 111.736 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.947 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 10.1 t 171.22 51.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.907 1.336 . . . . 0.0 109.541 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.64 ' C ' ' H ' ' A' ' 76' ' ' ALA . 6.2 mt -133.33 162.24 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.667 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -73.36 22.97 0.07 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 172.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -65.41 -27.73 68.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.7 -39.9 86.14 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.947 177.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -76.41 -44.98 33.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.478 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -66.45 -18.04 65.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.612 -176.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.98 -53.24 5.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.612 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 81' ' ' VAL . 25.7 t -72.58 -34.53 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.965 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 110.425 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 83' ' ' THR . 0.3 OUTLIER -88.6 -6.18 57.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 67.17 26.02 8.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.251 1.145 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.085 176.303 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.29 165.9 23.01 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.501 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 34' ' ' ILE . 14.6 p -71.83 142.22 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.103 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -86.3 137.55 32.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.701 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.807 ' HA ' HG22 ' A' ' 34' ' ' ILE . 22.1 mp0 -70.61 87.04 0.66 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.1 -69.69 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.4 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -94.72 -52.25 4.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.653 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 30.1 t80 56.21 89.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.557 -173.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER 63.83 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.06 -166.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.17 109.05 54.65 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.554 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.81 115.92 3.68 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.796 2.331 . . . . 0.0 111.693 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -55.51 3.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.193 0.52 . . . . 0.0 109.854 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -128.04 -101.55 0.34 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.98 -45.56 0.65 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.89 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.488 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -63.44 -44.64 93.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.123 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -48.7 79.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.283 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' O ' HG12 ' A' ' 22' ' ' ILE . 2.5 mtpm? -61.5 -41.52 97.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.533 HD22 ' HB3' ' A' ' 54' ' ' GLN . 2.4 mp -66.18 -44.09 85.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.251 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -50.81 -43.41 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.612 0.57 . . . . 0.0 111.346 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -80.78 -23.84 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.667 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 18' ' ' LYS . 40.3 mm -90.72 -32.32 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.649 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -95.13 -30.08 14.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.929 -176.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.649 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER 59.22 -64.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.511 1.124 . . . . 0.0 112.309 -175.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -135.94 -1.57 2.43 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.827 HG13 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 68.28 -14.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.254 1.022 . . . . 0.0 112.954 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.827 HD23 HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -138.71 -57.53 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.76 -1.24 58.79 Favored Glycine 0 CA--C 1.5 -0.883 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.569 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 35.21 50.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 113.999 -1.1 . . . . 0.0 112.978 -179.03 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -149.35 57.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.371 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.415 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -133.05 -5.05 3.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.883 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.436 HG12 ' HA ' ' A' ' 24' ' ' GLU . 5.2 mm -76.18 108.98 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 117.736 0.768 . . . . 0.0 109.975 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.74 -153.42 7.83 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.415 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.807 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -70.91 -1.06 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.674 HD21 HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -167.9 51.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 12.9 m-20 60.37 -135.66 0.7 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -104.12 46.75 0.9 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.81 -98.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.284 0.99 . . . . 0.0 109.908 -168.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.608 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -136.26 50.48 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 110.349 175.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -150.78 45.32 0.85 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.673 172.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -90.34 -27.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.401 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.34 54.84 0.62 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.718 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 179.97 -81.78 0.06 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.505 ' HE2' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER 62.52 -60.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.967 1.707 . . . . 0.0 112.611 170.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 p -121.43 -50.13 2.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.472 0.653 . . . . 0.0 109.869 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 22.1 tp -68.73 -29.6 68.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.268 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.759 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.1 mmtp 48.76 57.42 6.38 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.632 0.582 . . . . 0.0 111.262 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.14 -5.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.934 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.718 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 7.0 mtp -56.41 -40.62 74.98 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.977 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HA ' ' HB1' ' A' ' 53' ' ' ALA . . . -79.11 -31.82 44.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.29 0.567 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.548 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 10.7 t -62.15 -25.43 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.473 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.59 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.48 -16.58 14.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.221 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -70.78 -54.72 10.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.9 pm0 -128.21 -29.67 2.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.197 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.882 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 77.8 t -66.05 -36.91 78.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.98 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.8 t60 -50.45 -51.17 49.17 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 57' ' ' ARG . 8.4 ptp85 -131.28 12.7 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.577 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 72.6 mm-40 -123.97 -12.88 7.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.282 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.882 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 6.9 m-85 -127.59 -41.88 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.924 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -14.24 36.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.2 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 t -61.64 -31.51 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.082 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.9 -74.74 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.351 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.62 137.05 8.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.54 150.16 13.06 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.699 2.266 . . . . 0.0 112.93 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.84 -60.62 2.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.343 177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.1 mttt 73.72 -141.95 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.692 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.5 m 57.34 21.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.153 0.981 . . . . 0.0 112.355 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -159.57 46.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.753 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.557 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 p90 -148.65 -55.23 0.2 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.111 -0.368 . . . . 0.0 111.317 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.759 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.19 60.79 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.473 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.93 ' HG3' ' HB3' ' A' ' 77' ' ' LEU . 2.5 pm0 -174.19 150.34 1.55 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.793 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HG2' HD12 ' A' ' 74' ' ' ILE . 5.2 Cg_endo -90.55 -77.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.299 2.666 . . . . 0.0 112.113 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.608 ' HA ' ' CD2' ' A' ' 39' ' ' PHE . 14.3 t -161.97 22.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.556 0.693 . . . . 0.0 110.344 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 72' ' ' PRO . 2.0 mt -108.54 39.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.818 -175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 16.45 5.49 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.081 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 71' ' ' GLN . . . -69.63 -28.63 66.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.171 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.93 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -56.71 -41.36 77.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.948 0.404 . . . . 0.0 111.231 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.607 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -76.11 -45.61 33.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.092 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.75 1.9 11.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.154 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.55 -56.8 2.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' HG12 ' A' ' 81' ' ' VAL . 47.7 t -74.9 -26.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.092 -176.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 78' ' ' ALA . . . -86.22 3.24 43.87 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.44 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.9 m -101.77 -28.62 12.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.405 0.621 . . . . 0.0 109.978 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -79.12 -27.51 42.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.826 177.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.18 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.512 0.672 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -46.95 124.05 5.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.575 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 51.35 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.456 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -167.11 97.66 0.66 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.497 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.1 124.37 10.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.678 2.252 . . . . 0.0 111.602 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -74.15 0.66 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.44 37.29 4.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.181 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.34 -62.64 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.055 0.542 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -45.87 90.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 0.0 110.207 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.09 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -44.18 97.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.209 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -63.76 -34.55 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.433 0.635 . . . . 0.0 110.193 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -45.59 76.82 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.063 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.496 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.55 -40.5 62.61 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.586 0.553 . . . . 0.0 111.589 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -79.28 -24.74 42.72 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.925 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -87.89 -27.43 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.613 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -109.82 -38.18 5.44 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.238 -175.224 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.6 tm-20 52.89 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.863 0.865 . . . . 0.0 110.642 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.3 mtt180 -110.27 -9.18 14.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.457 -177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 66.03 -2.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.702 -176.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -143.1 -54.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.064 -0.398 . . . . 0.0 111.487 -176.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.09 -6.48 27.88 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.3 m 32.93 80.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.898 0.879 . . . . 0.0 112.987 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.49 60.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.591 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -145.4 -59.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.653 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.468 HD11 HD12 ' A' ' 41' ' ' ILE . 12.8 mm -38.92 110.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.556 0.743 . . . . 0.0 112.149 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.78 -143.09 4.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.708 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -75.18 15.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.648 0.379 . . . . 0.0 111.882 -175.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.83 39.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 12.0 t70 64.21 -142.42 0.28 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.683 0.614 . . . . 0.0 110.018 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.591 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 8.2 t-20 -127.55 47.85 2.32 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.06 -101.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.691 -173.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -140.9 55.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.758 0.313 . . . . 0.0 110.733 177.376 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.5 pt20 -149.38 60.63 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.495 0.664 . . . . 0.0 110.956 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 32' ' ' ILE . 1.9 tt -106.81 -20.22 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.112 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.96 33.22 0.96 Allowed Glycine 0 C--O 1.229 -0.163 0 C-N-CA 119.825 -1.179 . . . . 0.0 113.29 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.07 -107.62 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.882 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 15.7 p-80 59.62 -51.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.015 1.726 . . . . 0.0 114.263 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 p -96.53 -65.65 0.95 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -92.33 -12.74 31.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.245 177.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 44' ' ' HIS . 5.1 mmtp 49.75 63.32 2.22 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.452 0.47 . . . . 0.0 111.232 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -178.95 -9.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.882 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.665 ' HE2' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -54.7 -41.16 69.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 110.976 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.25 -33.02 61.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 41.4 t -62.41 -26.42 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.497 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.36 -20.8 15.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.795 0.331 . . . . 0.0 111.124 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.47 12.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.941 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -118.23 -40.58 2.93 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.926 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -67.43 -59.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.848 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 70.1 t60 -51.79 -27.35 12.01 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -172.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 57' ' ' ARG . 9.5 ptt180 -127.08 2.45 6.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 7.4 mt-10 -138.99 -26.48 0.84 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 12.6 m-85 -126.43 -21.47 4.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.992 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -68.41 -15.12 63.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.79 -32.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.91 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.38 -84.99 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.889 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 131.65 15.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -86.32 112.53 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.602 2.201 . . . . 0.0 111.816 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -75.69 -32.11 59.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HE3' HG13 ' A' ' 81' ' ' VAL . 21.0 mtmt 61.5 -138.79 0.51 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.783 ' HB ' HD23 ' A' ' 77' ' ' LEU . 2.4 m 55.46 21.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.975 . . . . 0.0 113.464 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.805 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -151.64 37.94 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.609 0.718 . . . . 0.0 111.697 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 7.5 p90 -153.8 -46.51 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.667 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -88.22 41.01 0.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.559 -174.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.805 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.0 pm0 -153.06 138.65 11.75 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.298 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.0 Cg_endo -87.53 -42.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.15 2.567 . . . . 0.0 112.037 173.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.701 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 9.9 t 176.94 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.696 1.236 . . . . 0.0 109.609 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -121.51 163.04 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.96 24.35 0.13 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.836 0.827 . . . . 0.0 108.897 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -66.21 -21.6 66.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.003 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.77 -34.83 75.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -83.5 -38.16 22.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.912 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.77 3.62 16.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.373 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -108.4 -56.48 2.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.058 0.456 . . . . 0.0 109.821 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.716 HG21 ' H ' ' A' ' 67' ' ' VAL . 21.4 t -79.74 -11.72 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.655 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.05 21.61 13.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.781 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.139 174.611 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 7' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 122.41 1.1 . . . . 0.0 108.853 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 58.5 t80 -57.73 115.6 2.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.475 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG22 HD12 ' A' ' 32' ' ' ILE . 89.8 t 73.38 115.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.611 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.49 101.45 42.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.54 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 174.76 11.13 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.703 2.269 . . . . 0.0 112.459 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.71 -68.44 0.72 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -112.43 -100.37 0.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.4 -50.09 0.92 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.571 . . . . 0.0 109.664 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.21 -39.53 85.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.976 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -64.15 -37.97 89.37 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.515 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.4 73.25 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.49 -44.8 93.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -44.27 96.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.977 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.623 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.274 0.359 . . . . 0.0 110.779 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.7 pt-20 -80.78 -12.86 59.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.282 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 18' ' ' LYS . 25.4 mm -99.53 -37.47 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.623 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -88.7 -36.24 16.3 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.713 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.611 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 6.9 tt0 59.53 -57.47 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.623 1.169 . . . . 0.0 112.969 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.33 -6.35 1.79 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.48 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.07 -2.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.983 0.913 . . . . 0.0 112.802 -178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.71 -59.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.105 -0.372 . . . . 0.0 111.437 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.87 2.24 33.8 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.482 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.7 m 36.36 64.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.093 0.957 . . . . 0.0 113.02 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.44 59.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.958 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.49 -13.12 0.66 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.663 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.519 HD12 HG22 ' A' ' 9' ' ' VAL . 15.8 mm -71.55 112.93 7.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 117.108 0.454 . . . . 0.0 110.055 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -150.48 -143.02 3.65 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.906 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.44 -0.39 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.04 34.4 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 t70 59.65 -136.34 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.752 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 12.4 m-80 -105.89 44.08 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -92.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.991 0.807 . . . . 0.0 111.107 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.571 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.14 51.44 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 110.643 177.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -147.9 61.64 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.242 0.544 . . . . 0.0 110.052 174.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.6 -43.44 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.13 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.816 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.78 44.79 1.29 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.869 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 176.06 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.938 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -53.48 0.31 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.606 1.562 . . . . 0.0 112.221 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.1 p -113.39 -65.34 1.2 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 33.1 tp -67.65 -31.29 71.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.573 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.883 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 8.1 mmtm 53.8 62.5 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.389 0.431 . . . . 0.0 110.7 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.59 -18.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.573 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.6 -29.97 69.54 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.654 -176.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.816 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -76.39 -38.74 55.28 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.314 0.578 . . . . 0.0 110.055 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 28.9 t -61.13 -24.4 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.749 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -102.46 -17.15 15.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.33 8.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.431 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.9 pm0 -122.3 -35.48 3.12 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.367 -175.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.6 t -63.33 -53.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.823 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 39.7 t60 -45.15 -46.78 12.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.19 5.14 8.52 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -168.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.18 -15.15 1.12 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.681 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.6 m-85 -125.46 -37.59 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.654 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -16.41 63.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.41 -32.48 48.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.819 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -114.65 -78.19 0.58 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.056 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.22 128.99 6.94 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.804 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.41 115.22 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -70.49 -40.85 73.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.598 ' O ' HD23 ' A' ' 68' ' ' LEU . 10.1 mttt 61.76 -138.76 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.33 0.394 . . . . 0.0 111.036 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.808 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER 44.4 40.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.52 1.128 . . . . 0.0 113.308 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -164.87 37.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.821 0.82 . . . . 0.0 111.275 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -151.0 -49.74 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.883 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -89.99 57.51 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 77' ' ' LEU . 2.9 pm0 -164.63 136.58 3.55 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.399 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.673 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 5.0 Cg_exo -79.11 -44.22 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.962 2.441 . . . . 0.0 111.51 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 8.4 t 174.1 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.806 1.289 . . . . 0.0 109.256 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 76' ' ' ALA . 2.1 mt -126.75 168.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.493 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.46 18.57 0.09 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.388 0.614 . . . . 0.0 109.53 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -67.64 -23.65 65.37 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.383 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.764 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.15 -43.92 98.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.142 179.251 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.764 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -75.68 -40.24 56.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.114 0.483 . . . . 0.0 110.063 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -70.17 -20.04 63.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.351 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -83.25 -56.72 3.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.186 0.517 . . . . 0.0 110.315 -177.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.808 HG21 ' H ' ' A' ' 67' ' ' VAL . 98.1 t -69.1 -30.66 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.946 -175.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.34 -8.84 58.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.182 178.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.667 ' HD1' HG23 ' A' ' 9' ' ' VAL . 2.8 t80 -59.37 132.11 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.533 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.667 HG23 ' HD1' ' A' ' 8' ' ' TYR . 99.3 t 75.89 -55.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.116 0.567 . . . . 0.0 111.604 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 58.54 68.12 1.86 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 21.5 Cg_exo -65.43 160.2 43.9 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 112.318 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -67.76 0.86 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.951 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.485 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 64.0 m-80 -128.37 -89.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.198 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.79 -53.95 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 110.374 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' A' ' 58' ' ' GLU . 58.8 t -62.06 -41.44 91.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.345 0.593 . . . . 0.0 110.126 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.6 mp0 -63.52 -47.34 82.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.754 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.7 -46.53 89.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.478 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -64.85 -32.21 73.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.035 -178.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.41 -41.81 55.2 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.969 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.17 -41.61 62.74 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.567 0.542 . . . . 0.0 111.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG3' HG12 ' A' ' 22' ' ' ILE . 3.5 pt-20 -74.48 -38.47 62.88 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mm -109.63 45.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -147.26 -32.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.134 169.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HB3' HG12 ' A' ' 29' ' ' VAL . 15.8 tp10 65.04 -55.76 0.3 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.413 1.085 . . . . 0.0 112.482 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -150.24 -3.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.94 1.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.068 0.947 . . . . 0.0 113.545 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.33 -53.75 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.934 -0.479 . . . . 0.0 111.104 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.75 10.84 11.19 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.86 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER 35.05 72.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.078 0.951 . . . . 0.0 113.206 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.671 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -170.57 62.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.32 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.622 ' HA2' ' OD1' ' A' ' 37' ' ' ASN . . . -133.35 -45.39 0.12 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.042 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.8 mm -68.23 109.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 0.0 111.759 -171.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.32 -151.19 7.09 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.481 HG12 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.22 13.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.0 111.175 -177.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -167.58 36.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.65 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD2' ' HB ' ' A' ' 41' ' ' ILE . 11.8 t70 62.12 -151.17 0.37 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.622 ' OD1' ' HA2' ' A' ' 31' ' ' GLY . 19.4 t30 -91.11 59.28 3.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 49.35 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.533 1.146 . . . . 0.0 110.13 -170.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.512 ' HD1' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -150.25 50.99 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.873 0.368 . . . . 0.0 110.589 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -169.79 67.55 0.05 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 110.873 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -86.41 -35.27 8.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.956 -0.465 . . . . 0.0 111.788 -174.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.49 65.47 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.414 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -175.07 -119.97 0.58 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 58.14 -48.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.008 1.723 . . . . 0.0 114.266 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 p -94.16 -71.21 0.67 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.207 0.527 . . . . 0.0 109.633 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.0 tp -76.31 -22.01 55.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.177 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.721 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 12.9 mmtp 50.79 60.6 3.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.034 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.12 -5.97 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.296 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.4 mmm -53.61 -43.12 68.38 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 111.17 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.34 -30.54 48.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.202 0.525 . . . . 0.0 110.705 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -65.0 -27.23 41.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.813 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.16 -16.76 16.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.2 -53.55 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.993 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HB3' HD22 ' A' ' 19' ' ' LEU . 8.0 pm0 -128.11 -36.46 1.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.404 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 51' ' ' VAL . 60.5 t -60.38 -42.3 90.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.4 t-160 -54.3 -34.81 61.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 11.37 12.23 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.266 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' A' ' 15' ' ' VAL . 19.2 mm-40 -133.9 -25.54 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.9 -38.67 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.283 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -18.04 65.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.107 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.32 -31.54 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.242 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -113.78 -82.63 0.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.75 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.4 117.58 9.62 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.6 Cg_exo -80.82 123.3 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.024 2.483 . . . . 0.0 112.378 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -78.65 -41.5 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.836 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 30.5 mtmt 63.5 -141.24 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.937 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.78 30.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.054 0.542 . . . . 0.0 111.92 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.02 49.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -165.78 -48.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.855 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.721 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.5 67.29 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 111.132 -175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 7.6 pm0 -161.68 147.28 10.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.55 -60.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.359 2.039 . . . . 0.0 110.615 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -171.29 -41.48 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.814 0.816 . . . . 0.0 111.146 177.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.43 59.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.806 -164.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 77' ' ' LEU . 3.2 mttp 52.41 19.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.041 0.537 . . . . 0.0 111.79 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -64.93 -21.87 66.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -62.06 -49.32 76.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.458 175.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -70.21 -45.71 66.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.587 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.741 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 3.5 pt20 -68.06 -18.69 64.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -72.25 -52.57 15.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.621 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.76 -26.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.49 59.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.552 0.691 . . . . 0.0 109.312 177.236 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 3.9 mt-30 . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 120.556 0.217 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 37.0 t80 59.4 99.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 124.209 0.943 . . . . 0.0 109.589 -171.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.659 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 65.65 127.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.488 1.115 . . . . 0.0 110.381 -168.067 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.87 103.57 20.14 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.421 -173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 71.7 Cg_endo -95.38 152.18 1.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.026 2.484 . . . . 0.0 111.973 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -116.57 -65.9 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.353 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -124.15 -75.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.456 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.26 -54.82 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.926 0.393 . . . . 0.0 110.296 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.68 -38.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.404 0.621 . . . . 0.0 109.606 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -65.47 -43.96 88.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.969 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -63.84 -41.15 97.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.686 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 6.6 tptt -63.56 -33.74 76.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.349 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 54' ' ' GLN . 7.8 mt -70.76 -47.43 59.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.31 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.46 39.29 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.401 0.438 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -75.15 -40.66 59.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.184 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -125.05 69.02 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.982 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -171.12 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.685 171.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER 54.35 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.467 1.107 . . . . 0.0 111.555 175.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -105.68 -3.31 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.741 -175.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 49' ' ' MET . 0.3 OUTLIER 58.06 9.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.889 0.876 . . . . 0.0 112.908 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.54 -57.35 0.28 Allowed 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.95 -0.469 . . . . 0.0 111.446 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.01 4.31 14.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.506 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 10.0 m 31.79 81.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.194 0.997 . . . . 0.0 113.69 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.91 64.98 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.155 -0.34 . . . . 0.0 111.895 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.44 -6.75 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.679 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.939 HG12 ' HG2' ' A' ' 24' ' ' GLU . 36.2 mm -53.83 118.71 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.23 -154.24 6.91 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.49 -4.42 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -175.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 25.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.146 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 67.7 m-20 44.77 -125.46 1.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.382 -175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.575 ' HB2' HD12 ' A' ' 41' ' ' ILE . 4.6 m120 -117.09 29.57 7.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 38.56 -95.57 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.119 0.887 . . . . 0.0 111.736 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.53 43.61 3.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.358 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.586 ' HB3' HG23 ' A' ' 73' ' ' THR . 1.5 pt20 -139.72 54.93 1.67 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.1 tt -110.99 -23.89 4.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.684 -167.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -154.93 59.07 0.39 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.975 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 173.79 -127.36 1.33 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 57.57 -28.51 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.77 1.628 . . . . 0.0 115.001 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 p -92.23 -70.32 0.7 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.963 0.801 . . . . 0.0 110.293 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 48' ' ' ALA . 1.5 pp -102.5 -2.98 27.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.602 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 11.2 mmtp 51.85 66.86 1.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.593 0.558 . . . . 0.0 112.044 174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 176.12 -10.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.668 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.03 -35.26 71.03 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.701 -178.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.09 -33.1 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 110.473 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 66.5 t -64.09 -26.97 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.095 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.686 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -98.82 -16.45 18.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.87 -51.49 12.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.379 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -118.99 -48.28 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.949 0.404 . . . . 0.0 110.587 -176.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.5 t -55.12 -47.45 77.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.39 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.4 t60 -47.17 -43.46 21.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -121.63 3.74 10.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 -36.4 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 53.5 m-85 -118.03 -34.96 3.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -64.97 -13.62 57.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.445 0.64 . . . . 0.0 109.82 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.28 -35.23 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.622 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HG3' HD23 ' A' ' 63' ' ' LEU . 7.7 tp10 -124.03 -76.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.866 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -137.93 116.01 9.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.334 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 71.0 Cg_endo -86.77 113.25 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.665 2.244 . . . . 0.0 112.736 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.76 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.18 -59.17 2.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.627 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 51' ' ' VAL . 18.6 mtmt 68.12 -111.72 0.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.268 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER 55.12 37.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.832 0.348 . . . . 0.0 111.337 -178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 pt? -165.53 42.86 0.07 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.761 0.791 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.3 p90 -151.03 -48.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -171.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -95.92 61.56 2.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 0.0 111.09 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.7 pm0 -164.77 148.99 7.88 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 3.8 Cg_exo -77.12 -72.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 110.956 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -171.97 36.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.46 0.647 . . . . 0.0 110.729 178.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.72 -121.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -131.08 17.7 5.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.36 -37.6 83.94 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.198 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.41 -42.15 77.53 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.754 0.312 . . . . 0.0 111.672 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.551 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -68.24 -48.92 63.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.702 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 1.1 pt20 -78.19 -4.23 46.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.375 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 13.3 t80 -82.11 -54.17 5.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -69.11 -29.16 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.314 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 7.78 13.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.409 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 110.114 173.412 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 40.5 t80 -74.82 105.16 5.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.264 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 32' ' ' ILE . 7.0 m 29.03 70.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.576 1.173 . . . . 0.0 112.626 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -42.32 107.92 0.57 Allowed Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.261 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.9 Cg_exo -67.26 136.77 41.46 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.326 2.684 . . . . 0.0 112.289 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.533 ' HB ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -94.13 -70.74 0.69 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.782 0.325 . . . . 0.0 111.046 -176.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' A' ' 12' ' ' THR . 2.1 p30 -142.21 42.24 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.5 -51.23 0.56 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.955 0.502 . . . . 0.0 112.256 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.08 -53.58 41.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 0.0 110.281 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -39.0 93.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.9 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.0 -46.01 92.5 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.437 178.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.751 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -64.45 -40.14 95.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -40.77 96.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.117 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -54.39 -42.21 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -77.3 -23.54 51.03 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.516 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' HE3' ' A' ' 18' ' ' LYS . 1.5 mt -112.67 31.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -146.94 -34.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.603 170.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.4 tm-20 52.23 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.215 1.006 . . . . 0.0 111.37 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -107.91 -0.36 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.87 -177.076 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' A' ' 49' ' ' MET . 1.4 p 52.59 23.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.264 1.026 . . . . 0.0 112.552 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD21 ' HE2' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -164.88 -55.09 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.512 176.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.96 -11.82 25.37 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.928 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 15.4 m 36.09 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.436 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.94 65.14 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.77 -52.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.168 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.793 HG23 HG11 ' A' ' 9' ' ' VAL . 1.7 mm -38.4 116.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.44 1.096 . . . . 0.0 112.56 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.27 -152.15 6.09 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.44 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -77.48 13.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' HG ' HG12 ' A' ' 34' ' ' ILE . 12.9 mt -140.03 17.77 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER 66.36 -125.54 0.27 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.392 0.615 . . . . 0.0 109.529 177.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.507 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 2.9 t-20 -155.18 51.67 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.51 -106.69 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.659 -167.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.811 ' HD2' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -133.15 50.34 2.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.019 174.165 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.984 ' HB2' ' HB3' ' A' ' 44' ' ' HIS . 1.5 pt20 -143.96 63.38 1.34 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.866 0.841 . . . . 0.0 110.056 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 68' ' ' LEU . 21.0 tt -96.61 -26.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.215 -175.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -118.12 -60.77 0.29 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.922 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -76.1 -87.18 0.32 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.196 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 3.4 p-80 62.46 -47.15 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.215 1.806 . . . . 0.0 113.762 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.1 p -90.41 -88.59 0.17 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.93 5.78 24.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 176.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.9 mmtp 50.87 61.26 3.33 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.519 176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.649 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -179.61 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.679 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.623 ' HE2' HG13 ' A' ' 26' ' ' VAL . 3.6 mmm -52.6 -37.54 58.39 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.225 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.14 -34.91 68.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.45 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 81.2 t -64.28 -23.51 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.362 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.65 -19.82 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -82.25 -49.15 10.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.621 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.29 -41.18 3.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.595 -175.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.952 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -63.13 -46.77 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.37 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.709 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 5.5 t-160 -54.43 -37.53 65.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.45 -2.18 14.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.4 mm-40 -138.92 -33.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.952 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.9 m-85 -110.72 -39.68 4.79 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.743 -167.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -64.42 -22.69 67.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.409 0.624 . . . . 0.0 109.608 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -29.76 47.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.345 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.209 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -144.35 114.95 5.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.824 -174.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 5.9 Cg_exo -79.6 130.0 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.094 2.529 . . . . 0.0 112.428 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.83 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.56 -41.38 14.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.342 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' HB2' ' A' ' 64' ' ' PRO . 1.3 mtpt 64.52 -137.31 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.971 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.728 ' H ' HG21 ' A' ' 81' ' ' VAL . 2.0 m 54.67 21.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.4 1.08 . . . . 0.0 111.39 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.671 ' HA ' HE22 ' A' ' 71' ' ' GLN . 2.3 mt -145.49 33.2 1.06 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.306 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.501 ' HA ' ' H ' ' A' ' 43' ' ' GLY . 2.4 p90 -153.81 -50.29 0.09 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.299 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.036 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -88.84 46.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.066 0.46 . . . . 0.0 111.535 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.671 HE22 ' HA ' ' A' ' 68' ' ' LEU . 8.9 pm0 -166.57 134.77 2.23 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.769 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.625 ' HD2' HG13 ' A' ' 74' ' ' ILE . 1.3 Cg_endo -87.8 -40.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.868 2.379 . . . . 0.0 111.644 170.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.811 ' HA ' ' HD2' ' A' ' 39' ' ' PHE . 7.7 t 177.92 45.71 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.699 1.238 . . . . 0.0 109.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.625 HG13 ' HD2' ' A' ' 72' ' ' PRO . 2.7 mt -121.08 174.15 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 113.437 -1.711 . . . . 0.0 107.311 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -80.93 17.82 1.13 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HA ' ' CG ' ' A' ' 79' ' ' GLN . . . -62.66 -29.74 70.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.485 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -53.77 -47.82 70.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.462 177.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -74.41 -46.18 41.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.939 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.567 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -76.96 5.49 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.76 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -104.96 -62.71 1.31 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.992 0.425 . . . . 0.0 109.951 172.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.728 HG21 ' H ' ' A' ' 67' ' ' VAL . 6.9 t -78.68 -14.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.432 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -108.32 13.44 25.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.192 0.52 . . . . 0.0 110.671 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.264 173.54 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.295 0.569 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -72.26 124.97 26.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.042 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.552 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 2.8 t 55.37 50.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.697 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.3 116.6 2.16 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.11 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 3.3 Cg_exo -75.89 141.32 24.03 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.153 2.569 . . . . 0.0 111.669 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.18 -73.95 0.67 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.61 0.243 . . . . 0.0 110.422 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -137.4 50.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.47 -68.87 0.11 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.38 0.672 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.07 -47.87 82.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.411 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.523 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 mp0 -63.17 -35.84 81.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.392 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -65.7 -45.26 83.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.013 0.435 . . . . 0.0 110.932 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 18.6 mmmt -63.9 -36.98 85.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.529 0.681 . . . . 0.0 109.955 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -42.72 96.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.286 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -53.24 -43.77 67.6 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.415 0.447 . . . . 0.0 111.122 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 3.1 pt-20 -83.14 -10.83 58.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.224 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 22' ' ' ILE . 5.3 mm -97.37 -30.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -107.62 -26.09 11.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.294 -175.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER 57.43 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.519 -175.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.482 ' HD2' ' H ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -117.34 -5.78 11.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.989 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.64 -4.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.124 0.97 . . . . 0.0 112.972 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -139.48 -54.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 111.789 -177.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.7 -6.0 29.01 Favored Glycine 0 CA--C 1.504 -0.62 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.708 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 16.0 m 33.7 66.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.922 . . . . 0.0 113.149 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.482 ' H ' ' HD2' ' A' ' 25' ' ' ARG . 71.3 m -161.23 52.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 111.745 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . -121.27 -37.27 0.7 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.454 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.538 HG12 ' HG2' ' A' ' 24' ' ' GLU . 10.9 mm -31.88 110.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 112.343 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -78.65 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.624 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' C ' ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -133.03 -10.88 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -164.51 42.97 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.585 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 54.2 m-20 36.56 -112.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.908 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' HB2' HD12 ' A' ' 41' ' ' ILE . 67.6 m-80 -119.74 23.32 11.18 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.32 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.424 1.077 . . . . 0.0 112.286 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 43.31 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.452 0.644 . . . . 0.0 110.514 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -152.17 61.13 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.026 173.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -110.14 -19.76 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.241 -172.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.92 97.01 0.16 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.731 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 45' ' ' SER . . . 126.78 -113.46 1.77 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.72 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 58.92 -21.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.453 1.501 . . . . 0.0 114.081 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 43' ' ' GLY . 2.1 p -90.93 -89.35 0.17 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -8.7 59.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.0 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER 61.4 72.71 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.759 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.4 -12.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.138 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.407 ' HB2' ' N ' ' A' ' 43' ' ' GLY . 34.3 mmm -53.13 -39.75 63.73 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.65 -32.16 60.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.131 0.491 . . . . 0.0 110.552 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 1.1 t -62.23 -27.14 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.933 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -100.38 -18.1 16.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.785 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.28 -54.59 9.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.5 pm0 -124.77 -36.6 2.56 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.471 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.861 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 67.4 t -60.66 -44.55 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t60 -51.57 -46.21 63.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -127.87 9.67 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -170.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.1 mm-40 -131.49 -21.97 2.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.475 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.861 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m-85 -118.47 -28.53 5.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.815 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.5 -16.88 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.28 -36.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.014 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 2.1 tp10 -125.52 -80.08 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.979 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -148.29 129.01 6.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.196 -178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.34 111.96 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.418 2.079 . . . . 0.0 112.28 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -43.71 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HE3' HG13 ' A' ' 81' ' ' VAL . 6.5 mtmt 62.45 -143.32 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.229 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.756 HG12 HD23 ' A' ' 77' ' ' LEU . 1.8 t 62.16 36.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.205 0.602 . . . . 0.0 111.475 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.51 54.53 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 111.455 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.7 p90 -167.99 -46.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.296 -0.253 . . . . 0.0 111.619 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.027 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.4 56.36 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.397 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.671 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.1 pm0 -163.99 140.34 5.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.018 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 17.0 Cg_exo -68.79 -56.82 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.345 2.03 . . . . 0.0 110.931 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.1 t 173.26 46.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.883 0.849 . . . . 0.0 110.031 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -120.39 -107.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -146.14 19.57 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.342 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.628 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.03 -33.71 76.37 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.761 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.756 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.06 -42.69 73.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 111.385 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.605 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -75.11 -43.57 52.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 6.75 17.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.833 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -103.63 -59.36 1.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.145 0.497 . . . . 0.0 109.848 175.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG21 ' H ' ' A' ' 67' ' ' VAL . 46.8 t -70.82 -30.5 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.114 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.47 -2.69 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.217 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 111.342 179.325 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.55 HE21 ' N ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.977 0.418 . . . . 0.0 110.891 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 42.4 t80 -65.49 101.76 0.63 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 7.6 p 34.39 82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 124.474 1.109 . . . . 0.0 112.662 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.86 107.36 20.15 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 82.6 Cg_endo -96.55 -159.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.662 2.908 . . . . 0.0 112.422 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.86 -73.2 0.49 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.625 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.95 150.86 22.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.59 -42.59 16.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.826 0.704 . . . . 0.0 112.603 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.25 -49.02 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.919 0.39 . . . . 0.0 110.498 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -43.8 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 11.0 m -51.76 -54.93 23.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.329 0.393 . . . . 0.0 111.968 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -63.22 -38.77 92.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -67.48 -43.61 80.57 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.132 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.88 -41.01 63.96 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.577 0.548 . . . . 0.0 111.524 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 22' ' ' ILE . 5.7 pt-20 -80.39 -25.35 39.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.278 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.495 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 mm -115.05 30.3 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -134.64 -36.64 0.85 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 170.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.674 ' HA ' HG12 ' A' ' 32' ' ' ILE . 11.5 tt0 62.1 -71.19 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.349 1.06 . . . . 0.0 113.264 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.23 -5.04 7.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.24 -5.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 124.192 0.932 . . . . 0.0 112.827 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.656 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -142.24 -51.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.663 -177.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.9 3.04 24.33 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.694 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.647 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER 35.71 74.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 124.586 0.815 . . . . 0.0 112.163 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.25 64.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.705 -173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . 168.13 61.58 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.513 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.674 HG12 ' HA ' ' A' ' 24' ' ' GLU . 3.5 mm -134.14 116.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.25 -144.47 4.33 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.971 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -76.68 19.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.75 26.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.916 175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 32.36 -110.72 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.364 1.04 . . . . 0.0 112.446 -176.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 1.7 t-20 -148.32 36.37 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.47 -99.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.267 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.952 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.8 m-85 -122.66 37.53 4.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.018 0.437 . . . . 0.0 111.77 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.2 pt20 -147.73 60.0 1.13 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.522 0.677 . . . . 0.0 110.437 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' ILE . 1.7 tp -102.4 -34.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.733 -174.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.92 -68.27 0.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.82 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -74.33 -96.16 0.11 Allowed Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.289 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 62.13 -40.87 0.15 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.833 1.653 . . . . 0.0 113.949 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -90.31 -82.06 0.28 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 tp -76.13 -10.59 59.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.939 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.2 mmtm 58.65 56.13 4.38 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.445 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.34 -8.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.918 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -57.82 -32.65 67.79 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.324 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.77 -31.28 59.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.195 0.521 . . . . 0.0 110.176 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 94.7 t -69.42 -23.21 26.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.133 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.42 -17.45 16.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.83 -51.87 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.662 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.43 ' HB3' HD13 ' A' ' 19' ' ' LEU . 3.7 pt20 -121.93 -42.8 2.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 45.1 t -59.04 -43.22 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.251 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 7.8 t-160 -43.98 -41.67 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -17.89 10.23 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.05 -28.22 7.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 93.9 m-85 -115.51 -27.69 7.07 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.353 -171.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.82 -23.07 63.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.94 -35.48 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.909 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG3' HD23 ' A' ' 63' ' ' LEU . 3.7 tp10 -117.75 -78.33 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.751 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -154.98 141.66 13.34 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.198 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.88 119.62 5.97 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.308 2.005 . . . . 0.0 111.582 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 65' ' ' LEU . 1.1 pt? -66.05 -37.8 86.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 8.5 mtmt 60.89 -159.55 0.32 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.284 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 t 66.2 21.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.403 0.681 . . . . 0.0 111.794 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.941 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -164.0 47.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.389 0.614 . . . . 0.0 111.424 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.2 p90 -160.25 -45.97 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.196 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.33 47.24 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.121 0.486 . . . . 0.0 111.153 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.941 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.1 pm0 -159.82 140.1 8.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.9 Cg_exo -77.45 -39.37 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.763 2.309 . . . . 0.0 111.616 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.952 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 2.0 m 156.45 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.538 1.535 . . . . 0.0 108.043 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.484 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -141.83 -117.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.491 175.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 16.2 ptmt -136.0 17.0 3.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 173.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.66 66.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.064 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.02 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -55.71 -42.6 75.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.42 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.735 ' H ' HD22 ' A' ' 77' ' ' LEU . . . -88.84 -31.33 18.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.108 0.48 . . . . 0.0 110.151 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 0.25 9.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.96 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -109.93 -49.35 3.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.793 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -72.41 -21.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.712 -175.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.35 7.7 38.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 110.714 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.583 177.712 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 34' ' ' ILE . 29.2 t80 -69.79 111.05 5.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 32' ' ' ILE . 7.1 p 39.09 58.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.345 1.069 . . . . 0.0 112.066 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.93 122.51 77.56 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.757 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.37 173.27 14.78 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.766 2.311 . . . . 0.0 112.081 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -107.07 -63.37 1.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.59 -76.76 0.44 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.144 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.72 -44.16 0.48 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -67.2 -41.04 86.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.628 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -72.87 -36.68 67.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.96 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -53.61 55.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.928 0.394 . . . . 0.0 110.457 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -60.72 -39.51 88.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.178 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -70.72 -39.74 73.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.58 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.96 -43.31 73.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.741 0.305 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.66 -28.58 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.164 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.03 -50.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.603 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -75.92 -33.55 59.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.141 -170.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HG12 ' A' ' 29' ' ' VAL . 1.7 tp10 58.6 -64.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.049 0.94 . . . . 0.0 111.667 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.948 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -134.05 1.99 3.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.39 -5.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.651 1.18 . . . . 0.0 113.357 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.53 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -145.52 -56.58 0.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.961 0.41 . . . . 0.0 111.051 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.96 6.15 32.59 Favored Glycine 0 CA--C 1.501 -0.816 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.566 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.742 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 38.73 70.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 124.594 0.82 . . . . 0.0 112.518 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.948 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -160.15 60.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.767 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -126.88 -17.83 2.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.921 -170.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -81.55 87.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.492 0.646 . . . . 0.0 110.834 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.23 -159.01 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.539 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -73.48 -2.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.286 0.565 . . . . 0.0 111.75 -175.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -164.84 51.98 0.12 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.842 177.207 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 49.02 -128.75 2.02 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.604 -174.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.767 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -115.46 46.82 1.42 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.99 -97.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.328 1.017 . . . . 0.0 110.809 -175.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.758 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 11.0 m-85 -129.38 47.93 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.817 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.32 53.53 0.05 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.6 tt -93.52 -29.84 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.285 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.05 44.46 0.85 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.494 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -162.65 -112.93 0.29 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 61.08 -52.19 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.892 1.677 . . . . 0.0 114.031 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -88.51 -75.75 0.42 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.603 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 14.3 tp -80.74 -16.77 53.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.012 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.681 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 5.8 mmtm 53.46 61.42 3.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.52 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.89 -1.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.081 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.2 -35.56 75.68 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.698 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.55 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 110.317 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 2.9 t -63.93 -26.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.04 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.17 -23.19 16.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.0 110.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.7 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.324 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.564 ' HB3' HD13 ' A' ' 19' ' ' LEU . 7.0 pm0 -122.77 -43.7 2.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.118 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 95.3 t -57.42 -43.63 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.429 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.5 t60 -49.63 -33.88 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -128.86 18.22 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 4.2 mm-40 -139.11 -46.54 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.088 0.47 . . . . 0.0 111.797 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 62.0 m-85 -113.95 -15.48 12.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -168.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -12.81 58.2 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.75 -30.59 5.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.969 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.72 -78.96 0.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.961 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -159.96 121.79 1.81 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.692 -177.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 11.2 Cg_exo -70.48 130.7 18.88 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.75 2.3 . . . . 0.0 112.539 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -74.08 -63.16 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.144 177.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 2.7 mtmp? 82.44 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.406 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 m 45.01 33.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 112.239 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.566 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -151.94 25.49 0.64 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.23 -173.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.1 p90 -165.6 -49.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.005 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -91.35 56.7 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.47 . . . . 0.0 111.529 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 13.1 pm0 -151.35 147.16 19.87 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.352 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 73' ' ' THR . 3.4 Cg_exo -78.04 -72.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.011 2.474 . . . . 0.0 111.521 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -172.72 35.68 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.538 0.524 . . . . 0.0 112.189 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.7 HG22 ' HD2' ' A' ' 75' ' ' LYS . 2.9 mp -137.87 -89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.006 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.7 ' HD2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -145.38 18.56 1.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -174.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.49 -28.03 68.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.198 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD21 ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -51.42 -49.03 62.45 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.201 174.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.12 67.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -0.73 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.349 0.595 . . . . 0.0 111.18 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -104.71 -50.95 3.17 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.411 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.12 -26.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.376 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.5 10.57 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.917 0.389 . . . . 0.0 110.687 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.299 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 41.7 t80 -61.83 121.99 14.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 26.6 m 31.95 54.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.334 1.021 . . . . 0.0 112.143 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.4 127.46 57.59 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.091 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 3.7 Cg_exo -75.29 130.08 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.335 2.69 . . . . 0.0 111.678 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -68.06 0.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.458 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 67.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.049 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.26 -72.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.583 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.84 -48.61 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.41 -39.27 78.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.286 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.624 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -64.7 -46.67 81.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 0.0 111.591 -178.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -32.66 74.23 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.74 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -75.11 -49.65 18.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.41 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -39.14 41.4 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.53 0.519 . . . . 0.0 111.582 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.772 ' HG3' HG12 ' A' ' 22' ' ' ILE . 2.3 pt-20 -82.62 -28.67 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.704 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.772 HG12 ' HG3' ' A' ' 21' ' ' GLU . 10.7 mm -122.17 61.32 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.587 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -155.11 -42.22 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.112 163.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.838 ' HA ' HG12 ' A' ' 32' ' ' ILE . 1.9 tp10 63.58 -62.38 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.196 0.998 . . . . 0.0 112.924 176.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.801 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -139.19 6.9 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.406 . . . . 0.0 109.949 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER 56.65 18.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.274 1.03 . . . . 0.0 113.106 176.074 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -177.43 -51.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 111.253 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.11 37.3 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 32.69 76.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.297 1.039 . . . . 0.0 113.406 177.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.801 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -176.21 74.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.794 177.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -164.14 7.48 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.584 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.838 HG12 ' HA ' ' A' ' 24' ' ' GLU . 1.3 mm -82.1 127.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.376 0.588 . . . . 0.0 110.273 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -162.17 9.98 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.83 10.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 122.538 0.335 . . . . 0.0 111.761 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.43 35.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 41' ' ' ILE . 1.5 m-20 58.42 -135.24 0.97 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.892 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB2' HD12 ' A' ' 41' ' ' ILE . 1.4 t-20 -114.34 46.94 1.28 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 42.19 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.248 0.967 . . . . 0.0 111.727 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.999 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -127.99 43.42 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 -176.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.469 HE21 ' HE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -163.03 63.65 0.19 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.971 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -119.5 -11.69 10.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.033 -174.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -167.28 93.01 0.1 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.899 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.63 -107.46 0.33 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.663 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.2 m80 73.97 -57.48 0.62 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.963 0.905 . . . . 0.0 112.4 171.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -82.83 -80.12 0.18 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.411 0.624 . . . . 0.0 110.169 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 1.22 57.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.866 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 54.12 70.2 0.63 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.324 0.39 . . . . 0.0 110.47 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -177.17 -4.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.296 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.2 mmm -56.17 -38.13 70.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 54' ' ' GLN . . . -78.59 -31.33 47.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 98.5 t -62.57 -29.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.054 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -94.01 -17.93 22.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.67 -51.22 13.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.5 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -115.63 -53.22 2.6 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.651 -177.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.876 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 37.7 t -53.76 -47.33 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.646 -173.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.2 t60 -36.95 -52.72 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 5.71 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -173.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 5.1 mm-40 -124.28 -10.24 7.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.92 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.876 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -140.0 -33.75 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.771 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.871 ' HG2' HG12 ' A' ' 55' ' ' VAL . 4.1 mm100 -61.47 -26.77 68.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.091 0.472 . . . . 0.0 110.618 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -66.56 -36.19 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.024 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -77.22 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.02 112.62 3.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.638 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 15.0 Cg_exo -68.02 128.51 17.81 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.987 2.458 . . . . 0.0 112.468 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -56.98 2.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 42.0 mttt 63.84 -123.57 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.745 0.418 . . . . 0.0 111.053 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG22 HG21 ' A' ' 81' ' ' VAL . 2.0 t 62.81 28.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.309 0.644 . . . . 0.0 111.842 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.07 68.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.1 p90 -163.36 -48.21 0.03 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.788 0.327 . . . . 0.0 111.443 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -101.37 62.7 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.394 -173.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.2 pm0 -167.35 136.98 2.26 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 111.47 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 96.2 Cg_endo -94.42 59.57 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.493 2.795 . . . . 0.0 111.944 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.999 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 56.84 62.57 2.21 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 175.287 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mm -138.0 -86.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.2 13.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.792 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -66.91 -26.06 66.68 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.367 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -57.29 -44.64 84.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.985 0.421 . . . . 0.0 111.054 177.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.595 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.58 -50.56 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.736 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.95 5.0 7.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -177.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.705 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -97.4 -58.34 2.03 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.232 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG21 HG22 ' A' ' 67' ' ' VAL . 1.2 t -67.44 -33.65 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.827 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.1 -8.27 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.772 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 120.673 0.273 . . . . 0.0 111.654 -178.742 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.123 0.487 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.23 133.38 55.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.167 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 8' ' ' TYR . 1.2 m 61.43 -21.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.37 1.468 . . . . 0.0 113.593 -172.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . 56.21 73.87 0.77 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.053 0.541 . . . . 0.0 111.882 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 32.0 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.106 2.538 . . . . 0.0 112.34 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 -70.16 0.76 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.834 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -60.67 1.65 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.561 -0.855 . . . . 0.0 112.125 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.85 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.16 -44.26 80.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.44 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -70.4 -46.33 64.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.91 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.784 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -56.48 -51.39 68.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.482 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.3 tttt -60.91 -46.39 90.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.939 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -36.43 79.94 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.0 -44.91 79.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 1.3 pt-20 -84.48 -4.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 22' ' ' ILE . 6.4 mm -99.33 -44.38 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.078 0.465 . . . . 0.0 112.204 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -85.31 -31.69 22.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.075 -172.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 2.0 tt0 62.26 -62.22 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.2 mtt180 -135.78 -7.41 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.179 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 53' ' ' ALA . 0.3 OUTLIER 61.02 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.211 1.004 . . . . 0.0 113.314 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.28 -54.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.871 0.367 . . . . 0.0 110.789 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.63 -12.76 29.67 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.133 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.451 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 42.73 59.27 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.358 0.663 . . . . 0.0 111.807 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.24 65.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.75 -1.88 0.1 OUTLIER Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.323 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.441 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 4.0 mt -69.8 131.39 34.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.726 0.763 . . . . 0.0 110.539 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.93 -154.06 7.36 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.516 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -77.06 -3.31 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -176.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 24.47 0.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 1.5 m-20 39.96 -108.69 0.08 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.047 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.764 HD22 HD12 ' A' ' 41' ' ' ILE . 33.8 m-80 -122.29 28.0 7.67 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.94 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.32 -96.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.087 0.867 . . . . 0.0 111.99 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.842 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -117.49 36.25 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.267 0.556 . . . . 0.0 111.314 -175.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -154.25 59.67 0.71 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.082 177.619 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 HD22 ' A' ' 37' ' ' ASN . 1.1 tt -99.44 -37.3 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -148.45 81.63 0.2 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.902 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.751 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 151.43 -116.74 0.78 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.233 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 58.79 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.424 1.49 . . . . 0.0 113.825 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.7 p -87.56 -88.77 0.13 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -84.11 -0.91 53.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.317 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 53.61 68.95 0.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.13 -5.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.751 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 5.0 mtp -54.92 -41.02 70.48 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.283 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.81 -32.23 52.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 0.0 110.719 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 2.2 t -62.08 -26.99 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.023 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.667 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.09 -13.03 15.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 26' ' ' VAL . . . -71.15 -56.88 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.896 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 7.1 pm0 -125.98 -42.12 1.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.96 HG12 ' HB2' ' A' ' 60' ' ' GLN . 95.0 t -52.85 -42.75 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.871 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.667 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.3 t-160 -38.2 -52.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.304 1.003 . . . . 0.0 113.035 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -0.92 16.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.933 0.397 . . . . 0.0 111.463 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -104.3 -42.63 5.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -173.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.472 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . 6.4 m-85 -146.16 -22.77 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -169.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.96 ' HB2' HG12 ' A' ' 55' ' ' VAL . 3.5 tp60 -66.66 -13.28 61.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.344 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.23 -32.36 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.142 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.654 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 3.0 tt0 -130.4 -76.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.654 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -152.19 101.35 2.81 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 111.636 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.515 ' HB3' HG13 ' A' ' 55' ' ' VAL . 92.2 Cg_endo -86.0 160.39 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.807 2.338 . . . . 0.0 112.698 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.69 -40.03 42.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.157 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mttt 63.0 -132.19 0.47 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 77' ' ' LEU . 3.2 t 61.03 37.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.999 0.428 . . . . 0.0 111.21 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.7 pt? -161.54 40.75 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 112.283 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.91 -49.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.776 -0.577 . . . . 0.0 112.121 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -98.69 75.21 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 111.34 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 5.6 pm0 -162.22 137.01 5.24 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.154 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -87.4 53.88 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.097 2.531 . . . . 0.0 111.478 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.842 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 50.99 53.98 12.06 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.768 0.827 . . . . 0.0 112.906 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 8.1 mt -135.48 -108.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 pttt -135.3 11.67 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.512 . . . . 0.0 110.291 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -64.74 -27.48 68.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.582 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -56.08 -49.11 74.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.51 176.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.37 -38.14 56.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.195 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.41 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.77 -48.69 36.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.226 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -68.87 -31.27 49.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.25 62.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.545 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 m . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.73 178.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 pm0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.29 0.567 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.23 121.7 13.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.356 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 32' ' ' ILE . 75.8 t 67.56 124.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.489 0.662 . . . . 0.0 111.663 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.05 15.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' SER . 2.8 Cg_exo -76.85 -170.04 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.361 2.707 . . . . 0.0 112.508 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -117.56 -73.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.064 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -114.63 -101.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.454 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.36 -49.15 0.92 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.3 -43.44 96.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.829 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE1' ' HB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -60.57 -45.99 91.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.115 178.124 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -57.87 -47.83 81.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 178.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.99 -44.92 95.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.609 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -40.0 93.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.252 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.52 -39.57 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.423 0.452 . . . . 0.0 111.291 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.3 pt-20 -82.17 -17.66 45.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.254 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 18' ' ' LYS . 16.5 mt -93.61 -39.39 10.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 112.11 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.638 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -89.74 -31.16 17.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 -177.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.668 ' HG3' ' H ' ' A' ' 31' ' ' GLY . 1.0 OUTLIER 57.22 -64.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.881 1.273 . . . . 0.0 113.066 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.851 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -133.66 0.59 3.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.05 -8.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.999 . . . . 0.0 113.544 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -139.65 -57.93 0.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.449 -177.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.54 13.46 22.97 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.667 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 4.6 m 32.46 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.264 1.026 . . . . 0.0 113.255 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 47.4 m -151.15 58.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.209 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.668 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -116.72 -27.79 2.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.218 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.5 HG23 ' CG2' ' A' ' 9' ' ' VAL . 36.8 mm -72.42 98.93 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.152 0.501 . . . . 0.0 110.138 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.55 -155.09 7.59 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.2 pt -67.66 -12.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 123.434 0.693 . . . . 0.0 111.937 -171.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -160.0 43.21 0.21 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.852 177.195 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 66.82 -151.22 0.2 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.721 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -108.05 18.68 20.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.55 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.615 1.197 . . . . 0.0 112.152 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB3' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.58 43.24 3.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.955 -177.296 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -160.72 67.19 0.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.462 177.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.36 -33.32 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.6 -66.32 0.34 Allowed Glycine 0 C--O 1.223 -0.54 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.179 -174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -77.84 -100.67 0.19 Allowed Glycine 0 C--O 1.224 -0.505 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.706 -170.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.65 -50.17 0.45 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.001 1.32 . . . . 0.0 112.649 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 p -75.08 -82.43 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -90.08 4.13 51.25 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.539 172.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 20.4 mmtm 53.09 58.82 4.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.56 -3.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.929 -172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mmm -54.48 -35.57 63.2 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.049 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -77.24 -27.85 53.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.488 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 24.6 t -64.78 -29.0 46.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.83 -21.74 17.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.68 -46.77 15.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -117.9 -42.98 2.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -175.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 85.9 t -62.04 -56.29 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 11.6 t-160 -38.1 -45.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 4.42 8.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 79.8 mm-40 -131.91 -31.05 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.654 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -121.79 -19.54 6.73 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.139 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -67.7 -14.29 62.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 109.195 169.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.29 -32.1 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.649 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.72 -82.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.762 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 123.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.349 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 141.42 18.9 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.711 2.274 . . . . 0.0 112.87 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -86.72 -20.45 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 177.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 61.13 -131.83 0.73 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.477 175.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.614 ' H ' HG21 ' A' ' 81' ' ' VAL . 3.5 m 53.95 26.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.639 1.176 . . . . 0.0 113.335 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.885 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.6 OUTLIER -153.22 40.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.974 0.416 . . . . 0.0 111.849 177.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.502 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 2.9 p90 -153.68 -44.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.75 35.65 1.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.062 0.458 . . . . 0.0 111.476 -173.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 68' ' ' LEU . 16.7 pm0 -141.45 134.89 14.51 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.608 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 47.9 Cg_endo -76.04 -42.66 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.2 1.933 . . . . 0.0 111.946 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 t 168.88 52.73 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.931 1.348 . . . . 0.0 109.193 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -136.75 175.61 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.591 -1.64 . . . . 0.0 107.693 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -74.38 19.27 0.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.706 174.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -64.83 -18.83 65.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.275 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -51.89 -46.26 64.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.218 0.532 . . . . 0.0 110.241 173.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.651 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -88.42 -28.44 20.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 7.98 18.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.094 0.473 . . . . 0.0 111.263 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -120.74 -48.09 2.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.741 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.614 HG21 ' H ' ' A' ' 67' ' ' VAL . 97.6 t -82.01 -22.38 9.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.302 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -113.48 21.23 15.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.197 0.523 . . . . 0.0 110.113 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 -179.76 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 2.2 t80 48.04 78.4 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.447 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 72.42 132.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.81 0.814 . . . . 0.0 111.525 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.5 103.61 41.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.973 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.57 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 14.9 Cg_exo -70.04 157.89 58.36 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.913 2.409 . . . . 0.0 111.79 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.74 -64.88 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.75 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.474 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 63.6 m-80 -126.56 -81.36 0.61 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.71 -54.6 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.301 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.81 -38.1 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.82 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.2 mp0 -66.96 -45.01 79.07 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.49 -49.07 78.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.507 . . . . 0.0 110.945 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -45.25 93.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.861 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -45.88 79.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.138 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.69 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.588 0.555 . . . . 0.0 111.742 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 22' ' ' ILE . 15.7 pt-20 -83.34 -27.76 29.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.326 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.539 HG13 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -115.04 24.1 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 119.772 -0.771 . . . . 0.0 113.047 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -132.65 -48.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.123 -0.36 . . . . 0.0 110.667 172.643 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.1 tm-20 51.76 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.28 1.032 . . . . 0.0 111.443 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 1.6 mtt85 -103.31 -4.88 23.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.246 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.72 15.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.908 0.755 . . . . 0.0 112.071 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -147.49 -57.4 0.25 Allowed 'General case' 0 C--O 1.23 0.048 0 O-C-N 122.03 -0.419 . . . . 0.0 111.468 179.168 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.07 9.86 6.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.14 -1.028 . . . . 0.0 112.836 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 19.8 m 34.34 72.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 0.0 113.156 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.04 59.01 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -172.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 37' ' ' ASN . . . -149.47 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.986 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 9' ' ' VAL . 14.4 mm -48.72 111.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.341 0.591 . . . . 0.0 111.675 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -133.25 -118.0 1.87 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.455 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -1.88 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 110.257 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.2 40.93 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.412 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 4.9 m-20 59.7 -136.22 0.76 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.43 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' OD1' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -128.41 37.11 4.18 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.51 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.798 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 39.2 -100.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.526 -174.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.998 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 m-85 -128.46 43.13 3.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.139 0.495 . . . . 0.0 111.254 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.798 HE21 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt20 -151.36 64.35 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.458 0.646 . . . . 0.0 110.123 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 41' ' ' ILE . 1.3 tp -120.92 -11.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 122.161 0.981 . . . . 0.0 108.771 -175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -163.12 125.68 1.43 Allowed Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 109.12 -96.78 1.01 Allowed Glycine 0 C--N 1.303 -1.276 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.937 170.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.8 m80 79.99 -65.09 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.882 0.873 . . . . 0.0 111.882 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 p -94.14 -76.57 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -79.92 -4.14 51.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.105 177.453 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.981 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 mmtp 53.5 64.22 1.92 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 178.19 1.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.256 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -57.09 -35.52 69.51 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 177.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.74 62.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.47 0.652 . . . . 0.0 110.265 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.6 t -65.7 -24.13 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.165 177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.13 -11.26 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.064 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.62 -50.27 8.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.823 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -121.65 -30.73 4.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 0.0 111.588 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 12.2 t -73.17 -38.56 55.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 22.6 t-160 -35.2 -56.48 0.6 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.473 1.108 . . . . 0.0 113.371 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -138.66 14.55 2.72 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.191 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.2 -29.12 4.93 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.475 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -123.45 -27.06 4.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.504 -173.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -63.54 -16.75 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.328 0.585 . . . . 0.0 109.871 172.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -67.13 -32.41 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.835 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.51 -76.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.9 135.51 11.05 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.704 0.288 . . . . 0.0 110.742 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 62.1 Cg_endo -75.74 119.48 5.45 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.62 2.213 . . . . 0.0 112.314 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -49.67 12.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 12.9 mttt 60.52 -137.77 0.63 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.918 0.487 . . . . 0.0 111.48 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.501 HG22 HG11 ' A' ' 81' ' ' VAL . 1.7 t 62.71 26.41 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.626 0.77 . . . . 0.0 112.025 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.4 62.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 111.494 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 p90 -158.6 -49.18 0.06 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-O 120.916 0.388 . . . . 0.0 111.97 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.981 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.18 63.7 2.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.735 -173.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 2.7 pm0 -170.87 138.79 1.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 111.769 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 84.5 Cg_endo -99.6 52.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.749 2.966 . . . . 0.0 111.882 171.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.998 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.1 m 67.64 66.64 0.38 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.145 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 7.2 mt -134.55 -102.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -151.78 17.09 0.69 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.407 0.622 . . . . 0.0 110.048 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 71' ' ' GLN . . . -69.63 -32.63 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.242 -171.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.08 -45.88 75.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.027 0.442 . . . . 0.0 110.866 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.649 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.49 -50.74 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.848 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -66.71 -13.56 61.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -89.82 -56.55 3.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 67' ' ' VAL . 77.0 t -70.56 -33.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.93 -18.36 63.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.957 0.408 . . . . 0.0 110.542 178.569 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.523 -0.086 0 CA-C-O 121.538 0.685 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -79.53 129.04 34.1 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.03 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HA ' HG23 ' A' ' 32' ' ' ILE . 59.9 t 76.71 -85.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.52 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 159.87 71.68 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 124.232 0.958 . . . . 0.0 111.618 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 8.1 Cg_exo -72.96 109.24 2.77 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.035 1.823 . . . . 0.0 111.568 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -113.3 -74.71 0.62 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -177.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -141.22 38.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.394 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.52 -48.97 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.7 OUTLIER -64.43 -44.45 91.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.011 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.83 -43.4 98.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.422 -178.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.1 ttpp -62.66 -50.53 70.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.007 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -57.39 -43.19 83.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.653 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.15 -40.17 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.677 0.61 . . . . 0.0 111.477 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.31 -25.49 60.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.468 -178.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -87.4 -39.11 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.598 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -95.17 -36.27 11.54 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.5 -171.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.1 tm-20 53.78 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.796 0.838 . . . . 0.0 110.845 -173.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.3 mtt180 -114.6 -2.04 13.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.092 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.45 13.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.833 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.26 -55.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.58 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.4 -5.03 32.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.09 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 24' ' ' GLU . 6.9 m 31.26 78.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.997 0.919 . . . . 0.0 113.295 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 41.76 0.35 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.73 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -136.2 -58.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.47 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 9' ' ' VAL . 5.7 mm -28.83 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 113.118 -176.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.77 -126.95 2.11 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.301 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.95 22.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.761 0.315 . . . . 0.0 110.677 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.87 54.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.716 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER 64.86 -126.79 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.347 1.07 . . . . 0.0 111.964 170.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.73 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 3.6 t-20 -146.77 36.13 0.95 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.201 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.88 -99.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.203 -168.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.989 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.78 42.13 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.502 . . . . 0.0 111.929 -177.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -150.97 61.69 0.92 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 178.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.472 HD11 ' HE1' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -100.76 -59.4 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.417 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' ILE . . . -133.69 84.11 0.29 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.23 -0.51 . . . . 0.0 111.885 -175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 147.75 -118.57 1.01 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 12.4 p-80 56.51 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.496 1.518 . . . . 0.0 114.59 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.9 p -94.62 -85.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.62 -17.23 62.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.75 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 9.1 mmtm 59.66 59.95 2.38 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.425 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 175.49 -2.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.599 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.498 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.8 mmm -55.07 -37.51 66.86 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.662 0.268 . . . . 0.0 111.017 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.552 ' HA ' ' HZ3' ' A' ' 23' ' ' TRP . . . -70.27 -40.99 74.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.652 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 59.9 t -60.14 -21.84 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.622 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -108.91 -6.18 15.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.383 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -92.99 -47.19 7.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.441 ' OE1' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -113.32 -56.11 2.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.997 0.427 . . . . 0.0 109.884 -178.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 2.8 t -53.27 -45.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.333 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 19.0 t-160 -36.4 -56.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.84 3.24 9.46 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.199 -171.26 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 57' ' ' ARG . 73.8 mm-40 -119.93 -25.69 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.894 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.767 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 25.9 m-85 -125.49 -41.81 2.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.226 -172.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -12.6 59.53 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.737 0.303 . . . . 0.0 110.836 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.5 t -53.27 -31.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 168.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -81.82 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.709 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -124.34 131.15 24.15 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.78 0.324 . . . . 0.0 111.449 -171.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 71.7 Cg_endo -91.52 113.92 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.856 2.371 . . . . 0.0 112.133 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.05 -46.76 55.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 24.9 mtmt 68.11 -148.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.1 t 65.81 39.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.332 0.653 . . . . 0.0 112.146 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -171.11 37.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.252 0.549 . . . . 0.0 111.434 176.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 3.0 p90 -151.13 -51.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -97.37 65.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 111.433 -172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 4.2 pm0 -155.25 129.36 4.71 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.19 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 2.0 Cg_endo -85.64 62.63 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.044 2.496 . . . . 0.0 110.953 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.989 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 14.2 t 51.04 51.51 16.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.755 1.264 . . . . 0.0 112.121 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.5 mt -130.24 -179.66 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 113.593 -1.64 . . . . 0.0 106.981 168.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.625 ' H ' HG22 ' A' ' 74' ' ' ILE . 8.7 mtmm -80.57 14.7 1.95 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.779 0.799 . . . . 0.0 108.862 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -61.47 -26.64 68.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.086 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -52.68 -49.86 64.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.346 0.593 . . . . 0.0 110.349 176.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.707 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -79.83 -39.9 29.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.065 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.85 10.23 2.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.627 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -111.08 -59.66 1.94 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' A' ' 67' ' ' VAL . 8.9 t -75.45 -25.62 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.664 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.68 0.48 52.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.564 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 177.276 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 34' ' ' ILE . 2.4 t80 53.18 58.91 4.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.579 0.55 . . . . 0.0 111.579 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 32' ' ' ILE . 53.7 t 67.02 91.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.586 0.708 . . . . 0.0 110.913 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.03 131.52 66.38 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.452 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.29 163.93 36.59 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.809 2.34 . . . . 0.0 112.556 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -106.52 -65.78 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 61.5 m-80 -126.94 -89.09 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.0 110.925 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.99 -59.66 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.088 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.91 -40.35 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.512 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 13.0 mp0 -63.7 -46.43 85.53 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.829 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -62.93 -42.24 99.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.792 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 3.4 mtpm? -70.03 -40.82 74.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.674 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.01 -40.2 83.02 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.738 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -56.51 -38.61 72.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.4 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.9 pt-20 -75.96 -26.67 57.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.055 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 18' ' ' LYS . 6.7 mt -93.24 -36.8 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.529 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -90.01 -33.37 16.38 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.85 -172.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.847 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 58.01 -66.36 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.052 0.941 . . . . 0.0 111.674 -174.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HB2' ' H ' ' A' ' 30' ' ' SER . 6.6 ttt85 -135.21 2.86 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.245 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER 54.65 20.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 -56.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.733 -0.605 . . . . 0.0 111.857 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.05 13.85 9.03 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.974 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.847 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 39.96 73.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.781 0.832 . . . . 0.0 112.697 177.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.788 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -158.28 59.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.718 177.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -124.84 -16.3 3.02 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.876 -172.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.476 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -97.2 82.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -116.41 43.67 1.61 Allowed Glycine 0 C--O 1.225 -0.463 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.022 -167.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.451 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 8.0 mm 79.03 -20.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.986 0.898 . . . . 0.0 110.09 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.652 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -147.5 42.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.846 -172.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 61.53 -143.22 0.45 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.083 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.59 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -127.54 36.75 4.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 41.51 -102.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.735 -173.677 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 1.088 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.0 m-85 -132.51 49.0 2.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.856 0.36 . . . . 0.0 111.012 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.75 57.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.893 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 37' ' ' ASN . 3.3 tt -101.43 -33.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.859 -174.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -122.74 -55.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.699 -174.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . -77.31 -99.61 0.18 Allowed Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.554 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 60.23 -44.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.597 1.559 . . . . 0.0 114.52 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 p -97.19 -73.97 0.59 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 49' ' ' MET . 13.2 tp -75.1 -19.86 59.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.082 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 10.8 mmtp 56.11 54.36 7.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.903 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.82 -17.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.465 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -53.78 -34.86 60.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.75 0.31 . . . . 0.0 111.432 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.54 -29.77 52.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.97 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.2 t -66.25 -29.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -92.61 -19.39 21.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.099 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 -49.9 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.811 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -122.45 -47.13 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.153 -177.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 60' ' ' GLN . 36.7 t -55.05 -47.69 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.064 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.712 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 20.9 t-160 -41.23 -48.36 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 112.826 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -118.86 5.74 11.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -170.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 18.1 mm-40 -134.02 -19.33 2.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 14.1 m-85 -133.72 -44.2 0.81 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.386 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.733 ' HB2' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -62.31 -15.9 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.233 0.539 . . . . 0.0 111.201 -178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 t -68.91 -31.08 49.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.361 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 5.1 tp10 -129.08 -76.6 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.209 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -117.4 117.74 36.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HG3' HE22 ' A' ' 60' ' ' GLN . 82.2 Cg_exo -47.21 -48.91 13.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.741 2.961 . . . . 0.0 113.895 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 61.72 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.492 0.495 . . . . 0.0 110.933 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG2' HG22 ' A' ' 51' ' ' VAL . 72.2 mttt 61.75 -124.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.046 0.538 . . . . 0.0 111.105 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 63.35 49.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.991 0.516 . . . . 0.0 111.219 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.9 pt? -174.03 39.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.399 0.619 . . . . 0.0 112.059 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' A' ' 70' ' ' ALA . 4.4 p90 -151.45 -54.93 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.403 -0.811 . . . . 0.0 112.43 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -100.25 75.97 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.915 0.388 . . . . 0.0 111.428 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 3.8 pm0 -162.23 139.78 6.46 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.824 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' A' ' 74' ' ' ILE . 85.1 Cg_endo -88.64 46.78 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.154 2.569 . . . . 0.0 112.563 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 1.088 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER 60.55 39.61 17.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.223 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 72' ' ' PRO . 7.2 mt -139.96 48.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 122.304 -0.247 . . . . 0.0 110.562 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 pttt 46.71 23.8 0.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.221 1.008 . . . . 0.0 112.502 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -72.41 -15.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.759 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.67 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -59.38 -44.38 92.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.312 0.577 . . . . 0.0 110.003 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.67 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -72.3 -43.43 64.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.814 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -75.47 5.18 6.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.796 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.2 -62.49 1.31 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.73 -31.73 42.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.394 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.3 2.61 50.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.94 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.025 0.441 . . . . 0.0 109.934 176.641 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.366 0.603 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.49 109.01 5.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.201 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 32' ' ' ILE . 62.1 t 70.25 -71.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.675 0.609 . . . . 0.0 111.756 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 81.55 0.19 Allowed Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.373 0.669 . . . . 0.0 110.967 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 34.3 Cg_exo -58.98 154.64 43.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.134 2.556 . . . . 0.0 112.036 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -86.97 -65.84 0.97 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.2 m-80 -128.53 -83.91 0.58 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.38 174.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.91 -49.84 0.22 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.447 0.642 . . . . 0.0 109.298 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.76 -45.74 91.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.691 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 34.6 mp0 -67.42 -43.01 82.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.611 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.553 ' CB ' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -54.49 -52.95 60.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -59.92 -44.64 94.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.87 89.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.023 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.01 -42.82 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 17' ' ' SER . 2.1 pt-20 -83.19 -14.24 53.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.315 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.0 mm -91.31 -39.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 0.0 112.086 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.14 -29.53 15.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -176.231 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.4 tp10 59.74 -64.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.409 1.084 . . . . 0.0 111.705 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.623 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -141.1 5.15 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.374 170.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 63.45 -5.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.622 1.169 . . . . 0.0 113.885 176.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 HG12 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -140.1 -60.78 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.855 0.359 . . . . 0.0 111.2 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.86 7.45 25.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.762 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 24' ' ' GLU . 12.4 m 36.22 76.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.623 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -155.78 57.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.13 0.491 . . . . 0.0 110.009 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -125.39 -50.75 0.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.475 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 ' CG2' ' A' ' 9' ' ' VAL . 49.3 mm -60.6 108.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.527 0.68 . . . . 0.0 111.086 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.93 -163.59 13.75 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -76.24 14.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 111.511 -175.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.68 7.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 51.08 -127.07 2.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.753 -176.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -128.55 26.22 5.66 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.091 -176.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.84 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.552 1.158 . . . . 0.0 111.291 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -135.21 51.54 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.044 0.449 . . . . 0.0 110.768 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -154.72 51.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.982 0.42 . . . . 0.0 111.009 176.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.1 tt -106.35 -15.28 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.345 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.52 45.64 0.46 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.83 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.36 -123.73 0.69 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.846 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.747 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 13.5 p-80 58.82 -47.89 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.061 1.744 . . . . 0.0 114.346 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -96.01 -68.9 0.78 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.302 0.573 . . . . 0.0 110.272 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 18.0 tp -78.73 -18.22 54.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.092 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 48.47 52.38 13.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . . . 173.74 10.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.97 -171.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.24 -39.27 93.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.364 0.602 . . . . 0.0 109.449 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.84 -30.55 45.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.45 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 11.0 t -63.95 -28.23 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.109 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -99.15 -18.74 17.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -51.95 15.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.09 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.89 -41.35 2.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.366 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.958 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 66.4 t -58.56 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.2 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.3 t60 -54.91 -38.98 68.31 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -109.39 -4.84 16.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -168.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -142.9 -11.07 0.77 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.958 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 10.5 m-85 -124.88 -48.01 1.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.79 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.7 -18.84 63.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.019 0.437 . . . . 0.0 110.918 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.4 -32.87 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.268 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 -74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.873 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.11 127.91 15.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.74 0.305 . . . . 0.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.93 118.58 5.76 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.539 2.159 . . . . 0.0 112.09 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -90.99 -63.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.605 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 4.6 mtpt 64.15 -132.75 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.7 0.4 . . . . 0.0 111.375 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.986 HG22 HG21 ' A' ' 81' ' ' VAL . 0.2 OUTLIER 60.12 33.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.483 0.713 . . . . 0.0 112.599 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -170.27 46.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.444 0.64 . . . . 0.0 112.37 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.8 p90 -156.33 -47.78 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.418 -0.801 . . . . 0.0 112.752 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.42 50.9 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.196 0.522 . . . . 0.0 111.686 -172.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.74 132.72 4.2 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.747 ' HA ' ' HB3' ' A' ' 44' ' ' HIS . 31.5 Cg_endo -69.21 -40.67 5.86 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.169 1.913 . . . . 0.0 111.278 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 8.8 t 168.27 45.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 123.427 1.584 . . . . 0.0 108.208 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.9 mt -118.97 176.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 112.628 -2.078 . . . . 0.0 107.482 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -81.66 17.28 1.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.25 -25.49 68.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.891 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.789 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.98 -44.63 96.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.421 . . . . 0.0 110.911 176.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.789 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.22 -41.52 49.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.175 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -29.8 70.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.312 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -73.77 -48.15 33.76 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.133 -178.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.986 HG21 HG22 ' A' ' 67' ' ' VAL . 1.2 t -73.99 -24.86 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.67 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.39 177.456 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -65.27 119.07 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.062 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 32' ' ' ILE . 3.4 t 56.74 51.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.96 116.78 1.01 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.988 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.21 151.09 20.47 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.759 2.306 . . . . 0.0 112.217 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.1 -74.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.943 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -128.92 39.94 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.1 -57.53 0.42 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.294 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.22 -47.93 91.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 -44.04 97.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.995 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 -44.86 87.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.6 ttpp -64.25 -40.87 96.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.349 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.497 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.4 -43.76 68.16 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.554 0.533 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.3 pt-20 -81.8 -13.8 57.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.666 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 18' ' ' LYS . 44.9 mm -102.7 -16.62 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 112.025 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.553 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -111.3 -32.67 6.66 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.217 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG12 ' A' ' 32' ' ' ILE . 6.0 tt0 61.22 -66.45 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.983 0.913 . . . . 0.0 111.801 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.797 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.81 2.09 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.25 -15.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.139 . . . . 0.0 113.308 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -136.14 -53.53 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.048 0.452 . . . . 0.0 111.074 -175.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.45 4.18 32.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.175 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 3.3 m 34.77 74.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.949 1.029 . . . . 0.0 112.927 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.797 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -156.94 61.43 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.886 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.714 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . -121.61 -46.78 0.31 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.665 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.773 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.1 mm -44.47 121.61 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.565 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.91 -161.18 12.63 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.78 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -66.47 -5.86 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.008 0.523 . . . . 0.0 111.607 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -171.53 38.18 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 175.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 2.5 m-20 45.08 -121.27 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.394 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.619 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 1.8 m-20 -112.83 41.2 2.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HD2' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER 42.02 -93.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.411 1.069 . . . . 0.0 111.404 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.4 59.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HB2' ' NE2' ' A' ' 44' ' ' HIS . 2.0 pt20 -164.32 66.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.25 0.547 . . . . 0.0 110.704 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -111.27 -32.45 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.581 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.44 86.66 0.14 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.48 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 168.84 -126.67 1.41 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.405 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m80 66.28 -54.14 0.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -72.57 -74.09 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.338 0.59 . . . . 0.0 109.9 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 7.4 tp -93.73 -10.21 35.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.172 173.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.9 mmtp 55.53 67.65 0.98 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.139 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 173.19 1.97 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.128 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.735 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 7.6 mmm -61.13 -34.11 74.47 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 -177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.44 65.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.413 0.625 . . . . 0.0 109.976 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.5 t -63.29 -24.13 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.317 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.99 -12.21 16.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.489 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.68 -51.11 6.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.448 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.16 -35.94 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.718 -174.217 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.948 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 58.8 t -70.08 -40.94 78.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.342 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.8 t-160 -44.2 -52.2 7.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.996 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.79 13.97 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 65.8 mm-40 -135.85 -7.8 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.834 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -134.46 -42.16 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.875 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -21.54 64.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.8 t -58.1 -32.05 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.922 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.69 -80.67 0.63 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 135.81 18.15 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.265 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.449 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 73.8 Cg_endo -82.01 115.86 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.331 2.021 . . . . 0.0 112.011 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -81.29 -40.27 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.422 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.5 mtmt 58.25 -120.64 1.21 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.391 0.432 . . . . 0.0 110.898 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.564 ' H ' HG21 ' A' ' 81' ' ' VAL . 15.9 m 48.37 25.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.208 1.403 . . . . 0.0 114.573 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -173.19 66.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.0 111.887 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 5.3 p90 -162.98 -47.69 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 -176.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -99.33 84.53 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.907 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -158.75 148.96 15.47 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.464 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 58.5 Cg_endo -100.34 40.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.014 3.143 . . . . 0.0 111.403 168.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.496 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 0.2 OUTLIER 55.52 55.37 7.37 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.767 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' HG2' ' A' ' 75' ' ' LYS . 4.3 mt -134.38 -103.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -139.68 16.23 2.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.233 0.539 . . . . 0.0 110.261 175.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.82 -32.14 73.7 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.77 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -59.14 -44.64 92.07 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.408 0.623 . . . . 0.0 110.523 178.523 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.685 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -74.74 -43.44 54.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.255 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -27.49 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.301 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.2 t80 -66.86 -53.4 32.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.418 0.628 . . . . 0.0 109.383 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.564 HG21 ' H ' ' A' ' 67' ' ' VAL . 99.1 t -71.28 -23.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.643 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.41 -0.04 39.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.48 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.972 0.415 . . . . 0.0 109.932 174.273 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 9.0 pt20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.977 0.418 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.404 ' CE1' HG22 ' A' ' 32' ' ' ILE . 1.6 t80 -69.46 121.23 16.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.79 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 2.0 t 56.63 49.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.74 109.71 1.09 Allowed Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.26 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.59 165.49 1.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.383 2.722 . . . . 0.0 111.837 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.02 -69.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.282 174.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.9 m-80 -124.55 -86.9 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.491 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.68 -49.64 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.0 t -60.54 -43.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.785 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 8.9 mp0 -67.68 -48.82 65.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.023 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -41.79 92.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.91 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -46.69 88.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -60.34 -48.96 79.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.826 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.08 -40.25 57.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.544 0.527 . . . . 0.0 111.622 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -87.0 -12.54 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.325 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 22' ' ' ILE . 4.1 mm -95.42 -38.77 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.931 -177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -101.52 -29.82 11.76 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -174.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.78 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.2 tt0 57.37 -68.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.011 0.924 . . . . 0.0 111.496 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -130.6 2.59 4.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 175.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.55 0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.308 1.043 . . . . 0.0 113.586 177.008 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -146.14 -57.76 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.15 -0.344 . . . . 0.0 111.367 -179.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.67 -1.0 29.09 Favored Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.964 -172.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 39.35 67.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.337 0.655 . . . . 0.0 112.393 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 60.04 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.958 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.76 -15.26 2.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.238 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.639 HG23 HG22 ' A' ' 9' ' ' VAL . 43.2 mm -71.8 83.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.009 0.433 . . . . 0.0 110.1 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.52 -85.66 1.87 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.938 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -136.95 -5.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 110.731 177.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.736 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.4 OUTLIER -167.53 43.56 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.897 -178.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m-20 49.63 -129.04 2.11 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.705 -173.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.637 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 22.2 m120 -116.54 27.06 9.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.92 -91.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.113 0.883 . . . . 0.0 111.744 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.641 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.83 40.81 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.258 0.551 . . . . 0.0 111.696 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -138.72 52.59 1.79 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.712 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.437 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 3.9 tt -110.78 -28.1 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -144.66 45.99 0.83 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.983 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -179.34 -103.0 0.17 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.755 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' GLN . 4.8 p-80 59.96 -50.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.223 1.809 . . . . 0.0 113.898 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 p -106.06 -68.31 0.88 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.22 -25.93 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.89 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 7.0 mmtp 53.24 63.66 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.9 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.0 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.242 -174.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.443 ' H ' ' HG2' ' A' ' 49' ' ' MET . 31.1 mmm -52.82 -42.46 65.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.489 0.185 . . . . 0.0 111.242 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.564 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.76 -29.59 51.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.556 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 16.0 t -62.65 -29.1 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.971 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.91 -20.78 15.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.664 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.2 -51.78 12.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.038 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.603 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 4.7 pm0 -120.93 -38.03 2.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.143 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 30.2 t -64.62 -41.86 93.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.312 -174.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -40.41 -59.36 1.34 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -132.14 18.41 4.51 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 9.5 mm-40 -130.16 -6.4 4.36 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.829 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 40.0 m-85 -137.83 -54.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.567 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -19.0 65.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.33 . . . . 0.0 111.337 -174.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.29 -34.94 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.325 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.69 -73.51 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.957 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 113.95 9.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.947 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.66 127.23 15.15 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.664 2.243 . . . . 0.0 111.615 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -58.21 2.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.653 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 14.1 mttt 62.35 -134.49 0.5 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.421 0.288 . . . . 0.0 110.98 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 t 60.73 27.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.14 62.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 111.524 177.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.579 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 5.6 p90 -165.84 -50.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.705 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.859 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -87.83 45.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.609 -173.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.8 pm0 -154.12 143.2 14.84 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.8 Cg_exo -64.7 -56.47 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.313 2.009 . . . . 0.0 110.853 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.8 t 170.72 48.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.817 0.818 . . . . 0.0 109.898 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -125.55 -106.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.576 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -141.21 13.69 2.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.059 0.456 . . . . 0.0 110.531 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' GLN . . . -63.99 -26.66 68.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.216 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.7 -48.31 75.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.551 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.74 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.14 -43.77 66.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.164 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.24 0.06 12.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.238 0.542 . . . . 0.0 111.403 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.5 t80 -100.46 -63.31 1.14 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.81 -28.67 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.596 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -95.54 10.08 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.488 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.485 173.648 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 45.1 t80 -74.73 116.71 15.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 21' ' ' GLU . 4.7 t 56.53 55.73 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.682 0.753 . . . . 0.0 109.276 -168.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -49.62 126.91 18.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.078 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.4 Cg_exo -68.29 138.58 43.35 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.063 2.508 . . . . 0.0 112.32 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.603 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -103.94 -73.98 0.66 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.791 0.329 . . . . 0.0 110.345 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -137.01 45.61 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.054 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.21 -69.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.246 0.619 . . . . 0.0 111.165 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.39 -48.76 76.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.603 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.49 -34.95 79.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.542 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -45.14 94.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.124 0.488 . . . . 0.0 110.526 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 18.2 ttpt -64.76 -40.96 96.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.377 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -67.0 -34.29 77.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.533 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -58.41 -44.52 89.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.657 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 pt-20 -79.29 -14.17 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 18' ' ' LYS . 2.2 mm -118.22 32.32 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.279 . . . . 0.0 111.719 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.669 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -144.96 -47.82 0.24 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.724 171.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 28.1 tt0 60.48 -65.65 0.05 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.058 0.943 . . . . 0.0 112.306 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 25' ' ' ARG . 3.5 mtp180 -134.77 -1.76 2.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.526 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 63.62 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.13 -51.65 0.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.048 -0.408 . . . . 0.0 111.102 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.65 -14.98 28.24 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.111 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 43.29 72.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 124.423 0.719 . . . . 0.0 112.018 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 m -162.51 70.37 0.28 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.563 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -169.94 10.2 0.05 OUTLIER Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.01 -1.091 . . . . 0.0 114.477 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.31 129.74 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 117.949 0.875 . . . . 0.0 110.022 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.19 5.87 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.073 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.59 18.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.401 0.28 . . . . 0.0 111.754 -176.155 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.33 42.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 7.3 m-20 59.73 -121.47 1.04 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.726 ' HB2' HD12 ' A' ' 41' ' ' ILE . 2.4 t-20 -128.82 43.79 3.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.49 -101.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.147 0.905 . . . . 0.0 111.229 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -124.49 43.77 2.93 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.1 pt20 -160.8 67.38 0.32 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.7 OUTLIER -105.66 -41.05 6.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.27 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.11 89.98 0.13 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.092 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.791 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 160.52 -121.93 1.08 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 66.52 -51.99 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 113.013 174.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -84.0 -73.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.296 0.569 . . . . 0.0 110.277 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.498 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 9.5 tp -84.29 -13.19 53.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.457 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.5 mmtm 51.12 65.28 1.53 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.604 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.65 -6.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.307 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.791 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 21.4 mmm -53.42 -37.79 62.88 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.183 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -74.84 -35.73 62.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.186 0.517 . . . . 0.0 110.596 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 59.2 t -61.87 -27.52 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.211 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.59 -15.86 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -48.54 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.62 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.83 -39.85 1.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.165 -177.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -58.55 -51.33 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.337 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.4 t-160 -59.43 -26.62 65.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -174.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.98 -4.44 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -138.12 -19.82 1.12 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 37.2 m-85 -124.76 -50.43 1.72 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.221 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -12.0 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.606 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.88 -30.89 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.293 0.568 . . . . 0.0 110.051 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.72 -62.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.601 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.58 140.25 14.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.77 154.1 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.517 2.145 . . . . 0.0 111.819 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -119.23 -42.77 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.937 179.243 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mppt? 63.87 -145.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.587 0.355 . . . . 0.0 111.367 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.0 t 65.6 26.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -166.33 42.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 111.849 174.204 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.5 p90 -148.2 -45.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.09 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.86 53.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.056 0.455 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -141.33 119.15 7.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 73' ' ' THR . 23.4 Cg_exo -65.95 -69.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.478 2.118 . . . . 0.0 111.285 170.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -179.7 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 109.806 175.282 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.94 38.62 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.458 -171.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 60.34 23.61 13.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.172 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.27 -24.77 66.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -55.1 -48.64 73.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.487 175.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.66 62.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.487 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 -6.95 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -100.02 -50.77 3.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 67' ' ' VAL . 5.8 p -69.47 -23.05 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.997 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.18 18.66 14.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.233 0.539 . . . . 0.0 110.697 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.0 m . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.269 176.573 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 120.684 0.278 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.738 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 8.5 t80 49.24 82.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.127 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 32' ' ' ILE . 3.3 p 33.94 96.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 124.97 1.419 . . . . 0.0 112.42 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -68.43 115.18 27.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.242 -169.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.0 Cg_endo -95.8 138.73 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.891 3.061 . . . . 0.0 112.586 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -128.12 -71.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.43 60.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.628 -0.429 . . . . 0.0 112.064 -169.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -46.87 -47.8 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 122.949 0.5 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -44.04 74.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.556 -176.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.21 -51.96 66.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.391 -177.03 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.592 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.87 -38.48 91.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.771 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -44.92 76.92 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.568 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.42 -38.36 68.86 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.453 0.471 . . . . 0.0 111.611 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -86.73 -19.2 29.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.34 . . . . 0.0 110.67 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -90.08 -29.52 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -174.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -102.68 -27.86 12.47 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 -176.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 6.8 tm-20 59.71 -79.81 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.943 0.897 . . . . 0.0 110.513 -175.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -115.88 -12.25 11.43 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.838 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.01 5.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.356 1.035 . . . . 0.0 113.146 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -136.17 -55.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.798 -0.564 . . . . 0.0 110.876 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.79 -13.88 5.91 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.771 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 m 46.44 96.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 122.558 1.17 . . . . 0.0 112.192 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -86.33 -37.97 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.253 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . 139.13 70.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.842 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -55.31 127.97 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 177.106 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.36 -138.82 2.61 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.617 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -70.55 -2.54 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -4.08 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 9' ' ' VAL . 5.3 t70 62.03 -142.03 0.44 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' A' ' 41' ' ' ILE . 3.2 m-80 -135.41 23.99 3.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.2 -97.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.489 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.965 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.8 m-85 -122.22 37.32 4.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.043 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -155.56 63.59 0.6 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.429 . . . . 0.0 110.804 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.2 tt -108.76 -21.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 0.0 111.041 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -158.83 96.9 0.16 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.636 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 49' ' ' MET . . . 124.11 -117.7 3.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.596 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.537 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 16.4 p-80 56.89 -26.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.196 1.399 . . . . 0.0 114.501 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 43' ' ' GLY . 1.2 p -89.4 -75.04 0.45 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.117 0.484 . . . . 0.0 109.909 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.573 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -83.35 -11.77 57.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.994 174.186 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 15.0 mmtp 57.23 64.32 1.65 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.467 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 174.81 -9.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.774 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.573 ' HG2' HD23 ' A' ' 46' ' ' LEU . 4.7 mmt -50.32 -42.51 52.87 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.21 -30.11 60.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.829 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 53.3 t -64.28 -27.41 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.029 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.32 -21.38 14.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -77.16 -46.61 22.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -120.78 -50.37 2.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.493 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 53.9 t -52.1 -45.69 42.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 14.4 t-160 -39.63 -56.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.902 0.752 . . . . 0.0 112.753 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -114.02 1.61 14.71 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.277 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -116.27 -23.34 8.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.665 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -134.12 -42.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.533 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.93 55.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.703 0.287 . . . . 0.0 111.371 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.97 -36.09 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.388 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -121.06 -70.42 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.674 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.03 117.72 9.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.91 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 10.2 Cg_exo -69.73 121.56 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.522 2.148 . . . . 0.0 111.442 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -54.14 4.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.843 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 64.92 -116.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.492 -177.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.624 HG22 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER 57.96 27.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.5 0.72 . . . . 0.0 112.557 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.4 69.71 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 111.132 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.1 p90 -165.22 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.694 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.71 51.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.129 0.49 . . . . 0.0 111.16 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.27 136.03 6.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.511 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 60.1 Cg_endo -79.85 -36.09 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.159 1.906 . . . . 0.0 111.736 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.965 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 10.1 t 171.22 51.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.907 1.336 . . . . 0.0 109.541 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 76' ' ' ALA . 6.2 mt -133.33 162.24 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.667 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 22.97 0.07 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 172.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -65.41 -27.73 68.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.7 -39.9 86.14 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.947 177.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.599 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.41 -44.98 33.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -66.45 -18.04 65.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.612 -176.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.98 -53.24 5.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.612 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.624 HG21 HG22 ' A' ' 67' ' ' VAL . 25.7 t -72.58 -34.53 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.965 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 110.425 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.404 ' OE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 mt-30 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.458 ' O ' HG22 ' A' ' 9' ' ' VAL . 30.1 t80 56.21 89.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.557 -173.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.591 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 63.83 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.06 -166.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.17 109.05 54.65 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.554 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.81 115.92 3.68 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.796 2.331 . . . . 0.0 111.693 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -55.51 3.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.193 0.52 . . . . 0.0 109.854 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -128.04 -101.55 0.34 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.98 -45.56 0.65 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.89 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.488 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -63.44 -44.64 93.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.123 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -48.7 79.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.283 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 22' ' ' ILE . 2.5 mtpm? -61.5 -41.52 97.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -66.18 -44.09 85.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.251 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -50.81 -43.41 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.612 0.57 . . . . 0.0 111.346 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -80.78 -23.84 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.667 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 18' ' ' LYS . 40.3 mm -90.72 -32.32 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.646 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -95.13 -30.08 14.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.929 -176.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.646 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER 59.22 -64.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.511 1.124 . . . . 0.0 112.309 -175.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 -1.57 2.43 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.789 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 68.28 -14.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.254 1.022 . . . . 0.0 112.954 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.789 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -138.71 -57.53 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.76 -1.24 58.79 Favored Glycine 0 CA--C 1.5 -0.883 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.582 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 35.21 50.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 113.999 -1.1 . . . . 0.0 112.978 -179.03 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -149.35 57.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.371 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -133.05 -5.05 3.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.883 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 HG12 ' A' ' 9' ' ' VAL . 5.2 mm -76.18 108.98 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 117.736 0.768 . . . . 0.0 109.975 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.74 -153.42 7.83 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.415 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -1.06 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' HB3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -167.9 51.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 12.9 m-20 60.37 -135.66 0.7 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.543 ' HA ' HD22 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -104.12 46.75 0.9 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.403 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.81 -98.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.284 0.99 . . . . 0.0 109.908 -168.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -136.26 50.48 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 110.349 175.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -150.78 45.32 0.85 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.673 172.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 36' ' ' ASP . 1.5 tt -90.34 -27.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.401 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.34 54.84 0.62 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 179.97 -81.78 0.06 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 -60.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.967 1.707 . . . . 0.0 112.611 170.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 p -121.43 -50.13 2.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.472 0.653 . . . . 0.0 109.869 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.656 HD23 ' HG2' ' A' ' 49' ' ' MET . 22.1 tp -68.73 -29.6 68.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.268 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.755 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.1 mmtp 48.76 57.42 6.38 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.632 0.582 . . . . 0.0 111.262 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.14 -5.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.934 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.722 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 7.0 mtp -56.41 -40.62 74.98 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.977 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.11 -31.82 44.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.29 0.567 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.564 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 10.7 t -62.15 -25.43 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.473 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.48 -16.58 14.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.221 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.72 10.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.9 pm0 -128.21 -29.67 2.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.197 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 77.8 t -66.05 -36.91 78.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.98 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.8 t60 -50.45 -51.17 49.17 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 57' ' ' ARG . 8.4 ptp85 -131.28 12.7 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.577 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 72.6 mm-40 -123.97 -12.88 7.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.282 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 6.9 m-85 -127.59 -41.88 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.924 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -14.24 36.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.2 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 t -61.64 -31.51 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.082 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.9 -74.74 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.351 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.62 137.05 8.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.54 150.16 13.06 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.699 2.266 . . . . 0.0 112.93 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD23 ' HE2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -84.84 -60.62 2.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.343 177.213 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.1 mttt 73.72 -141.95 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.692 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 66' ' ' LYS . 1.5 m 57.34 21.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.153 0.981 . . . . 0.0 112.355 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -159.57 46.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.753 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 p90 -148.65 -55.23 0.2 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.111 -0.368 . . . . 0.0 111.317 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.19 60.79 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.473 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.937 ' HG3' ' HB3' ' A' ' 77' ' ' LEU . 2.5 pm0 -174.19 150.34 1.55 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.793 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 40' ' ' GLN . 5.2 Cg_endo -90.55 -77.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.299 2.666 . . . . 0.0 112.113 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.618 ' HA ' ' CD2' ' A' ' 39' ' ' PHE . 14.3 t -161.97 22.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.556 0.693 . . . . 0.0 110.344 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.54 39.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.818 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 16.45 5.49 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.081 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -69.63 -28.63 66.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.171 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.937 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -56.71 -41.36 77.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.948 0.404 . . . . 0.0 111.231 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.751 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.11 -45.61 33.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.092 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.75 1.9 11.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.154 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.55 -56.8 2.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.9 -26.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.092 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.22 3.24 43.87 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.44 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.405 0.621 . . . . 0.0 109.978 174.258 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpp? . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.018 0.437 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.24 122.81 2.9 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.917 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.29 128.57 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.707 0.289 . . . . 0.0 110.517 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.48 169.04 9.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.3 pm0 -79.14 80.96 5.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.321 0.582 . . . . 0.0 111.743 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.43 -54.1 6.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -97.5 36.09 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.512 0.672 . . . . 0.0 109.763 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 3.5 t80 -46.95 124.05 5.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.575 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 51.35 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.456 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -167.11 97.66 0.66 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.497 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.1 124.37 10.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.678 2.252 . . . . 0.0 111.602 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -74.15 0.66 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.44 37.29 4.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.181 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.34 -62.64 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.055 0.542 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -45.87 90.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 0.0 110.207 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.09 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -44.18 97.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.209 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -63.76 -34.55 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.433 0.635 . . . . 0.0 110.193 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -45.59 76.82 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.063 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.55 -40.5 62.61 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.586 0.553 . . . . 0.0 111.589 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -79.28 -24.74 42.72 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.925 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -87.89 -27.43 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.613 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -109.82 -38.18 5.44 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.238 -175.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.6 tm-20 52.89 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.863 0.865 . . . . 0.0 110.642 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.3 mtt180 -110.27 -9.18 14.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.457 -177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 66.03 -2.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.702 -176.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -143.1 -54.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.064 -0.398 . . . . 0.0 111.487 -176.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.09 -6.48 27.88 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.3 m 32.93 80.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.898 0.879 . . . . 0.0 112.987 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.49 60.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.591 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -145.4 -59.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.653 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.468 HD11 HD12 ' A' ' 41' ' ' ILE . 12.8 mm -38.92 110.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.556 0.743 . . . . 0.0 112.149 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.78 -143.09 4.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.708 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -75.18 15.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.648 0.379 . . . . 0.0 111.882 -175.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.83 39.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 12.0 t70 64.21 -142.42 0.28 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.683 0.614 . . . . 0.0 110.018 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.591 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 8.2 t-20 -127.55 47.85 2.32 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.06 -101.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.691 -173.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -140.9 55.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.758 0.313 . . . . 0.0 110.733 177.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.5 pt20 -149.38 60.63 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.495 0.664 . . . . 0.0 110.956 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 32' ' ' ILE . 1.9 tt -106.81 -20.22 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.112 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.96 33.22 0.96 Allowed Glycine 0 C--O 1.229 -0.163 0 C-N-CA 119.825 -1.179 . . . . 0.0 113.29 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.07 -107.62 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.882 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 15.7 p-80 59.62 -51.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.015 1.726 . . . . 0.0 114.263 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 p -96.53 -65.65 0.95 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -92.33 -12.74 31.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.245 177.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 44' ' ' HIS . 5.1 mmtp 49.75 63.32 2.22 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.452 0.47 . . . . 0.0 111.232 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -178.95 -9.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.882 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.665 ' HE2' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -54.7 -41.16 69.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 110.976 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.25 -33.02 61.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 41.4 t -62.41 -26.42 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.497 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.36 -20.8 15.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.795 0.331 . . . . 0.0 111.124 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.47 12.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.941 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -118.23 -40.58 2.93 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.926 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -67.43 -59.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.848 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 70.1 t60 -51.79 -27.35 12.01 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -172.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 57' ' ' ARG . 9.5 ptt180 -127.08 2.45 6.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 7.4 mt-10 -138.99 -26.48 0.84 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 12.6 m-85 -126.43 -21.47 4.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.992 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -68.41 -15.12 63.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.79 -32.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.91 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.38 -84.99 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.889 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 131.65 15.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -86.32 112.53 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.602 2.201 . . . . 0.0 111.816 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -75.69 -32.11 59.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HE3' HG13 ' A' ' 81' ' ' VAL . 21.0 mtmt 61.5 -138.79 0.51 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.783 ' HB ' HD23 ' A' ' 77' ' ' LEU . 2.4 m 55.46 21.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.975 . . . . 0.0 113.464 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.805 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -151.64 37.94 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.609 0.718 . . . . 0.0 111.697 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 7.5 p90 -153.8 -46.51 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.667 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -88.22 41.01 0.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.559 -174.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.805 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.0 pm0 -153.06 138.65 11.75 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.298 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.0 Cg_endo -87.53 -42.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.15 2.567 . . . . 0.0 112.037 173.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.701 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 9.9 t 176.94 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.696 1.236 . . . . 0.0 109.609 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -121.51 163.04 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.96 24.35 0.13 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.836 0.827 . . . . 0.0 108.897 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -66.21 -21.6 66.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.003 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.77 -34.83 75.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -83.5 -38.16 22.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.912 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.77 3.62 16.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.373 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -108.4 -56.48 2.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.058 0.456 . . . . 0.0 109.821 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.716 HG21 ' H ' ' A' ' 67' ' ' VAL . 21.4 t -79.74 -11.72 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.655 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.05 21.61 13.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.781 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 m -134.85 -36.15 0.85 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.139 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -103.47 14.63 30.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 109.536 175.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 18.7 m . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.52 100.63 2.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.645 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.98 91.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 110.748 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 39.08 2.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -104.9 137.75 42.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 34' ' ' ILE . . . -118.22 -82.17 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -147.78 87.17 1.61 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.41 1.1 . . . . 0.0 108.853 170.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 58.5 t80 -57.73 115.6 2.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.475 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG22 HD12 ' A' ' 32' ' ' ILE . 89.8 t 73.38 115.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.611 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.49 101.45 42.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.54 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.05 174.76 11.13 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.703 2.269 . . . . 0.0 112.459 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.71 -68.44 0.72 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -112.43 -100.37 0.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.4 -50.09 0.92 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.571 . . . . 0.0 109.664 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.21 -39.53 85.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.976 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -64.15 -37.97 89.37 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.515 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.4 73.25 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.49 -44.8 93.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -44.27 96.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.977 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.623 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.274 0.359 . . . . 0.0 110.779 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.7 pt-20 -80.78 -12.86 59.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.282 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 18' ' ' LYS . 25.4 mm -99.53 -37.47 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.623 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -88.7 -36.24 16.3 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.713 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.611 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 6.9 tt0 59.53 -57.47 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.623 1.169 . . . . 0.0 112.969 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.33 -6.35 1.79 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.48 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.07 -2.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.983 0.913 . . . . 0.0 112.802 -178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.71 -59.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.105 -0.372 . . . . 0.0 111.437 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.87 2.24 33.8 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.482 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.7 m 36.36 64.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.093 0.957 . . . . 0.0 113.02 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.44 59.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.958 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.49 -13.12 0.66 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.663 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.519 HD12 HG22 ' A' ' 9' ' ' VAL . 15.8 mm -71.55 112.93 7.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 117.108 0.454 . . . . 0.0 110.055 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -150.48 -143.02 3.65 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.906 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -70.44 -0.39 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.04 34.4 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 t70 59.65 -136.34 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.752 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 12.4 m-80 -105.89 44.08 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -92.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.991 0.807 . . . . 0.0 111.107 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.14 51.44 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 110.643 177.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -147.9 61.64 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.242 0.544 . . . . 0.0 110.052 174.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.6 -43.44 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.13 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.816 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.78 44.79 1.29 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.869 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 176.06 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.938 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -53.48 0.31 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.606 1.562 . . . . 0.0 112.221 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.1 p -113.39 -65.34 1.2 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 33.1 tp -67.65 -31.29 71.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.573 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.883 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 8.1 mmtm 53.8 62.5 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.389 0.431 . . . . 0.0 110.7 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.59 -18.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.573 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.6 -29.97 69.54 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.654 -176.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.816 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -76.39 -38.74 55.28 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.314 0.578 . . . . 0.0 110.055 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 28.9 t -61.13 -24.4 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.749 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -102.46 -17.15 15.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.33 8.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.431 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.9 pm0 -122.3 -35.48 3.12 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.367 -175.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.6 t -63.33 -53.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.823 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 39.7 t60 -45.15 -46.78 12.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.19 5.14 8.52 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -168.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.18 -15.15 1.12 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.681 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.6 m-85 -125.46 -37.59 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.654 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -16.41 63.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.41 -32.48 48.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.819 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -114.65 -78.19 0.58 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.056 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.22 128.99 6.94 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.804 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.41 115.22 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -70.49 -40.85 73.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.598 ' O ' HD23 ' A' ' 68' ' ' LEU . 10.1 mttt 61.76 -138.76 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.33 0.394 . . . . 0.0 111.036 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.808 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER 44.4 40.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.52 1.128 . . . . 0.0 113.308 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -164.87 37.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.821 0.82 . . . . 0.0 111.275 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -151.0 -49.74 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.883 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -89.99 57.51 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 77' ' ' LEU . 2.9 pm0 -164.63 136.58 3.55 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.399 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.673 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 5.0 Cg_exo -79.11 -44.22 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.962 2.441 . . . . 0.0 111.51 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 8.4 t 174.1 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.806 1.289 . . . . 0.0 109.256 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 76' ' ' ALA . 2.1 mt -126.75 168.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.493 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.46 18.57 0.09 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.388 0.614 . . . . 0.0 109.53 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -67.64 -23.65 65.37 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.383 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.764 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.15 -43.92 98.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.142 179.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.764 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -75.68 -40.24 56.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.114 0.483 . . . . 0.0 110.063 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -70.17 -20.04 63.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.351 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -83.25 -56.72 3.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.186 0.517 . . . . 0.0 110.315 -177.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.808 HG21 ' H ' ' A' ' 67' ' ' VAL . 98.1 t -69.1 -30.66 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.946 -175.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.34 -8.84 58.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m -101.45 -35.11 9.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.571 ' HD3' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -95.09 -23.1 17.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.412 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' HD3' ' A' ' 84' ' ' ARG . 63.0 m . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.391 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.67 -103.68 0.21 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.24 82.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.126 0.965 . . . . 0.0 108.691 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.01 7.21 6.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.946 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -94.38 81.82 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.707 -175.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.58 -20.59 60.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.442 0.639 . . . . 0.0 109.929 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -78.02 -8.71 58.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.803 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.667 ' HD1' HG23 ' A' ' 9' ' ' VAL . 2.8 t80 -59.37 132.11 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.533 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.667 HG23 ' HD1' ' A' ' 8' ' ' TYR . 99.3 t 75.89 -55.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.116 0.567 . . . . 0.0 111.604 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 58.54 68.12 1.86 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 21.5 Cg_exo -65.43 160.2 43.9 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 112.318 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -67.76 0.86 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.951 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.485 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 64.0 m-80 -128.37 -89.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.198 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.79 -53.95 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 110.374 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' A' ' 58' ' ' GLU . 58.8 t -62.06 -41.44 91.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.345 0.593 . . . . 0.0 110.126 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.6 mp0 -63.52 -47.34 82.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.754 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.7 -46.53 89.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.478 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -64.85 -32.21 73.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.035 -178.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.41 -41.81 55.2 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.969 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.17 -41.61 62.74 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.567 0.542 . . . . 0.0 111.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG3' HG12 ' A' ' 22' ' ' ILE . 3.5 pt-20 -74.48 -38.47 62.88 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mm -109.63 45.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -147.26 -32.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.134 169.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HB3' HG12 ' A' ' 29' ' ' VAL . 15.8 tp10 65.04 -55.76 0.3 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.413 1.085 . . . . 0.0 112.482 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -150.24 -3.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.94 1.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.068 0.947 . . . . 0.0 113.545 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.33 -53.75 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.934 -0.479 . . . . 0.0 111.104 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.75 10.84 11.19 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.86 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER 35.05 72.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.078 0.951 . . . . 0.0 113.206 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.671 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -170.57 62.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.32 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.622 ' HA2' ' OD1' ' A' ' 37' ' ' ASN . . . -133.35 -45.39 0.12 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.042 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.8 mm -68.23 109.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 0.0 111.759 -171.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.32 -151.19 7.09 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG12 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.22 13.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.0 111.175 -177.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -167.58 36.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.65 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD2' ' HB ' ' A' ' 41' ' ' ILE . 11.8 t70 62.12 -151.17 0.37 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.622 ' OD1' ' HA2' ' A' ' 31' ' ' GLY . 19.4 t30 -91.11 59.28 3.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 49.35 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.533 1.146 . . . . 0.0 110.13 -170.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.512 ' HD1' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -150.25 50.99 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.873 0.368 . . . . 0.0 110.589 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -169.79 67.55 0.05 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 110.873 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -86.41 -35.27 8.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.956 -0.465 . . . . 0.0 111.788 -174.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.49 65.47 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.414 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -175.07 -119.97 0.58 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 58.14 -48.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.008 1.723 . . . . 0.0 114.266 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 p -94.16 -71.21 0.67 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.207 0.527 . . . . 0.0 109.633 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.0 tp -76.31 -22.01 55.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.177 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.721 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 12.9 mmtp 50.79 60.6 3.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.034 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.12 -5.97 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.296 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.4 mmm -53.61 -43.12 68.38 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 111.17 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.34 -30.54 48.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.202 0.525 . . . . 0.0 110.705 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -65.0 -27.23 41.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.813 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.16 -16.76 16.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.2 -53.55 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.993 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HB3' HD22 ' A' ' 19' ' ' LEU . 8.0 pm0 -128.11 -36.46 1.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.404 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 51' ' ' VAL . 60.5 t -60.38 -42.3 90.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.4 t-160 -54.3 -34.81 61.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 11.37 12.23 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.266 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' A' ' 15' ' ' VAL . 19.2 mm-40 -133.9 -25.54 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.9 -38.67 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.283 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -18.04 65.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.107 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.32 -31.54 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.242 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -113.78 -82.63 0.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.75 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.4 117.58 9.62 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.6 Cg_exo -80.82 123.3 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.024 2.483 . . . . 0.0 112.378 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -78.65 -41.5 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.836 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 30.5 mtmt 63.5 -141.24 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.937 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.78 30.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.054 0.542 . . . . 0.0 111.92 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.02 49.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -165.78 -48.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.855 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.721 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.5 67.29 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 111.132 -175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 7.6 pm0 -161.68 147.28 10.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.55 -60.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.359 2.039 . . . . 0.0 110.615 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -171.29 -41.48 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.814 0.816 . . . . 0.0 111.146 177.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.43 59.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.806 -164.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 77' ' ' LEU . 3.2 mttp 52.41 19.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.041 0.537 . . . . 0.0 111.79 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -64.93 -21.87 66.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -62.06 -49.32 76.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.458 175.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -70.21 -45.71 66.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.587 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.741 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 3.5 pt20 -68.06 -18.69 64.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 85.4 t80 -72.25 -52.57 15.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.621 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.76 -26.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.49 59.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -99.91 -15.4 18.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.552 0.691 . . . . 0.0 109.312 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.48 42.9 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.409 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.569 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.71 0.291 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.75 -53.66 5.77 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.93 101.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.18 142.18 39.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.094 0.473 . . . . 0.0 111.413 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.95 79.73 2.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.953 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.53 -48.48 32.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.586 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 3.9 mt-30 -102.9 -81.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.552 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 37.0 t80 59.4 99.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 124.209 0.943 . . . . 0.0 109.589 -171.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.659 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 65.65 127.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.488 1.115 . . . . 0.0 110.381 -168.067 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.87 103.57 20.14 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.421 -173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 71.7 Cg_endo -95.38 152.18 1.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.026 2.484 . . . . 0.0 111.973 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -116.57 -65.9 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.353 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -124.15 -75.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.456 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.26 -54.82 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.926 0.393 . . . . 0.0 110.296 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.68 -38.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.404 0.621 . . . . 0.0 109.606 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -65.47 -43.96 88.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.969 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -63.84 -41.15 97.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.686 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 6.6 tptt -63.56 -33.74 76.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.349 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 54' ' ' GLN . 7.8 mt -70.76 -47.43 59.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.31 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.46 39.29 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.401 0.438 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -75.15 -40.66 59.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.184 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -125.05 69.02 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.982 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -171.12 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.685 171.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER 54.35 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.467 1.107 . . . . 0.0 111.555 175.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -105.68 -3.31 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.741 -175.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 49' ' ' MET . 0.3 OUTLIER 58.06 9.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.889 0.876 . . . . 0.0 112.908 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.54 -57.35 0.28 Allowed 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.95 -0.469 . . . . 0.0 111.446 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.01 4.31 14.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.506 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 10.0 m 31.79 81.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.194 0.997 . . . . 0.0 113.69 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.91 64.98 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.155 -0.34 . . . . 0.0 111.895 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.44 -6.75 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.679 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.939 HG12 ' HG2' ' A' ' 24' ' ' GLU . 36.2 mm -53.83 118.71 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.23 -154.24 6.91 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.49 -4.42 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -175.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 25.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.146 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 67.7 m-20 44.77 -125.46 1.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.382 -175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.575 ' HB2' HD12 ' A' ' 41' ' ' ILE . 4.6 m120 -117.09 29.57 7.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 38.56 -95.57 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.119 0.887 . . . . 0.0 111.736 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.53 43.61 3.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.358 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.586 ' HB3' HG23 ' A' ' 73' ' ' THR . 1.5 pt20 -139.72 54.93 1.67 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.1 tt -110.99 -23.89 4.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.684 -167.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -154.93 59.07 0.39 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.975 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 173.79 -127.36 1.33 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 57.57 -28.51 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.77 1.628 . . . . 0.0 115.001 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 p -92.23 -70.32 0.7 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.963 0.801 . . . . 0.0 110.293 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 48' ' ' ALA . 1.5 pp -102.5 -2.98 27.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.602 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 11.2 mmtp 51.85 66.86 1.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.593 0.558 . . . . 0.0 112.044 174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 176.12 -10.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.668 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.03 -35.26 71.03 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.701 -178.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.09 -33.1 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 110.473 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 66.5 t -64.09 -26.97 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.095 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.686 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -98.82 -16.45 18.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.87 -51.49 12.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.379 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -118.99 -48.28 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.949 0.404 . . . . 0.0 110.587 -176.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.5 t -55.12 -47.45 77.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.39 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.4 t60 -47.17 -43.46 21.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -121.63 3.74 10.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 -36.4 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 53.5 m-85 -118.03 -34.96 3.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -64.97 -13.62 57.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.445 0.64 . . . . 0.0 109.82 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.28 -35.23 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.622 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HG3' HD23 ' A' ' 63' ' ' LEU . 7.7 tp10 -124.03 -76.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.866 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -137.93 116.01 9.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.334 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 71.0 Cg_endo -86.77 113.25 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.665 2.244 . . . . 0.0 112.736 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.18 -59.17 2.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.627 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 51' ' ' VAL . 18.6 mtmt 68.12 -111.72 0.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.268 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER 55.12 37.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.832 0.348 . . . . 0.0 111.337 -178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 pt? -165.53 42.86 0.07 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.761 0.791 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.3 p90 -151.03 -48.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -171.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -95.92 61.56 2.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 0.0 111.09 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.7 pm0 -164.77 148.99 7.88 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 3.8 Cg_exo -77.12 -72.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 110.956 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -171.97 36.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.46 0.647 . . . . 0.0 110.729 178.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.72 -121.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -131.08 17.7 5.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.36 -37.6 83.94 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.198 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.41 -42.15 77.53 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.754 0.312 . . . . 0.0 111.672 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.551 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -68.24 -48.92 63.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.702 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 1.1 pt20 -78.19 -4.23 46.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.375 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 13.3 t80 -82.11 -54.17 5.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -69.11 -29.16 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.314 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 7.78 13.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.409 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -102.0 -43.97 5.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 110.114 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -11.38 59.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.687 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.78 153.78 20.52 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.508 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.99 111.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.234 0.54 . . . . 0.0 110.348 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.487 ' HB ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.93 110.01 20.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.267 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.73 -20.03 65.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.65 26.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.042 0.449 . . . . 0.0 111.472 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 7.6 pt20 -163.59 -32.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.461 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 40.5 t80 -74.82 105.16 5.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.264 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 32' ' ' ILE . 7.0 m 29.03 70.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.576 1.173 . . . . 0.0 112.626 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -42.32 107.92 0.57 Allowed Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.261 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.9 Cg_exo -67.26 136.77 41.46 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.326 2.684 . . . . 0.0 112.289 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.533 ' HB ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -94.13 -70.74 0.69 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.782 0.325 . . . . 0.0 111.046 -176.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' A' ' 12' ' ' THR . 2.1 p30 -142.21 42.24 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.5 -51.23 0.56 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.955 0.502 . . . . 0.0 112.256 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.08 -53.58 41.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 0.0 110.281 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -39.0 93.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.9 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.0 -46.01 92.5 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.437 178.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.751 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -64.45 -40.14 95.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -40.77 96.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.117 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -54.39 -42.21 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -77.3 -23.54 51.03 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.516 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' HE3' ' A' ' 18' ' ' LYS . 1.5 mt -112.67 31.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -146.94 -34.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.603 170.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.4 tm-20 52.23 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.215 1.006 . . . . 0.0 111.37 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -107.91 -0.36 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.87 -177.076 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' A' ' 49' ' ' MET . 1.4 p 52.59 23.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.264 1.026 . . . . 0.0 112.552 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD21 ' HE2' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -164.88 -55.09 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.512 176.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.96 -11.82 25.37 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.928 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 15.4 m 36.09 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.436 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.94 65.14 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.77 -52.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.168 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.793 HG23 HG11 ' A' ' 9' ' ' VAL . 1.7 mm -38.4 116.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.44 1.096 . . . . 0.0 112.56 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.27 -152.15 6.09 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.44 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -77.48 13.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' HG ' HG12 ' A' ' 34' ' ' ILE . 12.9 mt -140.03 17.77 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER 66.36 -125.54 0.27 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.392 0.615 . . . . 0.0 109.529 177.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 2.9 t-20 -155.18 51.67 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.51 -106.69 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.659 -167.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.811 ' HD2' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -133.15 50.34 2.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.019 174.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.984 ' HB2' ' HB3' ' A' ' 44' ' ' HIS . 1.5 pt20 -143.96 63.38 1.34 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.866 0.841 . . . . 0.0 110.056 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 68' ' ' LEU . 21.0 tt -96.61 -26.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.215 -175.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -118.12 -60.77 0.29 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.922 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -76.1 -87.18 0.32 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.196 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 3.4 p-80 62.46 -47.15 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.215 1.806 . . . . 0.0 113.762 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.1 p -90.41 -88.59 0.17 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.93 5.78 24.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 176.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.9 mmtp 50.87 61.26 3.33 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.519 176.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.649 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -179.61 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.679 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.623 ' HE2' HG13 ' A' ' 26' ' ' VAL . 3.6 mmm -52.6 -37.54 58.39 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.225 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.14 -34.91 68.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.45 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 81.2 t -64.28 -23.51 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.362 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.65 -19.82 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -82.25 -49.15 10.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.621 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.29 -41.18 3.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.595 -175.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.952 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -63.13 -46.77 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.37 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.709 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 5.5 t-160 -54.43 -37.53 65.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.45 -2.18 14.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.4 mm-40 -138.92 -33.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.952 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.9 m-85 -110.72 -39.68 4.79 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.743 -167.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -64.42 -22.69 67.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.409 0.624 . . . . 0.0 109.608 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -29.76 47.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.345 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.209 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -144.35 114.95 5.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.824 -174.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 5.9 Cg_exo -79.6 130.0 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.094 2.529 . . . . 0.0 112.428 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.83 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.56 -41.38 14.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.342 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' HB2' ' A' ' 64' ' ' PRO . 1.3 mtpt 64.52 -137.31 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.971 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.728 ' H ' HG21 ' A' ' 81' ' ' VAL . 2.0 m 54.67 21.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.4 1.08 . . . . 0.0 111.39 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.671 ' HA ' HE22 ' A' ' 71' ' ' GLN . 2.3 mt -145.49 33.2 1.06 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.306 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.501 ' HA ' ' H ' ' A' ' 43' ' ' GLY . 2.4 p90 -153.81 -50.29 0.09 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.299 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.036 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -88.84 46.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.066 0.46 . . . . 0.0 111.535 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.671 HE22 ' HA ' ' A' ' 68' ' ' LEU . 8.9 pm0 -166.57 134.77 2.23 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.769 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.625 ' HD2' HG13 ' A' ' 74' ' ' ILE . 1.3 Cg_endo -87.8 -40.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.868 2.379 . . . . 0.0 111.644 170.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.811 ' HA ' ' HD2' ' A' ' 39' ' ' PHE . 7.7 t 177.92 45.71 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.699 1.238 . . . . 0.0 109.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.625 HG13 ' HD2' ' A' ' 72' ' ' PRO . 2.7 mt -121.08 174.15 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 113.437 -1.711 . . . . 0.0 107.311 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -80.93 17.82 1.13 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HA ' ' CG ' ' A' ' 79' ' ' GLN . . . -62.66 -29.74 70.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.485 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -53.77 -47.82 70.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.462 177.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -74.41 -46.18 41.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.939 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.567 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -76.96 5.49 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.76 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -104.96 -62.71 1.31 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.992 0.425 . . . . 0.0 109.951 172.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.728 HG21 ' H ' ' A' ' 67' ' ' VAL . 6.9 t -78.68 -14.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.432 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -108.32 13.44 25.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.192 0.52 . . . . 0.0 110.671 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.0 m -126.41 -36.31 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.264 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.34 -13.19 17.43 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.049 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.9 m . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.263 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.6 135.48 2.12 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.033 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.669 HG13 HG23 ' A' ' 34' ' ' ILE . 49.1 t -122.38 101.82 10.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.81 109.34 1.21 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.265 0.555 . . . . 0.0 110.888 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 10.4 tt0 -72.55 68.49 0.82 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.337 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.02 -62.68 1.45 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.099 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -84.54 -12.36 54.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.626 173.711 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.737 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 10.3 t80 -72.26 124.97 26.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.042 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.552 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 2.8 t 55.37 50.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.697 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.3 116.6 2.16 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.11 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 3.3 Cg_exo -75.89 141.32 24.03 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.153 2.569 . . . . 0.0 111.669 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.18 -73.95 0.67 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.61 0.243 . . . . 0.0 110.422 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -137.4 50.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.47 -68.87 0.11 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.38 0.672 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.07 -47.87 82.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.411 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.523 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 mp0 -63.17 -35.84 81.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.392 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -65.7 -45.26 83.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.013 0.435 . . . . 0.0 110.932 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 18.6 mmmt -63.9 -36.98 85.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.529 0.681 . . . . 0.0 109.955 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -42.72 96.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.286 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -53.24 -43.77 67.6 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.415 0.447 . . . . 0.0 111.122 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 3.1 pt-20 -83.14 -10.83 58.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.224 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 22' ' ' ILE . 5.3 mm -97.37 -30.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -107.62 -26.09 11.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.294 -175.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER 57.43 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.519 -175.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.482 ' HD2' ' H ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -117.34 -5.78 11.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.989 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.64 -4.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.124 0.97 . . . . 0.0 112.972 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -139.48 -54.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 111.789 -177.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.7 -6.0 29.01 Favored Glycine 0 CA--C 1.504 -0.62 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.708 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 16.0 m 33.7 66.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.922 . . . . 0.0 113.149 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.482 ' H ' ' HD2' ' A' ' 25' ' ' ARG . 71.3 m -161.23 52.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 111.745 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . -121.27 -37.27 0.7 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.454 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.538 HG12 ' HG2' ' A' ' 24' ' ' GLU . 10.9 mm -31.88 110.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 112.343 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -78.65 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.624 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.669 HG23 HG13 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -133.03 -10.88 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -164.51 42.97 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.585 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 54.2 m-20 36.56 -112.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.908 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' HB2' HD12 ' A' ' 41' ' ' ILE . 67.6 m-80 -119.74 23.32 11.18 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.32 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.424 1.077 . . . . 0.0 112.286 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 43.31 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.452 0.644 . . . . 0.0 110.514 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -152.17 61.13 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.026 173.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -110.14 -19.76 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.241 -172.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.92 97.01 0.16 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.731 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 45' ' ' SER . . . 126.78 -113.46 1.77 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.72 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 58.92 -21.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.453 1.501 . . . . 0.0 114.081 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 43' ' ' GLY . 2.1 p -90.93 -89.35 0.17 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -8.7 59.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.0 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER 61.4 72.71 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.759 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.4 -12.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.138 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.407 ' HB2' ' N ' ' A' ' 43' ' ' GLY . 34.3 mmm -53.13 -39.75 63.73 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.65 -32.16 60.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.131 0.491 . . . . 0.0 110.552 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 1.1 t -62.23 -27.14 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.933 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -100.38 -18.1 16.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.785 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.28 -54.59 9.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.5 pm0 -124.77 -36.6 2.56 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.471 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.861 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 67.4 t -60.66 -44.55 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t60 -51.57 -46.21 63.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -127.87 9.67 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -170.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.1 mm-40 -131.49 -21.97 2.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.475 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.861 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m-85 -118.47 -28.53 5.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.815 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.5 -16.88 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.28 -36.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.014 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 2.1 tp10 -125.52 -80.08 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.979 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -148.29 129.01 6.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.196 -178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.34 111.96 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.418 2.079 . . . . 0.0 112.28 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -43.71 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HE3' HG13 ' A' ' 81' ' ' VAL . 6.5 mtmt 62.45 -143.32 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.229 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.756 HG12 HD23 ' A' ' 77' ' ' LEU . 1.8 t 62.16 36.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.205 0.602 . . . . 0.0 111.475 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.51 54.53 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 111.455 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.7 p90 -167.99 -46.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.296 -0.253 . . . . 0.0 111.619 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.027 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.4 56.36 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.397 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.671 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.1 pm0 -163.99 140.34 5.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.018 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 17.0 Cg_exo -68.79 -56.82 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.345 2.03 . . . . 0.0 110.931 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.1 t 173.26 46.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.883 0.849 . . . . 0.0 110.031 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -120.39 -107.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -146.14 19.57 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.342 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.628 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.03 -33.71 76.37 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.761 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.756 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.06 -42.69 73.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 111.385 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.605 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -75.11 -43.57 52.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 6.75 17.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.833 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -103.63 -59.36 1.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.145 0.497 . . . . 0.0 109.848 175.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG21 ' H ' ' A' ' 67' ' ' VAL . 46.8 t -70.82 -30.5 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.114 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.47 -2.69 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.217 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 m -107.78 -36.63 6.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 111.342 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 -33.42 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.938 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.514 -176.566 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtp . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.37 -156.05 15.79 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.749 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.35 112.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 0.0 110.628 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -153.61 103.7 2.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.433 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.27 72.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.592 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -11.58 59.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -83.8 -8.95 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.891 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 42.4 t80 -65.49 101.76 0.63 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 7.6 p 34.39 82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 124.474 1.109 . . . . 0.0 112.662 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.86 107.36 20.15 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 82.6 Cg_endo -96.55 -159.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.662 2.908 . . . . 0.0 112.422 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.86 -73.2 0.49 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.625 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.95 150.86 22.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.59 -42.59 16.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.826 0.704 . . . . 0.0 112.603 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.25 -49.02 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.919 0.39 . . . . 0.0 110.498 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -43.8 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 11.0 m -51.76 -54.93 23.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.329 0.393 . . . . 0.0 111.968 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -63.22 -38.77 92.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -67.48 -43.61 80.57 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.132 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.88 -41.01 63.96 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.577 0.548 . . . . 0.0 111.524 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 22' ' ' ILE . 5.7 pt-20 -80.39 -25.35 39.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.278 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.495 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 mm -115.05 30.3 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -134.64 -36.64 0.85 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 170.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.674 ' HA ' HG12 ' A' ' 32' ' ' ILE . 11.5 tt0 62.1 -71.19 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.349 1.06 . . . . 0.0 113.264 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.23 -5.04 7.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.24 -5.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 124.192 0.932 . . . . 0.0 112.827 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.656 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -142.24 -51.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.663 -177.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.9 3.04 24.33 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.694 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.647 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER 35.71 74.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 124.586 0.815 . . . . 0.0 112.163 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.25 64.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.705 -173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . 168.13 61.58 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.513 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.674 HG12 ' HA ' ' A' ' 24' ' ' GLU . 3.5 mm -134.14 116.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.25 -144.47 4.33 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.971 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -76.68 19.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.75 26.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.916 175.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 32.36 -110.72 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.364 1.04 . . . . 0.0 112.446 -176.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 1.7 t-20 -148.32 36.37 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.47 -99.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.267 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.952 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.8 m-85 -122.66 37.53 4.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.018 0.437 . . . . 0.0 111.77 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.2 pt20 -147.73 60.0 1.13 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.522 0.677 . . . . 0.0 110.437 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' ILE . 1.7 tp -102.4 -34.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.733 -174.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.92 -68.27 0.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.82 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -74.33 -96.16 0.11 Allowed Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.289 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 62.13 -40.87 0.15 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.833 1.653 . . . . 0.0 113.949 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -90.31 -82.06 0.28 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 tp -76.13 -10.59 59.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.939 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.2 mmtm 58.65 56.13 4.38 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.445 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.34 -8.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.918 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -57.82 -32.65 67.79 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.324 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.77 -31.28 59.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.195 0.521 . . . . 0.0 110.176 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 94.7 t -69.42 -23.21 26.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.133 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.42 -17.45 16.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.83 -51.87 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.662 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.43 ' HB3' HD13 ' A' ' 19' ' ' LEU . 3.7 pt20 -121.93 -42.8 2.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 45.1 t -59.04 -43.22 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.251 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 7.8 t-160 -43.98 -41.67 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -17.89 10.23 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.05 -28.22 7.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 93.9 m-85 -115.51 -27.69 7.07 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.353 -171.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.82 -23.07 63.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.94 -35.48 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.909 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG3' HD23 ' A' ' 63' ' ' LEU . 3.7 tp10 -117.75 -78.33 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.751 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -154.98 141.66 13.34 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.198 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.88 119.62 5.97 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.308 2.005 . . . . 0.0 111.582 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 65' ' ' LEU . 1.1 pt? -66.05 -37.8 86.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 8.5 mtmt 60.89 -159.55 0.32 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.284 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 t 66.2 21.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.403 0.681 . . . . 0.0 111.794 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.941 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -164.0 47.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.389 0.614 . . . . 0.0 111.424 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.2 p90 -160.25 -45.97 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.196 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.33 47.24 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.121 0.486 . . . . 0.0 111.153 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.941 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.1 pm0 -159.82 140.1 8.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.9 Cg_exo -77.45 -39.37 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.763 2.309 . . . . 0.0 111.616 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.952 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 2.0 m 156.45 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.538 1.535 . . . . 0.0 108.043 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.484 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -141.83 -117.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.491 175.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 16.2 ptmt -136.0 17.0 3.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 173.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.66 66.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.064 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.02 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -55.71 -42.6 75.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.42 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.735 ' H ' HD22 ' A' ' 77' ' ' LEU . . . -88.84 -31.33 18.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.108 0.48 . . . . 0.0 110.151 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 0.25 9.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.96 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -109.93 -49.35 3.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.793 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -72.41 -21.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.712 -175.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.35 7.7 38.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 110.714 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.46 HG22 ' HD2' ' A' ' 84' ' ' ARG . 92.1 m -119.1 -38.46 3.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.583 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 83' ' ' THR . 1.7 mmm180 -117.16 -20.42 9.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.519 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 75.7 m . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.956 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.94 72.07 2.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.112 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.97 158.26 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.742 HG23 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -143.3 140.48 30.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.2 0.524 . . . . 0.0 110.224 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -75.89 5.3 6.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.288 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.742 ' H ' HG23 ' A' ' 4' ' ' THR . . . -82.72 -16.64 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.57 -41.6 2.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.099 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 34' ' ' ILE . 29.2 t80 -69.79 111.05 5.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 32' ' ' ILE . 7.1 p 39.09 58.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.345 1.069 . . . . 0.0 112.066 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.93 122.51 77.56 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.757 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.37 173.27 14.78 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.766 2.311 . . . . 0.0 112.081 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -107.07 -63.37 1.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.59 -76.76 0.44 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.144 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.72 -44.16 0.48 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -67.2 -41.04 86.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.628 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -72.87 -36.68 67.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.96 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -53.61 55.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.928 0.394 . . . . 0.0 110.457 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -60.72 -39.51 88.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.178 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -70.72 -39.74 73.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.58 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.96 -43.31 73.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.741 0.305 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.66 -28.58 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.164 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.03 -50.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.603 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -75.92 -33.55 59.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.141 -170.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HG12 ' A' ' 29' ' ' VAL . 1.7 tp10 58.6 -64.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.049 0.94 . . . . 0.0 111.667 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.948 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -134.05 1.99 3.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.39 -5.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.651 1.18 . . . . 0.0 113.357 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.53 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -145.52 -56.58 0.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.961 0.41 . . . . 0.0 111.051 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.96 6.15 32.59 Favored Glycine 0 CA--C 1.501 -0.816 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.566 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.742 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 38.73 70.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 124.594 0.82 . . . . 0.0 112.518 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.948 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -160.15 60.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.767 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -126.88 -17.83 2.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.921 -170.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -81.55 87.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.492 0.646 . . . . 0.0 110.834 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.23 -159.01 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.539 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -73.48 -2.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.286 0.565 . . . . 0.0 111.75 -175.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -164.84 51.98 0.12 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.842 177.207 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 49.02 -128.75 2.02 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.604 -174.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.767 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -115.46 46.82 1.42 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.99 -97.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.328 1.017 . . . . 0.0 110.809 -175.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.758 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 11.0 m-85 -129.38 47.93 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.817 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.32 53.53 0.05 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.6 tt -93.52 -29.84 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.285 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.05 44.46 0.85 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.494 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -162.65 -112.93 0.29 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 61.08 -52.19 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.892 1.677 . . . . 0.0 114.031 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -88.51 -75.75 0.42 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.603 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 14.3 tp -80.74 -16.77 53.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.012 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.681 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 5.8 mmtm 53.46 61.42 3.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.52 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.89 -1.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.081 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.2 -35.56 75.68 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.698 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.55 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 110.317 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 2.9 t -63.93 -26.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.04 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.17 -23.19 16.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.0 110.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.7 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.324 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.564 ' HB3' HD13 ' A' ' 19' ' ' LEU . 7.0 pm0 -122.77 -43.7 2.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.118 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 95.3 t -57.42 -43.63 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.429 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.5 t60 -49.63 -33.88 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -128.86 18.22 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 4.2 mm-40 -139.11 -46.54 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.088 0.47 . . . . 0.0 111.797 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 62.0 m-85 -113.95 -15.48 12.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -168.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -12.81 58.2 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.75 -30.59 5.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.969 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.72 -78.96 0.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.961 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -159.96 121.79 1.81 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.692 -177.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 11.2 Cg_exo -70.48 130.7 18.88 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.75 2.3 . . . . 0.0 112.539 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -74.08 -63.16 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.144 177.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 2.7 mtmp? 82.44 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.406 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 m 45.01 33.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 112.239 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.566 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -151.94 25.49 0.64 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.23 -173.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.1 p90 -165.6 -49.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.005 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -91.35 56.7 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.47 . . . . 0.0 111.529 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 13.1 pm0 -151.35 147.16 19.87 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.352 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 73' ' ' THR . 3.4 Cg_exo -78.04 -72.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.011 2.474 . . . . 0.0 111.521 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -172.72 35.68 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.538 0.524 . . . . 0.0 112.189 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.7 HG22 ' HD2' ' A' ' 75' ' ' LYS . 2.9 mp -137.87 -89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.006 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.7 ' HD2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -145.38 18.56 1.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -174.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.49 -28.03 68.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.198 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD21 ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -51.42 -49.03 62.45 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.201 174.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.12 67.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -0.73 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.349 0.595 . . . . 0.0 111.18 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -104.71 -50.95 3.17 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.411 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -72.12 -26.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.376 -176.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.5 10.57 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.917 0.389 . . . . 0.0 110.687 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -117.9 -36.23 3.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -141.44 52.88 1.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.268 0.556 . . . . 0.0 111.135 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 54.9 m . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.707 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.581 0.229 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.65 -122.79 6.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.389 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t 57.22 41.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 0.0 110.821 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -58.44 3.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.18 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.75 48.52 0.66 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.777 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.93 -30.01 20.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.26 0.553 . . . . 0.0 110.345 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.566 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 41.7 t80 -61.83 121.99 14.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 26.6 m 31.95 54.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.334 1.021 . . . . 0.0 112.143 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.4 127.46 57.59 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.091 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 3.7 Cg_exo -75.29 130.08 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.335 2.69 . . . . 0.0 111.678 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -68.06 0.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.458 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 67.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.049 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.26 -72.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.583 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.84 -48.61 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.41 -39.27 78.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.286 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.624 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -64.7 -46.67 81.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 0.0 111.591 -178.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -32.66 74.23 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.74 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -75.11 -49.65 18.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.41 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -39.14 41.4 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.53 0.519 . . . . 0.0 111.582 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.772 ' HG3' HG12 ' A' ' 22' ' ' ILE . 2.3 pt-20 -82.62 -28.67 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.704 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.772 HG12 ' HG3' ' A' ' 21' ' ' GLU . 10.7 mm -122.17 61.32 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.587 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -155.11 -42.22 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.112 163.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.838 ' HA ' HG12 ' A' ' 32' ' ' ILE . 1.9 tp10 63.58 -62.38 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.196 0.998 . . . . 0.0 112.924 176.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.801 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -139.19 6.9 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.406 . . . . 0.0 109.949 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER 56.65 18.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.274 1.03 . . . . 0.0 113.106 176.074 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -177.43 -51.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 111.253 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.11 37.3 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 32.69 76.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.297 1.039 . . . . 0.0 113.406 177.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.801 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -176.21 74.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.794 177.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -164.14 7.48 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.584 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.838 HG12 ' HA ' ' A' ' 24' ' ' GLU . 1.3 mm -82.1 127.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.376 0.588 . . . . 0.0 110.273 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -162.17 9.98 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.83 10.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 122.538 0.335 . . . . 0.0 111.761 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.43 35.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 41' ' ' ILE . 1.5 m-20 58.42 -135.24 0.97 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.892 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB2' HD12 ' A' ' 41' ' ' ILE . 1.4 t-20 -114.34 46.94 1.28 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 42.19 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.248 0.967 . . . . 0.0 111.727 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.999 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -127.99 43.42 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 -176.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.469 HE21 ' HE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -163.03 63.65 0.19 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.971 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -119.5 -11.69 10.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.033 -174.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -167.28 93.01 0.1 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.899 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.63 -107.46 0.33 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.663 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.2 m80 73.97 -57.48 0.62 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.963 0.905 . . . . 0.0 112.4 171.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -82.83 -80.12 0.18 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.411 0.624 . . . . 0.0 110.169 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 1.22 57.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.866 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 54.12 70.2 0.63 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.324 0.39 . . . . 0.0 110.47 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -177.17 -4.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.296 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.2 mmm -56.17 -38.13 70.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 54' ' ' GLN . . . -78.59 -31.33 47.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 98.5 t -62.57 -29.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.054 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -94.01 -17.93 22.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.67 -51.22 13.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.5 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -115.63 -53.22 2.6 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.651 -177.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.876 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 37.7 t -53.76 -47.33 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.646 -173.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.2 t60 -36.95 -52.72 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 5.71 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -173.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 5.1 mm-40 -124.28 -10.24 7.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.92 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.876 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -140.0 -33.75 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.771 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.871 ' HG2' HG12 ' A' ' 55' ' ' VAL . 4.1 mm100 -61.47 -26.77 68.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.091 0.472 . . . . 0.0 110.618 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -66.56 -36.19 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.024 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -77.22 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.02 112.62 3.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.638 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 15.0 Cg_exo -68.02 128.51 17.81 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.987 2.458 . . . . 0.0 112.468 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -56.98 2.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 42.0 mttt 63.84 -123.57 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.745 0.418 . . . . 0.0 111.053 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG22 HG21 ' A' ' 81' ' ' VAL . 2.0 t 62.81 28.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.309 0.644 . . . . 0.0 111.842 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.07 68.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.1 p90 -163.36 -48.21 0.03 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.788 0.327 . . . . 0.0 111.443 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -101.37 62.7 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.394 -173.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.2 pm0 -167.35 136.98 2.26 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 111.47 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 96.2 Cg_endo -94.42 59.57 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.493 2.795 . . . . 0.0 111.944 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.999 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 56.84 62.57 2.21 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 175.287 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mm -138.0 -86.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.2 13.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.792 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -66.91 -26.06 66.68 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.367 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -57.29 -44.64 84.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.985 0.421 . . . . 0.0 111.054 177.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.595 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.58 -50.56 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.736 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.95 5.0 7.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -177.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.705 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -97.4 -58.34 2.03 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.232 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.901 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 1.2 t -67.44 -33.65 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.827 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.1 -8.27 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.772 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -112.9 -32.27 6.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.673 0.273 . . . . 0.0 111.654 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 3.8 ptp180 -147.13 -12.6 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.901 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 70.1 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.87 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.48 84.55 0.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.676 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.57 130.56 68.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.34 126.38 53.33 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 2.5 pm0 -94.32 34.71 1.25 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.148 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 47.36 0.72 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.304 0.573 . . . . 0.0 111.156 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -177.5 -24.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.738 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -61.23 133.38 55.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.167 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 8' ' ' TYR . 1.2 m 61.43 -21.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.37 1.468 . . . . 0.0 113.593 -172.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . 56.21 73.87 0.77 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.053 0.541 . . . . 0.0 111.882 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 32.0 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.106 2.538 . . . . 0.0 112.34 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 -70.16 0.76 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.834 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.54 -60.67 1.65 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.561 -0.855 . . . . 0.0 112.125 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.85 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.6 t -69.16 -44.26 80.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.44 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -70.4 -46.33 64.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.91 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.784 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -56.48 -51.39 68.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.482 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.3 tttt -60.91 -46.39 90.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.939 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -36.43 79.94 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.0 -44.91 79.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 1.3 pt-20 -84.48 -4.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 22' ' ' ILE . 6.4 mm -99.33 -44.38 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.078 0.465 . . . . 0.0 112.204 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -85.31 -31.69 22.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.075 -172.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 2.0 tt0 62.26 -62.22 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.2 mtt180 -135.78 -7.41 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.179 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 53' ' ' ALA . 0.3 OUTLIER 61.02 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.211 1.004 . . . . 0.0 113.314 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.28 -54.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.871 0.367 . . . . 0.0 110.789 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.63 -12.76 29.67 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.133 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.451 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 42.73 59.27 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.358 0.663 . . . . 0.0 111.807 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.24 65.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.75 -1.88 0.1 OUTLIER Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.323 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.441 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 4.0 mt -69.8 131.39 34.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.726 0.763 . . . . 0.0 110.539 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.93 -154.06 7.36 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.516 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -77.06 -3.31 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -176.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 24.47 0.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 1.5 m-20 39.96 -108.69 0.08 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.047 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.764 HD22 HD12 ' A' ' 41' ' ' ILE . 33.8 m-80 -122.29 28.0 7.67 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.94 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.32 -96.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.087 0.867 . . . . 0.0 111.99 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.842 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -117.49 36.25 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.267 0.556 . . . . 0.0 111.314 -175.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -154.25 59.67 0.71 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.082 177.619 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 HD22 ' A' ' 37' ' ' ASN . 1.1 tt -99.44 -37.3 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -148.45 81.63 0.2 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.902 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.751 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 151.43 -116.74 0.78 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.233 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 58.79 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.424 1.49 . . . . 0.0 113.825 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.7 p -87.56 -88.77 0.13 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -84.11 -0.91 53.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.317 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 53.61 68.95 0.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.13 -5.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -173.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.751 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 5.0 mtp -54.92 -41.02 70.48 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.283 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.81 -32.23 52.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 0.0 110.719 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 2.2 t -62.08 -26.99 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.023 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.667 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.09 -13.03 15.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 26' ' ' VAL . . . -71.15 -56.88 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.896 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 7.1 pm0 -125.98 -42.12 1.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.96 HG12 ' HB2' ' A' ' 60' ' ' GLN . 95.0 t -52.85 -42.75 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.871 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.667 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.3 t-160 -38.2 -52.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.304 1.003 . . . . 0.0 113.035 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -0.92 16.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.933 0.397 . . . . 0.0 111.463 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -104.3 -42.63 5.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -173.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . 6.4 m-85 -146.16 -22.77 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -169.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.96 ' HB2' HG12 ' A' ' 55' ' ' VAL . 3.5 tp60 -66.66 -13.28 61.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.344 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.23 -32.36 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.142 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.654 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 3.0 tt0 -130.4 -76.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.654 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -152.19 101.35 2.81 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 111.636 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.515 ' HB3' HG13 ' A' ' 55' ' ' VAL . 92.2 Cg_endo -86.0 160.39 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.807 2.338 . . . . 0.0 112.698 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.69 -40.03 42.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.157 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mttt 63.0 -132.19 0.47 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 77' ' ' LEU . 3.2 t 61.03 37.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.999 0.428 . . . . 0.0 111.21 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.7 pt? -161.54 40.75 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 112.283 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.91 -49.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.776 -0.577 . . . . 0.0 112.121 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -98.69 75.21 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 111.34 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 5.6 pm0 -162.22 137.01 5.24 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.154 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -87.4 53.88 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.097 2.531 . . . . 0.0 111.478 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.842 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 50.99 53.98 12.06 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.768 0.827 . . . . 0.0 112.906 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 8.1 mt -135.48 -108.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 pttt -135.3 11.67 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.512 . . . . 0.0 110.291 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -64.74 -27.48 68.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.582 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -56.08 -49.11 74.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.51 176.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.37 -38.14 56.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.195 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.41 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.77 -48.69 36.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.226 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -68.87 -31.27 49.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.25 62.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.545 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 m -62.3 -49.7 74.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.73 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.25 -25.38 42.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.79 176.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 73.0 m . . . . . 0 C--O 1.243 0.755 0 O-C-N 124.071 0.857 . . . . 0.0 111.431 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.843 0.354 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.1 125.41 1.68 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.551 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.75 28.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.198 0.999 . . . . 0.0 108.864 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.95 91.86 4.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.765 -173.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -97.47 79.62 2.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.188 176.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.44 -27.06 38.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 pm0 -76.34 -13.65 60.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.755 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -62.23 121.7 13.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.356 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 32' ' ' ILE . 75.8 t 67.56 124.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.489 0.662 . . . . 0.0 111.663 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.05 15.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' SER . 2.8 Cg_exo -76.85 -170.04 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.361 2.707 . . . . 0.0 112.508 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -117.56 -73.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.064 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -114.63 -101.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.454 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.36 -49.15 0.92 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.3 -43.44 96.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.829 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE1' ' HB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -60.57 -45.99 91.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.115 178.124 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -57.87 -47.83 81.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 178.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.99 -44.92 95.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.609 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -40.0 93.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.252 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.52 -39.57 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.423 0.452 . . . . 0.0 111.291 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.3 pt-20 -82.17 -17.66 45.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.254 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 18' ' ' LYS . 16.5 mt -93.61 -39.39 10.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 112.11 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.638 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -89.74 -31.16 17.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 -177.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.668 ' HG3' ' H ' ' A' ' 31' ' ' GLY . 1.0 OUTLIER 57.22 -64.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.881 1.273 . . . . 0.0 113.066 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.851 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -133.66 0.59 3.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.05 -8.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.999 . . . . 0.0 113.544 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -139.65 -57.93 0.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.449 -177.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.54 13.46 22.97 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.667 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 4.6 m 32.46 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.264 1.026 . . . . 0.0 113.255 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 47.4 m -151.15 58.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.209 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.668 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -116.72 -27.79 2.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.218 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.5 HG23 ' CG2' ' A' ' 9' ' ' VAL . 36.8 mm -72.42 98.93 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.152 0.501 . . . . 0.0 110.138 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.55 -155.09 7.59 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.2 pt -67.66 -12.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 123.434 0.693 . . . . 0.0 111.937 -171.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -160.0 43.21 0.21 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.852 177.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 66.82 -151.22 0.2 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.721 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -108.05 18.68 20.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.55 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.615 1.197 . . . . 0.0 112.152 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB3' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.58 43.24 3.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.955 -177.296 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -160.72 67.19 0.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.462 177.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.36 -33.32 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.6 -66.32 0.34 Allowed Glycine 0 C--O 1.223 -0.54 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.179 -174.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -77.84 -100.67 0.19 Allowed Glycine 0 C--O 1.224 -0.505 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.706 -170.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.65 -50.17 0.45 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.001 1.32 . . . . 0.0 112.649 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 p -75.08 -82.43 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -90.08 4.13 51.25 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.539 172.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 20.4 mmtm 53.09 58.82 4.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.56 -3.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.929 -172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mmm -54.48 -35.57 63.2 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.049 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -77.24 -27.85 53.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.488 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 24.6 t -64.78 -29.0 46.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.83 -21.74 17.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.68 -46.77 15.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -117.9 -42.98 2.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -175.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 85.9 t -62.04 -56.29 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 11.6 t-160 -38.1 -45.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 4.42 8.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 79.8 mm-40 -131.91 -31.05 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.654 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -121.79 -19.54 6.73 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.139 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -67.7 -14.29 62.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 109.195 169.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.29 -32.1 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.649 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.72 -82.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.762 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 123.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.349 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 141.42 18.9 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.711 2.274 . . . . 0.0 112.87 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -86.72 -20.45 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 177.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 61.13 -131.83 0.73 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.477 175.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.614 ' H ' HG21 ' A' ' 81' ' ' VAL . 3.5 m 53.95 26.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.639 1.176 . . . . 0.0 113.335 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.885 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.6 OUTLIER -153.22 40.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.974 0.416 . . . . 0.0 111.849 177.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.502 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 2.9 p90 -153.68 -44.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.75 35.65 1.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.062 0.458 . . . . 0.0 111.476 -173.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 68' ' ' LEU . 16.7 pm0 -141.45 134.89 14.51 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.608 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 47.9 Cg_endo -76.04 -42.66 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.2 1.933 . . . . 0.0 111.946 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 t 168.88 52.73 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.931 1.348 . . . . 0.0 109.193 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -136.75 175.61 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.591 -1.64 . . . . 0.0 107.693 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -74.38 19.27 0.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.706 174.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -64.83 -18.83 65.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.275 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -51.89 -46.26 64.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.218 0.532 . . . . 0.0 110.241 173.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.651 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -88.42 -28.44 20.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 7.98 18.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.094 0.473 . . . . 0.0 111.263 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -120.74 -48.09 2.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.741 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.614 HG21 ' H ' ' A' ' 67' ' ' VAL . 97.6 t -82.01 -22.38 9.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.302 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -113.48 21.23 15.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.197 0.523 . . . . 0.0 110.113 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.0 m -137.75 -32.48 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -125.73 -64.65 1.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.463 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.503 ' OXT' ' HA ' ' A' ' 81' ' ' VAL . 15.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.747 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.35 125.17 8.27 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.441 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.45 106.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.27 164.23 14.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -173.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.76 94.76 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.62 -83.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.206 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -108.62 -48.26 3.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.917 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 2.2 t80 48.04 78.4 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.447 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 72.42 132.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.81 0.814 . . . . 0.0 111.525 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.5 103.61 41.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.973 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.57 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 14.9 Cg_exo -70.04 157.89 58.36 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.913 2.409 . . . . 0.0 111.79 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.74 -64.88 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.75 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.474 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 63.6 m-80 -126.56 -81.36 0.61 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.71 -54.6 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.301 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.81 -38.1 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.82 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.2 mp0 -66.96 -45.01 79.07 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.49 -49.07 78.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.507 . . . . 0.0 110.945 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -45.25 93.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.861 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -45.88 79.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.138 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.69 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.588 0.555 . . . . 0.0 111.742 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 22' ' ' ILE . 15.7 pt-20 -83.34 -27.76 29.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.326 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.539 HG13 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -115.04 24.1 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 119.772 -0.771 . . . . 0.0 113.047 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -132.65 -48.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.123 -0.36 . . . . 0.0 110.667 172.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.1 tm-20 51.76 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.28 1.032 . . . . 0.0 111.443 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 1.6 mtt85 -103.31 -4.88 23.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.246 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.72 15.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.908 0.755 . . . . 0.0 112.071 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -147.49 -57.4 0.25 Allowed 'General case' 0 C--O 1.23 0.048 0 O-C-N 122.03 -0.419 . . . . 0.0 111.468 179.168 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.07 9.86 6.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.14 -1.028 . . . . 0.0 112.836 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 19.8 m 34.34 72.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 0.0 113.156 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.04 59.01 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -172.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA3' ' OD1' ' A' ' 37' ' ' ASN . . . -149.47 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.986 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 9' ' ' VAL . 14.4 mm -48.72 111.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.341 0.591 . . . . 0.0 111.675 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -133.25 -118.0 1.87 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.455 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -1.88 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 110.257 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.2 40.93 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.412 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 4.9 m-20 59.7 -136.22 0.76 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.43 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' OD1' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -128.41 37.11 4.18 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.51 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.798 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 39.2 -100.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.526 -174.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.998 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 m-85 -128.46 43.13 3.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.139 0.495 . . . . 0.0 111.254 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.798 HE21 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt20 -151.36 64.35 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.458 0.646 . . . . 0.0 110.123 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 41' ' ' ILE . 1.3 tp -120.92 -11.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 122.161 0.981 . . . . 0.0 108.771 -175.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -163.12 125.68 1.43 Allowed Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 109.12 -96.78 1.01 Allowed Glycine 0 C--N 1.303 -1.276 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.937 170.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.8 m80 79.99 -65.09 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.882 0.873 . . . . 0.0 111.882 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 p -94.14 -76.57 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -79.92 -4.14 51.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.105 177.453 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.981 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 mmtp 53.5 64.22 1.92 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 178.19 1.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.256 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -57.09 -35.52 69.51 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 177.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.74 62.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.47 0.652 . . . . 0.0 110.265 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.6 t -65.7 -24.13 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.165 177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.13 -11.26 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.064 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.62 -50.27 8.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.823 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -121.65 -30.73 4.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 0.0 111.588 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 12.2 t -73.17 -38.56 55.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 22.6 t-160 -35.2 -56.48 0.6 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.473 1.108 . . . . 0.0 113.371 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -138.66 14.55 2.72 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.191 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.2 -29.12 4.93 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.475 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -123.45 -27.06 4.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.504 -173.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -63.54 -16.75 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.328 0.585 . . . . 0.0 109.871 172.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -67.13 -32.41 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.835 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.51 -76.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.9 135.51 11.05 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.704 0.288 . . . . 0.0 110.742 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 62.1 Cg_endo -75.74 119.48 5.45 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.62 2.213 . . . . 0.0 112.314 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -49.67 12.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 12.9 mttt 60.52 -137.77 0.63 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.918 0.487 . . . . 0.0 111.48 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.501 HG22 HG11 ' A' ' 81' ' ' VAL . 1.7 t 62.71 26.41 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.626 0.77 . . . . 0.0 112.025 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.4 62.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 111.494 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 p90 -158.6 -49.18 0.06 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-O 120.916 0.388 . . . . 0.0 111.97 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.981 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.18 63.7 2.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.735 -173.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 2.7 pm0 -170.87 138.79 1.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 111.769 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 84.5 Cg_endo -99.6 52.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.749 2.966 . . . . 0.0 111.882 171.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.998 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.1 m 67.64 66.64 0.38 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.145 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 7.2 mt -134.55 -102.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -151.78 17.09 0.69 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.407 0.622 . . . . 0.0 110.048 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 71' ' ' GLN . . . -69.63 -32.63 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.242 -171.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.08 -45.88 75.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.027 0.442 . . . . 0.0 110.866 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.649 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.49 -50.74 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.848 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -66.71 -13.56 61.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -89.82 -56.55 3.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 67' ' ' VAL . 77.0 t -70.56 -33.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.93 -18.36 63.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -93.12 -38.61 11.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.957 0.408 . . . . 0.0 110.542 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 7.8 mmt180 -83.31 -29.84 28.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.702 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.531 -179.162 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.14 -66.37 0.55 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.617 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -140.32 -179.4 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.34 -15.86 58.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.808 0.337 . . . . 0.0 110.368 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 79.05 -11.92 1.15 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.793 0.837 . . . . 0.0 112.502 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.31 -22.0 63.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.974 0.416 . . . . 0.0 110.998 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.14 -6.95 22.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.538 0.685 . . . . 0.0 110.803 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -79.53 129.04 34.1 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.03 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HA ' HG23 ' A' ' 32' ' ' ILE . 59.9 t 76.71 -85.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.52 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 159.87 71.68 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 124.232 0.958 . . . . 0.0 111.618 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 8.1 Cg_exo -72.96 109.24 2.77 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.035 1.823 . . . . 0.0 111.568 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -113.3 -74.71 0.62 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -177.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -141.22 38.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.394 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.52 -48.97 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.7 OUTLIER -64.43 -44.45 91.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.011 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.83 -43.4 98.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.422 -178.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.1 ttpp -62.66 -50.53 70.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.007 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -57.39 -43.19 83.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.653 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.15 -40.17 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.677 0.61 . . . . 0.0 111.477 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.31 -25.49 60.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.468 -178.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -87.4 -39.11 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.598 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -95.17 -36.27 11.54 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.5 -171.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.1 tm-20 53.78 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.796 0.838 . . . . 0.0 110.845 -173.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.3 mtt180 -114.6 -2.04 13.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.092 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.45 13.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.833 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.26 -55.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.58 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.4 -5.03 32.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.09 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 24' ' ' GLU . 6.9 m 31.26 78.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.997 0.919 . . . . 0.0 113.295 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 41.76 0.35 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.73 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -136.2 -58.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.47 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 9' ' ' VAL . 5.7 mm -28.83 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 113.118 -176.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.77 -126.95 2.11 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.301 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.559 HG21 HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -95.95 22.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.761 0.315 . . . . 0.0 110.677 -175.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.87 54.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.716 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER 64.86 -126.79 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.347 1.07 . . . . 0.0 111.964 170.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.73 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 3.6 t-20 -146.77 36.13 0.95 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.201 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.88 -99.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.203 -168.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.989 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.78 42.13 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.502 . . . . 0.0 111.929 -177.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -150.97 61.69 0.92 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 178.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.472 HD11 ' HE1' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -100.76 -59.4 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.417 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' ILE . . . -133.69 84.11 0.29 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.23 -0.51 . . . . 0.0 111.885 -175.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 147.75 -118.57 1.01 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 12.4 p-80 56.51 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.496 1.518 . . . . 0.0 114.59 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.9 p -94.62 -85.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.62 -17.23 62.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.75 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 9.1 mmtm 59.66 59.95 2.38 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.425 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 175.49 -2.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.599 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.498 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.8 mmm -55.07 -37.51 66.86 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.662 0.268 . . . . 0.0 111.017 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.552 ' HA ' ' HZ3' ' A' ' 23' ' ' TRP . . . -70.27 -40.99 74.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.652 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 59.9 t -60.14 -21.84 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.622 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -108.91 -6.18 15.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.383 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -92.99 -47.19 7.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' OE1' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -113.32 -56.11 2.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.997 0.427 . . . . 0.0 109.884 -178.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 2.8 t -53.27 -45.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.333 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 19.0 t-160 -36.4 -56.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.84 3.24 9.46 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.199 -171.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 57' ' ' ARG . 73.8 mm-40 -119.93 -25.69 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.894 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.767 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 25.9 m-85 -125.49 -41.81 2.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.226 -172.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -12.6 59.53 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.737 0.303 . . . . 0.0 110.836 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.5 t -53.27 -31.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 168.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -81.82 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.709 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -124.34 131.15 24.15 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.78 0.324 . . . . 0.0 111.449 -171.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 71.7 Cg_endo -91.52 113.92 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.856 2.371 . . . . 0.0 112.133 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.05 -46.76 55.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 24.9 mtmt 68.11 -148.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.1 t 65.81 39.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.332 0.653 . . . . 0.0 112.146 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -171.11 37.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.252 0.549 . . . . 0.0 111.434 176.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 3.0 p90 -151.13 -51.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -97.37 65.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 111.433 -172.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 4.2 pm0 -155.25 129.36 4.71 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.19 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 2.0 Cg_endo -85.64 62.63 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.044 2.496 . . . . 0.0 110.953 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.989 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 14.2 t 51.04 51.51 16.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.755 1.264 . . . . 0.0 112.121 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.5 mt -130.24 -179.66 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 113.593 -1.64 . . . . 0.0 106.981 168.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' H ' HG22 ' A' ' 74' ' ' ILE . 8.7 mtmm -80.57 14.7 1.95 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.779 0.799 . . . . 0.0 108.862 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -61.47 -26.64 68.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.086 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -52.68 -49.86 64.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.346 0.593 . . . . 0.0 110.349 176.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.707 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -79.83 -39.9 29.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.065 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.85 10.23 2.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.627 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CE1' ' HD3' ' A' ' 84' ' ' ARG . 54.1 t80 -111.08 -59.66 1.94 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' A' ' 67' ' ' VAL . 8.9 t -75.45 -25.62 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.664 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.68 0.48 52.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.564 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 m -105.13 -42.15 5.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.416 ' HD3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -138.78 17.53 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.807 -176.032 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.572 179.0 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.048 0.451 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.69 61.43 0.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.103 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.33 145.57 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.12 116.99 20.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.34 177.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.72 ' HA ' HG23 ' A' ' 34' ' ' ILE . 11.2 pm0 -69.33 144.55 53.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.85 -30.53 26.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.879 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -158.21 -36.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.397 175.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 2.4 t80 53.18 58.91 4.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.579 0.55 . . . . 0.0 111.579 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 32' ' ' ILE . 53.7 t 67.02 91.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.586 0.708 . . . . 0.0 110.913 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.03 131.52 66.38 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.452 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.29 163.93 36.59 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.809 2.34 . . . . 0.0 112.556 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -106.52 -65.78 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 61.5 m-80 -126.94 -89.09 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.0 110.925 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.99 -59.66 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.088 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.91 -40.35 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.512 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 13.0 mp0 -63.7 -46.43 85.53 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.829 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -62.93 -42.24 99.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.792 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 3.4 mtpm? -70.03 -40.82 74.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.674 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.01 -40.2 83.02 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.738 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -56.51 -38.61 72.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.4 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.9 pt-20 -75.96 -26.67 57.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.055 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 18' ' ' LYS . 6.7 mt -93.24 -36.8 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.529 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -90.01 -33.37 16.38 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.85 -172.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.847 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 58.01 -66.36 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.052 0.941 . . . . 0.0 111.674 -174.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HB2' ' H ' ' A' ' 30' ' ' SER . 6.6 ttt85 -135.21 2.86 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.245 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER 54.65 20.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 -56.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.733 -0.605 . . . . 0.0 111.857 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.05 13.85 9.03 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.974 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.847 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 39.96 73.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.781 0.832 . . . . 0.0 112.697 177.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.788 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -158.28 59.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.718 177.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -124.84 -16.3 3.02 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.876 -172.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.476 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -97.2 82.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -116.41 43.67 1.61 Allowed Glycine 0 C--O 1.225 -0.463 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.022 -167.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.72 HG23 ' HA ' ' A' ' 5' ' ' GLU . 8.0 mm 79.03 -20.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.986 0.898 . . . . 0.0 110.09 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.652 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -147.5 42.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.846 -172.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 61.53 -143.22 0.45 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.083 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.59 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -127.54 36.75 4.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 41.51 -102.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.735 -173.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 1.088 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.0 m-85 -132.51 49.0 2.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.856 0.36 . . . . 0.0 111.012 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.75 57.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.893 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 37' ' ' ASN . 3.3 tt -101.43 -33.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.859 -174.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -122.74 -55.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.699 -174.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . -77.31 -99.61 0.18 Allowed Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.554 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 60.23 -44.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.597 1.559 . . . . 0.0 114.52 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 p -97.19 -73.97 0.59 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 49' ' ' MET . 13.2 tp -75.1 -19.86 59.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.082 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 10.8 mmtp 56.11 54.36 7.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.903 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.82 -17.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.465 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -53.78 -34.86 60.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.75 0.31 . . . . 0.0 111.432 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.54 -29.77 52.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.97 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.2 t -66.25 -29.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -92.61 -19.39 21.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.099 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 -49.9 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.811 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -122.45 -47.13 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.153 -177.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 60' ' ' GLN . 36.7 t -55.05 -47.69 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.064 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.712 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 20.9 t-160 -41.23 -48.36 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 112.826 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -118.86 5.74 11.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -170.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 18.1 mm-40 -134.02 -19.33 2.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 14.1 m-85 -133.72 -44.2 0.81 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.386 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.733 ' HB2' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -62.31 -15.9 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.233 0.539 . . . . 0.0 111.201 -178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 t -68.91 -31.08 49.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.361 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 5.1 tp10 -129.08 -76.6 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.209 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -117.4 117.74 36.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HG3' HE22 ' A' ' 60' ' ' GLN . 82.2 Cg_exo -47.21 -48.91 13.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.741 2.961 . . . . 0.0 113.895 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 61.72 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.492 0.495 . . . . 0.0 110.933 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG2' HG22 ' A' ' 51' ' ' VAL . 72.2 mttt 61.75 -124.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.046 0.538 . . . . 0.0 111.105 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 63.35 49.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.991 0.516 . . . . 0.0 111.219 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.9 pt? -174.03 39.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.399 0.619 . . . . 0.0 112.059 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' A' ' 70' ' ' ALA . 4.4 p90 -151.45 -54.93 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.403 -0.811 . . . . 0.0 112.43 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -100.25 75.97 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.915 0.388 . . . . 0.0 111.428 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 3.8 pm0 -162.23 139.78 6.46 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.824 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' A' ' 74' ' ' ILE . 85.1 Cg_endo -88.64 46.78 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.154 2.569 . . . . 0.0 112.563 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 1.088 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER 60.55 39.61 17.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.223 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 72' ' ' PRO . 7.2 mt -139.96 48.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 122.304 -0.247 . . . . 0.0 110.562 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 pttt 46.71 23.8 0.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.221 1.008 . . . . 0.0 112.502 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -72.41 -15.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.759 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.67 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -59.38 -44.38 92.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.312 0.577 . . . . 0.0 110.003 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.67 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -72.3 -43.43 64.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.814 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -75.47 5.18 6.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.796 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.2 -62.49 1.31 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.73 -31.73 42.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.394 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.3 2.61 50.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.94 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -106.86 -38.2 6.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.025 0.441 . . . . 0.0 109.934 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -84.56 -60.71 1.99 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.608 -179.861 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.214 0.53 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 3' ' ' VAL . . . -153.34 -147.83 4.73 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 2' ' ' GLY . 2.8 p 170.83 -30.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.043 0.449 . . . . 0.0 110.394 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.846 HG23 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -154.93 138.82 16.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.085 0.469 . . . . 0.0 110.081 -177.124 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 17.11 10.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.018 0.437 . . . . 0.0 110.739 -176.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.846 ' H ' HG23 ' A' ' 4' ' ' THR . . . -83.62 -33.41 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -81.0 -24.21 38.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.366 0.603 . . . . 0.0 109.684 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.49 109.01 5.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.201 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 32' ' ' ILE . 62.1 t 70.25 -71.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.675 0.609 . . . . 0.0 111.756 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 81.55 0.19 Allowed Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.373 0.669 . . . . 0.0 110.967 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 34.3 Cg_exo -58.98 154.64 43.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.134 2.556 . . . . 0.0 112.036 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -86.97 -65.84 0.97 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.2 m-80 -128.53 -83.91 0.58 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.38 174.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.91 -49.84 0.22 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.447 0.642 . . . . 0.0 109.298 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.76 -45.74 91.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.691 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 34.6 mp0 -67.42 -43.01 82.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.611 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.553 ' CB ' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -54.49 -52.95 60.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -59.92 -44.64 94.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.87 89.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.023 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.01 -42.82 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 17' ' ' SER . 2.1 pt-20 -83.19 -14.24 53.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.315 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.0 mm -91.31 -39.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 0.0 112.086 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.14 -29.53 15.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -176.231 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.4 tp10 59.74 -64.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.409 1.084 . . . . 0.0 111.705 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.623 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -141.1 5.15 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.374 170.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 63.45 -5.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.622 1.169 . . . . 0.0 113.885 176.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 HG12 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -140.1 -60.78 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.855 0.359 . . . . 0.0 111.2 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.86 7.45 25.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.762 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 24' ' ' GLU . 12.4 m 36.22 76.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.623 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -155.78 57.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.13 0.491 . . . . 0.0 110.009 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -125.39 -50.75 0.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.475 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 ' CG2' ' A' ' 9' ' ' VAL . 49.3 mm -60.6 108.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.527 0.68 . . . . 0.0 111.086 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.93 -163.59 13.75 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -76.24 14.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 111.511 -175.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.68 7.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 51.08 -127.07 2.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.753 -176.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -128.55 26.22 5.66 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.091 -176.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.84 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.552 1.158 . . . . 0.0 111.291 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -135.21 51.54 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.044 0.449 . . . . 0.0 110.768 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -154.72 51.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.982 0.42 . . . . 0.0 111.009 176.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.1 tt -106.35 -15.28 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.345 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.52 45.64 0.46 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.83 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.36 -123.73 0.69 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.846 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.747 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 13.5 p-80 58.82 -47.89 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.061 1.744 . . . . 0.0 114.346 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -96.01 -68.9 0.78 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.302 0.573 . . . . 0.0 110.272 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 18.0 tp -78.73 -18.22 54.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.092 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 48.47 52.38 13.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . . . 173.74 10.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.97 -171.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.24 -39.27 93.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.364 0.602 . . . . 0.0 109.449 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.84 -30.55 45.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.45 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 11.0 t -63.95 -28.23 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.109 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -99.15 -18.74 17.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -51.95 15.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.09 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.89 -41.35 2.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.366 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.958 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 66.4 t -58.56 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.2 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.3 t60 -54.91 -38.98 68.31 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -109.39 -4.84 16.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -168.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -142.9 -11.07 0.77 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.958 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 10.5 m-85 -124.88 -48.01 1.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.79 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.7 -18.84 63.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.019 0.437 . . . . 0.0 110.918 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.4 -32.87 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.268 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 -74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.873 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.11 127.91 15.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.74 0.305 . . . . 0.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.93 118.58 5.76 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.539 2.159 . . . . 0.0 112.09 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -90.99 -63.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.605 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 4.6 mtpt 64.15 -132.75 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.7 0.4 . . . . 0.0 111.375 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.986 HG22 HG21 ' A' ' 81' ' ' VAL . 0.2 OUTLIER 60.12 33.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.483 0.713 . . . . 0.0 112.599 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -170.27 46.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.444 0.64 . . . . 0.0 112.37 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.8 p90 -156.33 -47.78 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.418 -0.801 . . . . 0.0 112.752 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.42 50.9 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.196 0.522 . . . . 0.0 111.686 -172.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.74 132.72 4.2 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.747 ' HA ' ' HB3' ' A' ' 44' ' ' HIS . 31.5 Cg_endo -69.21 -40.67 5.86 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.169 1.913 . . . . 0.0 111.278 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 8.8 t 168.27 45.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 123.427 1.584 . . . . 0.0 108.208 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.9 mt -118.97 176.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 112.628 -2.078 . . . . 0.0 107.482 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -81.66 17.28 1.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.25 -25.49 68.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.891 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.789 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.98 -44.63 96.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.421 . . . . 0.0 110.911 176.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.789 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.22 -41.52 49.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.175 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -29.8 70.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.312 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -73.77 -48.15 33.76 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.133 -178.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.986 HG21 HG22 ' A' ' 67' ' ' VAL . 1.2 t -73.99 -24.86 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.67 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.9 m -82.91 -32.29 27.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.39 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -92.32 6.14 47.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.7 176.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 2.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.621 172.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.06 177.77 43.84 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.185 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.15 -36.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.882 0.373 . . . . 0.0 111.265 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -150.89 146.9 26.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.737 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.739 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 11.8 mp0 -117.49 5.86 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.48 65.18 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -114.63 -10.68 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 177.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.739 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 79.3 t80 -65.27 119.07 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.062 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 32' ' ' ILE . 3.4 t 56.74 51.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.96 116.78 1.01 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.988 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.21 151.09 20.47 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.759 2.306 . . . . 0.0 112.217 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.1 -74.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.943 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -128.92 39.94 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.1 -57.53 0.42 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.294 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.22 -47.93 91.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 -44.04 97.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.995 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 -44.86 87.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.6 ttpp -64.25 -40.87 96.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.349 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.497 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.4 -43.76 68.16 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.554 0.533 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.3 pt-20 -81.8 -13.8 57.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.666 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 18' ' ' LYS . 44.9 mm -102.7 -16.62 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 112.025 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.553 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -111.3 -32.67 6.66 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.217 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG12 ' A' ' 32' ' ' ILE . 6.0 tt0 61.22 -66.45 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.983 0.913 . . . . 0.0 111.801 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.797 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.81 2.09 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.25 -15.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.139 . . . . 0.0 113.308 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -136.14 -53.53 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.048 0.452 . . . . 0.0 111.074 -175.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.45 4.18 32.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.175 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 3.3 m 34.77 74.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.949 1.029 . . . . 0.0 112.927 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.797 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -156.94 61.43 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.886 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.714 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . -121.61 -46.78 0.31 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.665 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.773 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.1 mm -44.47 121.61 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.565 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.91 -161.18 12.63 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.78 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -66.47 -5.86 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.008 0.523 . . . . 0.0 111.607 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -171.53 38.18 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 175.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 2.5 m-20 45.08 -121.27 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.394 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.619 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 1.8 m-20 -112.83 41.2 2.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HD2' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER 42.02 -93.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.411 1.069 . . . . 0.0 111.404 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.4 59.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HB2' ' NE2' ' A' ' 44' ' ' HIS . 2.0 pt20 -164.32 66.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.25 0.547 . . . . 0.0 110.704 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -111.27 -32.45 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.581 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.44 86.66 0.14 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.48 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 168.84 -126.67 1.41 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.405 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m80 66.28 -54.14 0.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -72.57 -74.09 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.338 0.59 . . . . 0.0 109.9 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 7.4 tp -93.73 -10.21 35.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.172 173.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.9 mmtp 55.53 67.65 0.98 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.139 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 173.19 1.97 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.128 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.735 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 7.6 mmm -61.13 -34.11 74.47 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 -177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.44 65.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.413 0.625 . . . . 0.0 109.976 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.5 t -63.29 -24.13 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.317 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.99 -12.21 16.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.489 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.68 -51.11 6.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.448 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.16 -35.94 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.718 -174.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.948 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 58.8 t -70.08 -40.94 78.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.342 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.8 t-160 -44.2 -52.2 7.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.996 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.79 13.97 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 65.8 mm-40 -135.85 -7.8 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.834 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -134.46 -42.16 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.875 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -21.54 64.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.8 t -58.1 -32.05 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.922 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.69 -80.67 0.63 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 135.81 18.15 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.265 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.449 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 73.8 Cg_endo -82.01 115.86 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.331 2.021 . . . . 0.0 112.011 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -81.29 -40.27 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.422 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.5 mtmt 58.25 -120.64 1.21 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.391 0.432 . . . . 0.0 110.898 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.564 ' H ' HG21 ' A' ' 81' ' ' VAL . 15.9 m 48.37 25.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.208 1.403 . . . . 0.0 114.573 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -173.19 66.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.0 111.887 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 5.3 p90 -162.98 -47.69 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 -176.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -99.33 84.53 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.907 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -158.75 148.96 15.47 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.464 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 58.5 Cg_endo -100.34 40.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.014 3.143 . . . . 0.0 111.403 168.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.496 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 0.2 OUTLIER 55.52 55.37 7.37 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.767 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' HG2' ' A' ' 75' ' ' LYS . 4.3 mt -134.38 -103.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -139.68 16.23 2.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.233 0.539 . . . . 0.0 110.261 175.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.82 -32.14 73.7 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.77 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -59.14 -44.64 92.07 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.408 0.623 . . . . 0.0 110.523 178.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.685 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -74.74 -43.44 54.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.255 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -27.49 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.301 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.2 t80 -66.86 -53.4 32.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.418 0.628 . . . . 0.0 109.383 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.564 HG21 ' H ' ' A' ' 67' ' ' VAL . 99.1 t -71.28 -23.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.643 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.41 -0.04 39.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.48 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -95.86 -42.41 8.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.972 0.415 . . . . 0.0 109.932 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -45.38 14.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.241 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.528 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.85 168.72 14.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.691 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.89 166.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.029 0.442 . . . . 0.0 110.699 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -151.55 163.65 38.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 3.6 tt0 -139.41 18.44 2.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.235 0.541 . . . . 0.0 110.21 173.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.52 -58.47 3.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.876 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 9.0 pt20 -100.01 -16.56 17.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.67 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 1.6 t80 -69.46 121.23 16.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.79 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 2.0 t 56.63 49.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.74 109.71 1.09 Allowed Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.26 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.59 165.49 1.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.383 2.722 . . . . 0.0 111.837 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.02 -69.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.282 174.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.9 m-80 -124.55 -86.9 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.491 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.68 -49.64 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.0 t -60.54 -43.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.785 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 8.9 mp0 -67.68 -48.82 65.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.023 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -41.79 92.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.91 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -46.69 88.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -60.34 -48.96 79.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.826 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.08 -40.25 57.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.544 0.527 . . . . 0.0 111.622 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -87.0 -12.54 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.325 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 22' ' ' ILE . 4.1 mm -95.42 -38.77 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.931 -177.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -101.52 -29.82 11.76 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -174.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.78 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.2 tt0 57.37 -68.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.011 0.924 . . . . 0.0 111.496 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -130.6 2.59 4.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 175.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.55 0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.308 1.043 . . . . 0.0 113.586 177.008 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -146.14 -57.76 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.15 -0.344 . . . . 0.0 111.367 -179.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.67 -1.0 29.09 Favored Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.964 -172.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 39.35 67.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.337 0.655 . . . . 0.0 112.393 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 60.04 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.958 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.76 -15.26 2.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.238 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.639 HG23 HG22 ' A' ' 9' ' ' VAL . 43.2 mm -71.8 83.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.009 0.433 . . . . 0.0 110.1 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.52 -85.66 1.87 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.938 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -136.95 -5.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 110.731 177.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.736 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.4 OUTLIER -167.53 43.56 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.897 -178.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m-20 49.63 -129.04 2.11 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.705 -173.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.637 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 22.2 m120 -116.54 27.06 9.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.92 -91.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.113 0.883 . . . . 0.0 111.744 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.641 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.83 40.81 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.258 0.551 . . . . 0.0 111.696 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -138.72 52.59 1.79 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.712 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.437 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 3.9 tt -110.78 -28.1 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -144.66 45.99 0.83 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.983 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -179.34 -103.0 0.17 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.755 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' GLN . 4.8 p-80 59.96 -50.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.223 1.809 . . . . 0.0 113.898 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 p -106.06 -68.31 0.88 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.22 -25.93 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.89 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 7.0 mmtp 53.24 63.66 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.9 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.0 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.242 -174.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.443 ' H ' ' HG2' ' A' ' 49' ' ' MET . 31.1 mmm -52.82 -42.46 65.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.489 0.185 . . . . 0.0 111.242 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.564 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.76 -29.59 51.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.556 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 16.0 t -62.65 -29.1 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.971 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.91 -20.78 15.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.664 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.2 -51.78 12.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.038 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 4.7 pm0 -120.93 -38.03 2.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.143 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 30.2 t -64.62 -41.86 93.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.312 -174.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -40.41 -59.36 1.34 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -132.14 18.41 4.51 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 9.5 mm-40 -130.16 -6.4 4.36 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.829 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 40.0 m-85 -137.83 -54.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.567 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -19.0 65.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.33 . . . . 0.0 111.337 -174.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.29 -34.94 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.325 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.69 -73.51 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.957 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 113.95 9.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.947 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.66 127.23 15.15 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.664 2.243 . . . . 0.0 111.615 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -58.21 2.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.653 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 14.1 mttt 62.35 -134.49 0.5 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.421 0.288 . . . . 0.0 110.98 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 t 60.73 27.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.14 62.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 111.524 177.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.579 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 5.6 p90 -165.84 -50.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.705 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.859 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -87.83 45.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.609 -173.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.8 pm0 -154.12 143.2 14.84 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.8 Cg_exo -64.7 -56.47 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.313 2.009 . . . . 0.0 110.853 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.8 t 170.72 48.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.817 0.818 . . . . 0.0 109.898 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -125.55 -106.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.576 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -141.21 13.69 2.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.059 0.456 . . . . 0.0 110.531 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' GLN . . . -63.99 -26.66 68.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.216 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.7 -48.31 75.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.551 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.74 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.14 -43.77 66.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.164 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.24 0.06 12.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.238 0.542 . . . . 0.0 111.403 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.5 t80 -100.46 -63.31 1.14 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.81 -28.67 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.596 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -95.54 10.08 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.488 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.1 m -120.11 -35.38 3.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.485 173.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -75.23 -16.24 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.632 177.225 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.653 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.832 0.349 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.35 -178.19 48.3 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.82 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p -142.06 131.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.294 0.568 . . . . 0.0 110.86 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.57 126.05 34.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.712 0.768 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 4.4 pt-20 -96.34 44.95 1.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.185 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.02 -31.38 66.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.183 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -17.77 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.644 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 45.1 t80 -74.73 116.71 15.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 21' ' ' GLU . 4.7 t 56.53 55.73 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.682 0.753 . . . . 0.0 109.276 -168.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -49.62 126.91 18.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.078 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.4 Cg_exo -68.29 138.58 43.35 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.063 2.508 . . . . 0.0 112.32 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.603 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -103.94 -73.98 0.66 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.791 0.329 . . . . 0.0 110.345 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -137.01 45.61 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.054 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.21 -69.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.246 0.619 . . . . 0.0 111.165 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.39 -48.76 76.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.603 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.49 -34.95 79.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.542 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -45.14 94.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.124 0.488 . . . . 0.0 110.526 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 18.2 ttpt -64.76 -40.96 96.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.377 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -67.0 -34.29 77.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.533 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -58.41 -44.52 89.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.657 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 pt-20 -79.29 -14.17 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 18' ' ' LYS . 2.2 mm -118.22 32.32 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.279 . . . . 0.0 111.719 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.669 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -144.96 -47.82 0.24 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.724 171.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 28.1 tt0 60.48 -65.65 0.05 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.058 0.943 . . . . 0.0 112.306 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 25' ' ' ARG . 3.5 mtp180 -134.77 -1.76 2.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.526 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 63.62 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.13 -51.65 0.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.048 -0.408 . . . . 0.0 111.102 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.65 -14.98 28.24 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.111 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 43.29 72.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 124.423 0.719 . . . . 0.0 112.018 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 m -162.51 70.37 0.28 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.563 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -169.94 10.2 0.05 OUTLIER Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.01 -1.091 . . . . 0.0 114.477 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.31 129.74 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 117.949 0.875 . . . . 0.0 110.022 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.19 5.87 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.073 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.59 18.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.401 0.28 . . . . 0.0 111.754 -176.155 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.33 42.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 7.3 m-20 59.73 -121.47 1.04 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.726 ' HB2' HD12 ' A' ' 41' ' ' ILE . 2.4 t-20 -128.82 43.79 3.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.49 -101.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.147 0.905 . . . . 0.0 111.229 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -124.49 43.77 2.93 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.1 pt20 -160.8 67.38 0.32 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.7 OUTLIER -105.66 -41.05 6.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.27 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.11 89.98 0.13 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.092 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.791 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 160.52 -121.93 1.08 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 66.52 -51.99 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 113.013 174.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -84.0 -73.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.296 0.569 . . . . 0.0 110.277 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.498 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 9.5 tp -84.29 -13.19 53.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.457 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.5 mmtm 51.12 65.28 1.53 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.604 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.65 -6.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.307 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.791 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 21.4 mmm -53.42 -37.79 62.88 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.183 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -74.84 -35.73 62.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.186 0.517 . . . . 0.0 110.596 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 59.2 t -61.87 -27.52 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.211 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.59 -15.86 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -48.54 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.62 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -127.83 -39.85 1.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.165 -177.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -58.55 -51.33 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.337 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.4 t-160 -59.43 -26.62 65.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -174.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.98 -4.44 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -138.12 -19.82 1.12 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 37.2 m-85 -124.76 -50.43 1.72 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.221 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -12.0 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.606 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.88 -30.89 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.293 0.568 . . . . 0.0 110.051 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.72 -62.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.601 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.58 140.25 14.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.77 154.1 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.517 2.145 . . . . 0.0 111.819 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -119.23 -42.77 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.937 179.243 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mppt? 63.87 -145.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.587 0.355 . . . . 0.0 111.367 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.0 t 65.6 26.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.41 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -166.33 42.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 111.849 174.204 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.5 p90 -148.2 -45.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.09 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.86 53.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.056 0.455 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -141.33 119.15 7.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 73' ' ' THR . 23.4 Cg_exo -65.95 -69.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.478 2.118 . . . . 0.0 111.285 170.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -179.7 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 109.806 175.282 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.94 38.62 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.458 -171.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 60.34 23.61 13.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.172 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.27 -24.77 66.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.614 HD21 ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -55.1 -48.64 73.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.487 175.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.66 62.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.487 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 -6.95 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -100.02 -50.77 3.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 67' ' ' VAL . 5.8 p -69.47 -23.05 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.997 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.18 18.66 14.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.233 0.539 . . . . 0.0 110.697 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.0 m -123.22 -43.99 2.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.269 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.464 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -83.19 -76.87 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.046 173.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.015 0 O-C-N 124.851 1.344 . . . . 0.0 107.795 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.46 171.28 55.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.604 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.65 58.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.135 0.493 . . . . 0.0 110.071 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 107.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.49 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -63.56 126.02 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.428 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.18 -41.34 13.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -110.45 -59.89 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.39 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.738 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 8.5 t80 49.24 82.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.127 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 32' ' ' ILE . 3.3 p 33.94 96.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 124.97 1.419 . . . . 0.0 112.42 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -68.43 115.18 27.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.242 -169.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.0 Cg_endo -95.8 138.73 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.891 3.061 . . . . 0.0 112.586 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -128.12 -71.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.43 60.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.628 -0.429 . . . . 0.0 112.064 -169.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -46.87 -47.8 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 122.949 0.5 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -44.04 74.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.556 -176.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.21 -51.96 66.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.391 -177.03 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.592 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.87 -38.48 91.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.771 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -44.92 76.92 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.568 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.42 -38.36 68.86 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.453 0.471 . . . . 0.0 111.611 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -86.73 -19.2 29.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.34 . . . . 0.0 110.67 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -90.08 -29.52 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -174.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -102.68 -27.86 12.47 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 -176.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 6.8 tm-20 59.71 -79.81 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.943 0.897 . . . . 0.0 110.513 -175.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -115.88 -12.25 11.43 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.838 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.01 5.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.356 1.035 . . . . 0.0 113.146 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -136.17 -55.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.798 -0.564 . . . . 0.0 110.876 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.79 -13.88 5.91 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.771 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 m 46.44 96.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 122.558 1.17 . . . . 0.0 112.192 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -86.33 -37.97 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.253 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . 139.13 70.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.842 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -55.31 127.97 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 177.106 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.36 -138.82 2.61 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.617 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -70.55 -2.54 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -4.08 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 9' ' ' VAL . 5.3 t70 62.03 -142.03 0.44 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' A' ' 41' ' ' ILE . 3.2 m-80 -135.41 23.99 3.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.2 -97.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.489 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.965 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.8 m-85 -122.22 37.32 4.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.043 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -155.56 63.59 0.6 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.429 . . . . 0.0 110.804 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.2 tt -108.76 -21.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 0.0 111.041 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -158.83 96.9 0.16 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.636 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 49' ' ' MET . . . 124.11 -117.7 3.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.596 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.537 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 16.4 p-80 56.89 -26.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.196 1.399 . . . . 0.0 114.501 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 43' ' ' GLY . 1.2 p -89.4 -75.04 0.45 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.117 0.484 . . . . 0.0 109.909 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.573 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -83.35 -11.77 57.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.994 174.186 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 15.0 mmtp 57.23 64.32 1.65 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.467 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 174.81 -9.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.774 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.573 ' HG2' HD23 ' A' ' 46' ' ' LEU . 4.7 mmt -50.32 -42.51 52.87 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.21 -30.11 60.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.829 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 53.3 t -64.28 -27.41 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.029 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.32 -21.38 14.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -77.16 -46.61 22.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -120.78 -50.37 2.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.493 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 53.9 t -52.1 -45.69 42.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 14.4 t-160 -39.63 -56.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.902 0.752 . . . . 0.0 112.753 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -114.02 1.61 14.71 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -116.27 -23.34 8.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.665 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -134.12 -42.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.533 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.93 55.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.703 0.287 . . . . 0.0 111.371 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.97 -36.09 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.388 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -121.06 -70.42 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.674 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.03 117.72 9.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.91 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 10.2 Cg_exo -69.73 121.56 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.522 2.148 . . . . 0.0 111.442 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -54.14 4.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.843 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 64.92 -116.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.492 -177.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.624 HG22 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER 57.96 27.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.5 0.72 . . . . 0.0 112.557 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.4 69.71 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 111.132 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.1 p90 -165.22 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.694 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.71 51.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.129 0.49 . . . . 0.0 111.16 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.27 136.03 6.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.511 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 60.1 Cg_endo -79.85 -36.09 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.159 1.906 . . . . 0.0 111.736 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.965 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 10.1 t 171.22 51.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.907 1.336 . . . . 0.0 109.541 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 76' ' ' ALA . 6.2 mt -133.33 162.24 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.667 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 22.97 0.07 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 172.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -65.41 -27.73 68.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.7 -39.9 86.14 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.947 177.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.599 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.41 -44.98 33.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -66.45 -18.04 65.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.612 -176.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.98 -53.24 5.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.612 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.624 HG21 HG22 ' A' ' 67' ' ' VAL . 25.7 t -72.58 -34.53 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.965 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 110.425 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -88.6 -6.18 57.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 67.17 26.02 8.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.251 1.145 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.085 176.303 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.29 165.9 23.01 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.501 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 34' ' ' ILE . 14.6 p -71.83 142.22 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.103 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -86.3 137.55 32.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.701 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.1 mp0 -70.61 87.04 0.66 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.1 -69.69 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.4 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' OE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 mt-30 -94.72 -52.25 4.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.667 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 30.1 t80 56.21 89.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.557 -173.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.591 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 63.83 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.06 -166.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.17 109.05 54.65 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.554 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.81 115.92 3.68 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.796 2.331 . . . . 0.0 111.693 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -55.51 3.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.193 0.52 . . . . 0.0 109.854 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -128.04 -101.55 0.34 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.98 -45.56 0.65 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.89 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.488 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -63.44 -44.64 93.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.123 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -48.7 79.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.283 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 22' ' ' ILE . 2.5 mtpm? -61.5 -41.52 97.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -66.18 -44.09 85.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.251 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -50.81 -43.41 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.612 0.57 . . . . 0.0 111.346 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -80.78 -23.84 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.667 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 18' ' ' LYS . 40.3 mm -90.72 -32.32 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.646 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -95.13 -30.08 14.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.929 -176.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.646 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER 59.22 -64.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.511 1.124 . . . . 0.0 112.309 -175.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 -1.57 2.43 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.789 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 68.28 -14.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.254 1.022 . . . . 0.0 112.954 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.789 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -138.71 -57.53 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.76 -1.24 58.79 Favored Glycine 0 CA--C 1.5 -0.883 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 35.21 50.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 113.999 -1.1 . . . . 0.0 112.978 -179.03 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -149.35 57.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.371 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -133.05 -5.05 3.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.883 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 HG12 ' A' ' 9' ' ' VAL . 5.2 mm -76.18 108.98 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 117.736 0.768 . . . . 0.0 109.975 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.74 -153.42 7.83 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.415 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -70.91 -1.06 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' HB3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -167.9 51.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 12.9 m-20 60.37 -135.66 0.7 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.543 ' HA ' HD22 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -104.12 46.75 0.9 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.403 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.81 -98.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.284 0.99 . . . . 0.0 109.908 -168.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -136.26 50.48 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 110.349 175.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -150.78 45.32 0.85 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.673 172.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 36' ' ' ASP . 1.5 tt -90.34 -27.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.401 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.34 54.84 0.62 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 179.97 -81.78 0.06 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 -60.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.967 1.707 . . . . 0.0 112.611 170.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 p -121.43 -50.13 2.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.472 0.653 . . . . 0.0 109.869 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.656 HD23 ' HG2' ' A' ' 49' ' ' MET . 22.1 tp -68.73 -29.6 68.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.268 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.755 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.1 mmtp 48.76 57.42 6.38 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.632 0.582 . . . . 0.0 111.262 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.14 -5.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.934 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.722 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 7.0 mtp -56.41 -40.62 74.98 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.977 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.11 -31.82 44.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.29 0.567 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.564 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 10.7 t -62.15 -25.43 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.473 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.48 -16.58 14.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.221 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.72 10.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.9 pm0 -128.21 -29.67 2.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.197 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 77.8 t -66.05 -36.91 78.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.98 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.8 t60 -50.45 -51.17 49.17 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 57' ' ' ARG . 8.4 ptp85 -131.28 12.7 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.577 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 72.6 mm-40 -123.97 -12.88 7.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.282 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 6.9 m-85 -127.59 -41.88 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.924 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -14.24 36.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.2 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 t -61.64 -31.51 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.082 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.9 -74.74 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.351 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.62 137.05 8.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.54 150.16 13.06 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.699 2.266 . . . . 0.0 112.93 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD23 ' HE2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -84.84 -60.62 2.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.343 177.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.1 mttt 73.72 -141.95 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.692 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 66' ' ' LYS . 1.5 m 57.34 21.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.153 0.981 . . . . 0.0 112.355 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -159.57 46.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.753 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 p90 -148.65 -55.23 0.2 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.111 -0.368 . . . . 0.0 111.317 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.19 60.79 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.473 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.937 ' HG3' ' HB3' ' A' ' 77' ' ' LEU . 2.5 pm0 -174.19 150.34 1.55 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.793 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 40' ' ' GLN . 5.2 Cg_endo -90.55 -77.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.299 2.666 . . . . 0.0 112.113 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.618 ' HA ' ' CD2' ' A' ' 39' ' ' PHE . 14.3 t -161.97 22.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.556 0.693 . . . . 0.0 110.344 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.54 39.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.818 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 16.45 5.49 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.081 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -69.63 -28.63 66.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.171 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.937 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -56.71 -41.36 77.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.948 0.404 . . . . 0.0 111.231 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.751 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.11 -45.61 33.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.092 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.75 1.9 11.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.154 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.55 -56.8 2.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.9 -26.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.092 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.22 3.24 43.87 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.44 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.9 m -101.77 -28.62 12.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.405 0.621 . . . . 0.0 109.978 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -79.12 -27.51 42.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.826 177.353 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.18 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 121.512 0.672 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -46.95 124.05 5.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.575 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 51.35 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.456 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -167.11 97.66 0.66 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.497 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.1 124.37 10.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.678 2.252 . . . . 0.0 111.602 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -74.15 0.66 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.44 37.29 4.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.181 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.34 -62.64 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.055 0.542 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -45.87 90.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 0.0 110.207 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.09 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -44.18 97.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.209 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -63.76 -34.55 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.433 0.635 . . . . 0.0 110.193 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -45.59 76.82 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.063 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.496 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.55 -40.5 62.61 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.586 0.553 . . . . 0.0 111.589 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -79.28 -24.74 42.72 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.925 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -87.89 -27.43 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.613 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -109.82 -38.18 5.44 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.238 -175.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.6 tm-20 52.89 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.863 0.865 . . . . 0.0 110.642 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.3 mtt180 -110.27 -9.18 14.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.457 -177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 66.03 -2.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.702 -176.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -143.1 -54.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.064 -0.398 . . . . 0.0 111.487 -176.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.09 -6.48 27.88 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.3 m 32.93 80.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.898 0.879 . . . . 0.0 112.987 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.49 60.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.591 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -145.4 -59.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.653 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.468 HD11 HD12 ' A' ' 41' ' ' ILE . 12.8 mm -38.92 110.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.556 0.743 . . . . 0.0 112.149 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.78 -143.09 4.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.708 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -75.18 15.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.648 0.379 . . . . 0.0 111.882 -175.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.83 39.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 12.0 t70 64.21 -142.42 0.28 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.683 0.614 . . . . 0.0 110.018 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.591 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 8.2 t-20 -127.55 47.85 2.32 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.06 -101.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.691 -173.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -140.9 55.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.758 0.313 . . . . 0.0 110.733 177.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.5 pt20 -149.38 60.63 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.495 0.664 . . . . 0.0 110.956 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 32' ' ' ILE . 1.9 tt -106.81 -20.22 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.112 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.96 33.22 0.96 Allowed Glycine 0 C--O 1.229 -0.163 0 C-N-CA 119.825 -1.179 . . . . 0.0 113.29 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.07 -107.62 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.882 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 15.7 p-80 59.62 -51.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.015 1.726 . . . . 0.0 114.263 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 p -96.53 -65.65 0.95 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -92.33 -12.74 31.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.245 177.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 44' ' ' HIS . 5.1 mmtp 49.75 63.32 2.22 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.452 0.47 . . . . 0.0 111.232 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -178.95 -9.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.882 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.665 ' HE2' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -54.7 -41.16 69.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 110.976 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.25 -33.02 61.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 41.4 t -62.41 -26.42 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.497 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.36 -20.8 15.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.795 0.331 . . . . 0.0 111.124 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.47 12.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.941 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -118.23 -40.58 2.93 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.926 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -67.43 -59.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.848 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 70.1 t60 -51.79 -27.35 12.01 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -172.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 57' ' ' ARG . 9.5 ptt180 -127.08 2.45 6.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 7.4 mt-10 -138.99 -26.48 0.84 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 12.6 m-85 -126.43 -21.47 4.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.992 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -68.41 -15.12 63.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.79 -32.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.91 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.38 -84.99 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.889 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 131.65 15.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -86.32 112.53 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.602 2.201 . . . . 0.0 111.816 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -75.69 -32.11 59.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HE3' HG13 ' A' ' 81' ' ' VAL . 21.0 mtmt 61.5 -138.79 0.51 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.783 ' HB ' HD23 ' A' ' 77' ' ' LEU . 2.4 m 55.46 21.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.975 . . . . 0.0 113.464 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.805 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -151.64 37.94 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.609 0.718 . . . . 0.0 111.697 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 7.5 p90 -153.8 -46.51 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.667 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -88.22 41.01 0.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.559 -174.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.805 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.0 pm0 -153.06 138.65 11.75 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.298 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.0 Cg_endo -87.53 -42.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.15 2.567 . . . . 0.0 112.037 173.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.701 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 9.9 t 176.94 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.696 1.236 . . . . 0.0 109.609 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -121.51 163.04 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.96 24.35 0.13 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.836 0.827 . . . . 0.0 108.897 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -66.21 -21.6 66.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.003 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.77 -34.83 75.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -83.5 -38.16 22.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.912 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.77 3.62 16.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.373 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -108.4 -56.48 2.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.058 0.456 . . . . 0.0 109.821 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.716 HG21 ' H ' ' A' ' 67' ' ' VAL . 21.4 t -79.74 -11.72 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.655 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.05 21.61 13.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.781 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.139 174.611 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 7' ' ' GLN . 9.3 tt0 . . . . . 0 N--CA 1.438 -1.039 0 CA-C-O 122.41 1.1 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 58.5 t80 -57.73 115.6 2.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.475 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG22 HD12 ' A' ' 32' ' ' ILE . 89.8 t 73.38 115.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.611 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.49 101.45 42.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.54 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD2' HE21 ' A' ' 7' ' ' GLN . 89.8 Cg_endo -80.05 174.76 11.13 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.703 2.269 . . . . 0.0 112.459 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.71 -68.44 0.72 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -112.43 -100.37 0.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.4 -50.09 0.92 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.571 . . . . 0.0 109.664 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.21 -39.53 85.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.976 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -64.15 -37.97 89.37 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.515 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.4 73.25 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.49 -44.8 93.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -44.27 96.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.977 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.623 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.274 0.359 . . . . 0.0 110.779 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.7 pt-20 -80.78 -12.86 59.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.282 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 18' ' ' LYS . 25.4 mm -99.53 -37.47 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.623 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -88.7 -36.24 16.3 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.713 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.611 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 6.9 tt0 59.53 -57.47 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.623 1.169 . . . . 0.0 112.969 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.33 -6.35 1.79 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.48 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.07 -2.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.983 0.913 . . . . 0.0 112.802 -178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.71 -59.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.105 -0.372 . . . . 0.0 111.437 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.87 2.24 33.8 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.482 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.7 m 36.36 64.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.093 0.957 . . . . 0.0 113.02 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.44 59.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.958 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.49 -13.12 0.66 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.663 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.519 HD12 HG22 ' A' ' 9' ' ' VAL . 15.8 mm -71.55 112.93 7.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 117.108 0.454 . . . . 0.0 110.055 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -150.48 -143.02 3.65 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.906 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.44 -0.39 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.04 34.4 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 t70 59.65 -136.34 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.752 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 12.4 m-80 -105.89 44.08 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -92.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.991 0.807 . . . . 0.0 111.107 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.571 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.14 51.44 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 110.643 177.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -147.9 61.64 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.242 0.544 . . . . 0.0 110.052 174.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.6 -43.44 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.13 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.816 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.78 44.79 1.29 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.869 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 176.06 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.938 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -53.48 0.31 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.606 1.562 . . . . 0.0 112.221 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.1 p -113.39 -65.34 1.2 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 33.1 tp -67.65 -31.29 71.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.573 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.883 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 8.1 mmtm 53.8 62.5 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.389 0.431 . . . . 0.0 110.7 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.59 -18.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.573 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.6 -29.97 69.54 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.654 -176.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.816 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -76.39 -38.74 55.28 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.314 0.578 . . . . 0.0 110.055 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 28.9 t -61.13 -24.4 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.749 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -102.46 -17.15 15.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.33 8.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.431 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.9 pm0 -122.3 -35.48 3.12 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.367 -175.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.6 t -63.33 -53.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.823 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 39.7 t60 -45.15 -46.78 12.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.19 5.14 8.52 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -168.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.18 -15.15 1.12 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.681 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.6 m-85 -125.46 -37.59 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.654 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -16.41 63.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.41 -32.48 48.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.819 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -114.65 -78.19 0.58 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.056 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.22 128.99 6.94 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.804 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.41 115.22 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -70.49 -40.85 73.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.598 ' O ' HD23 ' A' ' 68' ' ' LEU . 10.1 mttt 61.76 -138.76 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.33 0.394 . . . . 0.0 111.036 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.808 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER 44.4 40.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.52 1.128 . . . . 0.0 113.308 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -164.87 37.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.821 0.82 . . . . 0.0 111.275 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -151.0 -49.74 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.883 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -89.99 57.51 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 77' ' ' LEU . 2.9 pm0 -164.63 136.58 3.55 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.399 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.673 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 5.0 Cg_exo -79.11 -44.22 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.962 2.441 . . . . 0.0 111.51 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 8.4 t 174.1 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.806 1.289 . . . . 0.0 109.256 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 76' ' ' ALA . 2.1 mt -126.75 168.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.493 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.46 18.57 0.09 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.388 0.614 . . . . 0.0 109.53 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -67.64 -23.65 65.37 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.383 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.764 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.15 -43.92 98.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.142 179.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.764 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -75.68 -40.24 56.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.114 0.483 . . . . 0.0 110.063 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -70.17 -20.04 63.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.351 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -83.25 -56.72 3.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.186 0.517 . . . . 0.0 110.315 -177.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.808 HG21 ' H ' ' A' ' 67' ' ' VAL . 98.1 t -69.1 -30.66 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.946 -175.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.34 -8.84 58.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.328 -0.337 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.182 178.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.966 0.412 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.667 ' HD1' HG23 ' A' ' 9' ' ' VAL . 2.8 t80 -59.37 132.11 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.533 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.667 HG23 ' HD1' ' A' ' 8' ' ' TYR . 99.3 t 75.89 -55.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.116 0.567 . . . . 0.0 111.604 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 58.54 68.12 1.86 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 21.5 Cg_exo -65.43 160.2 43.9 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 112.318 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -67.76 0.86 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.951 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.485 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 64.0 m-80 -128.37 -89.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.198 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.79 -53.95 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 110.374 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' A' ' 58' ' ' GLU . 58.8 t -62.06 -41.44 91.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.345 0.593 . . . . 0.0 110.126 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.6 mp0 -63.52 -47.34 82.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.754 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.7 -46.53 89.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.478 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -64.85 -32.21 73.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.035 -178.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.41 -41.81 55.2 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.969 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.17 -41.61 62.74 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.567 0.542 . . . . 0.0 111.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG3' HG12 ' A' ' 22' ' ' ILE . 3.5 pt-20 -74.48 -38.47 62.88 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.504 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mm -109.63 45.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -147.26 -32.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.134 169.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HB3' HG12 ' A' ' 29' ' ' VAL . 15.8 tp10 65.04 -55.76 0.3 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.413 1.085 . . . . 0.0 112.482 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -150.24 -3.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.94 1.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.068 0.947 . . . . 0.0 113.545 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.33 -53.75 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.934 -0.479 . . . . 0.0 111.104 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.75 10.84 11.19 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.86 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER 35.05 72.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.078 0.951 . . . . 0.0 113.206 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.671 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -170.57 62.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.32 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.776 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -133.35 -45.39 0.12 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.042 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.8 mm -68.23 109.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 0.0 111.759 -171.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.32 -151.19 7.09 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.481 HG12 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.22 13.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.0 111.175 -177.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -167.58 36.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.65 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD2' ' HB ' ' A' ' 41' ' ' ILE . 11.8 t70 62.12 -151.17 0.37 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.776 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -91.11 59.28 3.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 49.35 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.533 1.146 . . . . 0.0 110.13 -170.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.512 ' HD1' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -150.25 50.99 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.873 0.368 . . . . 0.0 110.589 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -169.79 67.55 0.05 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 110.873 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -86.41 -35.27 8.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.956 -0.465 . . . . 0.0 111.788 -174.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.49 65.47 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.414 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -175.07 -119.97 0.58 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 58.14 -48.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.008 1.723 . . . . 0.0 114.266 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 p -94.16 -71.21 0.67 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.207 0.527 . . . . 0.0 109.633 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.0 tp -76.31 -22.01 55.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.177 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.721 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 12.9 mmtp 50.79 60.6 3.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.034 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.12 -5.97 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.296 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.4 mmm -53.61 -43.12 68.38 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 111.17 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.34 -30.54 48.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.202 0.525 . . . . 0.0 110.705 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -65.0 -27.23 41.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.813 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.16 -16.76 16.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.2 -53.55 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.993 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HB3' HD22 ' A' ' 19' ' ' LEU . 8.0 pm0 -128.11 -36.46 1.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.404 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 51' ' ' VAL . 60.5 t -60.38 -42.3 90.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.4 t-160 -54.3 -34.81 61.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 11.37 12.23 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.266 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' A' ' 15' ' ' VAL . 19.2 mm-40 -133.9 -25.54 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.9 -38.67 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.283 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -18.04 65.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.107 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.32 -31.54 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.242 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -113.78 -82.63 0.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.75 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.4 117.58 9.62 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.6 Cg_exo -80.82 123.3 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.024 2.483 . . . . 0.0 112.378 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -78.65 -41.5 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.836 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 30.5 mtmt 63.5 -141.24 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.937 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.78 30.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.054 0.542 . . . . 0.0 111.92 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.02 49.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -165.78 -48.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.855 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.721 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.5 67.29 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 111.132 -175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 7.6 pm0 -161.68 147.28 10.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.55 -60.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.359 2.039 . . . . 0.0 110.615 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -171.29 -41.48 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.814 0.816 . . . . 0.0 111.146 177.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.43 59.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.806 -164.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 77' ' ' LEU . 3.2 mttp 52.41 19.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.041 0.537 . . . . 0.0 111.79 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -64.93 -21.87 66.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -62.06 -49.32 76.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.458 175.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -70.21 -45.71 66.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.587 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.741 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 3.5 pt20 -68.06 -18.69 64.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -72.25 -52.57 15.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.621 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.76 -26.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.49 59.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.552 0.691 . . . . 0.0 109.312 177.236 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 3.9 mt-30 . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 120.556 0.217 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 37.0 t80 59.4 99.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 124.209 0.943 . . . . 0.0 109.589 -171.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.659 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 65.65 127.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.488 1.115 . . . . 0.0 110.381 -168.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.87 103.57 20.14 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.421 -173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 71.7 Cg_endo -95.38 152.18 1.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.026 2.484 . . . . 0.0 111.973 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -116.57 -65.9 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.353 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -124.15 -75.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.456 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.26 -54.82 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.926 0.393 . . . . 0.0 110.296 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.68 -38.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.404 0.621 . . . . 0.0 109.606 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -65.47 -43.96 88.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.969 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -63.84 -41.15 97.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.686 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 6.6 tptt -63.56 -33.74 76.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.349 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 54' ' ' GLN . 7.8 mt -70.76 -47.43 59.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.31 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.46 39.29 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.401 0.438 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -75.15 -40.66 59.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.184 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -125.05 69.02 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.982 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -171.12 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.685 171.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER 54.35 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.467 1.107 . . . . 0.0 111.555 175.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -105.68 -3.31 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.741 -175.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 49' ' ' MET . 0.3 OUTLIER 58.06 9.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.889 0.876 . . . . 0.0 112.908 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.54 -57.35 0.28 Allowed 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.95 -0.469 . . . . 0.0 111.446 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.01 4.31 14.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.506 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 10.0 m 31.79 81.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.194 0.997 . . . . 0.0 113.69 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.91 64.98 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.155 -0.34 . . . . 0.0 111.895 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' HA3' HD21 ' A' ' 37' ' ' ASN . . . -157.44 -6.75 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.679 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.939 HG12 ' HG2' ' A' ' 24' ' ' GLU . 36.2 mm -53.83 118.71 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.23 -154.24 6.91 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.49 -4.42 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -175.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 25.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.146 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 67.7 m-20 44.77 -125.46 1.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.382 -175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.578 HD21 ' HA3' ' A' ' 31' ' ' GLY . 14.2 m-80 -117.09 29.57 7.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 38.56 -95.57 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.119 0.887 . . . . 0.0 111.736 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.53 43.61 3.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.358 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.586 ' HB3' HG23 ' A' ' 73' ' ' THR . 4.2 pt20 -139.72 54.93 1.67 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.1 tt -110.99 -23.89 4.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.684 -167.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -154.93 59.07 0.39 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.975 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 173.79 -127.36 1.33 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 57.57 -28.51 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.77 1.628 . . . . 0.0 115.001 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 p -92.23 -70.32 0.7 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.963 0.801 . . . . 0.0 110.293 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 48' ' ' ALA . 1.5 pp -102.5 -2.98 27.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.602 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 11.2 mmtp 51.85 66.86 1.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.593 0.558 . . . . 0.0 112.044 174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 176.12 -10.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.668 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.03 -35.26 71.03 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.701 -178.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.09 -33.1 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 110.473 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 66.5 t -64.09 -26.97 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.095 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.686 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -98.82 -16.45 18.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.87 -51.49 12.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.379 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -118.99 -48.28 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.949 0.404 . . . . 0.0 110.587 -176.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.5 t -55.12 -47.45 77.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.39 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.4 t60 -47.17 -43.46 21.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -121.63 3.74 10.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 -36.4 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 53.5 m-85 -118.03 -34.96 3.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -64.97 -13.62 57.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.445 0.64 . . . . 0.0 109.82 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.28 -35.23 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.622 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HG3' HD23 ' A' ' 63' ' ' LEU . 7.7 tp10 -124.03 -76.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.866 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -137.93 116.01 9.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.334 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 71.0 Cg_endo -86.77 113.25 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.665 2.244 . . . . 0.0 112.736 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.76 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.18 -59.17 2.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.627 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 51' ' ' VAL . 18.6 mtmt 68.12 -111.72 0.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.268 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER 55.12 37.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.832 0.348 . . . . 0.0 111.337 -178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 pt? -165.53 42.86 0.07 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.761 0.791 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.3 p90 -151.03 -48.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -171.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -95.92 61.56 2.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 0.0 111.09 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.508 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.7 pm0 -164.77 148.99 7.88 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 3.8 Cg_exo -77.12 -72.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 110.956 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -171.97 36.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.46 0.647 . . . . 0.0 110.729 178.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.72 -121.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -131.08 17.7 5.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.36 -37.6 83.94 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.198 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.41 -42.15 77.53 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.754 0.312 . . . . 0.0 111.672 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.551 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -68.24 -48.92 63.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.702 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 1.1 pt20 -78.19 -4.23 46.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.375 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 13.3 t80 -82.11 -54.17 5.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -69.11 -29.16 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.314 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 7.78 13.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.409 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 110.114 173.412 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 40.5 t80 -74.82 105.16 5.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.264 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 32' ' ' ILE . 7.0 m 29.03 70.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.576 1.173 . . . . 0.0 112.626 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -42.32 107.92 0.57 Allowed Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.261 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.9 Cg_exo -67.26 136.77 41.46 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.326 2.684 . . . . 0.0 112.289 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.533 ' HB ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -94.13 -70.74 0.69 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.782 0.325 . . . . 0.0 111.046 -176.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' A' ' 12' ' ' THR . 2.1 p30 -142.21 42.24 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.5 -51.23 0.56 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.955 0.502 . . . . 0.0 112.256 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.08 -53.58 41.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 0.0 110.281 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -39.0 93.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.9 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.0 -46.01 92.5 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.437 178.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.751 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -64.45 -40.14 95.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -40.77 96.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.117 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -54.39 -42.21 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -77.3 -23.54 51.03 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.516 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' HE3' ' A' ' 18' ' ' LYS . 1.5 mt -112.67 31.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -146.94 -34.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.603 170.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.4 tm-20 52.23 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.215 1.006 . . . . 0.0 111.37 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -107.91 -0.36 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.87 -177.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' A' ' 49' ' ' MET . 1.4 p 52.59 23.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.264 1.026 . . . . 0.0 112.552 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.441 HD21 ' HE2' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -164.88 -55.09 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.512 176.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.96 -11.82 25.37 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.928 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 15.4 m 36.09 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.436 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.94 65.14 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.77 -52.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.168 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.793 HG23 HG11 ' A' ' 9' ' ' VAL . 1.7 mm -38.4 116.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.44 1.096 . . . . 0.0 112.56 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.27 -152.15 6.09 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.44 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -77.48 13.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.546 ' HG ' HG12 ' A' ' 34' ' ' ILE . 12.9 mt -140.03 17.77 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER 66.36 -125.54 0.27 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.392 0.615 . . . . 0.0 109.529 177.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.507 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 2.9 t-20 -155.18 51.67 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.51 -106.69 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.659 -167.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.811 ' HD2' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -133.15 50.34 2.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.019 174.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.984 ' HB2' ' HB3' ' A' ' 44' ' ' HIS . 1.5 pt20 -143.96 63.38 1.34 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.866 0.841 . . . . 0.0 110.056 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 68' ' ' LEU . 21.0 tt -96.61 -26.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.215 -175.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -118.12 -60.77 0.29 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.922 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -76.1 -87.18 0.32 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.196 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 3.4 p-80 62.46 -47.15 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.215 1.806 . . . . 0.0 113.762 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.1 p -90.41 -88.59 0.17 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.93 5.78 24.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 176.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.9 mmtp 50.87 61.26 3.33 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.519 176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.649 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -179.61 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.679 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.623 ' HE2' HG13 ' A' ' 26' ' ' VAL . 3.6 mmm -52.6 -37.54 58.39 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.225 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.14 -34.91 68.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.45 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 81.2 t -64.28 -23.51 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.362 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.65 -19.82 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -82.25 -49.15 10.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.621 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.29 -41.18 3.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.595 -175.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.952 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -63.13 -46.77 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.37 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.709 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 5.5 t-160 -54.43 -37.53 65.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.45 -2.18 14.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.4 mm-40 -138.92 -33.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.952 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.9 m-85 -110.72 -39.68 4.79 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.743 -167.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -64.42 -22.69 67.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.409 0.624 . . . . 0.0 109.608 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -29.76 47.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.345 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.209 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -144.35 114.95 5.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.824 -174.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 5.9 Cg_exo -79.6 130.0 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.094 2.529 . . . . 0.0 112.428 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.83 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.56 -41.38 14.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.342 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' HB2' ' A' ' 64' ' ' PRO . 1.3 mtpt 64.52 -137.31 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.971 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.728 ' H ' HG21 ' A' ' 81' ' ' VAL . 2.0 m 54.67 21.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.4 1.08 . . . . 0.0 111.39 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.671 ' HA ' HE22 ' A' ' 71' ' ' GLN . 2.3 mt -145.49 33.2 1.06 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.306 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.501 ' HA ' ' H ' ' A' ' 43' ' ' GLY . 2.4 p90 -153.81 -50.29 0.09 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.299 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.036 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -88.84 46.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.066 0.46 . . . . 0.0 111.535 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.671 HE22 ' HA ' ' A' ' 68' ' ' LEU . 8.9 pm0 -166.57 134.77 2.23 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.769 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.625 ' HD2' HG13 ' A' ' 74' ' ' ILE . 1.3 Cg_endo -87.8 -40.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.868 2.379 . . . . 0.0 111.644 170.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.811 ' HA ' ' HD2' ' A' ' 39' ' ' PHE . 7.7 t 177.92 45.71 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.699 1.238 . . . . 0.0 109.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.625 HG13 ' HD2' ' A' ' 72' ' ' PRO . 2.7 mt -121.08 174.15 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 113.437 -1.711 . . . . 0.0 107.311 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -80.93 17.82 1.13 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HA ' ' CG ' ' A' ' 79' ' ' GLN . . . -62.66 -29.74 70.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.485 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -53.77 -47.82 70.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.462 177.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -74.41 -46.18 41.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.939 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.567 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -76.96 5.49 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.76 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -104.96 -62.71 1.31 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.992 0.425 . . . . 0.0 109.951 172.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.728 HG21 ' H ' ' A' ' 67' ' ' VAL . 6.9 t -78.68 -14.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.432 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -108.32 13.44 25.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.192 0.52 . . . . 0.0 110.671 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.0 m . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.264 173.54 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.295 0.569 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -72.26 124.97 26.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.042 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.552 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 2.8 t 55.37 50.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.697 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.3 116.6 2.16 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.11 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 3.3 Cg_exo -75.89 141.32 24.03 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.153 2.569 . . . . 0.0 111.669 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.18 -73.95 0.67 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.61 0.243 . . . . 0.0 110.422 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -137.4 50.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.47 -68.87 0.11 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.38 0.672 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.07 -47.87 82.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.411 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.523 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 mp0 -63.17 -35.84 81.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.392 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -65.7 -45.26 83.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.013 0.435 . . . . 0.0 110.932 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 18.6 mmmt -63.9 -36.98 85.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.529 0.681 . . . . 0.0 109.955 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -42.72 96.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.286 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -53.24 -43.77 67.6 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.415 0.447 . . . . 0.0 111.122 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 3.1 pt-20 -83.14 -10.83 58.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.224 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 22' ' ' ILE . 5.3 mm -97.37 -30.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -107.62 -26.09 11.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.294 -175.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER 57.43 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.519 -175.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.482 ' HD2' ' H ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -117.34 -5.78 11.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.989 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.64 -4.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.124 0.97 . . . . 0.0 112.972 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -139.48 -54.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 111.789 -177.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.7 -6.0 29.01 Favored Glycine 0 CA--C 1.504 -0.62 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.708 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 16.0 m 33.7 66.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.922 . . . . 0.0 113.149 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.482 ' H ' ' HD2' ' A' ' 25' ' ' ARG . 71.3 m -161.23 52.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 111.745 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.578 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . -121.27 -37.27 0.7 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.454 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.538 HG12 ' HG2' ' A' ' 24' ' ' GLU . 10.9 mm -31.88 110.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 112.343 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -78.65 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.624 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' C ' ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -133.03 -10.88 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -164.51 42.97 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.585 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 54.2 m-20 36.56 -112.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.908 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.567 ' HB2' HD12 ' A' ' 41' ' ' ILE . 67.6 m-80 -119.74 23.32 11.18 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.32 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.424 1.077 . . . . 0.0 112.286 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 43.31 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.452 0.644 . . . . 0.0 110.514 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -152.17 61.13 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.026 173.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -110.14 -19.76 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.241 -172.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.92 97.01 0.16 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.731 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 45' ' ' SER . . . 126.78 -113.46 1.77 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.72 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 58.92 -21.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.453 1.501 . . . . 0.0 114.081 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 43' ' ' GLY . 2.1 p -90.93 -89.35 0.17 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -8.7 59.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.0 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER 61.4 72.71 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.759 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.4 -12.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.138 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.407 ' HB2' ' N ' ' A' ' 43' ' ' GLY . 34.3 mmm -53.13 -39.75 63.73 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.65 -32.16 60.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.131 0.491 . . . . 0.0 110.552 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 1.1 t -62.23 -27.14 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.933 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -100.38 -18.1 16.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.785 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.28 -54.59 9.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.5 pm0 -124.77 -36.6 2.56 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.471 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.861 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 67.4 t -60.66 -44.55 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t60 -51.57 -46.21 63.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -127.87 9.67 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -170.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.1 mm-40 -131.49 -21.97 2.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.475 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.861 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m-85 -118.47 -28.53 5.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.815 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.5 -16.88 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.28 -36.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.014 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 2.1 tp10 -125.52 -80.08 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.979 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -148.29 129.01 6.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.196 -178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.34 111.96 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.418 2.079 . . . . 0.0 112.28 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -43.71 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HE3' HG13 ' A' ' 81' ' ' VAL . 6.5 mtmt 62.45 -143.32 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.229 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.756 HG12 HD23 ' A' ' 77' ' ' LEU . 1.8 t 62.16 36.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.205 0.602 . . . . 0.0 111.475 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.51 54.53 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 111.455 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.7 p90 -167.99 -46.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.296 -0.253 . . . . 0.0 111.619 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.027 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.4 56.36 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.397 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.671 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.1 pm0 -163.99 140.34 5.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.018 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 17.0 Cg_exo -68.79 -56.82 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.345 2.03 . . . . 0.0 110.931 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.1 t 173.26 46.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.883 0.849 . . . . 0.0 110.031 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -120.39 -107.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -146.14 19.57 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.342 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.628 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.03 -33.71 76.37 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.761 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.756 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.06 -42.69 73.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 111.385 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.605 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -75.11 -43.57 52.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 6.75 17.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.833 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -103.63 -59.36 1.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.145 0.497 . . . . 0.0 109.848 175.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG21 ' H ' ' A' ' 67' ' ' VAL . 46.8 t -70.82 -30.5 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.114 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.47 -2.69 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.217 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 111.342 179.325 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.977 0.418 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 42.4 t80 -65.49 101.76 0.63 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 7.6 p 34.39 82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 124.474 1.109 . . . . 0.0 112.662 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.86 107.36 20.15 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 82.6 Cg_endo -96.55 -159.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.662 2.908 . . . . 0.0 112.422 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.86 -73.2 0.49 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.625 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.95 150.86 22.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.59 -42.59 16.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.826 0.704 . . . . 0.0 112.603 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.25 -49.02 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.919 0.39 . . . . 0.0 110.498 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -43.8 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 11.0 m -51.76 -54.93 23.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.329 0.393 . . . . 0.0 111.968 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -63.22 -38.77 92.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -67.48 -43.61 80.57 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.132 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.88 -41.01 63.96 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.577 0.548 . . . . 0.0 111.524 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 22' ' ' ILE . 5.7 pt-20 -80.39 -25.35 39.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.278 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.495 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 mm -115.05 30.3 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -134.64 -36.64 0.85 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 170.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.674 ' HA ' HG12 ' A' ' 32' ' ' ILE . 11.5 tt0 62.1 -71.19 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.349 1.06 . . . . 0.0 113.264 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.23 -5.04 7.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.24 -5.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 124.192 0.932 . . . . 0.0 112.827 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.656 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -142.24 -51.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.663 -177.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.9 3.04 24.33 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.694 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.647 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER 35.71 74.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 124.586 0.815 . . . . 0.0 112.163 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.25 64.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.705 -173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . 168.13 61.58 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.513 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.674 HG12 ' HA ' ' A' ' 24' ' ' GLU . 3.5 mm -134.14 116.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.25 -144.47 4.33 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.971 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -76.68 19.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.75 26.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.916 175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 32.36 -110.72 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.364 1.04 . . . . 0.0 112.446 -176.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 1.7 t-20 -148.32 36.37 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.47 -99.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.267 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.952 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.8 m-85 -122.66 37.53 4.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.018 0.437 . . . . 0.0 111.77 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.2 pt20 -147.73 60.0 1.13 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.522 0.677 . . . . 0.0 110.437 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' ILE . 1.7 tp -102.4 -34.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.733 -174.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.92 -68.27 0.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.82 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -74.33 -96.16 0.11 Allowed Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.289 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 62.13 -40.87 0.15 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.833 1.653 . . . . 0.0 113.949 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -90.31 -82.06 0.28 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 tp -76.13 -10.59 59.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.939 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.2 mmtm 58.65 56.13 4.38 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.445 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.34 -8.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.918 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -57.82 -32.65 67.79 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.324 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.77 -31.28 59.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.195 0.521 . . . . 0.0 110.176 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 94.7 t -69.42 -23.21 26.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.133 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.42 -17.45 16.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.83 -51.87 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.662 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.43 ' HB3' HD13 ' A' ' 19' ' ' LEU . 3.7 pt20 -121.93 -42.8 2.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 45.1 t -59.04 -43.22 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.251 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 7.8 t-160 -43.98 -41.67 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -17.89 10.23 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.05 -28.22 7.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 93.9 m-85 -115.51 -27.69 7.07 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.353 -171.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.82 -23.07 63.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.94 -35.48 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.909 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG3' HD23 ' A' ' 63' ' ' LEU . 3.7 tp10 -117.75 -78.33 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.751 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -154.98 141.66 13.34 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.198 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.88 119.62 5.97 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.308 2.005 . . . . 0.0 111.582 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 65' ' ' LEU . 1.1 pt? -66.05 -37.8 86.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 8.5 mtmt 60.89 -159.55 0.32 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.284 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 t 66.2 21.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.403 0.681 . . . . 0.0 111.794 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.941 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -164.0 47.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.389 0.614 . . . . 0.0 111.424 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.2 p90 -160.25 -45.97 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.196 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.33 47.24 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.121 0.486 . . . . 0.0 111.153 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.941 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.1 pm0 -159.82 140.1 8.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.9 Cg_exo -77.45 -39.37 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.763 2.309 . . . . 0.0 111.616 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.952 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 2.0 m 156.45 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.538 1.535 . . . . 0.0 108.043 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.484 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -141.83 -117.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.491 175.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 16.2 ptmt -136.0 17.0 3.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 173.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.66 66.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.064 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.02 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -55.71 -42.6 75.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.42 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.735 ' H ' HD22 ' A' ' 77' ' ' LEU . . . -88.84 -31.33 18.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.108 0.48 . . . . 0.0 110.151 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 0.25 9.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.96 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -109.93 -49.35 3.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.793 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -72.41 -21.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.712 -175.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.35 7.7 38.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 110.714 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.583 177.712 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.979 0.419 . . . . 0.0 110.099 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 34' ' ' ILE . 29.2 t80 -69.79 111.05 5.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 32' ' ' ILE . 7.1 p 39.09 58.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.345 1.069 . . . . 0.0 112.066 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.93 122.51 77.56 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.757 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.37 173.27 14.78 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.766 2.311 . . . . 0.0 112.081 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -107.07 -63.37 1.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.59 -76.76 0.44 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.144 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.72 -44.16 0.48 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -67.2 -41.04 86.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.628 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -72.87 -36.68 67.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.96 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -53.61 55.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.928 0.394 . . . . 0.0 110.457 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.588 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -60.72 -39.51 88.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.178 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -70.72 -39.74 73.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.58 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.96 -43.31 73.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.741 0.305 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.66 -28.58 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.164 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.03 -50.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.603 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -75.92 -33.55 59.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.141 -170.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HG12 ' A' ' 29' ' ' VAL . 1.7 tp10 58.6 -64.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.049 0.94 . . . . 0.0 111.667 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.948 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -134.05 1.99 3.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.39 -5.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.651 1.18 . . . . 0.0 113.357 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.53 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -145.52 -56.58 0.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.961 0.41 . . . . 0.0 111.051 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.96 6.15 32.59 Favored Glycine 0 CA--C 1.501 -0.816 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.566 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.742 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 38.73 70.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 124.594 0.82 . . . . 0.0 112.518 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.948 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -160.15 60.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.767 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -126.88 -17.83 2.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.921 -170.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -81.55 87.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.492 0.646 . . . . 0.0 110.834 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.23 -159.01 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.539 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -73.48 -2.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.286 0.565 . . . . 0.0 111.75 -175.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -164.84 51.98 0.12 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.842 177.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 49.02 -128.75 2.02 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.604 -174.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.767 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -115.46 46.82 1.42 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.99 -97.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.328 1.017 . . . . 0.0 110.809 -175.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.758 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 11.0 m-85 -129.38 47.93 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.817 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.32 53.53 0.05 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.6 tt -93.52 -29.84 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.285 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.05 44.46 0.85 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.494 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -162.65 -112.93 0.29 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 61.08 -52.19 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.892 1.677 . . . . 0.0 114.031 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -88.51 -75.75 0.42 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.603 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 14.3 tp -80.74 -16.77 53.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.012 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.681 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 5.8 mmtm 53.46 61.42 3.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.52 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.89 -1.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.081 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.2 -35.56 75.68 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.698 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.55 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 110.317 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 2.9 t -63.93 -26.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.04 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.17 -23.19 16.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.0 110.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.7 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.324 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.564 ' HB3' HD13 ' A' ' 19' ' ' LEU . 7.0 pm0 -122.77 -43.7 2.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.118 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 95.3 t -57.42 -43.63 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.429 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.5 t60 -49.63 -33.88 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -128.86 18.22 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 4.2 mm-40 -139.11 -46.54 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.088 0.47 . . . . 0.0 111.797 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 62.0 m-85 -113.95 -15.48 12.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -168.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -12.81 58.2 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.75 -30.59 5.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.969 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.72 -78.96 0.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.961 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -159.96 121.79 1.81 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.692 -177.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 11.2 Cg_exo -70.48 130.7 18.88 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.75 2.3 . . . . 0.0 112.539 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -74.08 -63.16 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.144 177.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 2.7 mtmp? 82.44 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.406 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 m 45.01 33.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 112.239 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.566 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -151.94 25.49 0.64 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.23 -173.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.543 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.1 p90 -165.6 -49.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.005 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -91.35 56.7 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.47 . . . . 0.0 111.529 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 13.1 pm0 -151.35 147.16 19.87 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.352 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 73' ' ' THR . 3.4 Cg_exo -78.04 -72.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.011 2.474 . . . . 0.0 111.521 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -172.72 35.68 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.538 0.524 . . . . 0.0 112.189 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.7 HG22 ' HD2' ' A' ' 75' ' ' LYS . 2.9 mp -137.87 -89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.006 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.7 ' HD2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -145.38 18.56 1.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -174.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.49 -28.03 68.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.198 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.744 HD21 ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -51.42 -49.03 62.45 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.201 174.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.12 67.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -0.73 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.349 0.595 . . . . 0.0 111.18 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -104.71 -50.95 3.17 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.411 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.12 -26.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.376 -176.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.5 10.57 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.917 0.389 . . . . 0.0 110.687 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.299 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.185 0.517 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 41.7 t80 -61.83 121.99 14.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 26.6 m 31.95 54.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.334 1.021 . . . . 0.0 112.143 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.4 127.46 57.59 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.091 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 3.7 Cg_exo -75.29 130.08 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.335 2.69 . . . . 0.0 111.678 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -68.06 0.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.458 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 67.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.049 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.26 -72.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.583 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.84 -48.61 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.41 -39.27 78.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.286 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.624 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -64.7 -46.67 81.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 0.0 111.591 -178.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -32.66 74.23 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.74 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -75.11 -49.65 18.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.41 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -39.14 41.4 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.53 0.519 . . . . 0.0 111.582 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.772 ' HG3' HG12 ' A' ' 22' ' ' ILE . 2.3 pt-20 -82.62 -28.67 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.704 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.772 HG12 ' HG3' ' A' ' 21' ' ' GLU . 10.7 mm -122.17 61.32 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.587 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -155.11 -42.22 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.112 163.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.838 ' HA ' HG12 ' A' ' 32' ' ' ILE . 1.9 tp10 63.58 -62.38 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.196 0.998 . . . . 0.0 112.924 176.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.801 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -139.19 6.9 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.406 . . . . 0.0 109.949 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER 56.65 18.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.274 1.03 . . . . 0.0 113.106 176.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -177.43 -51.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 111.253 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.11 37.3 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 32.69 76.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.297 1.039 . . . . 0.0 113.406 177.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.801 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -176.21 74.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.794 177.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -164.14 7.48 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.584 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.838 HG12 ' HA ' ' A' ' 24' ' ' GLU . 1.3 mm -82.1 127.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.376 0.588 . . . . 0.0 110.273 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -162.17 9.98 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.83 10.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 122.538 0.335 . . . . 0.0 111.761 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.43 35.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 41' ' ' ILE . 1.5 m-20 58.42 -135.24 0.97 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.892 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB2' HD12 ' A' ' 41' ' ' ILE . 1.4 t-20 -114.34 46.94 1.28 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 42.19 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.248 0.967 . . . . 0.0 111.727 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.999 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -127.99 43.42 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 -176.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.469 HE21 ' HE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -163.03 63.65 0.19 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.971 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -119.5 -11.69 10.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.033 -174.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -167.28 93.01 0.1 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.899 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.63 -107.46 0.33 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.663 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.2 m80 73.97 -57.48 0.62 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.963 0.905 . . . . 0.0 112.4 171.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -82.83 -80.12 0.18 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.411 0.624 . . . . 0.0 110.169 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 1.22 57.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.866 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 54.12 70.2 0.63 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.324 0.39 . . . . 0.0 110.47 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -177.17 -4.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.296 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.2 mmm -56.17 -38.13 70.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 54' ' ' GLN . . . -78.59 -31.33 47.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 98.5 t -62.57 -29.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.054 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -94.01 -17.93 22.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.67 -51.22 13.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.5 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -115.63 -53.22 2.6 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.651 -177.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.876 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 37.7 t -53.76 -47.33 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.646 -173.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.2 t60 -36.95 -52.72 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 5.71 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -173.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 5.1 mm-40 -124.28 -10.24 7.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.92 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.876 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -140.0 -33.75 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.771 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.871 ' HG2' HG12 ' A' ' 55' ' ' VAL . 4.1 mm100 -61.47 -26.77 68.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.091 0.472 . . . . 0.0 110.618 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -66.56 -36.19 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.024 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -77.22 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.02 112.62 3.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.638 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 15.0 Cg_exo -68.02 128.51 17.81 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.987 2.458 . . . . 0.0 112.468 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -56.98 2.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 42.0 mttt 63.84 -123.57 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.745 0.418 . . . . 0.0 111.053 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG22 HG21 ' A' ' 81' ' ' VAL . 2.0 t 62.81 28.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.309 0.644 . . . . 0.0 111.842 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.07 68.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.1 p90 -163.36 -48.21 0.03 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.788 0.327 . . . . 0.0 111.443 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -101.37 62.7 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.394 -173.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.539 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.2 pm0 -167.35 136.98 2.26 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 111.47 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 96.2 Cg_endo -94.42 59.57 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.493 2.795 . . . . 0.0 111.944 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.999 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 56.84 62.57 2.21 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 175.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mm -138.0 -86.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.2 13.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.792 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -66.91 -26.06 66.68 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.367 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -57.29 -44.64 84.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.985 0.421 . . . . 0.0 111.054 177.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.595 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.58 -50.56 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.736 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.95 5.0 7.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -177.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.705 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -97.4 -58.34 2.03 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG21 HG22 ' A' ' 67' ' ' VAL . 1.2 t -67.44 -33.65 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.827 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.1 -8.27 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.772 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m . . . . . 0 C--N 1.322 -0.618 0 CA-C-O 120.673 0.273 . . . . 0.0 111.654 -178.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' A' ' 7' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 121.123 0.487 . . . . 0.0 109.738 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' O ' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -61.23 133.38 55.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.167 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 8' ' ' TYR . 1.2 m 61.43 -21.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.37 1.468 . . . . 0.0 113.593 -172.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . 56.21 73.87 0.77 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.053 0.541 . . . . 0.0 111.882 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 32.0 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.106 2.538 . . . . 0.0 112.34 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 -70.16 0.76 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.834 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -120.54 -60.67 1.65 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.561 -0.855 . . . . 0.0 112.125 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.85 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.55 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 72.6 t -69.16 -44.26 80.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.44 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -70.4 -46.33 64.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.91 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.784 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -56.48 -51.39 68.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.482 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.3 tttt -60.91 -46.39 90.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.939 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -36.43 79.94 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.0 -44.91 79.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 1.3 pt-20 -84.48 -4.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 22' ' ' ILE . 6.4 mm -99.33 -44.38 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.078 0.465 . . . . 0.0 112.204 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -85.31 -31.69 22.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.075 -172.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.488 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 2.0 tt0 62.26 -62.22 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.2 mtt180 -135.78 -7.41 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.179 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 53' ' ' ALA . 0.3 OUTLIER 61.02 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.211 1.004 . . . . 0.0 113.314 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.28 -54.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.871 0.367 . . . . 0.0 110.789 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.63 -12.76 29.67 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.133 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.451 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 42.73 59.27 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.358 0.663 . . . . 0.0 111.807 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.24 65.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.75 -1.88 0.1 OUTLIER Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.323 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.441 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 4.0 mt -69.8 131.39 34.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.726 0.763 . . . . 0.0 110.539 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.93 -154.06 7.36 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.516 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -77.06 -3.31 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -176.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 24.47 0.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 1.5 m-20 39.96 -108.69 0.08 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.047 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.764 HD22 HD12 ' A' ' 41' ' ' ILE . 33.8 m-80 -122.29 28.0 7.67 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.94 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.32 -96.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.087 0.867 . . . . 0.0 111.99 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.842 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -117.49 36.25 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.267 0.556 . . . . 0.0 111.314 -175.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -154.25 59.67 0.71 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.082 177.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 HD22 ' A' ' 37' ' ' ASN . 1.1 tt -99.44 -37.3 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -148.45 81.63 0.2 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.902 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.751 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 151.43 -116.74 0.78 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.233 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 58.79 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.424 1.49 . . . . 0.0 113.825 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.7 p -87.56 -88.77 0.13 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -84.11 -0.91 53.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.317 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 53.61 68.95 0.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.13 -5.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.751 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 5.0 mtp -54.92 -41.02 70.48 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.283 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.81 -32.23 52.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 0.0 110.719 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 2.2 t -62.08 -26.99 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.023 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.667 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.09 -13.03 15.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 26' ' ' VAL . . . -71.15 -56.88 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.896 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 7.1 pm0 -125.98 -42.12 1.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.96 HG12 ' HB2' ' A' ' 60' ' ' GLN . 95.0 t -52.85 -42.75 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.871 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.667 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.3 t-160 -38.2 -52.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.304 1.003 . . . . 0.0 113.035 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -0.92 16.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.933 0.397 . . . . 0.0 111.463 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -104.3 -42.63 5.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -173.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.472 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . 6.4 m-85 -146.16 -22.77 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -169.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.96 ' HB2' HG12 ' A' ' 55' ' ' VAL . 3.5 tp60 -66.66 -13.28 61.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.344 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.23 -32.36 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.142 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.654 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 3.0 tt0 -130.4 -76.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.654 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -152.19 101.35 2.81 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 111.636 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.515 ' HB3' HG13 ' A' ' 55' ' ' VAL . 92.2 Cg_endo -86.0 160.39 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.807 2.338 . . . . 0.0 112.698 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.69 -40.03 42.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mttt 63.0 -132.19 0.47 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 77' ' ' LEU . 3.2 t 61.03 37.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.999 0.428 . . . . 0.0 111.21 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.7 pt? -161.54 40.75 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 112.283 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.91 -49.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.776 -0.577 . . . . 0.0 112.121 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -98.69 75.21 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 111.34 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 5.6 pm0 -162.22 137.01 5.24 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.154 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -87.4 53.88 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.097 2.531 . . . . 0.0 111.478 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.842 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 50.99 53.98 12.06 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.768 0.827 . . . . 0.0 112.906 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 8.1 mt -135.48 -108.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 pttt -135.3 11.67 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.512 . . . . 0.0 110.291 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -64.74 -27.48 68.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.582 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -56.08 -49.11 74.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.51 176.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.37 -38.14 56.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.195 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.41 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.77 -48.69 36.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.226 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -68.87 -31.27 49.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.25 62.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.545 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 m . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.73 178.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 pm0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.29 0.567 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.23 121.7 13.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.356 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 32' ' ' ILE . 75.8 t 67.56 124.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.489 0.662 . . . . 0.0 111.663 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.05 15.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' SER . 2.8 Cg_exo -76.85 -170.04 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.361 2.707 . . . . 0.0 112.508 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -117.56 -73.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.064 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -114.63 -101.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.454 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.36 -49.15 0.92 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.3 -43.44 96.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.829 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE1' ' HB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -60.57 -45.99 91.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.115 178.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -57.87 -47.83 81.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 178.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.99 -44.92 95.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.609 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -40.0 93.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.252 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.52 -39.57 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.423 0.452 . . . . 0.0 111.291 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.3 pt-20 -82.17 -17.66 45.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.254 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 18' ' ' LYS . 16.5 mt -93.61 -39.39 10.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 112.11 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.638 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -89.74 -31.16 17.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 -177.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.668 ' HG3' ' H ' ' A' ' 31' ' ' GLY . 1.0 OUTLIER 57.22 -64.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.881 1.273 . . . . 0.0 113.066 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.851 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -133.66 0.59 3.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.05 -8.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.999 . . . . 0.0 113.544 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -139.65 -57.93 0.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.449 -177.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.54 13.46 22.97 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.667 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 4.6 m 32.46 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.264 1.026 . . . . 0.0 113.255 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 47.4 m -151.15 58.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.209 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.668 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -116.72 -27.79 2.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.218 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.5 HG23 ' CG2' ' A' ' 9' ' ' VAL . 36.8 mm -72.42 98.93 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.152 0.501 . . . . 0.0 110.138 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.55 -155.09 7.59 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.2 pt -67.66 -12.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 123.434 0.693 . . . . 0.0 111.937 -171.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -160.0 43.21 0.21 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.852 177.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 66.82 -151.22 0.2 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.721 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.52 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -108.05 18.68 20.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.55 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.615 1.197 . . . . 0.0 112.152 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB3' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.58 43.24 3.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.955 -177.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -160.72 67.19 0.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.462 177.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.36 -33.32 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.6 -66.32 0.34 Allowed Glycine 0 C--O 1.223 -0.54 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.179 -174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -77.84 -100.67 0.19 Allowed Glycine 0 C--O 1.224 -0.505 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.706 -170.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.65 -50.17 0.45 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.001 1.32 . . . . 0.0 112.649 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 p -75.08 -82.43 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -90.08 4.13 51.25 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.539 172.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 20.4 mmtm 53.09 58.82 4.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.56 -3.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.929 -172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mmm -54.48 -35.57 63.2 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.049 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -77.24 -27.85 53.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.488 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 24.6 t -64.78 -29.0 46.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.83 -21.74 17.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.68 -46.77 15.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -117.9 -42.98 2.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -175.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 85.9 t -62.04 -56.29 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 11.6 t-160 -38.1 -45.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 4.42 8.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 79.8 mm-40 -131.91 -31.05 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.654 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -121.79 -19.54 6.73 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.139 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -67.7 -14.29 62.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 109.195 169.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.29 -32.1 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.649 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.72 -82.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.762 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 123.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.349 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 141.42 18.9 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.711 2.274 . . . . 0.0 112.87 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -86.72 -20.45 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 177.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 61.13 -131.83 0.73 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.477 175.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.614 ' H ' HG21 ' A' ' 81' ' ' VAL . 3.5 m 53.95 26.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.639 1.176 . . . . 0.0 113.335 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.885 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.6 OUTLIER -153.22 40.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.974 0.416 . . . . 0.0 111.849 177.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.502 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 2.9 p90 -153.68 -44.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.75 35.65 1.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.062 0.458 . . . . 0.0 111.476 -173.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 68' ' ' LEU . 16.7 pm0 -141.45 134.89 14.51 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.608 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 47.9 Cg_endo -76.04 -42.66 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.2 1.933 . . . . 0.0 111.946 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 t 168.88 52.73 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.931 1.348 . . . . 0.0 109.193 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -136.75 175.61 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.591 -1.64 . . . . 0.0 107.693 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -74.38 19.27 0.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.706 174.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -64.83 -18.83 65.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.275 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -51.89 -46.26 64.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.218 0.532 . . . . 0.0 110.241 173.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.651 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -88.42 -28.44 20.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 7.98 18.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.094 0.473 . . . . 0.0 111.263 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -120.74 -48.09 2.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.741 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.614 HG21 ' H ' ' A' ' 67' ' ' VAL . 97.6 t -82.01 -22.38 9.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.302 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -113.48 21.23 15.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.197 0.523 . . . . 0.0 110.113 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 -179.76 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 2.2 t80 48.04 78.4 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.447 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 72.42 132.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.81 0.814 . . . . 0.0 111.525 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.5 103.61 41.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.973 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.57 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 14.9 Cg_exo -70.04 157.89 58.36 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.913 2.409 . . . . 0.0 111.79 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.74 -64.88 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.75 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.474 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 63.6 m-80 -126.56 -81.36 0.61 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.71 -54.6 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.301 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.81 -38.1 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.82 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.2 mp0 -66.96 -45.01 79.07 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.49 -49.07 78.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.507 . . . . 0.0 110.945 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -45.25 93.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.861 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -45.88 79.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.138 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.69 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.588 0.555 . . . . 0.0 111.742 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 22' ' ' ILE . 15.7 pt-20 -83.34 -27.76 29.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.326 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.539 HG13 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -115.04 24.1 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 119.772 -0.771 . . . . 0.0 113.047 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -132.65 -48.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.123 -0.36 . . . . 0.0 110.667 172.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.1 tm-20 51.76 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.28 1.032 . . . . 0.0 111.443 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 1.6 mtt85 -103.31 -4.88 23.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.246 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.72 15.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.908 0.755 . . . . 0.0 112.071 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -147.49 -57.4 0.25 Allowed 'General case' 0 C--O 1.23 0.048 0 O-C-N 122.03 -0.419 . . . . 0.0 111.468 179.168 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.07 9.86 6.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.14 -1.028 . . . . 0.0 112.836 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 19.8 m 34.34 72.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 0.0 113.156 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.04 59.01 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -172.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.615 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -149.47 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.986 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 9' ' ' VAL . 14.4 mm -48.72 111.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.341 0.591 . . . . 0.0 111.675 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -133.25 -118.0 1.87 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.455 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -1.88 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 110.257 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.2 40.93 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.412 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 4.9 m-20 59.7 -136.22 0.76 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.43 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 7.7 t-20 -128.41 37.11 4.18 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.798 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 39.2 -100.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.526 -174.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.998 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 m-85 -128.46 43.13 3.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.139 0.495 . . . . 0.0 111.254 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.798 HE21 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt20 -151.36 64.35 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.458 0.646 . . . . 0.0 110.123 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 41' ' ' ILE . 1.3 tp -120.92 -11.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 122.161 0.981 . . . . 0.0 108.771 -175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -163.12 125.68 1.43 Allowed Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 109.12 -96.78 1.01 Allowed Glycine 0 C--N 1.303 -1.276 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.937 170.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.8 m80 79.99 -65.09 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.882 0.873 . . . . 0.0 111.882 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 p -94.14 -76.57 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -79.92 -4.14 51.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.105 177.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.981 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 mmtp 53.5 64.22 1.92 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 178.19 1.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.256 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -57.09 -35.52 69.51 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 177.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.74 62.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.47 0.652 . . . . 0.0 110.265 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.6 t -65.7 -24.13 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.165 177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.13 -11.26 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.064 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.62 -50.27 8.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.823 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -121.65 -30.73 4.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 0.0 111.588 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 12.2 t -73.17 -38.56 55.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 22.6 t-160 -35.2 -56.48 0.6 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.473 1.108 . . . . 0.0 113.371 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -138.66 14.55 2.72 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.191 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.2 -29.12 4.93 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.475 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -123.45 -27.06 4.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.504 -173.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -63.54 -16.75 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.328 0.585 . . . . 0.0 109.871 172.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -67.13 -32.41 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.835 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.51 -76.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.9 135.51 11.05 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.704 0.288 . . . . 0.0 110.742 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 62.1 Cg_endo -75.74 119.48 5.45 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.62 2.213 . . . . 0.0 112.314 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -49.67 12.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 12.9 mttt 60.52 -137.77 0.63 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.918 0.487 . . . . 0.0 111.48 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.501 HG22 HG11 ' A' ' 81' ' ' VAL . 1.7 t 62.71 26.41 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.626 0.77 . . . . 0.0 112.025 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.4 62.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 111.494 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 p90 -158.6 -49.18 0.06 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-O 120.916 0.388 . . . . 0.0 111.97 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.981 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.18 63.7 2.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.735 -173.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 2.7 pm0 -170.87 138.79 1.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 111.769 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 84.5 Cg_endo -99.6 52.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.749 2.966 . . . . 0.0 111.882 171.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.998 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.1 m 67.64 66.64 0.38 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.145 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 7.2 mt -134.55 -102.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -151.78 17.09 0.69 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.407 0.622 . . . . 0.0 110.048 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 71' ' ' GLN . . . -69.63 -32.63 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.242 -171.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.08 -45.88 75.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.027 0.442 . . . . 0.0 110.866 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.649 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.49 -50.74 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.848 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -66.71 -13.56 61.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -89.82 -56.55 3.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 67' ' ' VAL . 77.0 t -70.56 -33.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.93 -18.36 63.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.326 -0.439 0 CA-C-O 120.957 0.408 . . . . 0.0 110.542 178.569 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.523 -0.086 0 CA-C-O 121.538 0.685 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -79.53 129.04 34.1 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.03 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HA ' HG23 ' A' ' 32' ' ' ILE . 59.9 t 76.71 -85.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.52 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 159.87 71.68 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 124.232 0.958 . . . . 0.0 111.618 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 8.1 Cg_exo -72.96 109.24 2.77 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.035 1.823 . . . . 0.0 111.568 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -113.3 -74.71 0.62 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -177.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -141.22 38.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.394 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.52 -48.97 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.7 OUTLIER -64.43 -44.45 91.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.011 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.83 -43.4 98.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.422 -178.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.1 ttpp -62.66 -50.53 70.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.007 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -57.39 -43.19 83.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.653 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.15 -40.17 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.677 0.61 . . . . 0.0 111.477 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.31 -25.49 60.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.468 -178.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -87.4 -39.11 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.598 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -95.17 -36.27 11.54 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.5 -171.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.547 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.1 tm-20 53.78 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.796 0.838 . . . . 0.0 110.845 -173.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.3 mtt180 -114.6 -2.04 13.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.092 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.45 13.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.833 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.26 -55.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.58 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.4 -5.03 32.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.09 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 24' ' ' GLU . 6.9 m 31.26 78.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.997 0.919 . . . . 0.0 113.295 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 41.76 0.35 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.73 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -136.2 -58.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.47 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 9' ' ' VAL . 5.7 mm -28.83 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 113.118 -176.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.77 -126.95 2.11 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.301 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.95 22.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.761 0.315 . . . . 0.0 110.677 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.87 54.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.716 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER 64.86 -126.79 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.347 1.07 . . . . 0.0 111.964 170.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.73 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 3.6 t-20 -146.77 36.13 0.95 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.201 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.88 -99.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.203 -168.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.989 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.78 42.13 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.502 . . . . 0.0 111.929 -177.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -150.97 61.69 0.92 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 178.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.472 HD11 ' HE1' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -100.76 -59.4 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.417 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' ILE . . . -133.69 84.11 0.29 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.23 -0.51 . . . . 0.0 111.885 -175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 147.75 -118.57 1.01 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 12.4 p-80 56.51 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.496 1.518 . . . . 0.0 114.59 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.9 p -94.62 -85.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.62 -17.23 62.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.75 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 9.1 mmtm 59.66 59.95 2.38 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.425 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 175.49 -2.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.599 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.498 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.8 mmm -55.07 -37.51 66.86 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.662 0.268 . . . . 0.0 111.017 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.552 ' HA ' ' HZ3' ' A' ' 23' ' ' TRP . . . -70.27 -40.99 74.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.652 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 59.9 t -60.14 -21.84 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.622 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -108.91 -6.18 15.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.383 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -92.99 -47.19 7.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.441 ' OE1' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -113.32 -56.11 2.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.997 0.427 . . . . 0.0 109.884 -178.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 2.8 t -53.27 -45.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.333 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 19.0 t-160 -36.4 -56.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.84 3.24 9.46 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.199 -171.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 57' ' ' ARG . 73.8 mm-40 -119.93 -25.69 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.894 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.767 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 25.9 m-85 -125.49 -41.81 2.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.226 -172.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -12.6 59.53 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.737 0.303 . . . . 0.0 110.836 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.5 t -53.27 -31.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 168.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -81.82 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.709 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -124.34 131.15 24.15 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.78 0.324 . . . . 0.0 111.449 -171.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 71.7 Cg_endo -91.52 113.92 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.856 2.371 . . . . 0.0 112.133 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.05 -46.76 55.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 24.9 mtmt 68.11 -148.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.1 t 65.81 39.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.332 0.653 . . . . 0.0 112.146 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -171.11 37.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.252 0.549 . . . . 0.0 111.434 176.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 3.0 p90 -151.13 -51.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -97.37 65.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 111.433 -172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 4.2 pm0 -155.25 129.36 4.71 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.19 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 2.0 Cg_endo -85.64 62.63 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.044 2.496 . . . . 0.0 110.953 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.989 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 14.2 t 51.04 51.51 16.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.755 1.264 . . . . 0.0 112.121 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.5 mt -130.24 -179.66 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 113.593 -1.64 . . . . 0.0 106.981 168.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.625 ' H ' HG22 ' A' ' 74' ' ' ILE . 8.7 mtmm -80.57 14.7 1.95 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.779 0.799 . . . . 0.0 108.862 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -61.47 -26.64 68.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.086 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -52.68 -49.86 64.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.346 0.593 . . . . 0.0 110.349 176.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.707 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -79.83 -39.9 29.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.065 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.85 10.23 2.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.627 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -111.08 -59.66 1.94 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' A' ' 67' ' ' VAL . 8.9 t -75.45 -25.62 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.664 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.68 0.48 52.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.564 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 177.276 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.451 ' HD1' ' HA ' ' A' ' 34' ' ' ILE . 2.4 t80 53.18 58.91 4.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.579 0.55 . . . . 0.0 111.579 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 32' ' ' ILE . 53.7 t 67.02 91.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.586 0.708 . . . . 0.0 110.913 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.03 131.52 66.38 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.452 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.29 163.93 36.59 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.809 2.34 . . . . 0.0 112.556 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -106.52 -65.78 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 61.5 m-80 -126.94 -89.09 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.0 110.925 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.99 -59.66 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.088 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.91 -40.35 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.512 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 13.0 mp0 -63.7 -46.43 85.53 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.829 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -62.93 -42.24 99.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.792 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 3.4 mtpm? -70.03 -40.82 74.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.674 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.01 -40.2 83.02 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.738 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -56.51 -38.61 72.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.4 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.9 pt-20 -75.96 -26.67 57.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.055 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 18' ' ' LYS . 6.7 mt -93.24 -36.8 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.529 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -90.01 -33.37 16.38 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.85 -172.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.847 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 58.01 -66.36 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.052 0.941 . . . . 0.0 111.674 -174.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HB2' ' H ' ' A' ' 30' ' ' SER . 6.6 ttt85 -135.21 2.86 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.245 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER 54.65 20.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 -56.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.733 -0.605 . . . . 0.0 111.857 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.05 13.85 9.03 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.974 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.847 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 39.96 73.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.781 0.832 . . . . 0.0 112.697 177.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.788 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -158.28 59.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.718 177.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -124.84 -16.3 3.02 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.876 -172.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.476 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -97.2 82.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -116.41 43.67 1.61 Allowed Glycine 0 C--O 1.225 -0.463 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.022 -167.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.451 ' HA ' ' HD1' ' A' ' 8' ' ' TYR . 8.0 mm 79.03 -20.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.986 0.898 . . . . 0.0 110.09 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.652 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -147.5 42.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.846 -172.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 61.53 -143.22 0.45 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.083 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.59 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -127.54 36.75 4.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 41.51 -102.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.735 -173.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 1.088 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.0 m-85 -132.51 49.0 2.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.856 0.36 . . . . 0.0 111.012 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.75 57.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.893 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 37' ' ' ASN . 3.3 tt -101.43 -33.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.859 -174.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -122.74 -55.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.699 -174.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . -77.31 -99.61 0.18 Allowed Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.554 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 60.23 -44.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.597 1.559 . . . . 0.0 114.52 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 p -97.19 -73.97 0.59 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 49' ' ' MET . 13.2 tp -75.1 -19.86 59.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.082 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 10.8 mmtp 56.11 54.36 7.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.903 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.82 -17.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.465 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -53.78 -34.86 60.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.75 0.31 . . . . 0.0 111.432 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.54 -29.77 52.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.97 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.2 t -66.25 -29.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -92.61 -19.39 21.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.099 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 -49.9 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.811 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -122.45 -47.13 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.153 -177.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 60' ' ' GLN . 36.7 t -55.05 -47.69 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.064 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.712 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 20.9 t-160 -41.23 -48.36 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 112.826 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -118.86 5.74 11.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -170.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 18.1 mm-40 -134.02 -19.33 2.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 14.1 m-85 -133.72 -44.2 0.81 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.386 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.733 ' HB2' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -62.31 -15.9 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.233 0.539 . . . . 0.0 111.201 -178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 t -68.91 -31.08 49.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.361 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 5.1 tp10 -129.08 -76.6 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.209 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -117.4 117.74 36.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HG3' HE22 ' A' ' 60' ' ' GLN . 82.2 Cg_exo -47.21 -48.91 13.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.741 2.961 . . . . 0.0 113.895 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 61.72 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.492 0.495 . . . . 0.0 110.933 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG2' HG22 ' A' ' 51' ' ' VAL . 72.2 mttt 61.75 -124.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.046 0.538 . . . . 0.0 111.105 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 63.35 49.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.991 0.516 . . . . 0.0 111.219 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.9 pt? -174.03 39.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.399 0.619 . . . . 0.0 112.059 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' A' ' 70' ' ' ALA . 4.4 p90 -151.45 -54.93 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.403 -0.811 . . . . 0.0 112.43 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -100.25 75.97 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.915 0.388 . . . . 0.0 111.428 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 3.8 pm0 -162.23 139.78 6.46 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.824 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' A' ' 74' ' ' ILE . 85.1 Cg_endo -88.64 46.78 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.154 2.569 . . . . 0.0 112.563 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 1.088 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER 60.55 39.61 17.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.223 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 72' ' ' PRO . 7.2 mt -139.96 48.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 122.304 -0.247 . . . . 0.0 110.562 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 pttt 46.71 23.8 0.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.221 1.008 . . . . 0.0 112.502 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -72.41 -15.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.759 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.67 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -59.38 -44.38 92.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.312 0.577 . . . . 0.0 110.003 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.67 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -72.3 -43.43 64.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.814 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -75.47 5.18 6.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.796 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.2 -62.49 1.31 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.73 -31.73 42.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.394 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.3 2.61 50.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.94 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.025 0.441 . . . . 0.0 109.934 176.641 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.366 0.603 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.49 109.01 5.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.201 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 32' ' ' ILE . 62.1 t 70.25 -71.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.675 0.609 . . . . 0.0 111.756 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 81.55 0.19 Allowed Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.373 0.669 . . . . 0.0 110.967 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 34.3 Cg_exo -58.98 154.64 43.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.134 2.556 . . . . 0.0 112.036 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -86.97 -65.84 0.97 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.2 m-80 -128.53 -83.91 0.58 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.38 174.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.91 -49.84 0.22 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.447 0.642 . . . . 0.0 109.298 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.76 -45.74 91.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.691 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 34.6 mp0 -67.42 -43.01 82.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.611 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.553 ' CB ' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -54.49 -52.95 60.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -59.92 -44.64 94.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.87 89.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.023 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.01 -42.82 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 17' ' ' SER . 2.1 pt-20 -83.19 -14.24 53.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.315 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.0 mm -91.31 -39.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 0.0 112.086 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.14 -29.53 15.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -176.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.4 tp10 59.74 -64.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.409 1.084 . . . . 0.0 111.705 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.623 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -141.1 5.15 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.374 170.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 63.45 -5.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.622 1.169 . . . . 0.0 113.885 176.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 HG12 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -140.1 -60.78 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.855 0.359 . . . . 0.0 111.2 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.86 7.45 25.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.762 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 24' ' ' GLU . 12.4 m 36.22 76.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.623 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -155.78 57.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.13 0.491 . . . . 0.0 110.009 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -125.39 -50.75 0.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.475 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 ' CG2' ' A' ' 9' ' ' VAL . 49.3 mm -60.6 108.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.527 0.68 . . . . 0.0 111.086 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.93 -163.59 13.75 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -76.24 14.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 111.511 -175.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.68 7.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.491 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 51.08 -127.07 2.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.753 -176.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -128.55 26.22 5.66 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.091 -176.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.84 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.552 1.158 . . . . 0.0 111.291 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -135.21 51.54 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.044 0.449 . . . . 0.0 110.768 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -154.72 51.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.982 0.42 . . . . 0.0 111.009 176.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.1 tt -106.35 -15.28 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.345 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.52 45.64 0.46 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.83 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.36 -123.73 0.69 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.846 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.747 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 13.5 p-80 58.82 -47.89 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.061 1.744 . . . . 0.0 114.346 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -96.01 -68.9 0.78 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.302 0.573 . . . . 0.0 110.272 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 18.0 tp -78.73 -18.22 54.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.092 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 48.47 52.38 13.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . . . 173.74 10.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.97 -171.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.24 -39.27 93.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.364 0.602 . . . . 0.0 109.449 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.84 -30.55 45.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.45 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 11.0 t -63.95 -28.23 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.109 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -99.15 -18.74 17.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -51.95 15.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.09 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.89 -41.35 2.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.366 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.958 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 66.4 t -58.56 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.2 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.3 t60 -54.91 -38.98 68.31 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -109.39 -4.84 16.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -168.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -142.9 -11.07 0.77 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.958 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 10.5 m-85 -124.88 -48.01 1.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.79 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.7 -18.84 63.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.019 0.437 . . . . 0.0 110.918 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.4 -32.87 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.268 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 -74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.873 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.11 127.91 15.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.74 0.305 . . . . 0.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.93 118.58 5.76 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.539 2.159 . . . . 0.0 112.09 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -90.99 -63.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.605 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.472 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 4.6 mtpt 64.15 -132.75 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.7 0.4 . . . . 0.0 111.375 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.986 HG22 HG21 ' A' ' 81' ' ' VAL . 0.2 OUTLIER 60.12 33.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.483 0.713 . . . . 0.0 112.599 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -170.27 46.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.444 0.64 . . . . 0.0 112.37 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.8 p90 -156.33 -47.78 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.418 -0.801 . . . . 0.0 112.752 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.42 50.9 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.196 0.522 . . . . 0.0 111.686 -172.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.74 132.72 4.2 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.747 ' HA ' ' HB3' ' A' ' 44' ' ' HIS . 31.5 Cg_endo -69.21 -40.67 5.86 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.169 1.913 . . . . 0.0 111.278 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 8.8 t 168.27 45.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 123.427 1.584 . . . . 0.0 108.208 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.9 mt -118.97 176.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 112.628 -2.078 . . . . 0.0 107.482 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -81.66 17.28 1.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.25 -25.49 68.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.891 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.789 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.98 -44.63 96.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.421 . . . . 0.0 110.911 176.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.789 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.22 -41.52 49.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.175 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -29.8 70.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.312 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -73.77 -48.15 33.76 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.133 -178.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.986 HG21 HG22 ' A' ' 67' ' ' VAL . 1.2 t -73.99 -24.86 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.67 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.39 177.456 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.037 0.446 . . . . 0.0 110.441 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -65.27 119.07 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.062 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 32' ' ' ILE . 3.4 t 56.74 51.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.96 116.78 1.01 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.988 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.21 151.09 20.47 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.759 2.306 . . . . 0.0 112.217 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.1 -74.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.943 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -128.92 39.94 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.1 -57.53 0.42 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.294 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.22 -47.93 91.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 -44.04 97.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.995 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 -44.86 87.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.6 ttpp -64.25 -40.87 96.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.349 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.497 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.4 -43.76 68.16 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.554 0.533 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.3 pt-20 -81.8 -13.8 57.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.666 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 18' ' ' LYS . 44.9 mm -102.7 -16.62 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 112.025 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.553 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -111.3 -32.67 6.66 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.217 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG12 ' A' ' 32' ' ' ILE . 6.0 tt0 61.22 -66.45 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.983 0.913 . . . . 0.0 111.801 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.797 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.81 2.09 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.25 -15.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.139 . . . . 0.0 113.308 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -136.14 -53.53 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.048 0.452 . . . . 0.0 111.074 -175.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.45 4.18 32.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.175 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 3.3 m 34.77 74.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.949 1.029 . . . . 0.0 112.927 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.797 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -156.94 61.43 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.886 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.714 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . -121.61 -46.78 0.31 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.665 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.773 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.1 mm -44.47 121.61 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.565 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.91 -161.18 12.63 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.78 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -66.47 -5.86 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.008 0.523 . . . . 0.0 111.607 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -171.53 38.18 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 175.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 2.5 m-20 45.08 -121.27 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.394 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.619 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 1.8 m-20 -112.83 41.2 2.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HD2' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER 42.02 -93.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.411 1.069 . . . . 0.0 111.404 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.4 59.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HB2' ' NE2' ' A' ' 44' ' ' HIS . 2.0 pt20 -164.32 66.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.25 0.547 . . . . 0.0 110.704 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -111.27 -32.45 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.581 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.44 86.66 0.14 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.48 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 168.84 -126.67 1.41 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.405 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m80 66.28 -54.14 0.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -72.57 -74.09 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.338 0.59 . . . . 0.0 109.9 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 7.4 tp -93.73 -10.21 35.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.172 173.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.9 mmtp 55.53 67.65 0.98 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.139 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 173.19 1.97 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.128 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.735 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 7.6 mmm -61.13 -34.11 74.47 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 -177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.44 65.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.413 0.625 . . . . 0.0 109.976 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.5 t -63.29 -24.13 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.317 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.99 -12.21 16.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.489 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.68 -51.11 6.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.448 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.16 -35.94 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.718 -174.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.948 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 58.8 t -70.08 -40.94 78.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.342 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.8 t-160 -44.2 -52.2 7.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.996 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.79 13.97 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 65.8 mm-40 -135.85 -7.8 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.834 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -134.46 -42.16 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.875 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -21.54 64.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.8 t -58.1 -32.05 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.922 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.69 -80.67 0.63 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 135.81 18.15 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.265 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.449 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 73.8 Cg_endo -82.01 115.86 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.331 2.021 . . . . 0.0 112.011 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -81.29 -40.27 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.422 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.5 mtmt 58.25 -120.64 1.21 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.391 0.432 . . . . 0.0 110.898 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.564 ' H ' HG21 ' A' ' 81' ' ' VAL . 15.9 m 48.37 25.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.208 1.403 . . . . 0.0 114.573 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -173.19 66.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.0 111.887 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 5.3 p90 -162.98 -47.69 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 -176.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -99.33 84.53 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.907 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.873 HE21 HD23 ' A' ' 77' ' ' LEU . 0.6 OUTLIER -158.75 148.96 15.47 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 58.5 Cg_endo -100.34 40.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.014 3.143 . . . . 0.0 111.403 168.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.496 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 0.2 OUTLIER 55.52 55.37 7.37 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.767 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' HG2' ' A' ' 75' ' ' LYS . 4.3 mt -134.38 -103.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -139.68 16.23 2.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.233 0.539 . . . . 0.0 110.261 175.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.82 -32.14 73.7 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.77 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.873 HD23 HE21 ' A' ' 71' ' ' GLN . 0.2 OUTLIER -59.14 -44.64 92.07 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.408 0.623 . . . . 0.0 110.523 178.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.685 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -74.74 -43.44 54.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.255 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -27.49 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.301 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.2 t80 -66.86 -53.4 32.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.418 0.628 . . . . 0.0 109.383 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.564 HG21 ' H ' ' A' ' 67' ' ' VAL . 99.1 t -71.28 -23.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.643 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.41 -0.04 39.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.48 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.972 0.415 . . . . 0.0 109.932 174.273 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 9.0 pt20 . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.977 0.418 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.404 ' CE1' HG22 ' A' ' 32' ' ' ILE . 1.6 t80 -69.46 121.23 16.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.79 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 2.0 t 56.63 49.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.74 109.71 1.09 Allowed Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.26 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.59 165.49 1.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.383 2.722 . . . . 0.0 111.837 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.02 -69.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.282 174.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.9 m-80 -124.55 -86.9 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.491 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.68 -49.64 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.0 t -60.54 -43.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.785 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 8.9 mp0 -67.68 -48.82 65.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.023 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -41.79 92.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.91 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -46.69 88.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -60.34 -48.96 79.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.826 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.08 -40.25 57.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.544 0.527 . . . . 0.0 111.622 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -87.0 -12.54 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.325 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 22' ' ' ILE . 4.1 mm -95.42 -38.77 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.931 -177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -101.52 -29.82 11.76 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -174.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.78 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.2 tt0 57.37 -68.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.011 0.924 . . . . 0.0 111.496 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -130.6 2.59 4.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 175.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.55 0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.308 1.043 . . . . 0.0 113.586 177.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -146.14 -57.76 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.15 -0.344 . . . . 0.0 111.367 -179.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.67 -1.0 29.09 Favored Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.964 -172.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 39.35 67.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.337 0.655 . . . . 0.0 112.393 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 60.04 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.958 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.628 ' HA3' HD21 ' A' ' 37' ' ' ASN . . . -127.76 -15.26 2.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.238 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.639 HG23 HG22 ' A' ' 9' ' ' VAL . 43.2 mm -71.8 83.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.009 0.433 . . . . 0.0 110.1 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.52 -85.66 1.87 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.938 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -136.95 -5.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 110.731 177.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.736 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.4 OUTLIER -167.53 43.56 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.897 -178.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m-20 49.63 -129.04 2.11 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.705 -173.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.637 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 61.9 m-80 -116.54 27.06 9.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.92 -91.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.113 0.883 . . . . 0.0 111.744 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.641 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.83 40.81 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.258 0.551 . . . . 0.0 111.696 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -138.72 52.59 1.79 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.712 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.437 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 3.9 tt -110.78 -28.1 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -144.66 45.99 0.83 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.983 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -179.34 -103.0 0.17 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.755 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' GLN . 4.8 p-80 59.96 -50.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.223 1.809 . . . . 0.0 113.898 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 p -106.06 -68.31 0.88 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.22 -25.93 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.89 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 7.0 mmtp 53.24 63.66 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.9 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.0 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.242 -174.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.443 ' H ' ' HG2' ' A' ' 49' ' ' MET . 31.1 mmm -52.82 -42.46 65.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.489 0.185 . . . . 0.0 111.242 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.564 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.76 -29.59 51.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.556 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 16.0 t -62.65 -29.1 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.971 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.91 -20.78 15.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.664 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.2 -51.78 12.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.038 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.603 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 4.7 pm0 -120.93 -38.03 2.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.143 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 30.2 t -64.62 -41.86 93.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.312 -174.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -40.41 -59.36 1.34 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -132.14 18.41 4.51 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 9.5 mm-40 -130.16 -6.4 4.36 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.829 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 40.0 m-85 -137.83 -54.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.567 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -19.0 65.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.33 . . . . 0.0 111.337 -174.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.29 -34.94 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.325 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.69 -73.51 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.957 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 113.95 9.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.947 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.66 127.23 15.15 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.664 2.243 . . . . 0.0 111.615 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -58.21 2.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.653 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 14.1 mttt 62.35 -134.49 0.5 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.421 0.288 . . . . 0.0 110.98 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 t 60.73 27.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.14 62.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 111.524 177.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.579 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 5.6 p90 -165.84 -50.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.705 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.859 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -87.83 45.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.609 -173.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.8 pm0 -154.12 143.2 14.84 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.8 Cg_exo -64.7 -56.47 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.313 2.009 . . . . 0.0 110.853 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.8 t 170.72 48.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.817 0.818 . . . . 0.0 109.898 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -125.55 -106.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.576 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -141.21 13.69 2.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.059 0.456 . . . . 0.0 110.531 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' GLN . . . -63.99 -26.66 68.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.216 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.7 -48.31 75.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.551 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.74 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.14 -43.77 66.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.164 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.24 0.06 12.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.238 0.542 . . . . 0.0 111.403 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.5 t80 -100.46 -63.31 1.14 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.81 -28.67 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.596 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -95.54 10.08 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.488 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.485 173.648 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.116 0.484 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 45.1 t80 -74.73 116.71 15.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 21' ' ' GLU . 4.7 t 56.53 55.73 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.682 0.753 . . . . 0.0 109.276 -168.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -49.62 126.91 18.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.078 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.4 Cg_exo -68.29 138.58 43.35 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.063 2.508 . . . . 0.0 112.32 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.603 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -103.94 -73.98 0.66 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.791 0.329 . . . . 0.0 110.345 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -137.01 45.61 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.054 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.21 -69.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.246 0.619 . . . . 0.0 111.165 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.39 -48.76 76.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.603 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.49 -34.95 79.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.542 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -45.14 94.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.124 0.488 . . . . 0.0 110.526 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 18.2 ttpt -64.76 -40.96 96.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.377 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -67.0 -34.29 77.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.533 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -58.41 -44.52 89.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.657 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 pt-20 -79.29 -14.17 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 18' ' ' LYS . 2.2 mm -118.22 32.32 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.279 . . . . 0.0 111.719 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.669 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -144.96 -47.82 0.24 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.724 171.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 28.1 tt0 60.48 -65.65 0.05 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.058 0.943 . . . . 0.0 112.306 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 25' ' ' ARG . 3.5 mtp180 -134.77 -1.76 2.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.526 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 63.62 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.13 -51.65 0.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.048 -0.408 . . . . 0.0 111.102 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.65 -14.98 28.24 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.111 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 43.29 72.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 124.423 0.719 . . . . 0.0 112.018 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 m -162.51 70.37 0.28 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.563 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -169.94 10.2 0.05 OUTLIER Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.01 -1.091 . . . . 0.0 114.477 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.31 129.74 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 117.949 0.875 . . . . 0.0 110.022 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.19 5.87 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.073 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.59 18.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.401 0.28 . . . . 0.0 111.754 -176.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.33 42.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 7.3 m-20 59.73 -121.47 1.04 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.726 ' HB2' HD12 ' A' ' 41' ' ' ILE . 2.4 t-20 -128.82 43.79 3.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.49 -101.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.147 0.905 . . . . 0.0 111.229 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -124.49 43.77 2.93 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.1 pt20 -160.8 67.38 0.32 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.7 OUTLIER -105.66 -41.05 6.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.11 89.98 0.13 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.092 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.791 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 160.52 -121.93 1.08 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 66.52 -51.99 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 113.013 174.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -84.0 -73.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.296 0.569 . . . . 0.0 110.277 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.498 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 9.5 tp -84.29 -13.19 53.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.457 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.5 mmtm 51.12 65.28 1.53 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.604 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.65 -6.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.307 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.791 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 21.4 mmm -53.42 -37.79 62.88 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.183 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -74.84 -35.73 62.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.186 0.517 . . . . 0.0 110.596 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 59.2 t -61.87 -27.52 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.211 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.59 -15.86 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -48.54 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.849 HE22 HD11 ' A' ' 68' ' ' LEU . 10.7 pm0 -127.83 -39.85 1.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.165 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -58.55 -51.33 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.337 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.4 t-160 -59.43 -26.62 65.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -174.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.98 -4.44 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -138.12 -19.82 1.12 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 37.2 m-85 -124.76 -50.43 1.72 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.221 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -12.0 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.606 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.88 -30.89 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.293 0.568 . . . . 0.0 110.051 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.72 -62.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.601 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.58 140.25 14.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.77 154.1 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.517 2.145 . . . . 0.0 111.819 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -119.23 -42.77 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.937 179.243 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mppt? 63.87 -145.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.587 0.355 . . . . 0.0 111.367 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.0 t 65.6 26.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.849 HD11 HE22 ' A' ' 54' ' ' GLN . 0.7 OUTLIER -166.33 42.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 111.849 174.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.5 p90 -148.2 -45.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.09 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.86 53.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.056 0.455 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.711 HE21 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.33 119.15 7.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 73' ' ' THR . 23.4 Cg_exo -65.95 -69.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.478 2.118 . . . . 0.0 111.285 170.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -179.7 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 109.806 175.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.94 38.62 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.458 -171.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 60.34 23.61 13.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.172 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.27 -24.77 66.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.711 HD23 HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -55.1 -48.64 73.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.487 175.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.66 62.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.487 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 -6.95 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -100.02 -50.77 3.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 67' ' ' VAL . 5.8 p -69.47 -23.05 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.997 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.18 18.66 14.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.233 0.539 . . . . 0.0 110.697 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.0 m . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.269 176.573 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 120.684 0.278 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.738 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 8.5 t80 49.24 82.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.127 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 32' ' ' ILE . 3.3 p 33.94 96.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 124.97 1.419 . . . . 0.0 112.42 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -68.43 115.18 27.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.242 -169.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.0 Cg_endo -95.8 138.73 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.891 3.061 . . . . 0.0 112.586 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -128.12 -71.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.43 60.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.628 -0.429 . . . . 0.0 112.064 -169.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -46.87 -47.8 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 122.949 0.5 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -44.04 74.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.556 -176.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.21 -51.96 66.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.391 -177.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.592 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.87 -38.48 91.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.771 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -44.92 76.92 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.568 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.42 -38.36 68.86 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.453 0.471 . . . . 0.0 111.611 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -86.73 -19.2 29.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.34 . . . . 0.0 110.67 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -90.08 -29.52 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -174.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -102.68 -27.86 12.47 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 -176.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 6.8 tm-20 59.71 -79.81 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.943 0.897 . . . . 0.0 110.513 -175.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -115.88 -12.25 11.43 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.838 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.01 5.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.356 1.035 . . . . 0.0 113.146 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -136.17 -55.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.798 -0.564 . . . . 0.0 110.876 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.79 -13.88 5.91 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.771 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 m 46.44 96.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 122.558 1.17 . . . . 0.0 112.192 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -86.33 -37.97 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.253 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . 139.13 70.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.842 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -55.31 127.97 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 177.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.36 -138.82 2.61 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.617 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -70.55 -2.54 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -4.08 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 9' ' ' VAL . 5.3 t70 62.03 -142.03 0.44 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' A' ' 41' ' ' ILE . 3.2 m-80 -135.41 23.99 3.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.2 -97.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.489 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.965 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.8 m-85 -122.22 37.32 4.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.043 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -155.56 63.59 0.6 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.429 . . . . 0.0 110.804 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.2 tt -108.76 -21.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 0.0 111.041 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -158.83 96.9 0.16 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.636 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 49' ' ' MET . . . 124.11 -117.7 3.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.596 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.537 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 16.4 p-80 56.89 -26.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.196 1.399 . . . . 0.0 114.501 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 43' ' ' GLY . 1.2 p -89.4 -75.04 0.45 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.117 0.484 . . . . 0.0 109.909 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.573 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -83.35 -11.77 57.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.994 174.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 15.0 mmtp 57.23 64.32 1.65 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.467 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 174.81 -9.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.774 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.573 ' HG2' HD23 ' A' ' 46' ' ' LEU . 4.7 mmt -50.32 -42.51 52.87 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.21 -30.11 60.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.829 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 53.3 t -64.28 -27.41 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.029 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.32 -21.38 14.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -77.16 -46.61 22.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -120.78 -50.37 2.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.493 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 53.9 t -52.1 -45.69 42.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 14.4 t-160 -39.63 -56.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.902 0.752 . . . . 0.0 112.753 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -114.02 1.61 14.71 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -116.27 -23.34 8.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -134.12 -42.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.533 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.93 55.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.703 0.287 . . . . 0.0 111.371 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.97 -36.09 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.388 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -121.06 -70.42 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.674 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.03 117.72 9.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.91 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 10.2 Cg_exo -69.73 121.56 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.522 2.148 . . . . 0.0 111.442 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -54.14 4.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.843 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 64.92 -116.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.492 -177.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.624 HG22 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER 57.96 27.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.5 0.72 . . . . 0.0 112.557 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.4 69.71 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 111.132 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.1 p90 -165.22 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.694 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.71 51.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.129 0.49 . . . . 0.0 111.16 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.27 136.03 6.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.511 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 60.1 Cg_endo -79.85 -36.09 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.159 1.906 . . . . 0.0 111.736 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.965 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 10.1 t 171.22 51.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.907 1.336 . . . . 0.0 109.541 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 76' ' ' ALA . 6.2 mt -133.33 162.24 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.667 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 22.97 0.07 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 172.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -65.41 -27.73 68.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.7 -39.9 86.14 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.947 177.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.599 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.41 -44.98 33.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -66.45 -18.04 65.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.612 -176.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.98 -53.24 5.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.612 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.624 HG21 HG22 ' A' ' 67' ' ' VAL . 25.7 t -72.58 -34.53 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.965 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 110.425 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.404 ' OE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 mt-30 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.458 ' O ' HG22 ' A' ' 9' ' ' VAL . 30.1 t80 56.21 89.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.557 -173.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.591 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 63.83 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.06 -166.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.17 109.05 54.65 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.554 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.81 115.92 3.68 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.796 2.331 . . . . 0.0 111.693 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -55.51 3.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.193 0.52 . . . . 0.0 109.854 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -128.04 -101.55 0.34 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.98 -45.56 0.65 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.89 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.488 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -63.44 -44.64 93.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.123 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -48.7 79.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.283 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 22' ' ' ILE . 2.5 mtpm? -61.5 -41.52 97.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -66.18 -44.09 85.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.251 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -50.81 -43.41 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.612 0.57 . . . . 0.0 111.346 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -80.78 -23.84 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.667 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 18' ' ' LYS . 40.3 mm -90.72 -32.32 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.646 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -95.13 -30.08 14.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.929 -176.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.646 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER 59.22 -64.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.511 1.124 . . . . 0.0 112.309 -175.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 -1.57 2.43 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.789 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 68.28 -14.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.254 1.022 . . . . 0.0 112.954 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.789 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -138.71 -57.53 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.76 -1.24 58.79 Favored Glycine 0 CA--C 1.5 -0.883 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.582 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 35.21 50.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 113.999 -1.1 . . . . 0.0 112.978 -179.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -149.35 57.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.371 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -133.05 -5.05 3.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.883 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 HG12 ' A' ' 9' ' ' VAL . 5.2 mm -76.18 108.98 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 117.736 0.768 . . . . 0.0 109.975 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.74 -153.42 7.83 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.415 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -1.06 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' HB3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -167.9 51.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 12.9 m-20 60.37 -135.66 0.7 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.543 ' HA ' HD22 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -104.12 46.75 0.9 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.403 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.81 -98.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.284 0.99 . . . . 0.0 109.908 -168.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -136.26 50.48 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 110.349 175.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -150.78 45.32 0.85 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.673 172.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 36' ' ' ASP . 1.5 tt -90.34 -27.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.401 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.34 54.84 0.62 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 179.97 -81.78 0.06 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 -60.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.967 1.707 . . . . 0.0 112.611 170.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 p -121.43 -50.13 2.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.472 0.653 . . . . 0.0 109.869 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.656 HD23 ' HG2' ' A' ' 49' ' ' MET . 22.1 tp -68.73 -29.6 68.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.268 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.755 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.1 mmtp 48.76 57.42 6.38 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.632 0.582 . . . . 0.0 111.262 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.14 -5.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.934 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.722 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 7.0 mtp -56.41 -40.62 74.98 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.977 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.11 -31.82 44.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.29 0.567 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.564 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 10.7 t -62.15 -25.43 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.473 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.48 -16.58 14.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.221 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.72 10.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.9 pm0 -128.21 -29.67 2.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.197 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 77.8 t -66.05 -36.91 78.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.98 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.8 t60 -50.45 -51.17 49.17 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 57' ' ' ARG . 8.4 ptp85 -131.28 12.7 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.577 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 72.6 mm-40 -123.97 -12.88 7.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.282 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 6.9 m-85 -127.59 -41.88 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.924 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -14.24 36.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.2 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 t -61.64 -31.51 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.082 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.9 -74.74 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.351 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.62 137.05 8.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.54 150.16 13.06 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.699 2.266 . . . . 0.0 112.93 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD23 ' HE2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -84.84 -60.62 2.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.343 177.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.1 mttt 73.72 -141.95 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.692 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 66' ' ' LYS . 1.5 m 57.34 21.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.153 0.981 . . . . 0.0 112.355 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -159.57 46.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.753 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 p90 -148.65 -55.23 0.2 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.111 -0.368 . . . . 0.0 111.317 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.19 60.79 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.473 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.937 ' HG3' ' HB3' ' A' ' 77' ' ' LEU . 2.5 pm0 -174.19 150.34 1.55 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.793 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 40' ' ' GLN . 5.2 Cg_endo -90.55 -77.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.299 2.666 . . . . 0.0 112.113 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.618 ' HA ' ' CD2' ' A' ' 39' ' ' PHE . 14.3 t -161.97 22.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.556 0.693 . . . . 0.0 110.344 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.54 39.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.818 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 16.45 5.49 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.081 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -69.63 -28.63 66.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.171 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.937 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -56.71 -41.36 77.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.948 0.404 . . . . 0.0 111.231 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.751 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.11 -45.61 33.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.092 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.75 1.9 11.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.154 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.55 -56.8 2.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.9 -26.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.092 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.22 3.24 43.87 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.44 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.405 0.621 . . . . 0.0 109.978 174.258 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpp? . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.018 0.437 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.24 122.81 2.9 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.917 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.29 128.57 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.707 0.289 . . . . 0.0 110.517 178.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.48 169.04 9.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.3 pm0 -79.14 80.96 5.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.321 0.582 . . . . 0.0 111.743 -177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.43 -54.1 6.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.619 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.442 ' HG2' ' H ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -97.5 36.09 1.55 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.512 0.672 . . . . 0.0 109.763 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 3.5 t80 -46.95 124.05 5.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.575 177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER 51.35 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.456 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.516 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -167.11 97.66 0.66 Allowed Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.497 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.1 124.37 10.87 Favored 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 122.678 2.252 . . . . 0.0 111.602 177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -74.15 0.66 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.44 37.29 4.15 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.181 -172.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.34 -62.64 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.055 0.542 . . . . 0.0 111.484 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.69 -45.87 90.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.088 0.471 . . . . 0.0 110.207 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -62.09 -43.41 98.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.394 178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.4 -44.18 97.07 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.841 0.353 . . . . 0.0 111.209 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -63.76 -34.55 78.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.433 0.635 . . . . 0.0 110.193 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -45.59 76.82 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.063 177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.55 -40.5 62.61 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.586 0.553 . . . . 0.0 111.589 -177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -79.28 -24.74 42.72 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.925 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -87.89 -27.43 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.613 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -109.82 -38.18 5.44 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.533 -0.467 . . . . 0.0 112.238 -175.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.6 tm-20 52.89 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.863 0.865 . . . . 0.0 110.642 -169.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' O ' HG12 ' A' ' 26' ' ' VAL . 1.3 mtt180 -110.27 -9.18 14.66 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.457 -177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.613 HG23 ' HB2' ' A' ' 23' ' ' TRP . 0.4 OUTLIER 66.03 -2.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.702 -176.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.535 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -143.1 -54.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.064 -0.398 . . . . 0.0 111.487 -176.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.09 -6.48 27.88 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.145 -174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.3 m 32.93 80.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.898 0.879 . . . . 0.0 112.987 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.49 60.4 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.591 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -145.4 -59.94 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.093 -1.051 . . . . 0.0 112.653 177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.468 HD11 HD12 ' A' ' 41' ' ' ILE . 12.8 mm -38.92 110.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.556 0.743 . . . . 0.0 112.149 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -134.78 -143.09 4.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.708 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.516 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -75.18 15.53 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.648 0.379 . . . . 0.0 111.882 -175.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.83 39.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.24 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 12.0 t70 64.21 -142.42 0.28 Allowed 'General case' 0 C--O 1.233 0.21 0 O-C-N 123.683 0.614 . . . . 0.0 110.018 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.591 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 8.2 t-20 -127.55 47.85 2.32 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.06 -101.16 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.691 -173.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.701 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -140.9 55.01 1.57 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.758 0.313 . . . . 0.0 110.733 177.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.551 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.5 pt20 -149.38 60.63 1.03 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.495 0.664 . . . . 0.0 110.956 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 32' ' ' ILE . 1.9 tt -106.81 -20.22 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.112 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -150.96 33.22 0.96 Allowed Glycine 0 C--O 1.229 -0.163 0 C-N-CA 119.825 -1.179 . . . . 0.0 113.29 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.07 -107.62 0.2 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.882 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.529 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 15.7 p-80 59.62 -51.51 0.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.015 1.726 . . . . 0.0 114.263 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 p -96.53 -65.65 0.95 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.304 0.573 . . . . 0.0 110.197 -176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -92.33 -12.74 31.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.245 177.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HE3' ' O ' ' A' ' 44' ' ' HIS . 5.1 mmtp 49.75 63.32 2.22 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.452 0.47 . . . . 0.0 111.232 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.635 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -178.95 -9.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.882 -173.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.665 ' HE2' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -54.7 -41.16 69.94 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.584 0.23 . . . . 0.0 110.976 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.697 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.25 -33.02 61.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.999 0.428 . . . . 0.0 110.481 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.417 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 41.4 t -62.41 -26.42 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.497 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.36 -20.8 15.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.795 0.331 . . . . 0.0 111.124 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.61 -43.47 12.64 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.941 -175.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -118.23 -40.58 2.93 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.926 -175.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -67.43 -59.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.848 -177.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 70.1 t60 -51.79 -27.35 12.01 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -172.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 57' ' ' ARG . 9.5 ptt180 -127.08 2.45 6.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.612 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 7.4 mt-10 -138.99 -26.48 0.84 Allowed 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.618 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 12.6 m-85 -126.43 -21.47 4.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.992 -171.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -68.41 -15.12 63.44 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 172.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.79 -32.02 56.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.91 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -126.38 -84.99 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.889 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 131.65 15.97 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -86.32 112.53 1.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.602 2.201 . . . . 0.0 111.816 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.461 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -75.69 -32.11 59.97 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.014 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.612 ' HE3' HG13 ' A' ' 81' ' ' VAL . 21.0 mtmt 61.5 -138.79 0.51 Allowed 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.687 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.783 ' HB ' HD23 ' A' ' 77' ' ' LEU . 2.4 m 55.46 21.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.139 0.975 . . . . 0.0 113.464 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.805 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -151.64 37.94 0.6 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.609 0.718 . . . . 0.0 111.697 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 7.5 p90 -153.8 -46.51 0.09 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.667 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -88.22 41.01 0.98 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.034 0.445 . . . . 0.0 111.559 -174.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.805 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.0 pm0 -153.06 138.65 11.75 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.298 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.0 Cg_endo -87.53 -42.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.15 2.567 . . . . 0.0 112.037 173.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.701 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 9.9 t 176.94 39.84 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 122.696 1.236 . . . . 0.0 109.609 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 76' ' ' ALA . 1.9 mt -121.51 163.04 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 173.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.96 24.35 0.13 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.836 0.827 . . . . 0.0 108.897 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -66.21 -21.6 66.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.003 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.783 HD23 ' HB ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -60.77 -34.83 75.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 176.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -83.5 -38.16 22.16 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.912 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.77 3.62 16.14 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.373 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -108.4 -56.48 2.25 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.058 0.456 . . . . 0.0 109.821 174.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.716 HG21 ' H ' ' A' ' 67' ' ' VAL . 21.4 t -79.74 -11.72 12.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.655 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.05 21.61 13.12 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 110.781 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 26.3 m -134.85 -36.15 0.85 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.139 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -103.47 14.63 30.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 109.536 175.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 18.7 m . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.52 100.63 2.7 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.645 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.98 91.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.926 0.393 . . . . 0.0 110.748 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 39.08 2.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.584 177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -104.9 137.75 42.2 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.41 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 34' ' ' ILE . . . -118.22 -82.17 0.63 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 7' ' ' GLN . 9.3 tt0 -147.78 87.17 1.61 Allowed 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.41 1.1 . . . . 0.0 108.853 170.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 58.5 t80 -57.73 115.6 2.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.475 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG22 HD12 ' A' ' 32' ' ' ILE . 89.8 t 73.38 115.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.611 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.49 101.45 42.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.54 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD2' HE21 ' A' ' 7' ' ' GLN . 89.8 Cg_endo -80.05 174.76 11.13 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.703 2.269 . . . . 0.0 112.459 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.71 -68.44 0.72 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.063 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -112.43 -100.37 0.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.4 -50.09 0.92 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.3 0.571 . . . . 0.0 109.664 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.21 -39.53 85.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.976 176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -64.15 -37.97 89.37 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.515 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.23 -50.4 73.25 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 121.139 0.495 . . . . 0.0 111.086 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.497 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.49 -44.8 93.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.496 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.35 -44.27 96.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.977 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.623 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.274 0.359 . . . . 0.0 110.779 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.7 pt-20 -80.78 -12.86 59.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.282 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 18' ' ' LYS . 25.4 mm -99.53 -37.47 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.623 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -88.7 -36.24 16.3 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.713 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.611 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 6.9 tt0 59.53 -57.47 0.06 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.623 1.169 . . . . 0.0 112.969 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -137.33 -6.35 1.79 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 175.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.48 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.07 -2.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.983 0.913 . . . . 0.0 112.802 -178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.71 -59.17 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.105 -0.372 . . . . 0.0 111.437 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.87 2.24 33.8 Favored Glycine 0 CA--C 1.503 -0.676 0 C-N-CA 120.411 -0.899 . . . . 0.0 111.482 -174.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' A' ' 24' ' ' GLU . 2.7 m 36.36 64.55 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 124.093 0.957 . . . . 0.0 113.02 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.44 59.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.958 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -139.49 -13.12 0.66 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.325 -0.94 . . . . 0.0 113.663 -177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.519 HD12 HG22 ' A' ' 9' ' ' VAL . 15.8 mm -71.55 112.93 7.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 117.108 0.454 . . . . 0.0 110.055 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -150.48 -143.02 3.65 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.906 -178.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 6' ' ' ALA . 0.2 OUTLIER -70.44 -0.39 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -170.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 179.04 34.4 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 t70 59.65 -136.34 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.752 -174.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.638 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 12.4 m-80 -105.89 44.08 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 43.5 -92.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.991 0.807 . . . . 0.0 111.107 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' HD1' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -137.14 51.44 1.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 110.643 177.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.673 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -147.9 61.64 1.13 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.242 0.544 . . . . 0.0 110.052 174.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.4 tp -106.6 -43.44 7.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.13 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.816 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.78 44.79 1.29 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.093 -1.051 . . . . 0.0 113.869 -171.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 176.06 -90.38 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.938 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -53.48 0.31 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.606 1.562 . . . . 0.0 112.221 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 59.1 p -113.39 -65.34 1.2 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.573 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 33.1 tp -67.65 -31.29 71.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.573 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.883 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 8.1 mmtm 53.8 62.5 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.389 0.431 . . . . 0.0 110.7 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -172.59 -18.05 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.573 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.6 -29.97 69.54 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.654 -176.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.816 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -76.39 -38.74 55.28 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.314 0.578 . . . . 0.0 110.055 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 28.9 t -61.13 -24.4 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.749 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.636 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -102.46 -17.15 15.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.066 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.0 -53.33 8.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.431 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.9 pm0 -122.3 -35.48 3.12 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.367 -175.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.885 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 87.6 t -63.33 -53.89 39.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.823 -176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.636 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 39.7 t60 -45.15 -46.78 12.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.19 5.14 8.52 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -168.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.18 -15.15 1.12 Allowed 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.681 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.885 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 8.6 m-85 -125.46 -37.59 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.654 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -16.41 63.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.783 0.325 . . . . 0.0 110.342 177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.41 -32.48 48.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.819 173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -114.65 -78.19 0.58 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.056 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.22 128.99 6.94 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.804 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -72.41 115.22 4.25 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.203 1.935 . . . . 0.0 111.586 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -70.49 -40.85 73.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -177.047 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.598 ' O ' HD23 ' A' ' 68' ' ' LEU . 10.1 mttt 61.76 -138.76 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 123.33 0.394 . . . . 0.0 111.036 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.808 ' H ' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER 44.4 40.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.52 1.128 . . . . 0.0 113.308 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -164.87 37.79 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.821 0.82 . . . . 0.0 111.275 175.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -151.0 -49.74 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -171.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.883 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -89.99 57.51 3.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 111.987 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 77' ' ' LEU . 2.9 pm0 -164.63 136.58 3.55 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.399 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.673 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 5.0 Cg_exo -79.11 -44.22 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.962 2.441 . . . . 0.0 111.51 174.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.571 ' HA ' ' HD1' ' A' ' 39' ' ' PHE . 8.4 t 174.1 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 122.806 1.289 . . . . 0.0 109.256 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.577 ' C ' ' H ' ' A' ' 76' ' ' ALA . 2.1 mt -126.75 168.33 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.493 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.46 18.57 0.09 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.388 0.614 . . . . 0.0 109.53 173.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -67.64 -23.65 65.37 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.383 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.764 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.15 -43.92 98.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.142 179.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.764 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -75.68 -40.24 56.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.114 0.483 . . . . 0.0 110.063 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -70.17 -20.04 63.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.351 -177.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -83.25 -56.72 3.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.186 0.517 . . . . 0.0 110.315 -177.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.808 HG21 ' H ' ' A' ' 67' ' ' VAL . 98.1 t -69.1 -30.66 47.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.946 -175.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.34 -8.84 58.89 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.5 m -101.45 -35.11 9.31 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.182 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.571 ' HD3' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -95.09 -23.1 17.48 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.412 -177.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.571 ' O ' ' HD3' ' A' ' 84' ' ' ARG . 63.0 m . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.391 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.67 -103.68 0.21 Allowed Glycine 0 CA--C 1.507 -0.433 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.24 82.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 122.126 0.965 . . . . 0.0 108.691 170.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.01 7.21 6.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.946 -172.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -94.38 81.82 4.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.707 -175.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.58 -20.59 60.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.442 0.639 . . . . 0.0 109.929 175.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -78.02 -8.71 58.54 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.803 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.667 ' HD1' HG23 ' A' ' 9' ' ' VAL . 2.8 t80 -59.37 132.11 53.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.533 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.667 HG23 ' HD1' ' A' ' 8' ' ' TYR . 99.3 t 75.89 -55.81 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.116 0.567 . . . . 0.0 111.604 178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 58.54 68.12 1.86 Allowed Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -175.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 21.5 Cg_exo -65.43 160.2 43.9 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.021 2.481 . . . . 0.0 112.318 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.69 -67.76 0.86 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.951 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.485 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 64.0 m-80 -128.37 -89.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.198 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.79 -53.95 0.71 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.89 0.376 . . . . 0.0 110.374 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.679 HG11 ' HG3' ' A' ' 58' ' ' GLU . 58.8 t -62.06 -41.44 91.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.345 0.593 . . . . 0.0 110.126 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.6 mp0 -63.52 -47.34 82.08 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.754 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.7 -46.53 89.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.478 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -64.85 -32.21 73.8 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.035 -178.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -75.41 -41.81 55.2 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.969 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.17 -41.61 62.74 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.567 0.542 . . . . 0.0 111.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG3' HG12 ' A' ' 22' ' ' ILE . 3.5 pt-20 -74.48 -38.47 62.88 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.749 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.504 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 mm -109.63 45.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.474 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -147.26 -32.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.134 169.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HB3' HG12 ' A' ' 29' ' ' VAL . 15.8 tp10 65.04 -55.76 0.3 Allowed 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.413 1.085 . . . . 0.0 112.482 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -150.24 -3.86 0.36 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 174.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.94 1.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.068 0.947 . . . . 0.0 113.545 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.33 -53.75 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.934 -0.479 . . . . 0.0 111.104 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.75 10.84 11.19 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.86 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER 35.05 72.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.078 0.951 . . . . 0.0 113.206 178.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.671 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -170.57 62.85 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.32 -179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.776 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -133.35 -45.39 0.12 Allowed Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.148 -1.025 . . . . 0.0 114.042 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.8 mm -68.23 109.02 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.321 0.581 . . . . 0.0 111.759 -171.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.32 -151.19 7.09 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.558 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG12 ' HG ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -80.22 13.12 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.9 0.381 . . . . 0.0 111.175 -177.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' HG ' HG12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -167.58 36.19 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.65 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' OD2' ' HB ' ' A' ' 41' ' ' ILE . 11.8 t70 62.12 -151.17 0.37 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.776 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.7 OUTLIER -91.11 59.28 3.96 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 175.251 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' CD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 49.35 -87.29 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 O-C-N 124.533 1.146 . . . . 0.0 110.13 -170.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.512 ' HD1' HG22 ' A' ' 73' ' ' THR . 0.0 OUTLIER -150.25 50.99 0.9 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 120.873 0.368 . . . . 0.0 110.589 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.634 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -169.79 67.55 0.05 Allowed 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.993 0.425 . . . . 0.0 110.873 178.34 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -86.41 -35.27 8.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 O-C-N 121.956 -0.465 . . . . 0.0 111.788 -174.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.49 65.47 0.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.414 -172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -175.07 -119.97 0.58 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 58.14 -48.91 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.008 1.723 . . . . 0.0 114.266 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.9 p -94.16 -71.21 0.67 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.207 0.527 . . . . 0.0 109.633 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 27.0 tp -76.31 -22.01 55.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.177 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.721 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 12.9 mmtp 50.79 60.6 3.75 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.034 -177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 174.12 -5.97 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.296 -172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 36.4 mmm -53.61 -43.12 68.38 Favored 'General case' 0 C--O 1.224 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 111.17 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.34 -30.54 48.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.202 0.525 . . . . 0.0 110.705 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -65.0 -27.23 41.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.813 178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.16 -16.76 16.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.732 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.2 -53.55 14.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.993 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.543 ' HB3' HD22 ' A' ' 19' ' ' LEU . 8.0 pm0 -128.11 -36.46 1.95 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.404 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 51' ' ' VAL . 60.5 t -60.38 -42.3 90.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -173.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.4 t-160 -54.3 -34.81 61.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.31 11.37 12.23 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.266 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.679 ' HG3' HG11 ' A' ' 15' ' ' VAL . 19.2 mm-40 -133.9 -25.54 1.61 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -135.9 -38.67 0.71 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.479 -0.488 . . . . 0.0 112.283 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.59 -18.04 65.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 111.107 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 t -72.32 -31.54 39.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.242 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -113.78 -82.63 0.6 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.75 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.4 117.58 9.62 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 4.6 Cg_exo -80.82 123.3 4.64 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.024 2.483 . . . . 0.0 112.378 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -78.65 -41.5 31.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.836 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.639 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 30.5 mtmt 63.5 -141.24 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.937 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t 63.78 30.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.054 0.542 . . . . 0.0 111.92 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.02 49.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.639 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 4.0 p90 -165.78 -48.39 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.855 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.721 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.5 67.29 3.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 111.132 -175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.768 ' HB2' ' HB3' ' A' ' 76' ' ' ALA . 7.6 pm0 -161.68 147.28 10.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.202 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.55 -60.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.359 2.039 . . . . 0.0 110.615 169.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.634 HG23 ' HG2' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -171.29 -41.48 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 121.814 0.816 . . . . 0.0 111.146 177.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.43 59.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.806 -164.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' HA ' ' CD1' ' A' ' 77' ' ' LEU . 3.2 mttp 52.41 19.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.041 0.537 . . . . 0.0 111.79 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.768 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -64.93 -21.87 66.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.047 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -62.06 -49.32 76.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.458 175.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -70.21 -45.71 66.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.587 -175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.741 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 3.5 pt20 -68.06 -18.69 64.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.092 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' CE1' ' HB2' ' A' ' 85' ' ' SER . 85.4 t80 -72.25 -52.57 15.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.621 177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -72.76 -26.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.49 59.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.6 m -99.91 -15.4 18.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.552 0.691 . . . . 0.0 109.312 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 68.48 42.9 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.409 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.569 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtm . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.71 0.291 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.75 -53.66 5.77 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.93 101.73 12.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.18 142.18 39.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.094 0.473 . . . . 0.0 111.413 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -75.95 79.73 2.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.953 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.53 -48.48 32.79 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.586 -177.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 3.9 mt-30 -102.9 -81.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.552 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 37.0 t80 59.4 99.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 124.209 0.943 . . . . 0.0 109.589 -171.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.659 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 65.65 127.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.488 1.115 . . . . 0.0 110.381 -168.067 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.87 103.57 20.14 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.421 -173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 71.7 Cg_endo -95.38 152.18 1.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.026 2.484 . . . . 0.0 111.973 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 m -116.57 -65.9 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.353 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -124.15 -75.98 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.456 176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.26 -54.82 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.926 0.393 . . . . 0.0 110.296 -177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.68 -38.98 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.404 0.621 . . . . 0.0 109.606 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -65.47 -43.96 88.66 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.969 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.7 OUTLIER -63.84 -41.15 97.89 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.686 179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 6.6 tptt -63.56 -33.74 76.26 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.349 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 54' ' ' GLN . 7.8 mt -70.76 -47.43 59.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.31 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.38 -41.46 39.29 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.401 0.438 . . . . 0.0 111.254 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -75.15 -40.66 59.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.184 179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm -125.05 69.02 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.916 0.389 . . . . 0.0 111.982 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.458 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -171.12 -43.89 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.685 171.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.939 ' HG2' HG12 ' A' ' 32' ' ' ILE . 0.2 OUTLIER 54.35 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.467 1.107 . . . . 0.0 111.555 175.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.533 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -105.68 -3.31 22.33 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.741 -175.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 49' ' ' MET . 0.3 OUTLIER 58.06 9.12 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.889 0.876 . . . . 0.0 112.908 -174.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.54 -57.35 0.28 Allowed 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.95 -0.469 . . . . 0.0 111.446 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.01 4.31 14.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.506 -174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.613 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 10.0 m 31.79 81.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.194 0.997 . . . . 0.0 113.69 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.91 64.98 0.13 Allowed 'General case' 0 C--O 1.236 0.345 0 O-C-N 122.155 -0.34 . . . . 0.0 111.895 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' HA3' HD21 ' A' ' 37' ' ' ASN . . . -157.44 -6.75 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.679 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.939 HG12 ' HG2' ' A' ' 24' ' ' GLU . 36.2 mm -53.83 118.71 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.042 0.448 . . . . 0.0 110.928 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.23 -154.24 6.91 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.429 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -69.49 -4.42 3.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -175.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 25.74 0.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.146 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 67.7 m-20 44.77 -125.46 1.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.382 -175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.578 HD21 ' HA3' ' A' ' 31' ' ' GLY . 14.2 m-80 -117.09 29.57 7.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 38.56 -95.57 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.119 0.887 . . . . 0.0 111.736 -175.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -129.53 43.61 3.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.291 0.567 . . . . 0.0 111.358 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.586 ' HB3' HG23 ' A' ' 73' ' ' THR . 4.2 pt20 -139.72 54.93 1.67 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.1 tt -110.99 -23.89 4.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.684 -167.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -154.93 59.07 0.39 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.975 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 173.79 -127.36 1.33 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.052 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 57.57 -28.51 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.77 1.628 . . . . 0.0 115.001 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.4 p -92.23 -70.32 0.7 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.963 0.801 . . . . 0.0 110.293 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.591 HD12 ' HB3' ' A' ' 48' ' ' ALA . 1.5 pp -102.5 -2.98 27.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.602 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 11.2 mmtp 51.85 66.86 1.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.593 0.558 . . . . 0.0 112.044 174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 176.12 -10.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.668 ' HB2' HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -58.03 -35.26 71.03 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.701 -178.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.09 -33.1 67.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.045 0.45 . . . . 0.0 110.473 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 66.5 t -64.09 -26.97 41.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.095 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.686 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -98.82 -16.45 18.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.87 -51.49 12.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.379 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -118.99 -48.28 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.949 0.404 . . . . 0.0 110.587 -176.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.643 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 65.5 t -55.12 -47.45 77.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.39 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 52.4 t60 -47.17 -43.46 21.19 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -121.63 3.74 10.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -171.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 -36.4 2.84 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 53.5 m-85 -118.03 -34.96 3.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -167.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -64.97 -13.62 57.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.445 0.64 . . . . 0.0 109.82 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.5 t -69.28 -35.23 66.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.622 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HG3' HD23 ' A' ' 63' ' ' LEU . 7.7 tp10 -124.03 -76.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.866 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -137.93 116.01 9.61 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.334 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 71.0 Cg_endo -86.77 113.25 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.665 2.244 . . . . 0.0 112.736 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD22 ' H ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.18 -59.17 2.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.627 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 51' ' ' VAL . 18.6 mtmt 68.12 -111.72 0.12 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.268 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 77' ' ' LEU . 0.9 OUTLIER 55.12 37.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.832 0.348 . . . . 0.0 111.337 -178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.682 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.4 pt? -165.53 42.86 0.07 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.761 0.791 . . . . 0.0 111.083 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.3 p90 -151.03 -48.6 0.12 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -171.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -95.92 61.56 2.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 0.0 111.09 -175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.508 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.7 pm0 -164.77 148.99 7.88 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 3.8 Cg_exo -77.12 -72.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.953 2.435 . . . . 0.0 110.956 172.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.586 HG23 ' HB3' ' A' ' 40' ' ' GLN . 0.1 OUTLIER -171.97 36.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.46 0.647 . . . . 0.0 110.729 178.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.72 -121.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -131.08 17.7 5.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -61.36 -37.6 83.94 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.198 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -56.41 -42.15 77.53 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 120.754 0.312 . . . . 0.0 111.672 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.551 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -68.24 -48.92 63.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.702 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' H ' ' HG2' ' A' ' 79' ' ' GLN . 1.1 pt20 -78.19 -4.23 46.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.375 -177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 13.3 t80 -82.11 -54.17 5.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.547 HG21 HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -69.11 -29.16 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.314 178.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.34 7.78 13.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.409 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -102.0 -43.97 5.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.879 0.371 . . . . 0.0 110.114 173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -11.38 59.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.027 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.82 -0.609 . . . . 0.0 109.687 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.78 153.78 20.52 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.508 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.99 111.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.234 0.54 . . . . 0.0 110.348 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.487 ' HB ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -88.93 110.01 20.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.267 179.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -67.73 -20.03 65.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.65 26.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.042 0.449 . . . . 0.0 111.472 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.487 ' HG2' ' HB ' ' A' ' 4' ' ' THR . 7.6 pt20 -163.59 -32.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.461 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.688 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 40.5 t80 -74.82 105.16 5.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.264 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 32' ' ' ILE . 7.0 m 29.03 70.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 124.576 1.173 . . . . 0.0 112.626 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -42.32 107.92 0.57 Allowed Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 115.112 -0.949 . . . . 0.0 112.261 -178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.458 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.9 Cg_exo -67.26 136.77 41.46 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.326 2.684 . . . . 0.0 112.289 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.533 ' HB ' ' ND2' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -94.13 -70.74 0.69 Allowed 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 120.782 0.325 . . . . 0.0 111.046 -176.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' A' ' 12' ' ' THR . 2.1 p30 -142.21 42.24 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -173.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 68.5 -51.23 0.56 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.955 0.502 . . . . 0.0 112.256 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.08 -53.58 41.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.222 0.534 . . . . 0.0 110.281 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -39.0 93.08 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.9 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.0 -46.01 92.5 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.843 0.354 . . . . 0.0 111.437 178.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.751 ' HE3' HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -64.45 -40.14 95.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.251 0.548 . . . . 0.0 110.53 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -40.77 96.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.117 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -54.39 -42.21 70.13 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.553 0.533 . . . . 0.0 111.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -77.3 -23.54 51.03 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.516 -178.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.751 HD11 ' HE3' ' A' ' 18' ' ' LYS . 1.5 mt -112.67 31.26 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -146.94 -34.7 0.26 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.603 170.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.4 tm-20 52.23 -89.75 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.215 1.006 . . . . 0.0 111.37 -174.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -107.91 -0.36 21.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.87 -177.076 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.623 HG13 ' HE2' ' A' ' 49' ' ' MET . 1.4 p 52.59 23.43 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.264 1.026 . . . . 0.0 112.552 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.441 HD21 ' HE2' ' A' ' 44' ' ' HIS . 0.5 OUTLIER -164.88 -55.09 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.512 176.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.96 -11.82 25.37 Favored Glycine 0 CA--C 1.506 -0.481 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.928 -174.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.564 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 15.4 m 36.09 74.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.436 ' N ' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.94 65.14 0.16 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.462 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -157.77 -52.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.168 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.793 HG23 HG11 ' A' ' 9' ' ' VAL . 1.7 mm -38.4 116.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 124.44 1.096 . . . . 0.0 112.56 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -155.27 -152.15 6.09 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.44 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -77.48 13.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 -177.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 ' HG ' HG12 ' A' ' 34' ' ' ILE . 12.9 mt -140.03 17.77 2.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.597 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER 66.36 -125.54 0.27 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.392 0.615 . . . . 0.0 109.529 177.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.507 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 2.9 t-20 -155.18 51.67 0.6 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.51 -106.69 0.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.659 -167.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.811 ' HD2' ' HA ' ' A' ' 73' ' ' THR . 0.1 OUTLIER -133.15 50.34 2.24 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.019 174.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.984 ' HB2' ' HB3' ' A' ' 44' ' ' HIS . 1.5 pt20 -143.96 63.38 1.34 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.866 0.841 . . . . 0.0 110.056 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.561 HG22 HD22 ' A' ' 68' ' ' LEU . 21.0 tt -96.61 -26.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.215 -175.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.866 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -118.12 -60.77 0.29 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.922 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -76.1 -87.18 0.32 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.196 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.984 ' HB3' ' HB2' ' A' ' 40' ' ' GLN . 3.4 p-80 62.46 -47.15 0.18 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.215 1.806 . . . . 0.0 113.762 172.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.1 p -90.41 -88.59 0.17 Allowed 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.93 5.78 24.18 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 176.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.9 mmtp 50.87 61.26 3.33 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 121.002 0.429 . . . . 0.0 111.519 176.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.649 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . -179.61 -13.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.679 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.623 ' HE2' HG13 ' A' ' 26' ' ' VAL . 3.6 mmm -52.6 -37.54 58.39 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.225 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -72.14 -34.91 68.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.046 0.45 . . . . 0.0 110.588 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 81.2 t -64.28 -23.51 33.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.362 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.709 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.65 -19.82 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.409 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -82.25 -49.15 10.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.621 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.29 -41.18 3.16 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.595 -175.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.952 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 98.7 t -63.13 -46.77 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.37 -177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.709 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 5.5 t-160 -54.43 -37.53 65.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -175.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.45 -2.18 14.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.4 mm-40 -138.92 -33.52 0.64 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.952 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 1.9 m-85 -110.72 -39.68 4.79 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.743 -167.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -64.42 -22.69 67.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.409 0.624 . . . . 0.0 109.608 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -29.76 47.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.345 177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 -80.74 0.56 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.209 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -144.35 114.95 5.32 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.824 -174.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' A' ' 66' ' ' LYS . 5.9 Cg_exo -79.6 130.0 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.094 2.529 . . . . 0.0 112.428 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.83 ' HB3' ' HE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -86.56 -41.38 14.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.342 178.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.596 ' HD2' ' HB2' ' A' ' 64' ' ' PRO . 1.3 mtpt 64.52 -137.31 0.27 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.971 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.728 ' H ' HG21 ' A' ' 81' ' ' VAL . 2.0 m 54.67 21.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.4 1.08 . . . . 0.0 111.39 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.671 ' HA ' HE22 ' A' ' 71' ' ' GLN . 2.3 mt -145.49 33.2 1.06 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.306 -170.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.501 ' HA ' ' H ' ' A' ' 43' ' ' GLY . 2.4 p90 -153.81 -50.29 0.09 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.119 -0.632 . . . . 0.0 112.299 -173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.036 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -88.84 46.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.066 0.46 . . . . 0.0 111.535 -172.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.671 HE22 ' HA ' ' A' ' 68' ' ' LEU . 8.9 pm0 -166.57 134.77 2.23 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.769 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.625 ' HD2' HG13 ' A' ' 74' ' ' ILE . 1.3 Cg_endo -87.8 -40.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.868 2.379 . . . . 0.0 111.644 170.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.811 ' HA ' ' HD2' ' A' ' 39' ' ' PHE . 7.7 t 177.92 45.71 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.699 1.238 . . . . 0.0 109.122 -177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.625 HG13 ' HD2' ' A' ' 72' ' ' PRO . 2.7 mt -121.08 174.15 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 113.437 -1.711 . . . . 0.0 107.311 175.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -80.93 17.82 1.13 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 173.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HA ' ' CG ' ' A' ' 79' ' ' GLN . . . -62.66 -29.74 70.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.485 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -53.77 -47.82 70.35 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.209 0.528 . . . . 0.0 110.462 177.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -74.41 -46.18 41.84 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.939 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.567 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -76.96 5.49 7.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.867 0.365 . . . . 0.0 111.76 -175.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -104.96 -62.71 1.31 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.992 0.425 . . . . 0.0 109.951 172.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.728 HG21 ' H ' ' A' ' 67' ' ' VAL . 6.9 t -78.68 -14.27 13.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.432 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -108.32 13.44 25.64 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.192 0.52 . . . . 0.0 110.671 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.0 m -126.41 -36.31 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.264 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.34 -13.19 17.43 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.049 177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 5.9 m . . . . . 0 C--O 1.249 1.038 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.263 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.6 135.48 2.12 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.033 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.669 HG13 HG23 ' A' ' 34' ' ' ILE . 49.1 t -122.38 101.82 10.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.81 109.34 1.21 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.265 0.555 . . . . 0.0 110.888 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.737 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 10.4 tt0 -72.55 68.49 0.82 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.337 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -120.02 -62.68 1.45 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.099 173.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -84.54 -12.36 54.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.626 173.711 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.737 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 10.3 t80 -72.26 124.97 26.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.042 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.552 ' HA ' ' CG ' ' A' ' 36' ' ' ASP . 2.8 t 55.37 50.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.697 -169.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -43.3 116.6 2.16 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 114.608 -1.178 . . . . 0.0 113.11 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 3.3 Cg_exo -75.89 141.32 24.03 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.153 2.569 . . . . 0.0 111.669 178.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -107.18 -73.95 0.67 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 120.61 0.243 . . . . 0.0 110.422 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -137.4 50.27 1.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.838 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.47 -68.87 0.11 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.38 0.672 . . . . 0.0 111.777 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 83.3 t -57.07 -47.87 82.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.411 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.523 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 1.1 mp0 -63.17 -35.84 81.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.392 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -65.7 -45.26 83.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.013 0.435 . . . . 0.0 110.932 179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 18' ' ' LYS . 18.6 mmmt -63.9 -36.98 85.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.529 0.681 . . . . 0.0 109.955 176.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -42.72 96.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.286 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -53.24 -43.77 67.6 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.415 0.447 . . . . 0.0 111.122 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 3.1 pt-20 -83.14 -10.83 58.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.224 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 22' ' ' ILE . 5.3 mm -97.37 -30.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.511 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -107.62 -26.09 11.03 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.294 -175.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 31' ' ' GLY . 0.7 OUTLIER 57.43 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.519 -175.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.482 ' HD2' ' H ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -117.34 -5.78 11.28 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.989 -178.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.64 -4.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.124 0.97 . . . . 0.0 112.972 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -139.48 -54.84 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 0.0 111.789 -177.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.7 -6.0 29.01 Favored Glycine 0 CA--C 1.504 -0.62 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.708 -175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.546 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 16.0 m 33.7 66.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.006 0.922 . . . . 0.0 113.149 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.482 ' H ' ' HD2' ' A' ' 25' ' ' ARG . 71.3 m -161.23 52.84 0.27 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.927 0.394 . . . . 0.0 111.745 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.578 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . -121.27 -37.27 0.7 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.454 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.538 HG12 ' HG2' ' A' ' 24' ' ' GLU . 10.9 mm -31.88 110.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.218 1.007 . . . . 0.0 112.343 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -78.65 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.624 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.669 HG23 HG13 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -133.03 -10.88 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.122 0.487 . . . . 0.0 110.548 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.588 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -164.51 42.97 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.585 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 54.2 m-20 36.56 -112.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.908 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.567 ' HB2' HD12 ' A' ' 41' ' ' ILE . 67.6 m-80 -119.74 23.32 11.18 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.32 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.424 1.077 . . . . 0.0 112.286 -177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.49 43.31 3.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.452 0.644 . . . . 0.0 110.514 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -152.17 61.13 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.026 173.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.567 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -110.14 -19.76 6.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.241 -172.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -158.92 97.01 0.16 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.731 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 45' ' ' SER . . . 126.78 -113.46 1.77 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.72 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 58.92 -21.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.453 1.501 . . . . 0.0 114.081 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.471 ' H ' ' C ' ' A' ' 43' ' ' GLY . 2.1 p -90.93 -89.35 0.17 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.2 -8.7 59.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.0 174.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.027 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER 61.4 72.71 0.5 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.759 179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -179.4 -12.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.138 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.407 ' HB2' ' N ' ' A' ' 43' ' ' GLY . 34.3 mmm -53.13 -39.75 63.73 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.65 -32.16 60.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.131 0.491 . . . . 0.0 110.552 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 1.1 t -62.23 -27.14 42.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.933 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -100.38 -18.1 16.91 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.785 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.28 -54.59 9.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.04 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' HG2' ' N ' ' A' ' 55' ' ' VAL . 2.5 pm0 -124.77 -36.6 2.56 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.471 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.861 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 67.4 t -60.66 -44.55 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.816 -177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.745 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.6 t60 -51.57 -46.21 63.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -127.87 9.67 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -170.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 3.1 mm-40 -131.49 -21.97 2.49 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.475 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.861 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m-85 -118.47 -28.53 5.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.815 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.5 -16.88 64.46 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.28 -36.13 70.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.014 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 63' ' ' LEU . 2.1 tp10 -125.52 -80.08 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.979 -174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -148.29 129.01 6.91 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.196 -178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -74.34 111.96 3.43 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.418 2.079 . . . . 0.0 112.28 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -43.71 30.68 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HE3' HG13 ' A' ' 81' ' ' VAL . 6.5 mtmt 62.45 -143.32 0.4 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.229 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.756 HG12 HD23 ' A' ' 77' ' ' LEU . 1.8 t 62.16 36.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.205 0.602 . . . . 0.0 111.475 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.51 54.53 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.725 0.298 . . . . 0.0 111.455 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.7 p90 -167.99 -46.11 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.296 -0.253 . . . . 0.0 111.619 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.027 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.4 56.36 3.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 111.397 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.671 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 4.1 pm0 -163.99 140.34 5.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.018 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 17.0 Cg_exo -68.79 -56.82 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.345 2.03 . . . . 0.0 110.931 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.1 t 173.26 46.62 0.0 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.883 0.849 . . . . 0.0 110.031 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.5 OUTLIER -120.39 -107.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -146.14 19.57 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.342 176.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.628 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.03 -33.71 76.37 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.761 -177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.756 HD23 HG12 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -55.06 -42.69 73.06 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.816 0.341 . . . . 0.0 111.385 178.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.605 ' N ' HD22 ' A' ' 77' ' ' LEU . . . -75.11 -43.57 52.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.627 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 6.75 17.32 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.833 -176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.628 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -103.63 -59.36 1.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.145 0.497 . . . . 0.0 109.848 175.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG21 ' H ' ' A' ' 67' ' ' VAL . 46.8 t -70.82 -30.5 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.114 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.47 -2.69 57.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.217 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 m -107.78 -36.63 6.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.966 0.412 . . . . 0.0 111.342 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 -33.42 8.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.938 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.514 -176.566 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mtp . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.37 -156.05 15.79 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.749 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.35 112.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 0.0 110.628 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.1 m -153.61 103.7 2.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.433 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.27 72.42 1.5 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.262 0.553 . . . . 0.0 110.592 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -11.58 59.95 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.644 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -83.8 -8.95 59.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.891 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 42.4 t80 -65.49 101.76 0.63 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.148 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 7.6 p 34.39 82.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 124.474 1.109 . . . . 0.0 112.662 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.86 107.36 20.15 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.964 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 9' ' ' VAL . 82.6 Cg_endo -96.55 -159.51 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.662 2.908 . . . . 0.0 112.422 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.86 -73.2 0.49 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.625 -176.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.95 150.86 22.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.59 -42.59 16.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.826 0.704 . . . . 0.0 112.603 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.25 -49.02 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.919 0.39 . . . . 0.0 110.498 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -43.8 70.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.548 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.459 ' HA ' ' CB ' ' A' ' 11' ' ' PRO . 11.0 m -51.76 -54.93 23.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 123.329 0.393 . . . . 0.0 111.968 175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' O ' HG12 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -63.22 -38.77 92.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 111.136 -175.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -67.48 -43.61 80.57 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.132 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -52.88 -41.01 63.96 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 123.577 0.548 . . . . 0.0 111.524 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 22' ' ' ILE . 5.7 pt-20 -80.39 -25.35 39.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.278 -178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.495 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 mm -115.05 30.3 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.635 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -134.64 -36.64 0.85 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.795 -0.566 . . . . 0.0 111.237 170.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.674 ' HA ' HG12 ' A' ' 32' ' ' ILE . 11.5 tt0 62.1 -71.19 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.349 1.06 . . . . 0.0 113.264 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.23 -5.04 7.84 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.24 -5.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 124.192 0.932 . . . . 0.0 112.827 -178.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.656 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -142.24 -51.31 0.39 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.911 0.386 . . . . 0.0 111.663 -177.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.9 3.04 24.33 Favored Glycine 0 CA--C 1.502 -0.749 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.694 -175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.647 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.2 OUTLIER 35.71 74.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 124.586 0.815 . . . . 0.0 112.163 -178.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.25 64.38 0.76 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.705 -173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.589 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . 168.13 61.58 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.513 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.674 HG12 ' HA ' ' A' ' 24' ' ' GLU . 3.5 mm -134.14 116.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 170.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.25 -144.47 4.33 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.971 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -76.68 19.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -175.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.75 26.97 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.916 175.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 32.36 -110.72 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.364 1.04 . . . . 0.0 112.446 -176.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 1.7 t-20 -148.32 36.37 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.47 -99.09 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.941 -1.027 . . . . 0.0 112.267 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.952 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.8 m-85 -122.66 37.53 4.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.018 0.437 . . . . 0.0 111.77 -174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.2 pt20 -147.73 60.0 1.13 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.522 0.677 . . . . 0.0 110.437 176.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 32' ' ' ILE . 1.7 tp -102.4 -34.66 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.733 -174.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -121.92 -68.27 0.25 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.073 -1.06 . . . . 0.0 112.82 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -74.33 -96.16 0.11 Allowed Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.289 -175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 62.13 -40.87 0.15 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.833 1.653 . . . . 0.0 113.949 174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -90.31 -82.06 0.28 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 12.2 tp -76.13 -10.59 59.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.939 175.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 6.2 mmtm 58.65 56.13 4.38 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.445 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.34 -8.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.918 -174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -57.82 -32.65 67.79 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.324 -178.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.865 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.77 -31.28 59.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.195 0.521 . . . . 0.0 110.176 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 94.7 t -69.42 -23.21 26.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.133 177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.42 -17.45 16.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.877 0.37 . . . . 0.0 110.895 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.83 -51.87 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.662 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.43 ' HB3' HD13 ' A' ' 19' ' ' LEU . 3.7 pt20 -121.93 -42.8 2.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.967 0.413 . . . . 0.0 110.679 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.758 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 45.1 t -59.04 -43.22 88.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.251 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 7.8 t-160 -43.98 -41.67 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.03 -17.89 10.23 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.05 -28.22 7.07 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -171.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.758 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 93.9 m-85 -115.51 -27.69 7.07 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.353 -171.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -59.82 -23.07 63.05 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 38.6 t -62.94 -35.48 71.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.909 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' HG3' HD23 ' A' ' 63' ' ' LEU . 3.7 tp10 -117.75 -78.33 0.58 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.751 -177.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -154.98 141.66 13.34 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.198 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.88 119.62 5.97 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.308 2.005 . . . . 0.0 111.582 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 65' ' ' LEU . 1.1 pt? -66.05 -37.8 86.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.157 -177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.531 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 8.5 mtmt 60.89 -159.55 0.32 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.284 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.3 t 66.2 21.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.403 0.681 . . . . 0.0 111.794 176.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.941 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.3 OUTLIER -164.0 47.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.389 0.614 . . . . 0.0 111.424 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.531 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.2 p90 -160.25 -45.97 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.196 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.855 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -89.33 47.24 1.46 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.121 0.486 . . . . 0.0 111.153 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.941 HE22 ' HA ' ' A' ' 68' ' ' LEU . 13.1 pm0 -159.82 140.1 8.73 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.08 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.535 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 2.9 Cg_exo -77.45 -39.37 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.763 2.309 . . . . 0.0 111.616 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.952 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 2.0 m 156.45 75.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.538 1.535 . . . . 0.0 108.043 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.484 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.7 OUTLIER -141.83 -117.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.491 175.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.484 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 16.2 ptmt -136.0 17.0 3.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 173.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.66 66.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.064 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.02 HD13 ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -55.71 -42.6 75.51 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.937 0.399 . . . . 0.0 110.42 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.735 ' H ' HD22 ' A' ' 77' ' ' LEU . . . -88.84 -31.33 18.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.108 0.48 . . . . 0.0 110.151 178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 0.25 9.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.96 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -109.93 -49.35 3.09 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.793 172.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -72.41 -21.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.712 -175.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -103.35 7.7 38.19 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 110.714 177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.46 HG22 ' HD2' ' A' ' 84' ' ' ARG . 92.1 m -119.1 -38.46 3.05 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.583 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' HD2' HG22 ' A' ' 83' ' ' THR . 1.7 mmm180 -117.16 -20.42 9.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.519 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 81' ' ' VAL . 75.7 m . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.956 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.94 72.07 2.88 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.112 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.97 158.26 3.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.742 HG23 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -143.3 140.48 30.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.2 0.524 . . . . 0.0 110.224 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -75.89 5.3 6.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.288 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.742 ' H ' HG23 ' A' ' 4' ' ' THR . . . -82.72 -16.64 47.29 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 174.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.594 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -122.57 -41.6 2.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.099 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 34' ' ' ILE . 29.2 t80 -69.79 111.05 5.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.537 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.589 HG21 HD13 ' A' ' 32' ' ' ILE . 7.1 p 39.09 58.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 122.345 1.069 . . . . 0.0 112.066 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.93 122.51 77.56 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.757 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.37 173.27 14.78 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.766 2.311 . . . . 0.0 112.081 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -107.07 -63.37 1.3 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.831 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.59 -76.76 0.44 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.097 -1.041 . . . . 0.0 113.144 169.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.72 -44.16 0.48 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -67.2 -41.04 86.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.628 176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -72.87 -36.68 67.43 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.96 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.82 -53.61 55.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 120.928 0.394 . . . . 0.0 110.457 176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.588 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -60.72 -39.51 88.87 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.178 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -70.72 -39.74 73.21 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.58 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.96 -43.31 73.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.741 0.305 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.66 -28.58 60.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.164 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.5 mm -86.03 -50.63 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.603 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -75.92 -33.55 59.89 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.141 -170.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.742 ' HB3' HG12 ' A' ' 29' ' ' VAL . 1.7 tp10 58.6 -64.64 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.049 0.94 . . . . 0.0 111.667 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.948 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -134.05 1.99 3.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 174.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 64.39 -5.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.651 1.18 . . . . 0.0 113.357 178.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.53 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -145.52 -56.58 0.31 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.961 0.41 . . . . 0.0 111.051 -178.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.96 6.15 32.59 Favored Glycine 0 CA--C 1.501 -0.816 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.566 -173.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.742 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 38.73 70.1 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 124.594 0.82 . . . . 0.0 112.518 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.948 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -160.15 60.58 0.35 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.767 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -126.88 -17.83 2.22 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.921 -170.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -81.55 87.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 117.492 0.646 . . . . 0.0 110.834 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -119.23 -159.01 10.86 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.539 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -73.48 -2.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.286 0.565 . . . . 0.0 111.75 -175.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -164.84 51.98 0.12 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.842 177.207 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' HB2' ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER 49.02 -128.75 2.02 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.604 -174.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.767 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -115.46 46.82 1.42 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 43.99 -97.46 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.328 1.017 . . . . 0.0 110.809 -175.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.758 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 11.0 m-85 -129.38 47.93 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.817 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -168.32 53.53 0.05 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.6 tt -93.52 -29.84 4.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.285 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.05 44.46 0.85 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.494 -173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -162.65 -112.93 0.29 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 61.08 -52.19 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.892 1.677 . . . . 0.0 114.031 171.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.3 p -88.51 -75.75 0.42 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.603 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 14.3 tp -80.74 -16.77 53.01 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.012 176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.681 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 5.8 mmtm 53.46 61.42 3.13 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.52 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 177.89 -1.46 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.081 -173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -60.2 -35.56 75.68 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.698 -179.092 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.55 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 110.317 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 2.9 t -63.93 -26.97 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.04 176.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.17 -23.19 16.85 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.972 0.415 . . . . 0.0 110.464 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.51 -50.7 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.324 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.564 ' HB3' HD13 ' A' ' 19' ' ' LEU . 7.0 pm0 -122.77 -43.7 2.24 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.118 -178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 95.3 t -57.42 -43.63 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.429 -173.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.611 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.5 t60 -49.63 -33.88 16.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -128.86 18.22 6.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 4.2 mm-40 -139.11 -46.54 0.47 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.088 0.47 . . . . 0.0 111.797 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.51 ' HB3' ' HA ' ' A' ' 64' ' ' PRO . 62.0 m-85 -113.95 -15.48 12.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.991 0.424 . . . . 0.0 111.538 -168.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.94 -12.81 58.2 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.75 -30.59 5.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.969 175.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -114.72 -78.96 0.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.961 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -159.96 121.79 1.81 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.692 -177.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 11.2 Cg_exo -70.48 130.7 18.88 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.75 2.3 . . . . 0.0 112.539 -176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -74.08 -63.16 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.144 177.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.627 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 2.7 mtmp? 82.44 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.406 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.9 m 45.01 33.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 112.239 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.566 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.5 OUTLIER -151.94 25.49 0.64 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.23 -173.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.543 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.1 p90 -165.6 -49.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.005 -172.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.681 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -91.35 56.7 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.47 . . . . 0.0 111.529 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 13.1 pm0 -151.35 147.16 19.87 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.352 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.544 ' O ' HG23 ' A' ' 73' ' ' THR . 3.4 Cg_exo -78.04 -72.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.011 2.474 . . . . 0.0 111.521 174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.758 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -172.72 35.68 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.538 0.524 . . . . 0.0 112.189 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.7 HG22 ' HD2' ' A' ' 75' ' ' LYS . 2.9 mp -137.87 -89.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.006 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.7 ' HD2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -145.38 18.56 1.54 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -174.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.58 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.49 -28.03 68.25 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.198 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.744 HD21 ' HD1' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -51.42 -49.03 62.45 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.201 174.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.89 -37.12 67.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.709 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -0.73 16.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.349 0.595 . . . . 0.0 111.18 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -104.71 -50.95 3.17 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.411 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.3 OUTLIER -72.12 -26.92 25.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.376 -176.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.5 10.57 31.92 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.917 0.389 . . . . 0.0 110.687 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.4 m -117.9 -36.23 3.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -141.44 52.88 1.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.268 0.556 . . . . 0.0 111.135 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 54.9 m . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.493 -0.765 . . . . 0.0 109.707 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.581 0.229 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.65 -122.79 6.0 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.389 -176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.3 t 57.22 41.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.521 0.676 . . . . 0.0 110.821 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -58.44 3.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.18 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 36.75 48.52 0.66 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.008 -1.451 . . . . 0.0 113.777 172.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.93 -30.01 20.4 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.26 0.553 . . . . 0.0 110.345 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -102.3 -11.41 18.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.566 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 41.7 t80 -61.83 121.99 14.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 26.6 m 31.95 54.42 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 124.334 1.021 . . . . 0.0 112.143 -172.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.4 127.46 57.59 Favored Pre-proline 0 N--CA 1.454 -0.258 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.091 -175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.624 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 3.7 Cg_exo -75.29 130.08 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.335 2.69 . . . . 0.0 111.678 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 -68.06 0.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.458 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.45 67.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.695 0.283 . . . . 0.0 111.049 -174.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.26 -72.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.583 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.84 -48.61 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.272 0.558 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -69.41 -39.27 78.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.286 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.624 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -64.7 -46.67 81.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.93 0.395 . . . . 0.0 111.591 -178.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -32.66 74.23 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.74 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -75.11 -49.65 18.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.41 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -39.14 41.4 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 123.53 0.519 . . . . 0.0 111.582 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.772 ' HG3' HG12 ' A' ' 22' ' ' ILE . 2.3 pt-20 -82.62 -28.67 30.62 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.704 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.772 HG12 ' HG3' ' A' ' 21' ' ' GLU . 10.7 mm -122.17 61.32 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.587 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -155.11 -42.22 0.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.112 163.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.838 ' HA ' HG12 ' A' ' 32' ' ' ILE . 1.9 tp10 63.58 -62.38 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.196 0.998 . . . . 0.0 112.924 176.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.801 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -139.19 6.9 2.39 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.051 -0.406 . . . . 0.0 109.949 171.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.456 HG13 HD23 ' A' ' 27' ' ' LEU . 0.6 OUTLIER 56.65 18.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.274 1.03 . . . . 0.0 113.106 176.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -177.43 -51.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.101 0.477 . . . . 0.0 111.253 -179.113 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.11 37.3 Favored Glycine 0 CA--C 1.501 -0.814 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 32.69 76.22 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.297 1.039 . . . . 0.0 113.406 177.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.801 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -176.21 74.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.794 177.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.58 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -164.14 7.48 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.584 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.838 HG12 ' HA ' ' A' ' 24' ' ' GLU . 1.3 mm -82.1 127.19 39.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.376 0.588 . . . . 0.0 110.273 178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -148.14 -162.17 9.98 Favored Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.83 10.56 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 122.538 0.335 . . . . 0.0 111.761 -177.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -166.43 35.53 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.658 ' HB3' HD13 ' A' ' 41' ' ' ILE . 1.5 m-20 58.42 -135.24 0.97 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.892 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.715 ' HB2' HD12 ' A' ' 41' ' ' ILE . 1.4 t-20 -114.34 46.94 1.28 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 42.19 -94.19 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.248 0.967 . . . . 0.0 111.727 -179.252 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.999 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.7 OUTLIER -127.99 43.42 3.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.046 0.451 . . . . 0.0 111.142 -176.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.469 HE21 ' HE2' ' A' ' 38' ' ' PHE . 0.6 OUTLIER -163.03 63.65 0.19 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.971 -179.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.715 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -119.5 -11.69 10.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.033 -174.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -167.28 93.01 0.1 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.899 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 152.63 -107.46 0.33 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.663 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.2 m80 73.97 -57.48 0.62 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.963 0.905 . . . . 0.0 112.4 171.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -82.83 -80.12 0.18 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.411 0.624 . . . . 0.0 110.169 -169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.57 1.22 57.29 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.23 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.866 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER 54.12 70.2 0.63 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 123.324 0.39 . . . . 0.0 110.47 178.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -177.17 -4.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.296 -173.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 41.2 mmm -56.17 -38.13 70.49 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.901 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 54' ' ' GLN . . . -78.59 -31.33 47.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.069 0.461 . . . . 0.0 110.498 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 98.5 t -62.57 -29.16 46.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.054 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -94.01 -17.93 22.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.67 -51.22 13.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.5 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -115.63 -53.22 2.6 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.651 -177.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.876 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 37.7 t -53.76 -47.33 62.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.646 -173.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.2 t60 -36.95 -52.72 0.95 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 5.71 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -173.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 5.1 mm-40 -124.28 -10.24 7.52 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.92 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.876 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.7 m-85 -140.0 -33.75 0.57 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.489 -0.485 . . . . 0.0 111.771 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.871 ' HG2' HG12 ' A' ' 55' ' ' VAL . 4.1 mm100 -61.47 -26.77 68.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.091 0.472 . . . . 0.0 110.618 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -66.56 -36.19 76.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.024 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -77.22 0.58 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.24 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.02 112.62 3.33 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.638 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 59' ' ' TYR . 15.0 Cg_exo -68.02 128.51 17.81 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.987 2.458 . . . . 0.0 112.468 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -56.98 2.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 64' ' ' PRO . 42.0 mttt 63.84 -123.57 0.53 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.745 0.418 . . . . 0.0 111.053 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG22 HG21 ' A' ' 81' ' ' VAL . 2.0 t 62.81 28.28 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.309 0.644 . . . . 0.0 111.842 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.07 68.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.818 0.342 . . . . 0.0 110.9 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.1 p90 -163.36 -48.21 0.03 OUTLIER 'General case' 0 C--O 1.24 0.565 0 CA-C-O 120.788 0.327 . . . . 0.0 111.443 -174.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.866 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -101.37 62.7 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.394 -173.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.2 pm0 -167.35 136.98 2.26 Favored Pre-proline 0 C--O 1.235 0.327 0 CA-C-O 121.184 0.516 . . . . 0.0 111.47 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 96.2 Cg_endo -94.42 59.57 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.493 2.795 . . . . 0.0 111.944 172.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.999 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER 56.84 62.57 2.21 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 175.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.1 mm -138.0 -86.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.2 13.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.792 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -66.91 -26.06 66.68 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.367 -175.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.595 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -57.29 -44.64 84.25 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.985 0.421 . . . . 0.0 111.054 177.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.595 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.58 -50.56 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.736 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.95 5.0 7.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.761 -177.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.705 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -97.4 -58.34 2.03 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 173.232 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.901 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 1.2 t -67.44 -33.65 63.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.827 -174.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.1 -8.27 59.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.772 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -112.9 -32.27 6.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.673 0.273 . . . . 0.0 111.654 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 80' ' ' TYR . 3.8 ptp180 -147.13 -12.6 0.42 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -176.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.901 ' HA ' ' HA ' ' A' ' 81' ' ' VAL . 70.1 m . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.87 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.48 84.55 0.75 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.676 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.57 130.56 68.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.34 126.38 53.33 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.549 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 2.5 pm0 -94.32 34.71 1.25 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.148 -174.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.62 47.36 0.72 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.304 0.573 . . . . 0.0 111.156 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' A' ' 7' ' ' GLN . 0.0 OUTLIER -177.5 -24.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.738 -179.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.549 ' CD1' ' HB2' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -61.23 133.38 55.86 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.167 -178.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 8' ' ' TYR . 1.2 m 61.43 -21.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 125.37 1.468 . . . . 0.0 113.593 -172.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 8' ' ' TYR . . . 56.21 73.87 0.77 Allowed Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 123.053 0.541 . . . . 0.0 111.882 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.784 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 32.0 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.106 2.538 . . . . 0.0 112.34 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.84 -70.16 0.76 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 121.271 -0.172 . . . . 0.0 110.834 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -120.54 -60.67 1.65 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.561 -0.855 . . . . 0.0 112.125 179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 179.85 -42.48 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 72.6 t -69.16 -44.26 80.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.28 -1.327 . . . . 0.0 108.44 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -70.4 -46.33 64.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.91 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.784 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -56.48 -51.39 68.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.482 179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.3 tttt -60.91 -46.39 90.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.939 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -36.43 79.94 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 -176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.0 -44.91 79.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 1.3 pt-20 -84.48 -4.33 58.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.018 -178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 22' ' ' ILE . 6.4 mm -99.33 -44.38 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.078 0.465 . . . . 0.0 112.204 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' HD1' ' H ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -85.31 -31.69 22.9 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.075 -172.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.488 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 2.0 tt0 62.26 -62.22 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.3 1.04 . . . . 0.0 112.115 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.463 ' O ' HG12 ' A' ' 26' ' ' VAL . 6.2 mtt180 -135.78 -7.41 2.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.179 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.61 HG21 ' HB1' ' A' ' 53' ' ' ALA . 0.3 OUTLIER 61.02 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.211 1.004 . . . . 0.0 113.314 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.28 -54.17 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.871 0.367 . . . . 0.0 110.789 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.63 -12.76 29.67 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.474 -0.869 . . . . 0.0 111.133 -176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.451 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 42.73 59.27 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 123.358 0.663 . . . . 0.0 111.807 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' N ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -163.24 65.67 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -156.75 -1.88 0.1 OUTLIER Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.146 -1.026 . . . . 0.0 114.323 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.441 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 4.0 mt -69.8 131.39 34.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 117.726 0.763 . . . . 0.0 110.539 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.93 -154.06 7.36 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.711 -0.555 . . . . 0.0 111.711 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.516 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -77.06 -3.31 5.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.106 0.479 . . . . 0.0 111.177 -176.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.67 24.47 0.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 1.5 m-20 39.96 -108.69 0.08 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 114.194 -1.367 . . . . 0.0 113.047 -175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.764 HD22 HD12 ' A' ' 41' ' ' ILE . 33.8 m-80 -122.29 28.0 7.67 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.94 -171.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.32 -96.49 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.087 0.867 . . . . 0.0 111.99 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.842 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.6 OUTLIER -117.49 36.25 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.267 0.556 . . . . 0.0 111.314 -175.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -154.25 59.67 0.71 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.082 177.619 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 HD22 ' A' ' 37' ' ' ASN . 1.1 tt -99.44 -37.3 5.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.405 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -148.45 81.63 0.2 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.902 -177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.751 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 151.43 -116.74 0.78 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.233 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 58.79 -29.69 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.424 1.49 . . . . 0.0 113.825 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.7 p -87.56 -88.77 0.13 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -84.11 -0.91 53.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.317 176.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER 53.61 68.95 0.77 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.035 177.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.659 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.13 -5.81 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.263 -173.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.751 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 5.0 mtp -54.92 -41.02 70.48 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.283 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.81 -32.23 52.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.224 0.535 . . . . 0.0 110.719 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 2.2 t -62.08 -26.99 41.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.023 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.667 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.09 -13.03 15.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 26' ' ' VAL . . . -71.15 -56.88 5.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.017 0.437 . . . . 0.0 110.896 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.618 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 7.1 pm0 -125.98 -42.12 1.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 -178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.96 HG12 ' HB2' ' A' ' 60' ' ' GLN . 95.0 t -52.85 -42.75 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.871 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.667 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 18.3 t-160 -38.2 -52.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.304 1.003 . . . . 0.0 113.035 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.86 -0.92 16.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.933 0.397 . . . . 0.0 111.463 -173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 1.0 OUTLIER -104.3 -42.63 5.43 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.65 -173.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . 6.4 m-85 -146.16 -22.77 0.44 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -169.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.96 ' HB2' HG12 ' A' ' 55' ' ' VAL . 3.5 tp60 -66.66 -13.28 61.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.084 0.469 . . . . 0.0 110.344 177.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.23 -32.36 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.142 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.654 ' HG2' ' HG ' ' A' ' 63' ' ' LEU . 3.0 tt0 -130.4 -76.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.654 ' HG ' ' HG2' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -152.19 101.35 2.81 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-O 121.035 0.445 . . . . 0.0 111.636 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.515 ' HB3' HG13 ' A' ' 55' ' ' VAL . 92.2 Cg_endo -86.0 160.39 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.807 2.338 . . . . 0.0 112.698 176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -77.69 -40.03 42.78 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.4 mttt 63.0 -132.19 0.47 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.475 ' CG1' ' HB2' ' A' ' 77' ' ' LEU . 3.2 t 61.03 37.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.999 0.428 . . . . 0.0 111.21 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.7 pt? -161.54 40.75 0.14 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.312 0.577 . . . . 0.0 112.283 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -157.91 -49.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.776 -0.577 . . . . 0.0 112.121 -174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -98.69 75.21 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.934 0.397 . . . . 0.0 111.34 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.499 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 5.6 pm0 -162.22 137.01 5.24 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.154 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -87.4 53.88 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.097 2.531 . . . . 0.0 111.478 173.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.842 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER 50.99 53.98 12.06 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.768 0.827 . . . . 0.0 112.906 -178.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 8.1 mt -135.48 -108.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 6.4 pttt -135.3 11.67 3.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.174 0.512 . . . . 0.0 110.291 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -64.74 -27.48 68.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.582 -173.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -56.08 -49.11 74.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.343 0.592 . . . . 0.0 110.51 176.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.68 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.37 -38.14 56.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.195 -176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.17 -30.41 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.096 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -72.77 -48.69 36.15 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.226 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -68.87 -31.27 49.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.25 62.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.545 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.9 m -62.3 -49.7 74.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.73 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -79.25 -25.38 42.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.79 176.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 73.0 m . . . . . 0 C--O 1.243 0.755 0 O-C-N 124.071 0.857 . . . . 0.0 111.431 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 120.843 0.354 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.1 125.41 1.68 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.551 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.75 28.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 122.198 0.999 . . . . 0.0 108.864 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.95 91.86 4.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.765 -173.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -97.47 79.62 2.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.188 176.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.44 -27.06 38.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.224 0.535 . . . . 0.0 110.782 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 15.3 pm0 -76.34 -13.65 60.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.755 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.567 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -62.23 121.7 13.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.356 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' CG2' HG23 ' A' ' 32' ' ' ILE . 75.8 t 67.56 124.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.489 0.662 . . . . 0.0 111.663 -175.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.05 15.93 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 17' ' ' SER . 2.8 Cg_exo -76.85 -170.04 0.83 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.361 2.707 . . . . 0.0 112.508 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.408 ' HB ' ' OE1' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -117.56 -73.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 111.064 -177.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -114.63 -101.11 0.43 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.454 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.36 -49.15 0.92 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.9 t -61.3 -43.44 96.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.829 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' OE1' ' HB ' ' A' ' 12' ' ' THR . 0.2 OUTLIER -60.57 -45.99 91.88 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.115 178.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.552 ' HA ' ' HB3' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -57.87 -47.83 81.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.325 178.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -61.99 -44.92 95.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.609 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.62 -40.0 93.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.252 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -56.52 -39.57 73.58 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 123.423 0.452 . . . . 0.0 111.291 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 17.3 pt-20 -82.17 -17.66 45.5 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.254 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 18' ' ' LYS . 16.5 mt -93.61 -39.39 10.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 121.0 0.428 . . . . 0.0 112.11 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.638 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -89.74 -31.16 17.57 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 -177.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.668 ' HG3' ' H ' ' A' ' 31' ' ' GLY . 1.0 OUTLIER 57.22 -64.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.881 1.273 . . . . 0.0 113.066 -178.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.851 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -133.66 0.59 3.29 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.387 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 66.05 -8.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.999 . . . . 0.0 113.544 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -139.65 -57.93 0.57 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.027 0.441 . . . . 0.0 111.449 -177.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.54 13.46 22.97 Favored Glycine 0 CA--C 1.504 -0.623 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -176.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.667 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 4.6 m 32.46 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.264 1.026 . . . . 0.0 113.255 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.851 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 47.4 m -151.15 58.81 0.91 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.209 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.668 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -116.72 -27.79 2.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.218 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.5 HG23 ' CG2' ' A' ' 9' ' ' VAL . 36.8 mm -72.42 98.93 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.152 0.501 . . . . 0.0 110.138 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -133.55 -155.09 7.59 Favored Glycine 0 N--CA 1.439 -1.124 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.529 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 1.2 pt -67.66 -12.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 123.434 0.693 . . . . 0.0 111.937 -171.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -160.0 43.21 0.21 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.852 177.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 66.82 -151.22 0.2 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.721 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.52 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -108.05 18.68 20.91 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 41.55 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.615 1.197 . . . . 0.0 112.152 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB3' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -128.58 43.24 3.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.026 0.441 . . . . 0.0 110.955 -177.296 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.623 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -160.72 67.19 0.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.462 177.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.36 -33.32 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -117.6 -66.32 0.34 Allowed Glycine 0 C--O 1.223 -0.54 0 C-N-CA 120.183 -1.008 . . . . 0.0 114.179 -174.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 69' ' ' PHE . . . -77.84 -100.67 0.19 Allowed Glycine 0 C--O 1.224 -0.505 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.706 -170.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 66.65 -50.17 0.45 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.001 1.32 . . . . 0.0 112.649 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.4 p -75.08 -82.43 0.07 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.125 0.488 . . . . 0.0 110.135 -172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -90.08 4.13 51.25 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.539 172.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.658 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 20.4 mmtm 53.09 58.82 4.92 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.101 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 46' ' ' LEU . . . 178.56 -3.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.929 -172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.3 mmm -54.48 -35.57 63.2 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.049 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -77.24 -27.85 53.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.488 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 24.6 t -64.78 -29.0 46.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.368 0.604 . . . . 0.0 109.618 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -96.83 -21.74 17.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.68 -46.77 15.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -117.9 -42.98 2.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -175.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 85.9 t -62.04 -56.29 18.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.534 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 11.6 t-160 -38.1 -45.97 0.98 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -174.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.04 4.42 8.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 79.8 mm-40 -131.91 -31.05 1.54 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.654 -176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.8 m-85 -121.79 -19.54 6.73 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.139 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.425 ' HG2' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -67.7 -14.29 62.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.531 0.682 . . . . 0.0 109.195 169.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.4 t -62.29 -32.1 53.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.649 172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -132.72 -82.73 0.48 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.762 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.23 123.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.349 -178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 141.42 18.9 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.711 2.274 . . . . 0.0 112.87 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -86.72 -20.45 27.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.51 177.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.502 ' HB3' ' HE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 61.13 -131.83 0.73 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.477 175.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.614 ' H ' HG21 ' A' ' 81' ' ' VAL . 3.5 m 53.95 26.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.639 1.176 . . . . 0.0 113.335 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.885 ' HA ' HE22 ' A' ' 71' ' ' GLN . 0.6 OUTLIER -153.22 40.85 0.54 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.974 0.416 . . . . 0.0 111.849 177.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.502 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 2.9 p90 -153.68 -44.58 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.75 35.65 1.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.062 0.458 . . . . 0.0 111.476 -173.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.885 HE22 ' HA ' ' A' ' 68' ' ' LEU . 16.7 pm0 -141.45 134.89 14.51 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.608 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 47.9 Cg_endo -76.04 -42.66 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.2 1.933 . . . . 0.0 111.946 174.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.5 t 168.88 52.73 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.585 0 CA-C-O 122.931 1.348 . . . . 0.0 109.193 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 76' ' ' ALA . 0.6 OUTLIER -136.75 175.61 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 CA-C-N 113.591 -1.64 . . . . 0.0 107.693 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.495 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -74.38 19.27 0.13 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.706 174.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -64.83 -18.83 65.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.275 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -51.89 -46.26 64.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.218 0.532 . . . . 0.0 110.241 173.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.651 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -88.42 -28.44 20.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 -178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 7.98 18.31 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.094 0.473 . . . . 0.0 111.263 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -120.74 -48.09 2.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.741 174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.614 HG21 ' H ' ' A' ' 67' ' ' VAL . 97.6 t -82.01 -22.38 9.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.302 -176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -113.48 21.23 15.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.197 0.523 . . . . 0.0 110.113 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.0 m -137.75 -32.48 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.197 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -125.73 -64.65 1.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.463 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.503 ' OXT' ' HA ' ' A' ' 81' ' ' VAL . 15.3 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.747 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.35 125.17 8.27 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.441 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.45 106.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.27 164.23 14.54 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.005 -173.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.76 94.76 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.62 -83.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.206 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -108.62 -48.26 3.35 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.917 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 2.2 t80 48.04 78.4 0.08 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.447 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 HG23 HD12 ' A' ' 32' ' ' ILE . 0.5 OUTLIER 72.42 132.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.81 0.814 . . . . 0.0 111.525 -178.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.5 103.61 41.0 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.973 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.57 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 14.9 Cg_exo -70.04 157.89 58.36 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.913 2.409 . . . . 0.0 111.79 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.74 -64.88 1.13 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.75 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.474 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 63.6 m-80 -126.56 -81.36 0.61 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.857 0.36 . . . . 0.0 111.292 174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.71 -54.6 0.25 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.301 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -61.81 -38.1 79.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.82 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 21.2 mp0 -66.96 -45.01 79.07 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.142 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.49 -49.07 78.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.164 0.507 . . . . 0.0 110.945 179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -45.25 93.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.861 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -45.88 79.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.138 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.6 -39.69 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.588 0.555 . . . . 0.0 111.742 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.539 ' HG3' HG13 ' A' ' 22' ' ' ILE . 15.7 pt-20 -83.34 -27.76 29.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.326 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.539 HG13 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -115.04 24.1 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 119.772 -0.771 . . . . 0.0 113.047 -177.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -132.65 -48.31 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.123 -0.36 . . . . 0.0 110.667 172.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.617 ' HB3' ' HA ' ' A' ' 29' ' ' VAL . 1.1 tm-20 51.76 -91.16 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.28 1.032 . . . . 0.0 111.443 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.544 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 1.6 mtt85 -103.31 -4.88 23.63 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.246 -175.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.53 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.72 15.71 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 123.908 0.755 . . . . 0.0 112.071 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -147.49 -57.4 0.25 Allowed 'General case' 0 C--O 1.23 0.048 0 O-C-N 122.03 -0.419 . . . . 0.0 111.468 179.168 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -129.07 9.86 6.28 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.14 -1.028 . . . . 0.0 112.836 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.617 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 19.8 m 34.34 72.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 0.0 113.156 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.04 59.01 1.24 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.942 0.401 . . . . 0.0 111.144 -172.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.615 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -149.47 -52.4 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.986 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.629 HD12 HG23 ' A' ' 9' ' ' VAL . 14.4 mm -48.72 111.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.341 0.591 . . . . 0.0 111.675 178.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -133.25 -118.0 1.87 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.455 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 -1.88 9.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.207 0.527 . . . . 0.0 110.257 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.2 40.93 0.88 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.412 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 4.9 m-20 59.7 -136.22 0.76 Allowed 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.43 179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.615 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 7.7 t-20 -128.41 37.11 4.18 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 175.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.798 ' HE2' HE21 ' A' ' 40' ' ' GLN . 0.0 OUTLIER 39.2 -100.92 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.526 -174.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.998 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 1.5 m-85 -128.46 43.13 3.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.139 0.495 . . . . 0.0 111.254 -176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.798 HE21 ' HE2' ' A' ' 38' ' ' PHE . 1.3 pt20 -151.36 64.35 0.89 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.458 0.646 . . . . 0.0 110.123 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 41' ' ' ILE . 1.3 tp -120.92 -11.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 122.161 0.981 . . . . 0.0 108.771 -175.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.789 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -163.12 125.68 1.43 Allowed Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . 109.12 -96.78 1.01 Allowed Glycine 0 C--N 1.303 -1.276 0 CA-C-N 115.237 -0.481 . . . . 0.0 111.937 170.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.8 m80 79.99 -65.09 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.882 0.873 . . . . 0.0 111.882 169.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 p -94.14 -76.57 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -79.92 -4.14 51.08 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.105 177.453 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.981 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 mmtp 53.5 64.22 1.92 Allowed 'General case' 0 C--N 1.344 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 110.915 176.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 178.19 1.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.256 -172.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.476 ' H ' ' HA2' ' A' ' 43' ' ' GLY . 0.4 OUTLIER -57.09 -35.52 69.51 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 120.812 0.339 . . . . 0.0 110.643 177.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.14 -31.74 62.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.47 0.652 . . . . 0.0 110.265 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.6 t -65.7 -24.13 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.165 177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.13 -11.26 17.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.064 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.62 -50.27 8.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.823 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -121.65 -30.73 4.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.093 0.473 . . . . 0.0 111.588 -175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 12.2 t -73.17 -38.56 55.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 22.6 t-160 -35.2 -56.48 0.6 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.473 1.108 . . . . 0.0 113.371 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -138.66 14.55 2.72 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.191 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.2 -29.12 4.93 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.475 178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.664 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -123.45 -27.06 4.13 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.504 -173.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -63.54 -16.75 61.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.328 0.585 . . . . 0.0 109.871 172.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.1 t -67.13 -32.41 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.835 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.51 -76.14 0.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.324 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.9 135.51 11.05 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.704 0.288 . . . . 0.0 110.742 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.448 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 62.1 Cg_endo -75.74 119.48 5.45 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.62 2.213 . . . . 0.0 112.314 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -49.67 12.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.194 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 12.9 mttt 60.52 -137.77 0.63 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 122.918 0.487 . . . . 0.0 111.48 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.501 HG22 HG11 ' A' ' 81' ' ' VAL . 1.7 t 62.71 26.41 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.626 0.77 . . . . 0.0 112.025 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -175.4 62.15 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.982 0.42 . . . . 0.0 111.494 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.789 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 p90 -158.6 -49.18 0.06 Allowed 'General case' 0 C--O 1.242 0.662 0 CA-C-O 120.916 0.388 . . . . 0.0 111.97 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.981 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.18 63.7 2.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.735 -173.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 76' ' ' ALA . 2.7 pm0 -170.87 138.79 1.24 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.996 0.427 . . . . 0.0 111.769 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 84.5 Cg_endo -99.6 52.85 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 123.749 2.966 . . . . 0.0 111.882 171.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.998 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 1.1 m 67.64 66.64 0.38 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.145 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 7.2 mt -134.55 -102.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 172.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.8 OUTLIER -151.78 17.09 0.69 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.407 0.622 . . . . 0.0 110.048 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 71' ' ' GLN . . . -69.63 -32.63 71.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.242 -171.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.649 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.08 -45.88 75.43 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.027 0.442 . . . . 0.0 110.866 178.771 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.649 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -76.49 -50.74 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.848 -176.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -66.71 -13.56 61.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.108 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -89.82 -56.55 3.19 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 120.962 0.411 . . . . 0.0 109.934 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG11 HG22 ' A' ' 67' ' ' VAL . 77.0 t -70.56 -33.46 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 -175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.93 -18.36 63.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.164 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.0 m -93.12 -38.61 11.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.957 0.408 . . . . 0.0 110.542 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 7.8 mmt180 -83.31 -29.84 28.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.702 -176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.531 -179.162 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 136.14 -66.37 0.55 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.617 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG11 HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -140.32 -179.4 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.34 -15.86 58.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.808 0.337 . . . . 0.0 110.368 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 79.05 -11.92 1.15 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.793 0.837 . . . . 0.0 112.502 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -69.31 -22.0 63.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.974 0.416 . . . . 0.0 110.998 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.14 -6.95 22.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.538 0.685 . . . . 0.0 110.803 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -79.53 129.04 34.1 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.03 -173.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.6 ' HA ' HG23 ' A' ' 32' ' ' ILE . 59.9 t 76.71 -85.06 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.52 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 9' ' ' VAL . . . 159.87 71.68 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 124.232 0.958 . . . . 0.0 111.618 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 8.1 Cg_exo -72.96 109.24 2.77 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.035 1.823 . . . . 0.0 111.568 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -113.3 -74.71 0.62 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -177.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -141.22 38.74 1.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 71.92 -57.42 0.62 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.394 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 t -62.52 -48.97 85.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.7 OUTLIER -64.43 -44.45 91.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.011 179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -61.83 -43.4 98.92 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.422 -178.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.621 ' O ' HG13 ' A' ' 22' ' ' ILE . 6.1 ttpp -62.66 -50.53 70.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.007 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.614 ' HA ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -57.39 -43.19 83.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.653 -178.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -54.15 -40.17 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.677 0.61 . . . . 0.0 111.477 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 0.5 OUTLIER -73.31 -25.49 60.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.468 -178.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -87.4 -39.11 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.598 ' NE1' ' HA ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -95.17 -36.27 11.54 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.5 -171.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.547 ' H ' ' HD1' ' A' ' 23' ' ' TRP . 1.1 tm-20 53.78 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.796 0.838 . . . . 0.0 110.845 -173.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' O ' HG12 ' A' ' 26' ' ' VAL . 9.3 mtt180 -114.6 -2.04 13.21 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.092 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.45 13.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.833 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.26 -55.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.58 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.4 -5.03 32.49 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.09 -171.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.538 HG12 ' HB3' ' A' ' 24' ' ' GLU . 6.9 m 31.26 78.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.997 0.919 . . . . 0.0 113.295 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 41.76 0.35 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.73 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -136.2 -58.29 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 119.906 -1.14 . . . . 0.0 113.47 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 9' ' ' VAL . 5.7 mm -28.83 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.392 1.077 . . . . 0.0 113.118 -176.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -142.77 -126.95 2.11 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.301 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.559 HG21 HG11 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -95.95 22.61 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.761 0.315 . . . . 0.0 110.677 -175.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.87 54.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.716 -178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 0.4 OUTLIER 64.86 -126.79 0.38 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 122.347 1.07 . . . . 0.0 111.964 170.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.73 ' ND2' ' HA3' ' A' ' 31' ' ' GLY . 3.6 t-20 -146.77 36.13 0.95 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.102 -1.863 . . . . 0.0 107.201 -178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 41.88 -99.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.203 -168.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.989 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -125.78 42.13 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.502 . . . . 0.0 111.929 -177.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -150.97 61.69 0.92 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.932 178.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.472 HD11 ' HE1' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -100.76 -59.4 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.417 -179.11 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' ILE . . . -133.69 84.11 0.29 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.23 -0.51 . . . . 0.0 111.885 -175.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 147.75 -118.57 1.01 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 12.4 p-80 56.51 -24.81 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.496 1.518 . . . . 0.0 114.59 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 43' ' ' GLY . 5.9 p -94.62 -85.82 0.3 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.62 -17.23 62.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.75 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 9.1 mmtm 59.66 59.95 2.38 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.425 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 175.49 -2.04 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.599 -172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.498 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 34.8 mmm -55.07 -37.51 66.86 Favored 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 120.662 0.268 . . . . 0.0 111.017 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.552 ' HA ' ' HZ3' ' A' ' 23' ' ' TRP . . . -70.27 -40.99 74.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.078 0.466 . . . . 0.0 109.93 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.652 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 59.9 t -60.14 -21.84 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.622 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.751 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -108.91 -6.18 15.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.383 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -92.99 -47.19 7.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.441 ' OE1' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -113.32 -56.11 2.44 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 120.997 0.427 . . . . 0.0 109.884 -178.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 2.8 t -53.27 -45.62 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.333 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.751 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 19.0 t-160 -36.4 -56.91 0.77 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -122.84 3.24 9.46 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.408 -0.517 . . . . 0.0 112.199 -171.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 57' ' ' ARG . 73.8 mm-40 -119.93 -25.69 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.894 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.767 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 25.9 m-85 -125.49 -41.81 2.0 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.226 -172.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -12.6 59.53 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 120.737 0.303 . . . . 0.0 110.836 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.5 t -53.27 -31.95 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 168.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.24 -81.82 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.709 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -124.34 131.15 24.15 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 120.78 0.324 . . . . 0.0 111.449 -171.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 71.7 Cg_endo -91.52 113.92 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.856 2.371 . . . . 0.0 112.133 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -72.05 -46.76 55.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.182 -177.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.528 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 24.9 mtmt 68.11 -148.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 176.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.617 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.1 t 65.81 39.89 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.332 0.653 . . . . 0.0 112.146 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -171.11 37.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.252 0.549 . . . . 0.0 111.434 176.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.528 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 3.0 p90 -151.13 -51.63 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -97.37 65.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.035 0.445 . . . . 0.0 111.433 -172.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 4.2 pm0 -155.25 129.36 4.71 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.19 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 2.0 Cg_endo -85.64 62.63 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.044 2.496 . . . . 0.0 110.953 173.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.989 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 14.2 t 51.04 51.51 16.9 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 122.755 1.264 . . . . 0.0 112.121 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.625 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.5 mt -130.24 -179.66 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-N 113.593 -1.64 . . . . 0.0 106.981 168.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' H ' HG22 ' A' ' 74' ' ' ILE . 8.7 mtmm -80.57 14.7 1.95 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.779 0.799 . . . . 0.0 108.862 178.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -61.47 -26.64 68.02 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.086 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.707 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -52.68 -49.86 64.43 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.346 0.593 . . . . 0.0 110.349 176.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.707 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -79.83 -39.9 29.68 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.065 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.85 10.23 2.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.627 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CE1' ' HD3' ' A' ' 84' ' ' ARG . 54.1 t80 -111.08 -59.66 1.94 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 171.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.617 ' HB ' HG22 ' A' ' 67' ' ' VAL . 8.9 t -75.45 -25.62 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.664 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -95.68 0.48 52.68 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.564 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 m -105.13 -42.15 5.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.09 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.416 ' HD3' ' CE1' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -138.78 17.53 2.68 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.807 -176.032 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 C--O 1.253 1.249 0 CA-C-O 118.811 -0.614 . . . . 0.0 111.572 179.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.048 0.451 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.69 61.43 0.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.103 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.33 145.57 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.856 0.36 . . . . 0.0 110.616 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.12 116.99 20.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.34 177.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.72 ' HA ' HG23 ' A' ' 34' ' ' ILE . 11.2 pm0 -69.33 144.55 53.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.866 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.85 -30.53 26.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.879 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.652 ' HG2' ' HA ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -158.21 -36.76 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.397 175.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' A' ' 5' ' ' GLU . 2.4 t80 53.18 58.91 4.81 Favored 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.579 0.55 . . . . 0.0 111.579 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 32' ' ' ILE . 53.7 t 67.02 91.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.586 0.708 . . . . 0.0 110.913 -177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.03 131.52 66.38 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.452 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.29 163.93 36.59 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.809 2.34 . . . . 0.0 112.556 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 m -106.52 -65.78 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 61.5 m-80 -126.94 -89.09 0.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.422 . . . . 0.0 110.925 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.99 -59.66 0.79 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.088 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.91 -40.35 75.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.512 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.466 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 13.0 mp0 -63.7 -46.43 85.53 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.829 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -62.93 -42.24 99.73 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.792 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 3.4 mtpm? -70.03 -40.82 74.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.674 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -68.01 -40.2 83.02 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.324 -0.551 . . . . 0.0 109.738 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -56.51 -38.61 72.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.4 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 14.9 pt-20 -75.96 -26.67 57.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.055 -177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 18' ' ' LYS . 6.7 mt -93.24 -36.8 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.529 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -90.01 -33.37 16.38 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.85 -172.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.847 ' HG2' ' HA ' ' A' ' 29' ' ' VAL . 0.7 OUTLIER 58.01 -66.36 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.052 0.941 . . . . 0.0 111.674 -174.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.788 ' HB2' ' H ' ' A' ' 30' ' ' SER . 6.6 ttt85 -135.21 2.86 3.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.245 176.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.9 OUTLIER 54.65 20.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 -56.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.733 -0.605 . . . . 0.0 111.857 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -122.05 13.85 9.03 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.974 -173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.847 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 39.96 73.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.781 0.832 . . . . 0.0 112.697 177.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.788 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -158.28 59.7 0.45 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.718 177.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -124.84 -16.3 3.02 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.876 -172.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.476 ' HA ' HG23 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -97.2 82.93 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 178.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.58 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -116.41 43.67 1.61 Allowed Glycine 0 C--O 1.225 -0.463 0 C-N-CA 119.857 -1.163 . . . . 0.0 114.022 -167.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.72 HG23 ' HA ' ' A' ' 5' ' ' GLU . 8.0 mm 79.03 -20.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.986 0.898 . . . . 0.0 110.09 176.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.652 ' HA ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -147.5 42.07 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.846 -172.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' OD1' ' HG3' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 61.53 -143.22 0.45 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.083 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.59 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -127.54 36.75 4.33 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.409 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 41.51 -102.24 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.735 -173.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 1.088 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 6.0 m-85 -132.51 49.0 2.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.856 0.36 . . . . 0.0 111.012 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.75 57.99 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.893 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 37' ' ' ASN . 3.3 tt -101.43 -33.12 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.859 -174.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.712 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -122.74 -55.45 0.2 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.699 -174.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . -77.31 -99.61 0.18 Allowed Glycine 0 C--O 1.222 -0.594 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.554 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 60.23 -44.53 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.597 1.559 . . . . 0.0 114.52 173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.9 p -97.19 -73.97 0.59 Allowed 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HB3' ' HG2' ' A' ' 49' ' ' MET . 13.2 tp -75.1 -19.86 59.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.082 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 10.8 mmtp 56.11 54.36 7.96 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.903 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.82 -17.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.465 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.441 ' HG2' ' H ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -53.78 -34.86 60.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.75 0.31 . . . . 0.0 111.432 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.54 -29.77 52.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.97 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.2 t -66.25 -29.82 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -92.61 -19.39 21.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.099 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 -49.9 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.811 -177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -122.45 -47.13 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.153 -177.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' A' ' 60' ' ' GLN . 36.7 t -55.05 -47.69 76.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.064 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.712 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 20.9 t-160 -41.23 -48.36 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.592 0.757 . . . . 0.0 112.826 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.402 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -118.86 5.74 11.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -170.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 18.1 mm-40 -134.02 -19.33 2.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.598 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 14.1 m-85 -133.72 -44.2 0.81 Allowed 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.386 -174.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.733 ' HB2' HG12 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -62.31 -15.9 50.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.233 0.539 . . . . 0.0 111.201 -178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.6 t -68.91 -31.08 49.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.361 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 5.1 tp10 -129.08 -76.6 0.55 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.209 -174.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -117.4 117.74 36.13 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HG3' HE22 ' A' ' 60' ' ' GLN . 82.2 Cg_exo -47.21 -48.91 13.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.741 2.961 . . . . 0.0 113.895 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 61.72 -90.65 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.492 0.495 . . . . 0.0 110.933 -178.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.461 ' HG2' HG22 ' A' ' 51' ' ' VAL . 72.2 mttt 61.75 -124.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.046 0.538 . . . . 0.0 111.105 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 63.35 49.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 122.991 0.516 . . . . 0.0 111.219 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 1.9 pt? -174.03 39.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.399 0.619 . . . . 0.0 112.059 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' A' ' 70' ' ' ALA . 4.4 p90 -151.45 -54.93 0.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.403 -0.811 . . . . 0.0 112.43 -172.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -100.25 75.97 1.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.915 0.388 . . . . 0.0 111.428 -173.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.557 ' HG3' ' HB3' ' A' ' 39' ' ' PHE . 3.8 pm0 -162.23 139.78 6.46 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.824 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HG2' HD12 ' A' ' 74' ' ' ILE . 85.1 Cg_endo -88.64 46.78 1.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.154 2.569 . . . . 0.0 112.563 176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 1.088 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER 60.55 39.61 17.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.223 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.549 HD12 ' HG2' ' A' ' 72' ' ' PRO . 7.2 mt -139.96 48.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 122.304 -0.247 . . . . 0.0 110.562 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.7 pttt 46.71 23.8 0.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.221 1.008 . . . . 0.0 112.502 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -72.41 -15.53 61.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.759 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.67 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -59.38 -44.38 92.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.312 0.577 . . . . 0.0 110.003 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.67 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -72.3 -43.43 64.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.814 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -75.47 5.18 6.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.796 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -104.2 -62.49 1.31 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.6 t -71.73 -31.73 42.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.394 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.3 2.61 50.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.94 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.4 m -106.86 -38.2 6.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.025 0.441 . . . . 0.0 109.934 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -84.56 -60.71 1.99 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.25 1.124 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.608 -179.861 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.214 0.53 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 3' ' ' VAL . . . -153.34 -147.83 4.73 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 2' ' ' GLY . 2.8 p 170.83 -30.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.043 0.449 . . . . 0.0 110.394 177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.846 HG23 ' H ' ' A' ' 6' ' ' ALA . 0.4 OUTLIER -154.93 138.82 16.28 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.085 0.469 . . . . 0.0 110.081 -177.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 17.11 10.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.018 0.437 . . . . 0.0 110.739 -176.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.846 ' H ' HG23 ' A' ' 4' ' ' THR . . . -83.62 -33.41 25.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.144 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -81.0 -24.21 38.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.366 0.603 . . . . 0.0 109.684 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.49 109.01 5.18 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.201 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 32' ' ' ILE . 62.1 t 70.25 -71.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.675 0.609 . . . . 0.0 111.756 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 69.71 81.55 0.19 Allowed Pre-proline 0 N--CA 1.465 0.289 0 C-N-CA 123.373 0.669 . . . . 0.0 110.967 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.553 ' HB3' ' CB ' ' A' ' 17' ' ' SER . 34.3 Cg_exo -58.98 154.64 43.45 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.134 2.556 . . . . 0.0 112.036 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -86.97 -65.84 0.97 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.537 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.2 m-80 -128.53 -83.91 0.58 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.38 174.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.91 -49.84 0.22 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.447 0.642 . . . . 0.0 109.298 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.76 -45.74 91.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.691 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.537 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 34.6 mp0 -67.42 -43.01 82.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.611 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.553 ' CB ' ' HB3' ' A' ' 11' ' ' PRO . 0.9 OUTLIER -54.49 -52.95 60.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.284 175.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -59.92 -44.64 94.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -40.87 89.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.023 -177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.01 -42.82 73.02 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.502 0.501 . . . . 0.0 110.977 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 17' ' ' SER . 2.1 pt-20 -83.19 -14.24 53.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.315 -177.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.0 mm -91.31 -39.28 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.082 0.468 . . . . 0.0 112.086 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -93.14 -29.53 15.7 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -176.231 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.4 tp10 59.74 -64.06 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.409 1.084 . . . . 0.0 111.705 -175.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.623 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -141.1 5.15 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.592 0.234 . . . . 0.0 110.374 170.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG12 HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER 63.45 -5.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.622 1.169 . . . . 0.0 113.885 176.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD23 HG12 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -140.1 -60.78 0.53 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.855 0.359 . . . . 0.0 111.2 -179.184 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -112.86 7.45 25.69 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.762 -175.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 24' ' ' GLU . 12.4 m 36.22 76.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.623 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -155.78 57.77 0.61 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.13 0.491 . . . . 0.0 110.009 179.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . -125.39 -50.75 0.18 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.475 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 ' CG2' ' A' ' 9' ' ' VAL . 49.3 mm -60.6 108.28 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.527 0.68 . . . . 0.0 111.086 -173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -159.93 -163.59 13.75 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 110.514 -1.035 . . . . 0.0 110.514 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.476 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -76.24 14.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.845 0.355 . . . . 0.0 111.511 -175.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.68 7.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.497 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.491 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 51.08 -127.07 2.39 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.103 0.954 . . . . 0.0 111.753 -176.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -128.55 26.22 5.66 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.091 -176.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.84 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 O-C-N 124.552 1.158 . . . . 0.0 111.291 -174.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.496 ' O ' ' HG2' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -135.21 51.54 2.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.044 0.449 . . . . 0.0 110.768 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -154.72 51.53 0.63 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.982 0.42 . . . . 0.0 111.009 176.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.1 tt -106.35 -15.28 8.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.345 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.52 45.64 0.46 Allowed Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.371 -0.918 . . . . 0.0 112.83 -174.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -169.36 -123.73 0.69 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.846 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.747 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 13.5 p-80 58.82 -47.89 0.06 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 126.061 1.744 . . . . 0.0 114.346 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -96.01 -68.9 0.78 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.302 0.573 . . . . 0.0 110.272 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 48' ' ' ALA . 18.0 tp -78.73 -18.22 54.6 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.092 175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp 48.47 52.38 13.75 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . . . 173.74 10.56 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.97 -171.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.1 mmt -64.24 -39.27 93.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.364 0.602 . . . . 0.0 109.449 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.84 -30.55 45.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.45 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 11.0 t -63.95 -28.23 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.109 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -99.15 -18.74 17.53 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.924 0.392 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.55 -51.95 15.17 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.09 -177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -124.89 -41.35 2.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.366 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.958 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 66.4 t -58.56 -52.73 56.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.2 -174.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.3 t60 -54.91 -38.98 68.31 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.421 ' H ' ' HG3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -109.39 -4.84 16.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -168.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -142.9 -11.07 0.77 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -173.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.958 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 10.5 m-85 -124.88 -48.01 1.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.79 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -62.7 -18.84 63.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.019 0.437 . . . . 0.0 110.918 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.4 -32.87 57.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.268 175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.89 -74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.873 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.11 127.91 15.05 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.74 0.305 . . . . 0.0 110.731 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.93 118.58 5.76 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.539 2.159 . . . . 0.0 112.09 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -90.99 -63.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.605 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 4.6 mtpt 64.15 -132.75 0.34 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 122.7 0.4 . . . . 0.0 111.375 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.986 HG22 HG21 ' A' ' 81' ' ' VAL . 0.2 OUTLIER 60.12 33.34 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.483 0.713 . . . . 0.0 112.599 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.677 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -170.27 46.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.444 0.64 . . . . 0.0 112.37 178.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 3.8 p90 -156.33 -47.78 0.07 Allowed 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.418 -0.801 . . . . 0.0 112.752 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.42 50.9 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.196 0.522 . . . . 0.0 111.686 -172.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.509 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.74 132.72 4.2 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.706 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.747 ' HA ' ' HB3' ' A' ' 44' ' ' HIS . 31.5 Cg_endo -69.21 -40.67 5.86 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.169 1.913 . . . . 0.0 111.278 174.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 8.8 t 168.27 45.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 123.427 1.584 . . . . 0.0 108.208 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 75' ' ' LYS . 1.9 mt -118.97 176.97 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 CA-C-N 112.628 -2.078 . . . . 0.0 107.482 174.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -81.66 17.28 1.49 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.25 -25.49 68.35 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.891 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.789 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.98 -44.63 96.34 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.421 . . . . 0.0 110.911 176.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.789 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.22 -41.52 49.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.175 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -29.8 70.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.312 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -73.77 -48.15 33.76 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.133 -178.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.986 HG21 HG22 ' A' ' 67' ' ' VAL . 1.2 t -73.99 -24.86 19.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.67 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.242 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.9 m -82.91 -32.29 27.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.39 177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -92.32 6.14 47.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.7 176.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 84' ' ' ARG . 2.1 m . . . . . 0 C--O 1.25 1.11 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.621 172.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.06 177.77 43.84 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.185 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.15 -36.51 12.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.882 0.373 . . . . 0.0 111.265 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -150.89 146.9 26.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.737 -178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.739 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 11.8 mp0 -117.49 5.86 12.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.48 65.18 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.06 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -114.63 -10.68 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 177.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.739 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 79.3 t80 -65.27 119.07 10.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.062 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 32' ' ' ILE . 3.4 t 56.74 51.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -169.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -38.96 116.78 1.01 Allowed Pre-proline 0 N--CA 1.464 0.247 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.988 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.21 151.09 20.47 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.759 2.306 . . . . 0.0 112.217 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.1 -74.63 0.61 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.943 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.7 m-80 -128.92 39.94 3.71 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.1 -57.53 0.42 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.165 0.586 . . . . 0.0 111.294 -177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.22 -47.93 91.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.178 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 -44.04 97.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.995 178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.08 -44.86 87.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.152 0.501 . . . . 0.0 111.15 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.559 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.6 ttpp -64.25 -40.87 96.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.349 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.94 -44.12 93.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.497 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -53.4 -43.76 68.16 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.554 0.533 . . . . 0.0 110.943 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 32' ' ' ILE . 9.3 pt-20 -81.8 -13.8 57.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.666 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 18' ' ' LYS . 44.9 mm -102.7 -16.62 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 112.025 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.553 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -111.3 -32.67 6.66 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.217 -179.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.773 ' HG3' HG12 ' A' ' 32' ' ' ILE . 6.0 tt0 61.22 -66.45 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.983 0.913 . . . . 0.0 111.801 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.797 ' HB2' ' H ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -137.81 2.09 2.36 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.65 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 67.25 -15.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.139 . . . . 0.0 113.308 178.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -136.14 -53.53 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.048 0.452 . . . . 0.0 111.074 -175.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.45 4.18 32.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.175 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.576 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 3.3 m 34.77 74.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 O-C-N 124.949 1.029 . . . . 0.0 112.927 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.797 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -156.94 61.43 0.52 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.886 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.714 ' H ' ' HG2' ' A' ' 24' ' ' GLU . . . -121.61 -46.78 0.31 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.665 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.773 HG12 ' HG3' ' A' ' 24' ' ' GLU . 41.1 mm -44.47 121.61 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.262 0.625 . . . . 0.0 112.565 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -163.91 -161.18 12.63 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.78 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' H ' HG13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -66.47 -5.86 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.008 0.523 . . . . 0.0 111.607 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -171.53 38.18 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 175.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 2.5 m-20 45.08 -121.27 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.39 -1.732 . . . . 0.0 111.394 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.619 ' ND2' ' HA2' ' A' ' 31' ' ' GLY . 1.8 m-20 -112.83 41.2 2.11 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HD2' ' CG2' ' A' ' 73' ' ' THR . 0.0 OUTLIER 42.02 -93.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.411 1.069 . . . . 0.0 111.404 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.719 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.4 59.61 1.71 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.5 ' HB2' ' NE2' ' A' ' 44' ' ' HIS . 2.0 pt20 -164.32 66.64 0.15 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.25 0.547 . . . . 0.0 110.704 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -111.27 -32.45 2.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.581 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.44 86.66 0.14 Allowed Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.48 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.735 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 168.84 -126.67 1.41 Allowed Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.405 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 40' ' ' GLN . 1.6 m80 66.28 -54.14 0.4 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 177.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -72.57 -74.09 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.338 0.59 . . . . 0.0 109.9 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.563 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 7.4 tp -93.73 -10.21 35.1 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.172 173.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.651 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.9 mmtp 55.53 67.65 0.98 Allowed 'General case' 0 C--N 1.343 0.313 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.139 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 173.19 1.97 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.128 -174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.735 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 7.6 mmm -61.13 -34.11 74.47 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 -177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.44 65.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.413 0.625 . . . . 0.0 109.976 176.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 58.5 t -63.29 -24.13 35.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.317 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.601 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -104.99 -12.21 16.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.489 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.68 -51.11 6.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.448 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -116.16 -35.94 4.22 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.718 -174.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.948 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 58.8 t -70.08 -40.94 78.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.342 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.601 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 6.8 t-160 -44.2 -52.2 7.59 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.996 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -129.79 13.97 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -171.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 65.8 mm-40 -135.85 -7.8 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.834 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.948 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 2.4 m-85 -134.46 -42.16 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.875 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -21.54 64.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.8 t -58.1 -32.05 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.922 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.69 -80.67 0.63 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.73 135.81 18.15 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.265 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.449 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 73.8 Cg_endo -82.01 115.86 2.72 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.331 2.021 . . . . 0.0 112.011 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -81.29 -40.27 23.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.422 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 4.5 mtmt 58.25 -120.64 1.21 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.391 0.432 . . . . 0.0 110.898 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.564 ' H ' HG21 ' A' ' 81' ' ' VAL . 15.9 m 48.37 25.56 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 125.208 1.403 . . . . 0.0 114.573 176.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.547 HD23 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -173.19 66.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 0.0 111.887 177.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' A' ' 66' ' ' LYS . 5.3 p90 -162.98 -47.69 0.04 OUTLIER 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.096 0.474 . . . . 0.0 110.692 -176.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.651 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -99.33 84.53 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.907 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.873 HE21 HD23 ' A' ' 77' ' ' LEU . 0.6 OUTLIER -158.75 148.96 15.47 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 71' ' ' GLN . 58.5 Cg_endo -100.34 40.24 0.07 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 124.014 3.143 . . . . 0.0 111.403 168.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.496 ' H ' ' HG2' ' A' ' 71' ' ' GLN . 0.2 OUTLIER 55.52 55.37 7.37 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.767 -177.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.543 HG22 ' HG2' ' A' ' 75' ' ' LYS . 4.3 mt -134.38 -103.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -139.68 16.23 2.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.233 0.539 . . . . 0.0 110.261 175.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -64.82 -32.14 73.7 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.77 -175.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.873 HD23 HE21 ' A' ' 71' ' ' GLN . 0.2 OUTLIER -59.14 -44.64 92.07 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.408 0.623 . . . . 0.0 110.523 178.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.685 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -74.74 -43.44 54.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.255 -176.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -27.49 66.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.301 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.539 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.2 t80 -66.86 -53.4 32.85 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.418 0.628 . . . . 0.0 109.383 178.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.564 HG21 ' H ' ' A' ' 67' ' ' VAL . 99.1 t -71.28 -23.19 22.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.643 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.41 -0.04 39.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.48 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.6 m -95.86 -42.41 8.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.972 0.415 . . . . 0.0 109.932 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.34 -45.38 14.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.241 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.528 -178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.85 168.72 14.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.691 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.89 166.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.029 0.442 . . . . 0.0 110.699 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 t -151.55 163.65 38.57 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 3.6 tt0 -139.41 18.44 2.56 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.235 0.541 . . . . 0.0 110.21 173.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.52 -58.47 3.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.876 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.736 ' O ' ' HA ' ' A' ' 35' ' ' LEU . 9.0 pt20 -100.01 -16.56 17.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.67 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' HB3' ' HA ' ' A' ' 5' ' ' GLU . 1.6 t80 -69.46 121.23 16.58 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.79 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 2.0 t 56.63 49.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -169.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.74 109.71 1.09 Allowed Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 114.624 -1.171 . . . . 0.0 113.26 -177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -95.59 165.49 1.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.383 2.722 . . . . 0.0 111.837 175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' HB ' ' CD ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -119.02 -69.66 0.84 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.282 174.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB2' ' OE1' ' A' ' 16' ' ' GLU . 57.9 m-80 -124.55 -86.9 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.491 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.68 -49.64 0.48 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.0 t -60.54 -43.94 95.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.785 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 13' ' ' ASN . 8.9 mp0 -67.68 -48.82 65.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.023 -176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.89 -41.79 92.37 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.91 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -46.69 88.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.593 178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -60.34 -48.96 79.5 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.826 179.422 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.08 -40.25 57.93 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 123.544 0.527 . . . . 0.0 111.622 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -87.0 -12.54 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.325 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 22' ' ' ILE . 4.1 mm -95.42 -38.77 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.957 0.408 . . . . 0.0 111.931 -177.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.5 OUTLIER -101.52 -29.82 11.76 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.602 0.594 . . . . 0.0 112.602 -174.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.78 ' HB3' HG12 ' A' ' 29' ' ' VAL . 2.2 tt0 57.37 -68.06 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.011 0.924 . . . . 0.0 111.496 -171.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -130.6 2.59 4.53 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 175.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 64.55 0.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.308 1.043 . . . . 0.0 113.586 177.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -146.14 -57.76 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.15 -0.344 . . . . 0.0 111.367 -179.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -110.67 -1.0 29.09 Favored Glycine 0 CA--C 1.502 -0.725 0 C-N-CA 120.375 -0.917 . . . . 0.0 111.964 -172.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 39.35 67.82 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.337 0.655 . . . . 0.0 112.393 -178.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.65 60.04 0.68 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.958 176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.628 ' HA3' HD21 ' A' ' 37' ' ' ASN . . . -127.76 -15.26 2.41 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.238 -174.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.639 HG23 HG22 ' A' ' 9' ' ' VAL . 43.2 mm -71.8 83.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.009 0.433 . . . . 0.0 110.1 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.52 -85.66 1.87 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.938 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -136.95 -5.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.242 0.544 . . . . 0.0 110.731 177.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.736 ' HA ' ' O ' ' A' ' 7' ' ' GLN . 0.4 OUTLIER -167.53 43.56 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.897 -178.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.79 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m-20 49.63 -129.04 2.11 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.705 -173.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.637 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 61.9 m-80 -116.54 27.06 9.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 40.92 -91.79 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 O-C-N 124.113 0.883 . . . . 0.0 111.744 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.641 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -132.83 40.81 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.258 0.551 . . . . 0.0 111.696 -179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -138.72 52.59 1.79 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.712 174.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.437 HG12 ' CZ2' ' A' ' 23' ' ' TRP . 3.9 tt -110.78 -28.1 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -171.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -144.66 45.99 0.83 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.983 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 69' ' ' PHE . . . -179.34 -103.0 0.17 Allowed Glycine 0 C--O 1.221 -0.694 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.755 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' GLN . 4.8 p-80 59.96 -50.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.223 1.809 . . . . 0.0 113.898 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 p -106.06 -68.31 0.88 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.7 tp -74.22 -25.93 59.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.89 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.859 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 7.0 mmtp 53.24 63.66 2.14 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.9 -177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -178.0 -12.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.242 -174.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.443 ' H ' ' HG2' ' A' ' 49' ' ' MET . 31.1 mmm -52.82 -42.46 65.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.489 0.185 . . . . 0.0 111.242 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.564 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -77.76 -29.59 51.1 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.229 0.538 . . . . 0.0 110.556 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 16.0 t -62.65 -29.1 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.971 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.91 -20.78 15.97 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.664 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.2 -51.78 12.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.038 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 4.7 pm0 -120.93 -38.03 2.89 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.143 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 30.2 t -64.62 -41.86 93.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.312 -174.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -40.41 -59.36 1.34 Allowed 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -132.14 18.41 4.51 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -174.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 9.5 mm-40 -130.16 -6.4 4.36 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.829 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 40.0 m-85 -137.83 -54.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.567 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -19.0 65.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.792 0.33 . . . . 0.0 111.337 -174.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -61.29 -34.94 62.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.325 174.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.69 -73.51 0.64 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.957 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.58 113.95 9.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.947 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.66 127.23 15.15 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.664 2.243 . . . . 0.0 111.615 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 -58.21 2.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.653 -177.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 14.1 mttt 62.35 -134.49 0.5 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.421 0.288 . . . . 0.0 110.98 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 t 60.73 27.38 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.553 0.741 . . . . 0.0 111.892 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -170.14 62.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 111.524 177.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.579 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 5.6 p90 -165.84 -50.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.705 -176.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.859 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -87.83 45.24 1.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.065 0.46 . . . . 0.0 111.609 -173.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 76' ' ' ALA . 3.8 pm0 -154.12 143.2 14.84 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.137 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB3' ' A' ' 40' ' ' GLN . 23.8 Cg_exo -64.7 -56.47 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.313 2.009 . . . . 0.0 110.853 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 72' ' ' PRO . 9.8 t 170.72 48.37 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.817 0.818 . . . . 0.0 109.898 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' HB ' ' H ' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -125.55 -106.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.576 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' H ' ' HB ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -141.21 13.69 2.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.059 0.456 . . . . 0.0 110.531 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' GLN . . . -63.99 -26.66 68.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.216 -175.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.74 HD12 ' H ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -55.7 -48.31 75.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.551 174.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.74 ' H ' HD12 ' A' ' 77' ' ' LEU . . . -71.14 -43.77 66.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.164 -178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.24 0.06 12.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.238 0.542 . . . . 0.0 111.403 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 2.5 t80 -100.46 -63.31 1.14 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 172.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.5 t -71.81 -28.67 31.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.596 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -95.54 10.08 37.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 0.0 110.488 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.1 m -120.11 -35.38 3.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.485 173.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 0.8 OUTLIER -75.23 -16.24 60.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.015 0.436 . . . . 0.0 110.632 177.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.653 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.832 0.349 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.35 -178.19 48.3 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.82 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p -142.06 131.88 23.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.294 0.568 . . . . 0.0 110.86 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.57 126.05 34.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 121.712 0.768 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' HB3' ' A' ' 8' ' ' TYR . 4.4 pt-20 -96.34 44.95 1.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.185 -177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.02 -31.38 66.14 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.183 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -17.77 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.644 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 45.1 t80 -74.73 116.71 15.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 21' ' ' GLU . 4.7 t 56.53 55.73 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.682 0.753 . . . . 0.0 109.276 -168.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -49.62 126.91 18.2 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.078 178.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 17.4 Cg_exo -68.29 138.58 43.35 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.063 2.508 . . . . 0.0 112.32 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.603 ' OG1' ' HB3' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -103.94 -73.98 0.66 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.791 0.329 . . . . 0.0 110.345 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -137.01 45.61 2.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.054 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 67.21 -69.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.246 0.619 . . . . 0.0 111.165 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -55.39 -48.76 76.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.603 ' HB3' ' OG1' ' A' ' 12' ' ' THR . 0.0 OUTLIER -64.49 -34.95 79.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.542 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.08 -45.14 94.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.124 0.488 . . . . 0.0 110.526 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 18.2 ttpt -64.76 -40.96 96.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.377 178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -67.0 -34.29 77.42 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.533 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.669 ' HA ' ' CD1' ' A' ' 23' ' ' TRP . . . -58.41 -44.52 89.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.872 0.368 . . . . 0.0 110.657 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.4 pt-20 -79.29 -14.17 59.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 18' ' ' LYS . 2.2 mm -118.22 32.32 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.685 0.279 . . . . 0.0 111.719 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.669 ' CD1' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -144.96 -47.82 0.24 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.724 171.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' CD1' ' A' ' 23' ' ' TRP . 28.1 tt0 60.48 -65.65 0.05 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.058 0.943 . . . . 0.0 112.306 -177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 25' ' ' ARG . 3.5 mtp180 -134.77 -1.76 2.71 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.526 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 63.62 -5.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.378 1.071 . . . . 0.0 113.563 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -142.13 -51.65 0.4 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.048 -0.408 . . . . 0.0 111.102 -178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.65 -14.98 28.24 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.111 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.432 HG12 ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 43.29 72.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 124.423 0.719 . . . . 0.0 112.018 -179.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.3 m -162.51 70.37 0.28 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.563 ' HA3' ' ND2' ' A' ' 37' ' ' ASN . . . -169.94 10.2 0.05 OUTLIER Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.01 -1.091 . . . . 0.0 114.477 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.31 129.74 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 117.949 0.875 . . . . 0.0 110.022 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.19 5.87 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.073 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -79.59 18.95 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 122.401 0.28 . . . . 0.0 111.754 -176.155 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -179.33 42.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 37' ' ' ASN . 7.3 m-20 59.73 -121.47 1.04 Allowed 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.726 ' HB2' HD12 ' A' ' 41' ' ' ILE . 2.4 t-20 -128.82 43.79 3.08 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 42.49 -101.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.147 0.905 . . . . 0.0 111.229 -175.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.614 ' HB3' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -124.49 43.77 2.93 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.04 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 1.1 pt20 -160.8 67.38 0.32 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.039 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB2' ' A' ' 37' ' ' ASN . 0.7 OUTLIER -105.66 -41.05 6.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -177.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 69' ' ' PHE . . . -151.11 89.98 0.13 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.958 -1.115 . . . . 0.0 113.092 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.791 ' HA2' ' HG2' ' A' ' 49' ' ' MET . . . 160.52 -121.93 1.08 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' A' ' 40' ' ' GLN . 0.1 OUTLIER 66.52 -51.99 0.44 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.06 0.944 . . . . 0.0 113.013 174.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 p -84.0 -73.12 0.43 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.296 0.569 . . . . 0.0 110.277 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.498 ' HB3' ' SD ' ' A' ' 49' ' ' MET . 9.5 tp -84.29 -13.19 53.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.457 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.09 ' HD2' ' HA ' ' A' ' 70' ' ' ALA . 17.5 mmtm 51.12 65.28 1.53 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.604 -177.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 176.65 -6.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.307 -171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.791 ' HG2' ' HA2' ' A' ' 43' ' ' GLY . 21.4 mmm -53.42 -37.79 62.88 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.183 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 69' ' ' PHE . . . -74.84 -35.73 62.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.186 0.517 . . . . 0.0 110.596 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.45 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 59.2 t -61.87 -27.52 42.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.211 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.456 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.59 -15.86 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.74 -48.54 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.849 HE22 HD11 ' A' ' 68' ' ' LEU . 10.7 pm0 -127.83 -39.85 1.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.165 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.634 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 39.7 t -58.55 -51.33 73.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.337 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 3.4 t-160 -59.43 -26.62 65.34 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -174.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -115.98 -4.44 12.03 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -172.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -138.12 -19.82 1.12 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.634 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 37.2 m-85 -124.76 -50.43 1.72 Allowed 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.221 -172.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -12.0 21.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.606 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.88 -30.89 43.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.293 0.568 . . . . 0.0 110.051 173.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -122.72 -62.88 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.601 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.58 140.25 14.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.987 -176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.77 154.1 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.517 2.145 . . . . 0.0 111.819 176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.615 ' HG ' ' N ' ' A' ' 66' ' ' LYS . 0.2 OUTLIER -119.23 -42.77 2.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.937 179.243 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.615 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mppt? 63.87 -145.86 0.31 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.587 0.355 . . . . 0.0 111.367 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.0 t 65.6 26.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 176.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.849 HD11 HE22 ' A' ' 54' ' ' GLN . 0.7 OUTLIER -166.33 42.11 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 111.849 174.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.594 ' HE1' ' HB3' ' A' ' 66' ' ' LYS . 5.5 p90 -148.2 -45.42 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.31 -178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.09 ' HA ' ' HD2' ' A' ' 47' ' ' LYS . . . -94.86 53.55 1.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.056 0.455 . . . . 0.0 110.832 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.711 HE21 HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.33 119.15 7.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.99 -176.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' O ' HG23 ' A' ' 73' ' ' THR . 23.4 Cg_exo -65.95 -69.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.478 2.118 . . . . 0.0 111.285 170.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -179.7 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.07 0.948 . . . . 0.0 109.806 175.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.94 38.62 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.458 -171.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 60.34 23.61 13.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.607 0.718 . . . . 0.0 110.172 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 71' ' ' GLN . . . -66.27 -24.77 66.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.734 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.711 HD23 HE21 ' A' ' 71' ' ' GLN . 0.0 OUTLIER -55.1 -48.64 73.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.487 175.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.66 62.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.487 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.47 -6.95 33.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.459 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -100.02 -50.77 3.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.631 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 67' ' ' VAL . 5.8 p -69.47 -23.05 25.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.997 -176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.18 18.66 14.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.233 0.539 . . . . 0.0 110.697 176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.0 m -123.22 -43.99 2.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.269 176.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.464 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -83.19 -76.87 0.26 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.046 173.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.015 0 O-C-N 124.851 1.344 . . . . 0.0 107.795 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.46 171.28 55.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.604 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.65 58.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.135 0.493 . . . . 0.0 110.071 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 107.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.49 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -63.56 126.02 26.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.428 -176.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.18 -41.34 13.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.267 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -110.45 -59.89 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.39 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.738 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 8.5 t80 49.24 82.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.127 -174.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 32' ' ' ILE . 3.3 p 33.94 96.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 124.97 1.419 . . . . 0.0 112.42 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -68.43 115.18 27.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.242 -169.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 17' ' ' SER . 18.0 Cg_endo -95.8 138.73 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.891 3.061 . . . . 0.0 112.586 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -128.12 -71.83 0.64 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.43 60.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.628 -0.429 . . . . 0.0 112.064 -169.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.62 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.6 t -46.87 -47.8 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 122.949 0.5 . . . . 0.0 111.132 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -44.04 74.34 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.556 -176.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.783 ' HB3' ' HB3' ' A' ' 11' ' ' PRO . 0.7 OUTLIER -61.21 -51.96 66.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 111.391 -177.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.592 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -63.87 -38.48 91.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.771 -178.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.6 -44.92 76.92 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.568 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -55.42 -38.36 68.86 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.453 0.471 . . . . 0.0 111.611 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -86.73 -19.2 29.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.813 0.34 . . . . 0.0 110.67 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' HB ' ' O ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -90.08 -29.52 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -174.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -102.68 -27.86 12.47 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.73 -176.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HG2' ' HB ' ' A' ' 32' ' ' ILE . 6.8 tm-20 59.71 -79.81 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.943 0.897 . . . . 0.0 110.513 -175.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -115.88 -12.25 11.43 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.838 179.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 25' ' ' ARG . 0.3 OUTLIER 58.01 5.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 124.356 1.035 . . . . 0.0 113.146 -173.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 25' ' ' ARG . 0.3 OUTLIER -136.17 -55.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.798 -0.564 . . . . 0.0 110.876 -178.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -119.79 -13.88 5.91 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 119.782 -1.199 . . . . 0.0 112.771 -177.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' H ' ' HB2' ' A' ' 25' ' ' ARG . 16.5 m 46.44 96.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 122.558 1.17 . . . . 0.0 112.192 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -86.33 -37.97 17.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.253 -174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 24' ' ' GLU . . . 139.13 70.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.676 -1.249 . . . . 0.0 112.842 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.621 HD12 ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -55.31 127.97 14.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.231 0.538 . . . . 0.0 110.206 177.106 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . . . -156.36 -138.82 2.61 Favored Glycine 0 N--CA 1.44 -1.097 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.617 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -70.55 -2.54 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.884 0.328 . . . . 0.0 111.884 -174.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.73 -4.08 11.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 9' ' ' VAL . 5.3 t70 62.03 -142.03 0.44 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.733 ' HB2' HD12 ' A' ' 41' ' ' ILE . 3.2 m-80 -135.41 23.99 3.46 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 39.2 -97.11 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.489 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.965 ' HB2' ' HA ' ' A' ' 73' ' ' THR . 27.8 m-85 -122.22 37.32 4.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.995 0.426 . . . . 0.0 111.043 -177.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -155.56 63.59 0.6 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.0 0.429 . . . . 0.0 110.804 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.733 HD12 ' HB2' ' A' ' 37' ' ' ASN . 1.2 tt -108.76 -21.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.207 0.527 . . . . 0.0 111.041 -176.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.664 ' HA3' ' HB2' ' A' ' 50' ' ' ALA . . . -158.83 96.9 0.16 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.636 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' A' ' 49' ' ' MET . . . 124.11 -117.7 3.2 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.596 -178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.537 ' HA ' ' HD3' ' A' ' 47' ' ' LYS . 16.4 p-80 56.89 -26.04 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.196 1.399 . . . . 0.0 114.501 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 43' ' ' GLY . 1.2 p -89.4 -75.04 0.45 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.117 0.484 . . . . 0.0 109.909 175.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.573 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.0 OUTLIER -83.35 -11.77 57.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.994 174.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 15.0 mmtp 57.23 64.32 1.65 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.467 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' H ' ' H ' ' A' ' 49' ' ' MET . . . 174.81 -9.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.774 -175.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.573 ' HG2' HD23 ' A' ' 46' ' ' LEU . 4.7 mmt -50.32 -42.51 52.87 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.601 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.664 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . . . -75.21 -30.11 60.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.829 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 53.3 t -64.28 -27.41 42.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.029 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -101.32 -21.38 14.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.889 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.463 ' HB3' ' HZ3' ' A' ' 23' ' ' TRP . . . -77.16 -46.61 22.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.309 -175.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.534 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -120.78 -50.37 2.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.493 -178.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 53.9 t -52.1 -45.69 42.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.234 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 14.4 t-160 -39.63 -56.84 1.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 O-C-N 123.902 0.752 . . . . 0.0 112.753 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' H ' ' HG2' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -114.02 1.61 14.71 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 0.3 OUTLIER -116.27 -23.34 8.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -134.12 -42.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.533 -173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -16.93 55.04 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.703 0.287 . . . . 0.0 111.371 -177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.97 -36.09 60.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.388 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -121.06 -70.42 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.674 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -138.03 117.72 9.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.91 -179.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 63' ' ' LEU . 10.2 Cg_exo -69.73 121.56 8.25 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.522 2.148 . . . . 0.0 111.442 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -54.14 4.18 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.843 -176.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 69' ' ' PHE . 0.5 OUTLIER 64.92 -116.68 0.38 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.492 -177.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.624 HG22 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER 57.96 27.54 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.5 0.72 . . . . 0.0 112.557 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.4 69.71 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 111.132 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.1 p90 -165.22 -45.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.694 -177.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -94.71 51.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.129 0.49 . . . . 0.0 111.16 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 77' ' ' LEU . 3.1 pm0 -160.27 136.03 6.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.511 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.415 ' O ' ' HB ' ' A' ' 73' ' ' THR . 60.1 Cg_endo -79.85 -36.09 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.159 1.906 . . . . 0.0 111.736 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.965 ' HA ' ' HB2' ' A' ' 39' ' ' PHE . 10.1 t 171.22 51.0 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 122.907 1.336 . . . . 0.0 109.541 -177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' C ' ' H ' ' A' ' 76' ' ' ALA . 6.2 mt -133.33 162.24 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.667 177.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.36 22.97 0.07 Allowed 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 172.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.584 ' H ' ' C ' ' A' ' 74' ' ' ILE . . . -65.41 -27.73 68.75 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.726 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.7 -39.9 86.14 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.947 177.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.599 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.41 -44.98 33.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.25 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' O ' ' HB ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -66.45 -18.04 65.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.612 -176.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.98 -53.24 5.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.612 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.624 HG21 HG22 ' A' ' 67' ' ' VAL . 25.7 t -72.58 -34.53 48.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.965 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.71 -31.3 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 110.425 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -88.6 -6.18 57.69 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.267 178.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 67.17 26.02 8.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.649 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 C--O 1.251 1.145 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.085 176.303 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.29 165.9 23.01 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.501 -178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 34' ' ' ILE . 14.6 p -71.83 142.22 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.016 0.436 . . . . 0.0 111.103 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -86.3 137.55 32.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.701 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 8' ' ' TYR . 22.1 mp0 -70.61 87.04 0.66 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.141 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.1 -69.69 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.4 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.404 ' OE1' ' HB3' ' A' ' 35' ' ' LEU . 1.2 mt-30 -94.72 -52.25 4.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.667 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 30.1 t80 56.21 89.8 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.557 -173.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.591 ' HA ' ' OD1' ' A' ' 36' ' ' ASP . 0.8 OUTLIER 63.83 117.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.06 -166.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.17 109.05 54.65 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.554 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.81 115.92 3.68 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.796 2.331 . . . . 0.0 111.693 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -55.51 3.98 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.193 0.52 . . . . 0.0 109.854 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -128.04 -101.55 0.34 Allowed 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.98 -45.56 0.65 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 173.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.89 -46.55 96.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.488 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -63.44 -44.64 93.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.123 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -48.7 79.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.283 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 22' ' ' ILE . 2.5 mtpm? -61.5 -41.52 97.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mp -66.18 -44.09 85.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.251 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.547 ' HA ' ' NE1' ' A' ' 23' ' ' TRP . . . -50.81 -43.41 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.612 0.57 . . . . 0.0 111.346 -178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -80.78 -23.84 39.02 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.667 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 18' ' ' LYS . 40.3 mm -90.72 -32.32 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.646 ' HD1' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -95.13 -30.08 14.23 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.929 -176.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.646 ' N ' ' HD1' ' A' ' 23' ' ' TRP . 0.9 OUTLIER 59.22 -64.65 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.511 1.124 . . . . 0.0 112.309 -175.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.94 -1.57 2.43 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.789 HG12 HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER 68.28 -14.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.254 1.022 . . . . 0.0 112.954 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.789 HD23 HG12 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -138.71 -57.53 0.62 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -97.76 -1.24 58.79 Favored Glycine 0 CA--C 1.5 -0.883 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' C ' ' HG2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 35.21 50.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 113.999 -1.1 . . . . 0.0 112.978 -179.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 m -149.35 57.31 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.371 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' H ' ' HG3' ' A' ' 24' ' ' GLU . . . -133.05 -5.05 3.16 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.883 -175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.488 HG23 HG12 ' A' ' 9' ' ' VAL . 5.2 mm -76.18 108.98 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 117.736 0.768 . . . . 0.0 109.975 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.74 -153.42 7.83 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.415 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.6 OUTLIER -70.91 -1.06 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -174.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' HB3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -167.9 51.32 0.06 Allowed 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.591 ' OD1' ' HA ' ' A' ' 9' ' ' VAL . 12.9 m-20 60.37 -135.66 0.7 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 -176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.543 ' HA ' HD22 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -104.12 46.75 0.9 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.403 ' HB2' ' H ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER 44.81 -98.75 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 124.284 0.99 . . . . 0.0 109.908 -168.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.618 ' CD2' ' HA ' ' A' ' 73' ' ' THR . 0.0 OUTLIER -136.26 50.48 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 110.349 175.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -150.78 45.32 0.85 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.673 172.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 36' ' ' ASP . 1.5 tt -90.34 -27.74 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.401 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.34 54.84 0.62 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.606 -173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.722 ' HA2' ' HG3' ' A' ' 49' ' ' MET . . . 179.97 -81.78 0.06 OUTLIER Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 -60.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 125.967 1.707 . . . . 0.0 112.611 170.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.3 p -121.43 -50.13 2.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.472 0.653 . . . . 0.0 109.869 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.656 HD23 ' HG2' ' A' ' 49' ' ' MET . 22.1 tp -68.73 -29.6 68.05 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.268 175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.755 ' HB3' ' HA ' ' A' ' 70' ' ' ALA . 2.1 mmtp 48.76 57.42 6.38 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.632 0.582 . . . . 0.0 111.262 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 179.14 -5.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.934 -173.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.722 ' HG3' ' HA2' ' A' ' 43' ' ' GLY . 7.0 mtp -56.41 -40.62 74.98 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.977 -177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.11 -31.82 44.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.29 0.567 . . . . 0.0 110.244 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.564 ' HA ' ' HB ' ' A' ' 55' ' ' VAL . 10.7 t -62.15 -25.43 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.473 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.616 ' HA ' ' HB2' ' A' ' 56' ' ' HIS . . . -105.48 -16.58 14.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.221 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.72 10.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.105 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 58' ' ' GLU . 8.9 pm0 -128.21 -29.67 2.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.197 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.894 ' HA ' ' HB2' ' A' ' 59' ' ' TYR . 77.8 t -66.05 -36.91 78.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.98 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.616 ' HB2' ' HA ' ' A' ' 52' ' ' ALA . 25.8 t60 -50.45 -51.17 49.17 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -172.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 57' ' ' ARG . 8.4 ptp85 -131.28 12.7 5.07 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.577 -175.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 54' ' ' GLN . 72.6 mm-40 -123.97 -12.88 7.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.282 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.894 ' HB2' ' HA ' ' A' ' 55' ' ' VAL . 6.9 m-85 -127.59 -41.88 1.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.924 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -14.24 36.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.2 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 17.8 t -61.64 -31.51 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.082 173.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.9 -74.74 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.351 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.62 137.05 8.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.656 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -83.54 150.16 13.06 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.699 2.266 . . . . 0.0 112.93 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD23 ' HE2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -84.84 -60.62 2.0 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.343 177.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 67' ' ' VAL . 1.1 mttt 73.72 -141.95 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.692 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 66' ' ' LYS . 1.5 m 57.34 21.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.153 0.981 . . . . 0.0 112.355 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 66' ' ' LYS . 0.7 OUTLIER -159.57 46.37 0.27 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.212 0.529 . . . . 0.0 111.753 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 p90 -148.65 -55.23 0.2 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.111 -0.368 . . . . 0.0 111.317 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.755 ' HA ' ' HB3' ' A' ' 47' ' ' LYS . . . -95.19 60.79 2.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.473 -173.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.937 ' HG3' ' HB3' ' A' ' 77' ' ' LEU . 2.5 pm0 -174.19 150.34 1.55 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.793 -178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 40' ' ' GLN . 5.2 Cg_endo -90.55 -77.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.299 2.666 . . . . 0.0 112.113 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.618 ' HA ' ' CD2' ' A' ' 39' ' ' PHE . 14.3 t -161.97 22.16 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.556 0.693 . . . . 0.0 110.344 -178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 mt -108.54 39.17 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.818 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.69 16.45 5.49 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.081 177.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.694 ' HB3' ' HB2' ' A' ' 71' ' ' GLN . . . -69.63 -28.63 66.07 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.171 -176.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.937 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -56.71 -41.36 77.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.948 0.404 . . . . 0.0 111.231 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.751 ' H ' HD13 ' A' ' 77' ' ' LEU . . . -76.11 -45.61 33.01 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.092 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.75 1.9 11.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.154 -174.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.55 -56.8 2.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.911 0.386 . . . . 0.0 110.671 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.9 -26.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.092 -176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -86.22 3.24 43.87 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.44 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.9 m -101.77 -28.62 12.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.405 0.621 . . . . 0.0 109.978 174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 84' ' ' ARG . 0.0 OUTLIER -79.12 -27.51 42.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.826 177.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.18 -179.118 . . . . . . . . 1 1 . 1 stop_ save_